<?xml version="1.0" encoding="utf-8"?>
<!--
- phpMyAdmin XML Dump
- version 4.5.1
- https://www.phpmyadmin.net
-
- Host: 127.0.0.1
- Generation Time: 2018-10-20 15:06:53
- 服务器版本： 10.1.13-MariaDB
- PHP Version: 5.6.23
-->

<pma_xml_export version="1.0" xmlns:pma="http://www.phpmyadmin.net/some_doc_url/">
    <!--
    - Structure schemas
    -->
    <pma:structure_schemas>
        <pma:database name="bdb8.2copp" collation="utf8_general_ci" charset="utf8">
            <pma:table name="target">
                CREATE TABLE `target` (
                  `TargetID` int(255) NOT NULL AUTO_INCREMENT,
                  `TargetName` varchar(255) NOT NULL,
                  `TargetSynonyms` text,
                  `TargetSource` varchar(255) NOT NULL,
                  `TargetType` enum('Organ and tissue','Cell','Virus','Protein&gt;Monoclonal antibody','Protein&gt;Polyclonal antibody','Protein&gt;Receptor','Protein&gt;Enzyme','Protein&gt;Others','Nucleic acids','Organic molecules or materials','Inorganic molecules or materials','Miscellaneous') NOT NULL,
                  `TargetSequence` tinytext,
                  `TargetStructure` text,
                  `TargetComments` text,
                  PRIMARY KEY (`TargetID`)
                ) ENGINE=MyISAM AUTO_INCREMENT=2008 DEFAULT CHARSET=utf8;
            </pma:table>
        </pma:database>
    </pma:structure_schemas>

    <!--
    - Database: 'bdb8.2copp'
    -->
    <database name="bdb8.2copp">
        <!-- 表 target -->
        <table name="target">
            <column name="TargetID">1</column>
            <column name="TargetName">Anti-Ogawa O-antigen monoclonal antibody S-20-4</column>
            <column name="TargetSynonyms">Mab S-20-4</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:9954938, GI:9954939</column>
            <column name="TargetStructure">1F4W, 1F4X, 1F4Y</column>
            <column name="TargetComments">S-20-4 mAb is an IgG1 specific for Ogawa O-antigen (O-specific polysaccharide; O-SP) of V. cholerae O1. Among solved structures, 1F4W contains the unliganded Fab fragment; 1F4X is the Fab fragment complexed with MGS; 1F4Y is the Fab fragment complexed with MGU.</column>
        </table>
        <table name="target">
            <column name="TargetID">2</column>
            <column name="TargetName">Anti-IA-2 monoclonal antibody 96/3</column>
            <column name="TargetSynonyms">Mab 96/3</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">H Chain : QVQLQESGPGLVKPSETLSLRCNVSGVSISGFYWGWIRQPPGKGLEWIGHIFSSGSTDYSPSLKSRVDVSMDTSKNHFSLKLSSVTAADTAVYYCARVLKGVATASFDFWGRGTLVTVSS
L Chain: SYVLTQPPSVSVAPGKTATITCGADNIGTKSVHWYQQRPGQAPMLVIYYNKNRPSGIPERFSGSNSGHTATLTISRVEAGDEAAYYCQVWDTRSDLVVFGGGTKLTVLG</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">B lymphocytes from 11 insulin-dependant diabetes mellitus (IDDM) patients exhibiting high anti-IA-2 Ab levels in their sera were subjected to EBV immortalization. Cell line 96/3 from patient 9 (2 years duration of IDDM) is the only cell line showed long term stability for 12 month and could be used as constant source of anti-IA-2 Ab with a production rate of 5-8 mg/million cells in 24 h. Anti-IA-2 monoclonal antibody 96/3 belongs to IgG1 subclass and λ type. And it also revealed high affinity to recombinant IA-2ic (KD=0.13 nM) by the BIAcore method. The nucleotide sequences of hAb96/3 were determined by cloning of the VL and VH DNA fragments as scFv Abs. The  amino acid sequences were then derived. However, the sequences were not included in the GenBank.</column>
        </table>
        <table name="target">
            <column name="TargetID">3</column>
            <column name="TargetName">Anti-AMA1 monoclonal antibody 4G2dc1</column>
            <column name="TargetSynonyms">Mab 4G2dc1</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Rat monoclonal antibody 4G2dc1 recognizes correctly folded AMA1 and blocks merozoite invasion of erythrocytes.</column>
        </table>
        <table name="target">
            <column name="TargetID">4</column>
            <column name="TargetName">C-C chemokine receptor type 5, CCR5</column>
            <column name="TargetSynonyms">CCR-5, CC-CKR-5, C-C CKR-5
HIV-1 fusion coreceptor
CHEMR13
CD_antigen=CD195</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P51681</column>
            <column name="TargetStructure">2L87, 2RLL, 2RRS, 4MBS</column>
            <column name="TargetComments">CCR5 is a member of the beta chemokine receptors family of integral membrane proteins. In Humans, the CCR5 gene location is on the short (p) arm at position 21 on chromosome 3. Certain populations have inherited the Delta 32 mutation resulting in the genetic deletion of a portion of the CCR5 gene. Homozygous carriers of this mutation are resistant to M-tropic strains of HIV-1 infection. There are several theoretical structure models of CCR5 in the PDB database, i.e. 1ND8, 1NE0, 1OPN, 1OPT and 1OPW.</column>
        </table>
        <table name="target">
            <column name="TargetID">5</column>
            <column name="TargetName">Interleukin-6 receptor subunit alpha</column>
            <column name="TargetSynonyms">IL-6 receptor subunit alpha, IL-6R subunit alpha, IL-6R-alpha, IL-6RA
IL-6R 1
Membrane glycoprotein 80, gp80
CD_antigen=CD126</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P08887</column>
            <column name="TargetStructure">1N26, 1P9M, 2ARW</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">6</column>
            <column name="TargetName">EWS-Fli1 protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q16198</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">7</column>
            <column name="TargetName">Anti-CD20 monoclonal antibody rituximab</column>
            <column name="TargetSynonyms">IDEC-C2B8
Rituxan
MabThera</column>
            <column name="TargetSource">Homo sapiens (Human):9606, Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:146387640, GI:146387641</column>
            <column name="TargetStructure">2OSL</column>
            <column name="TargetComments">Rituximab is a chimeric IgG1κ antibody against CD20. It was initially developed by IDEC Pharmaceuticals under the name IDEC-C2B8. It was approved by the U.S. Food and Drug Administration in 1997 to treat B-cell non-Hodgkin lymphomas resistant to other chemotherapy regimens. Now it is used in the treatment of many lymphomas, leukemias, transplant rejection and some autoimmune disorders.</column>
        </table>
        <table name="target">
            <column name="TargetID">8</column>
            <column name="TargetName">Anti-CD25 monoclonal antibody basiliximab</column>
            <column name="TargetSynonyms">Simulect</column>
            <column name="TargetSource">Homo sapiens (Human):9606, Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:284793973, GI:284793974, GI:284793975, GI:284793976, GI:284793977, GI:284793978</column>
            <column name="TargetStructure">3IU3</column>
            <column name="TargetComments">Basiliximab (trade name Simulect) is a chimeric (murine/human) monoclonal antibody (IgG1κ) against CD25. It was approved by the Food and Drug Administration in 1998 and used to prevent rejection in organ transplantation, especially in kidney transplants.</column>
        </table>
        <table name="target">
            <column name="TargetID">9</column>
            <column name="TargetName">Baculoviral IAP repeat-containing protein 4</column>
            <column name="TargetSynonyms">E3 ubiquitin-protein ligase XIAP
Inhibitor of apoptosis protein 3, IAP-3, hIAP-3, hIAP3
X-linked inhibitor of apoptosis protein, X-linked IAP
IAP-like protein, ILP, hILP
EC=6.3.2.-</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P98170</column>
            <column name="TargetStructure">1C9Q, 1F9X, 1G3F, 1G73, 1I3O, 1I4O, 1I51, 1KMC, 1NW9, 1TFQ, 1TFT, 2ECG, 2JK7, 2KNA, 2OPY, 2OPZ, 2POI, 2POP, 2QRA, 2VSL, 3CLX, 3CM2, 3CM7, 3EYL, 3G76, 3HL5</column>
            <column name="TargetComments">XIAP functions as a caspase inhibitor and is a member of the inhibitors of apoptosis (IAP) family of proteins.</column>
        </table>
        <table name="target">
            <column name="TargetID">10</column>
            <column name="TargetName">Anti-glycoprotein E2 monoclonal antibody AP33</column>
            <column name="TargetSynonyms">Mab AP33</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:406855809, GI:4068558010, GI:4068558011, GI:4068558012, GI:4068558013, GI:4068558014</column>
            <column name="TargetStructure">4G6A</column>
            <column name="TargetComments">Monoclonal antibody AP33 (MAb AP33) was generated by the following procedure. BALB/c mice were immunized subcutaneously with 20 μg of a recombinant form of mammalian cell-expressed HCV strain Gla E1E2 emulsified in Freund\'s complete adjuvant. After 4 weeks, the animals were boosted with E1E2 emulsified in Freund\'s incomplete adjuvant. Mice were further boosted twice at 2-week intervals. Eight days following the last injection, the sera from tail bleeds were tested for E1E2-specific antibodies. Three weeks following the last boost, the animals were given a final intraperitoneal injection of 100 μg of purified recombinant E1E2. Spleen cells from immunized animals were removed 5 days postinjection and fused with Sp2/0-Ag 14 myeloma cells (ratio, 10:1) by using 50% polyethylene glycol 1500 in DMEM. Cells were then resuspended in HAT medium (EFC10 supplemented with histone acetyltransferase) and 20% conditioned medium (i.e., clarified EFC10 that had previously been used to grow Sp2/0 cells), plated out into 96-well microtiter plates, placed in a CO2 humidified incubator at 37°C, and left for 12 to 14 days. Medium from wells containing colonies was removed and screened by ELISA for E1E2-specific MAbs. Cells from positive wells were removed and propagated. The epitopes recognized by MAb AP33 epitope was mapped to LINTNGSWHIN (412-423) using overlapping peptides. This epitope is highly conserved across all the major genotypes and that MAb AP33 is capable of broad neutralization was demostrated with the retroviral pseudoparticles (HCVpp) assay.</column>
        </table>
        <table name="target">
            <column name="TargetID">11</column>
            <column name="TargetName">Anti-glycoprotein E2 monoclonal antibody 3/11</column>
            <column name="TargetSynonyms">Mab 3/11</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb 3/11 was generated from rats after immunization with either baculovirus-expressed E1-E2 complexes or mammalian (human embryonal kidney) cell-expressed E2661 glycoprotein. MAb 3/11 and MAb AP33 recognize distinct yet overlapping epitopes. MAb 3/11 is capable of neutralizing HCVpp carrying strain H77 E1E2.</column>
        </table>
        <table name="target">
            <column name="TargetID">12</column>
            <column name="TargetName">Protein-glutamine gamma-glutamyltransferase 2</column>
            <column name="TargetSynonyms">Tissue transglutaminase
Transglutaminase C, TGase C, TG(C), TGC
Transglutaminase-2, TGase-2
Transglutaminase H, TGase H
EC=2.3.2.13
</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P21980</column>
            <column name="TargetStructure">1KV3, 2Q3Z, 3LY6, 3S3J, 3S3P, 3S3S</column>
            <column name="TargetComments">Protein-glutamine gamma-glutamyl transferase 2 catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins. Reduced TGM2 activity might contribute to disorders of glucose metabolism such as diabetes.</column>
        </table>
        <table name="target">
            <column name="TargetID">13</column>
            <column name="TargetName">Coagulation factor XIII A chain</column>
            <column name="TargetSynonyms">Coagulation factor XIIIa
Protein-glutamine gamma-glutamyltransferase A chain
Transglutaminase A chain
EC=2.3.2.13</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00488</column>
            <column name="TargetStructure">1EVU, 1EX0, 1F13, 1FIE, 1GGT, 1GGU, 1GGY, 1QRK</column>
            <column name="TargetComments">Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.</column>
        </table>
        <table name="target">
            <column name="TargetID">14</column>
            <column name="TargetName">Anti-AMA1 monoclonal antibody 45B1</column>
            <column name="TargetSynonyms">Mab 45B1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The monoclonal antibody 45B1 was produced from mice immunized with the purified P. yoelii yoelii AMA-1 (PyAMA-1). It belongs to the subclass IgG2a. The results of a passive immunization experiment showed that 45B1 protected mice from challenge infection of P. yoelii yoelii YM, with low parasitemias and 100% survival.</column>
        </table>
        <table name="target">
            <column name="TargetID">15</column>
            <column name="TargetName">Anti-P235 rhoptry protein monoclonal antibody 25.77</column>
            <column name="TargetSynonyms">Mab 25.77</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Spleen cells from two P. yoelii-immune BALB/c mice were fused with P3-NS1/1-Ag4-1 myeloma cells in the presence of polyethylene glycol. The cells were dispensed into 144 tissue culture wells in 2-ml volumes of hypoxanthine-aminopterine-thymidine-selective  mediums,  using  RPMI-1640  medium supplemented with 10% fetal calf serum as a base. After 10 days, the culture supernatants were tested for P. yoelii-specific antibody by indirect immunofluorescence (IIF). Of 143 cultures tested, 38 were positive, 20 producing antibody apparently directed against the infected erythrocyte membrane and 18 producing antibody against the parasite itself. From the initial screening, five distinct IIF specificities were detected. Cultures representative of each of the IIF specificities were expanded in selective medium without aminopterine, and hybridoma lines were subsequently cloned in semi-solid agar overlayed with medium. Hybridoma 25.77 was one of them. Monoclonal antibody 25.77 belongs to the subclass IgG2a. It was found that 25.77 bound to antigens only present in merozoites, free and within mature schizonts. Later, it was known that this antibody was specific for the P. yoelii yoelii 235-kDa rhoptry protein family. Passive immunization with MAb 25.77 suppressed blood-stage parasitemia and restricted the parasites to reticulocytes.</column>
        </table>
        <table name="target">
            <column name="TargetID">16</column>
            <column name="TargetName">Anti-ochratoxin A monoclonal antibody 10G7</column>
            <column name="TargetSynonyms">Mab 10G7</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-ochratoxin A monoclonal antibody 10G7 is an IgG2a, produced from hybridoma based on BALB/c mice immunized with ochratoxin A-KLH conjugates.</column>
        </table>
        <table name="target">
            <column name="TargetID">17</column>
            <column name="TargetName">Vibrio cholerae El Tor Typing Phage VP1</column>
            <column name="TargetSynonyms">Vibrio phage VP1</column>
            <column name="TargetSource">Unclassified phages&gt;Vibrio phage VP1:12333</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">VP1 phage was used as one of the typing phages in a phage-biotyping scheme that has been used for nearly 40 years in China for the typing of O1 El Tor strains. Based on the lytic patterns of the five typing phages, El Tor strains can be clustered into 32 phage types.</column>
        </table>
        <table name="target">
            <column name="TargetID">18</column>
            <column name="TargetName">Tumor necrosis factor ligand superfamily member 13B</column>
            <column name="TargetSynonyms">TNF- and APOL-related leukocyte expressed ligand 1, TALL-1
B lymphocyte stimulator, BLyS
B-cell-activating factor
BAFF
Dendritic cell-derived TNF-like molecule
CD_antigen=CD257</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9Y275</column>
            <column name="TargetStructure">1KXG, 1JH5, 1KD7, 1OQD, 1OQE, 1OSG, 1OTZ, 3V56</column>
            <column name="TargetComments">Tumor necrosis factor ligand superfamily member 13B has two isoforms, i.e. membrane form and soluble form. It abundantly expressed in B cell lineage cells, peripheral blood leukocytes, monocytes and macrophages. This cytokine binds to TNFRSF13B/TACI, TNFRSF17/BCMA and TNFRSF13C/BAFFR, involving in the stimulation of B- and T-cell function and the regulation of humoral immunity.</column>
        </table>
        <table name="target">
            <column name="TargetID">19</column>
            <column name="TargetName">Acetylcholinesterase</column>
            <column name="TargetSynonyms">AChE
EC=3.1.1.7</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P22303</column>
            <column name="TargetStructure">1B41, 1F8U, 1VZJ, 2X8B, 3LII, 4EY4, 4EY5, 4EY6, 4EY7, 4EY8</column>
            <column name="TargetComments">Acetylcholinesterase, is an enzyme that degrades the neurotransmitter acetylcholine, producing choline and an acetate group. It is mainly found at neuromuscular junctions and cholinergic nervous system, where its activity serves to terminate synaptic transmission. AChE has a very high catalytic activity - each molecule of AChE degrades about 25000 molecules of acetylcholine per second. Acetylcholinesterase is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen.</column>
        </table>
        <table name="target">
            <column name="TargetID">20</column>
            <column name="TargetName">Anti-aflatoxin B1 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The isotype of this monoclonal antibody is IgG.</column>
        </table>
        <table name="target">
            <column name="TargetID">21</column>
            <column name="TargetName">Avian infectious bronchitis virus (strain M41)</column>
            <column name="TargetSynonyms">IBV</column>
            <column name="TargetSource">Avian infectious bronchitis virus (IBV):11120</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">GI: 112949615</column>
            <column name="TargetStructure">3LD1</column>
            <column name="TargetComments">Avian infectious bronchitis virus is a coronavirus with a non-segmented, positive-sense single-stranded RNA genome. It infects the respiratory tract, gut, kidney and reproductive systems of chickens.</column>
        </table>
        <table name="target">
            <column name="TargetID">22</column>
            <column name="TargetName">Anti-arginine kinase monoclonal antibody 38G6</column>
            <column name="TargetSynonyms">MAb 38G6</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma 38G6 was established through a fusion of immune splenocytes of a BALB/c mouse immunized with crude cockroach (CR) extract and mouse myeloma cells. It secreted IgG1 monoclonal immunoglobulins. The monoclonal antibody was used in a capture ELISA to detect specific IgE in serum samples of allergic Thai patients. It was found that 72% of the patients had IgE antibodies to the epitope of MAb 38G6 indicating that it was against major CR allergens among the CR allergic Thai patients.</column>
        </table>
        <table name="target">
            <column name="TargetID">23</column>
            <column name="TargetName">Anti-cholera toxin peptide 3 (CTP3) monoclonal antibody TE33</column>
            <column name="TargetSynonyms">Mab TE33</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:494639, GI:494640</column>
            <column name="TargetStructure">1TET, 1ZEA</column>
            <column name="TargetComments">Mab TE33 is an affinity matured murine IgG1 monoclonal antibody raised against cholera toxin peptide 3.</column>
        </table>
        <table name="target">
            <column name="TargetID">24</column>
            <column name="TargetName">Shrimp white spot syndrome virus</column>
            <column name="TargetSynonyms">Prawn white spot bacilliform virus
White spot syndrome virus of shrimp
White Spot Bacilliform Virus
white spot syndrome virus
white spot syndrome virus of penaeid shrimp
white spot syndrome baculovirus
WSSV</column>
            <column name="TargetSource">White spot syndrome virus (WSSV) (White spot bacilliform virus):92652</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">GI:17158105</column>
            <column name="TargetStructure">2ZUG, 2ED6, 2EDM, 2GJ2, 2GJI</column>
            <column name="TargetComments">WSSV is a rod-shaped double-stranded DNA virus, and the size of the enveloped viral particles have been reported to be 240-380 nm long and 70-159 nm dia and nucleocapsid core is 120-205 nm long and 95-165 nm dia. The virus has an outer lipid bilayer membrane envelope, sometimes with a tail like appendage at one end of the virion. Transmission of the virus is mainly through oral ingestion and water borne routes in farms (horizontal transmission) and vertical transmission (from infected mother prawns) in case of shrimp hatcheries. The virus is present in the wild stocks of shrimp, especially in the coastal waters adjacent to shrimp farming regions in Asian countries, but mass mortalities of wild shrimps are yet to be observed.</column>
        </table>
        <table name="target">
            <column name="TargetID">25</column>
            <column name="TargetName">Osteosarcoma cell line OS-732</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The OS-732 tumor cell line was derived from a biopsy obtained before x-ray or Chemotherapy from an osteosarcorna of the distal right femur of a 13-year-old Caucasian girl (M.T.). Despite amputation and treatment with radiation therapy and chemotherapy, she died approximately 3 months later with extensive pulmonary metastases. Autopsy was not performed. OS-732 cells grew to high population density in liquid medium and formed colonies in agar medium. The cell line consisted of polygonal or fusiform cells resembling the cells of the original tumor. No collagen fibers or calcium apatite microcrystals could be demonstrated in the cultured cells by electron microscopy nor were virus particles detected. Isoenzyme studies of the cell line revealed the “B” band of glucose-6-phosphate dehydrogenase. Chromosome studies of the cell line revealed a range of stem line number from 58 to 65; chromosome counts ranged from 47 to 183. Some cells had marker chromosome of varied morphology and some had minute chromosomes. Chromosome breaks were found in 30.5% of the cells (PMID: 5100401).</column>
        </table>
        <table name="target">
            <column name="TargetID">26</column>
            <column name="TargetName">Virion infectivity factor</column>
            <column name="TargetSynonyms">Vif
SOR protein</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 (isolate NY5 group M subtype B) (HIV-1):11698</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P12504</column>
            <column name="TargetStructure">3DCG</column>
            <column name="TargetComments">Vif forms a complex with host APOBEC3F and APOBEC3G and directs them for proteasomal degradation. APOBEC3F and APOBEC3G are cytidine deaminases that can disrupts viral nucleic acids. Thus, Vif is very important for viral replication.</column>
        </table>
        <table name="target">
            <column name="TargetID">27</column>
            <column name="TargetName">Anti-ViCPS monoclonal antibody ATVi</column>
            <column name="TargetSynonyms">Mab ATVi</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The MAb ATVi was produced against Vi polysaccharide antigen of Salmonella typhi. It was found to be highly specific to Vi possessing bacteria (PMID: 8216560).</column>
        </table>
        <table name="target">
            <column name="TargetID">28</column>
            <column name="TargetName">Polyclonal antibody PTS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Polyclonal antibody PTS were from pooled sera of 10 typhoid patients. These patients was confirmed typhoid fever by high antibody titers (&gt;1:640) for one or both O and H antigens, as determined by Widal test.</column>
        </table>
        <table name="target">
            <column name="TargetID">29</column>
            <column name="TargetName">Anti-IL-4 monoclonal antibody 11B.11</column>
            <column name="TargetSynonyms">Mab 11B.11
Mab 11B11</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:50812705, GI:50812707</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mab 11B11 is a rat anti-mouse interleukin-4 monoclonal antibody of IgG1 isotype. The immunogen used to generate the 11B11 hybridoma was partially purified mouse IL-4 from PMA-stimulated EL-4 supernatant. Mab 11B11 binds with high affinity to and neutralizes both natural and recombinant mouse IL-4. It was found that administration of 11B11, like soluble IL-4R, similarly inhibited IgE production in response to anti-IgD.</column>
        </table>
        <table name="target">
            <column name="TargetID">30</column>
            <column name="TargetName">Plasminogen activator inhibitor 1</column>
            <column name="TargetSynonyms">PAI, PAI-1
Endothelial plasminogen activator inhibitor
Serpin E1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05121</column>
            <column name="TargetStructure">1A7C, 1B3K, 1C5G, 1DB2, 1DVM, 1DVN, 1LJ5, 1OC0, 3CVM, 3EOX, 3PB1, 3Q02, 3Q03, 3R4L, 3UT3, 4AQH, 9PAI</column>
            <column name="TargetComments">Plasminogen activator inhibitor 1 acts as trap for tissue plasminogen activator (TPA), urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis.</column>
        </table>
        <table name="target">
            <column name="TargetID">31</column>
            <column name="TargetName">Kallikrein-2</column>
            <column name="TargetSynonyms">Tissue kallikrein-2
Glandular kallikrein-1, hGK-1
EC=3.4.21.35</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P20151</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Kallikrein-2 cleaves Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin. It has 3 isoforms produced by alternative splicing.</column>
        </table>
        <table name="target">
            <column name="TargetID">32</column>
            <column name="TargetName">Listeria monocytogenes</column>
            <column name="TargetSynonyms">L. monocytogenes</column>
            <column name="TargetSource">Listeria monocytogenes:1639</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">GI:47097775 (serotype 1/2a str. F6854)
GI:47094674 (serotype 4b str. H7858)
GI:83316099 (serotype 4b str. F2365)
GI:16802048 (EGD-e)</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Listeria monocytogenes is a facultative anaerobe, which lives in the cell. It is one of the most virulent foodborne pathogens, causing listeriosis.</column>
        </table>
        <table name="target">
            <column name="TargetID">33</column>
            <column name="TargetName">Prostate-specific antigen</column>
            <column name="TargetSynonyms">PSA
Gamma-seminoprotein
Seminin
Kallikrein-3
P-30 antigen
Semenogelase
EC=3.4.21.77</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P07288</column>
            <column name="TargetStructure">2ZCH, 2ZCK, 2ZCL, 3QUM</column>
            <column name="TargetComments">PSA is a serine protease (-Tyr-|-Xaa-) produced almost exclusively by the prostate gland. It hydrolyze semenogelin-1, leading to the liquefaction of the seminal coagulum, which allows sperm to swim freely. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer and in other prostate disorders.</column>
        </table>
        <table name="target">
            <column name="TargetID">34</column>
            <column name="TargetName">Macrophage receptor MARCO</column>
            <column name="TargetSynonyms">Macrophage receptor with collagenous structure</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q60754</column>
            <column name="TargetStructure">2OY3, 2OYA</column>
            <column name="TargetComments">MARCO is a pattern recognition receptor containing a collagen-like domain and a scavenger receptor cysteine-rich (SRCR) domain. As a member of the class A scavenger receptor family, MARCO may bind both Gram-negative and Gram-positive bacteria via its intracellular, C-terminal SRCR domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">35</column>
            <column name="TargetName">Heat shock cognate 71 kDa protein</column>
            <column name="TargetSynonyms">Heat shock 70 kDa protein 8
HSPA8, HSC70, HSP73
</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P19120</column>
            <column name="TargetStructure">1ATR, 1ATS, 1BA0, 1BA1, 1BUP, 1HPM, 1HX1, 1KAX, 1KAY, 1KAZ, 1NGA, 1NGB, 1NGC, 1NGD, 1NGE, 1NGF, 1NGG, 1NGH, 1NGI, 1NGJ, 1Q2G, 1QQM, 1QQN, 1QQO, 1YUW, 2BUP, 2QW9, 2QWL, 2QWM, 2QWN, 2QWO, 2QWP, 2QWQ, 2QWR, 3C7N, 3HSC</column>
            <column name="TargetComments">Heat shock cognate 71 kDa protein is constitutively expressed. It binds to nascent polypeptides to facilitate correct protein folding. It also functions as an ATPase in the disassembly of clathrin-coated vesicles during transport of membrane components through the cell.</column>
        </table>
        <table name="target">
            <column name="TargetID">36</column>
            <column name="TargetName">Cetuximab</column>
            <column name="TargetSynonyms">IMC-C225
Erbitux</column>
            <column name="TargetSource">Homo sapiens (Human):9606, Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:66361252, GI:66361253</column>
            <column name="TargetStructure">1YY8, 1YY9</column>
            <column name="TargetComments">Cetuximab is a chimeric (mouse/human) IgG1κ antibody against epidermal growth factor receptor (EGFR). As an EGFR inhibitor, it was given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer.</column>
        </table>
        <table name="target">
            <column name="TargetID">37</column>
            <column name="TargetName">Trastuzumab</column>
            <column name="TargetSynonyms">Herceptin, rhuMab4D5</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:28948772 , GI:28948773</column>
            <column name="TargetStructure">1N8Z, 3D6G</column>
            <column name="TargetComments">Trastuzumab is a humanized IgG1κ antibody from its original version mumAb4D5, a mouse monoclonal antibody. The mumAb4D5 was generated against a HER2 over-expressing NIH 3T3 cell line. The recombinant humanized version of mumAb4D5 is also known as rhuMab4D5 and Herceptin (trade name).</column>
        </table>
        <table name="target">
            <column name="TargetID">38</column>
            <column name="TargetName">Anti-omp40 monoclonal antibody Pg-ompA1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">39</column>
            <column name="TargetName">Anti-vWF monoclonal antibody 82D6A3</column>
            <column name="TargetSynonyms">Mab 82D6A3</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:83753978, GI:83753979</column>
            <column name="TargetStructure">2ADF</column>
            <column name="TargetComments">The mouse monoclonal antibody 82D6A3 is an IgG2aκ raised against human von Willebrand factor (vWF). It binds with high affinity to the VWF A3-domain and inhibits VWF binding to collagen types I, III and IV, but has no effect on vWF binding to collagen VI. Interestingly, its antithrombotic effect is not associated with significantly increased bleeding times, even at high doses.</column>
        </table>
        <table name="target">
            <column name="TargetID">40</column>
            <column name="TargetName">Anti-coagulation factor VIII monoclonal antibody BO2C11</column>
            <column name="TargetSynonyms">Mab BO2C11,  MoAb BO2C11</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:15825659 , GI:15825660</column>
            <column name="TargetStructure">1IQD</column>
            <column name="TargetComments">The anti-coagulation factor VIII monoclonal antibody BO2C11 is a human IgG4k antibody produced by a cell line derived from the memory B-cell repertoire of a hemophilia A patient with inhibitor. BO2C11 recognizes the C2 domain of factor VIII and inhibits its binding to both von Willebrand factor (vWF) and phospholipids. It completely inhibits the procoagulant activity of native and activated factor VIII.</column>
        </table>
        <table name="target">
            <column name="TargetID">41</column>
            <column name="TargetName">Anti-spike glycoprotein monoclonal antibody 80R</column>
            <column name="TargetSynonyms">Mab 80R</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:116667257, GI:116667259</column>
            <column name="TargetStructure">2GHW</column>
            <column name="TargetComments">The monoclonal antibody 80R is a human IgG1κ selected from an nonimmune phage antibody library with recombinant S1 domain of spike protein of the SARS-CoV as antigen. It efficiently neutralizs SARS-CoV and inhibited syncytia formation between cells expressing the S protein and those expressing the SARS-CoV receptor angiotensin-converting enzyme 2 (ACE2).</column>
        </table>
        <table name="target">
            <column name="TargetID">42</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody b12</column>
            <column name="TargetSynonyms">Mab b12</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:126031291, GI:126031292 </column>
            <column name="TargetStructure">1HZH, 2NY7</column>
            <column name="TargetComments">The b12 was a human monoclonal IgG1 selected with recombinant gp120 from a phage Fab library that was constructed using bone marrow cDNA of an HIV-1-infected individual. The ability of b12 to neutralize laboratory-adapted HIV-1, primary HIV-1 isolates, and interfere both with the binding of gpl20 to CD4 and the interaction of gpl20 to CCR5 has been reported.</column>
        </table>
        <table name="target">
            <column name="TargetID">43</column>
            <column name="TargetName">Cytochrome b-245</column>
            <column name="TargetSynonyms">Cytochrome b-245 light chain alternative name(s):
p22 phagocyte B-cytochrome
Neutrophil cytochrome b 22 kDa polypeptide
p22-phox, p22phox
Cytochrome b(558) alpha chain
Cytochrome b558 subunit alpha
Superoxide-generating NADPH oxidase light chain subunit

Cytochrome b-245 heavy chain alternative name(s):
p22 phagocyte B-cytochrome
Neutrophil cytochrome b 91 kDa polypeptide
Heme-binding membrane glycoprotein gp91phox
CGD91-phox
gp91-phox
gp91-1
Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta
Superoxide-generating NADPH oxidase heavy chain subunit
NADPH oxidase 2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Cytochrome b-245 light chain: P13498, Cytochrome b-245 heavy chain: P04839</column>
            <column name="TargetStructure">Cytochrome b-245 light chain: 1WLP
Cytochrome b-245 heavy chain: 3A1F</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">44</column>
            <column name="TargetName">Neutrophil cytosol factor 1</column>
            <column name="TargetSynonyms">NCF-1
Neutrophil NADPH oxidase factor 1
47 kDa neutrophil oxidase factor
p47-phox
NCF-47K
47 kDa autosomal chronic granulomatous disease protein
Nox-organizing protein 2
Nox organizer 2
SH3 and PX domain-containing protein 1A</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P14598</column>
            <column name="TargetStructure">1GD5, 1K4U, 1KQ6, 1NG2, 1O7K, 1OV3, 1UEC, 1W70, 1WLP</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">45</column>
            <column name="TargetName">Bacillus subtilis spores</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bacillus subtilis:1423</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">46</column>
            <column name="TargetName">Tryptase</column>
            <column name="TargetSynonyms">Mast cell protease 7, mMCP-7
Tryptase alpha/beta-1
EC=3.4.21.59</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q02844</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">47</column>
            <column name="TargetName">Cryptococcus neoformans melanin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Cryptococcus neoformans (Filobasidiella neoformans):5207</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">48</column>
            <column name="TargetName">Growth factor receptor-bound protein 2</column>
            <column name="TargetSynonyms">Adapter protein GRB2
SH2/SH3 adapter GRB2
Protein Ash</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P62993</column>
            <column name="TargetStructure">1AZE, 1BM2, 1BMB, 1CJ1, 1FHS, 1FYR, 1GCQ, 1GFC, 1GFD, 1GHU, 1GRI, 1IO6, 1JYQ, 1JYR, 1JYU, 1QG1, 1TZE, 1X0N, 1ZFP, 2AOA, 2AOB, 2H46, 2H5K, 2HUW, 2VVK, 2VWF, 2W0Z, 3C7I, 3IMD, 3IMJ, 3IN7, 3IN8, 3KFJ, 3MXC, 3MXY, 3N7Y, 3N84, 3N8M, 3OV1, 3OVE, 3S8L, 3S8N, 3S8O</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">49</column>
            <column name="TargetName">Urokinase-type plasminogen activator</column>
            <column name="TargetSynonyms">U-plasminogen activator, uPA</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00749</column>
            <column name="TargetStructure">1C5W, 1C5X, 1C5Y, 1C5Z, 1EJN, 1F5K, 1F5L, 1F92, 1FV9, 1GI7, 1GI8, 1GI9, 1GJ7, 1GJ8, 1GJ9, 1GJA, 1GJB, 1GJC, 1GJD, 1KDU, 1LMW, 1O3P, 1O5A, 1O5B, 1O5C, 1OWD, 1OWE, 1OWH, 1OWI, 1OWJ, 1OWK, 1SC8, 1SQA, 1SQO, 1SQT, 1U6Q, 1URK, 1VJ9, 1VJA, 1W0Z, 1W10, 1W11, 1W12, 1W13, 1W14, 2FD6, 2I9A, 2I9B, 2NWN, 2O8T, 2O8U, 2O8W, 2R2W, 2VIN, 2VIO, 2VIP, 2VIQ, 2VIV, 2VIW, 2VNT, 3BT1, 3BT2, 3IG6, 3KGP, 3KHV, 3KID, 3M61, 3MHW, 3MWI, 3OX7, 3OY5, 3OY6, 3PB1, 3QN7, 3U73, 4DVA, 4DW2, 4FU7, 4FU8, 4FU9, 4FUB, 4FUC, 4FUD, 4FUE, 4FUF, 4FUG, 4FUH, 4FUI, 4FUJ, 4GLY</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">50</column>
            <column name="TargetName">Melanocyte-stimulating hormone receptor, MSH-R</column>
            <column name="TargetSynonyms">Melanocortin receptor 1, MC1-R</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q01726</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">51</column>
            <column name="TargetName">Polymeric immunoglobulin receptor</column>
            <column name="TargetSynonyms">Poly-Ig receptor, PIgR
Hepatocellular carcinoma-associated protein TB6</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P01833</column>
            <column name="TargetStructure">1XED, 2OCW, 3CHN, 3CM9</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">52</column>
            <column name="TargetName">Protein tonB</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02929</column>
            <column name="TargetStructure">1IHR, 1QXX, 1U07, 1XX3, 2GRX, 2GSK</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">53</column>
            <column name="TargetName">Iron(3+)-hydroxamate-binding protein fhuD</column>
            <column name="TargetSynonyms">Iron(III)-hydroxamate-binding protein fhuD
Ferrichrome-binding periplasmic protein
Ferric hydroxamate uptake protein D</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07822</column>
            <column name="TargetStructure">1EFD, 1ESZ, 1K2V, 1K7S</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">54</column>
            <column name="TargetName">Galectin-3, Gal-3</column>
            <column name="TargetSynonyms">Galactose-specific lectin 3
Mac-2 antigen
IgE-binding protein
35 kDa lectin
Carbohydrate-binding protein 35, CBP 35
Laminin-binding protein
Lectin L-29
L-31
Galactoside-binding protein, GALBP</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P17931</column>
            <column name="TargetStructure">1A3K, 1KJL, 1KJR, 2NMN, 2NMO, 2NN8, 2XG3, 3AYA, 3AYC, 3AYD, 3AYE, 3T1L, 3T1M, 3ZSJ, 3ZSK, 3ZSL, 3ZSM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">55</column>
            <column name="TargetName">Anti-CSFV monoclonal antibody 1B5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">56</column>
            <column name="TargetName">Anti-CSFV monoclonal antibody b4-22</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">57</column>
            <column name="TargetName">Anti-CSFV monoclonal antibody 24/16</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">58</column>
            <column name="TargetName">Anti-HMW-MAA monoclonal antibody 225.28S</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">59</column>
            <column name="TargetName">Anti-TRAP monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">60</column>
            <column name="TargetName">Metallo-beta-lactamase L1</column>
            <column name="TargetSynonyms">Beta-lactamase type II
Penicillinase
EC=3.5.2.6</column>
            <column name="TargetSource">Stenotrophomonas maltophilia (Pseudomonas maltophilia) (Xanthomonas maltophilia):40324</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P52700</column>
            <column name="TargetStructure">1SML, 2AIO, 2FM6, 2FU6, 2FU7, 2FU8, 2FU9, 2GFJ, 2GFK, 2H6A, 2HB9, 2QDT, 2QIN, 2QJS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">61</column>
            <column name="TargetName">SiHa cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The SiHa cell lines are derived from a HPV16 integrated human cervical carcinoma.</column>
        </table>
        <table name="target">
            <column name="TargetID">62</column>
            <column name="TargetName">Peptidyl-prolyl cis-trans isomerase A, PPIase A</column>
            <column name="TargetSynonyms">Rotamase A
Cyclophilin A
Cyclosporin A-binding protein
EC=5.2.1.8</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P62937</column>
            <column name="TargetStructure">1AK4, 1AWQ, 1AWR, 1AWS, 1AWT, 1AWU, 1AWV, 1BCK, 1CWA, 1CWB, 1CWC, 1CWF, 1CWH, 1CWI, 1CWJ, 1CWK, 1CWL, 1CWM, 1CWO, 1FGL, 1M63, 1M9C, 1M9D, 1M9E, 1M9F, 1M9X, 1M9Y, 1MF8, 1MIK, 1NMK, 1OCA, 1RMH, 1VBS, 1VBT, 1W8L, 1W8M, 1W8V, 1YND, 1ZKF, 2ALF, 2CPL, 2CYH, 2RMA, 2RMB, 2X25, 2X2A, 2X2C, 2X2D, 2XGY, 3CYH, 3CYS, 3K0M, 3K0N, 3K0O, 3K0P, 3K0Q, 3K0R, 3ODI, 3ODL, 3RDD, 4CYH, 5CYH</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">63</column>
            <column name="TargetName">Anti-PSA monoclonal antibody PSA-C1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PSA-C1 mab is obtained by immunization of mice with PSA-α2M complexes.</column>
        </table>
        <table name="target">
            <column name="TargetID">64</column>
            <column name="TargetName">Anti-PSA monoclonal antibody PSA-C2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PSA-C2 mab is obtained by immunization of mice with PSA-α2M complexes.</column>
        </table>
        <table name="target">
            <column name="TargetID">65</column>
            <column name="TargetName">Anti-PSA monoclonal antibody PSA-C4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PSA-C4 mab is obtained by immunization of mice with PSA-α2M complexes.</column>
        </table>
        <table name="target">
            <column name="TargetID">66</column>
            <column name="TargetName">DNA repair protein XRCC3</column>
            <column name="TargetSynonyms">X-ray repair cross-complementing protein 3</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O43542</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">67</column>
            <column name="TargetName">Anti-gastric cancer monoclonal antibody MG7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">68</column>
            <column name="TargetName">Epidermal growth factor receptor</column>
            <column name="TargetSynonyms">Receptor tyrosine-protein kinase ErbB-1
Proto-oncogene c-ErbB-1
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P00533</column>
            <column name="TargetStructure">1IVO, 1M14, 1M17, 1MOX, 1NQL, 1XKK, 1YY9, 1Z9I, 2EB2, 2EB3, 2GS2, 2GS6, 2GS7, 2ITN, 2ITO, 2ITP, 2ITQ, 2ITT, 2ITU, 2ITV, 2ITW, 2ITX, 2ITY, 2ITZ, 2J5E, 2J5F, 2J6M, 2JIT, 2JIU, 2JIV, 2KS1, 2M20, 2RF9, 2RFD, 2RFE, 2RGP, 3B2U, 3B2V, 3BEL, 3BUO, 3C09, 3G5V, 3G5Y, 3GOP, 3GT8, 3IKA, 3LZB, 3NJP, 3OB2, 3OP0, 3P0Y, 3PFV, 3POZ, 3QWQ, 3UG1, 3UG2, 3VJN, 3VJO, 3VRP, 3VRR, 3W2O, 3W2P, 3W2Q, 3W2R, 3W2S, 3W32, 3W33, 4G5J, 4G5P, 4HJO, 4I1Z, 4I20, 4I21, 4I22, 4I23, 4I24</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">69</column>
            <column name="TargetName">Anti-HMW-MAA monoclonal antibody 763.74</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">70</column>
            <column name="TargetName">Anti-HMW-MAA monoclonal antibody GH786</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">71</column>
            <column name="TargetName">Protein P</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Duck hepatitis B virus (isolate brown Shanghai duck S5) (DHBV):10439</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P17192</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">72</column>
            <column name="TargetName">Anti-type 8 PS monoclonal antibody NAD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">73</column>
            <column name="TargetName">Anti-NE2 monclonal antibody 8C11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">74</column>
            <column name="TargetName">Anti-NE2 monclonal antibody 8H3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">75</column>
            <column name="TargetName">Anti-hantaan virus monoclonal antibody F3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">76</column>
            <column name="TargetName">Anti-hantaan virus monoclonal antibody B11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">77</column>
            <column name="TargetName">Anti-gibberellin monoclonal antibody 8E9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">78</column>
            <column name="TargetName">Anti-SARS-CoV spike glycoprotein monoclonal antibody 2C5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">79</column>
            <column name="TargetName">Anti-IFN-alpha-2b polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">80</column>
            <column name="TargetName">Glucokinase regulatory protein</column>
            <column name="TargetSynonyms">Glucokinase regulator</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q07071</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">81</column>
            <column name="TargetName">Human airway epithelial cell 1HAEo-cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">82</column>
            <column name="TargetName">Anti-hTERT polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">83</column>
            <column name="TargetName">Anti-CD47 monoclonal antibody C5D5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">84</column>
            <column name="TargetName">CD8+ T cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A CD8+ T cell line was generated from immunomagnetic bead-purified CD8+ peripheral blood lymphocytes of a normal subject, by repeated stimulation with interleukin (IL)-2 and PHA in the presence of autologous, irradiated peripheral blood mononuclear cells (PBMC).</column>
        </table>
        <table name="target">
            <column name="TargetID">85</column>
            <column name="TargetName">Src SH3 domain of Proto-oncogene tyrosine-protein kinase Src</column>
            <column name="TargetSynonyms">Proto-oncogene tyrosine-protein kinase Src alternative name(s):
Proto-oncogene c-Src
pp60c-src, p60-Src
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P12931 [84-145]</column>
            <column name="TargetStructure">1A07, 1A08, 1A09, 1A1A, 1A1B, 1A1C, 1A1E, 1FMK, 1HCS, 1HCT, 1KSW, 1O41, 1O42, 1O43, 1O44, 1O45, 1O46, 1O47, 1O48, 1O49, 1O4A, 1O4B, 1O4C, 1O4D, 1O4E, 1O4F, 1O4G, 1O4H, 1O4I, 1O4J, 1O4K, 1O4L, 1O4M, 1O4N, 1O4O, 1O4P, 1O4Q, 1O4R, 1SHD, 1Y57, 1YI6, 1YOJ, 1YOL, 1YOM, 2BDF, 2BDJ, 2H8H, 2SRC, 3VRO, 4F59, 4F5A, 4F5B, 4HXJ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">86</column>
            <column name="TargetName">Fyn SH3 domain of tyrosine-protein kinase Fyn</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase Fyn alternative name(s):
Proto-oncogene c-Fyn
p59-Fyn
Proto-oncogene Syn
SLK
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P06241 [82-143]</column>
            <column name="TargetStructure">1A0N, 1AOT, 1AOU, 1AVZ, 1AZG, 1EFN, 1FYN, 1G83, 1M27, 1NYF, 1NYG, 1SHF, 1ZBJ, 2DQ7, 3H0F, 3H0H, 3H0I, 3UA6, 3UA7, 4D8D, 4EIK</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">87</column>
            <column name="TargetName">Lyn SH3 domain of tyrosine-protein kinase Lyn</column>
            <column name="TargetSynonyms">EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P07948 [62-128]</column>
            <column name="TargetStructure">1W1F, 1WA7, 3A4O</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">88</column>
            <column name="TargetName">PI3K SH3 domain of PI3-kinase subunit p85-alpha</column>
            <column name="TargetSynonyms">PI3-kinase subunit p85-alpha alternative name(s):
Phosphatidylinositol 3-kinase regulatory subunit alpha
PtdIns-3-kinase regulatory subunit alpha
PI3-kinase regulatory subunit alpha
PI3K regulatory subunit alpha
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha
PtdIns-3-kinase regulatory subunit p85-alpha</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P27986 [3-79]</column>
            <column name="TargetStructure">1A0N, 1AZG, 1H9O, 1PBW, 1PHT, 1PIC, 1PKS, 1PKT, 2IUG, 2IUH, 2IUI, 2RD0, 2V1Y, 3HHM, 3HIZ, 3I5R, 3I5S, 4A55</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">89</column>
            <column name="TargetName">Abl SH3 domain of tyrosine-protein kinase ABL1</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase ABL1 alternative name(s):
Abelson murine leukemia viral oncogene homolog 1
Proto-oncogene c-Abl
p150
EC=2.7.10.2</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00520 [61-121]</column>
            <column name="TargetStructure">1ABO, 1ABQ, 1FPU, 1IEP, 1M52, 1OPJ, 1OPK, 2HZN, 2QOH, 2Z60, 3DK3, 3DK6, 3DK7, 3IK3, 3K5V, 3KF4, 3KFA, 3MS9, 3MSS, 3OXZ, 3OY3</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">90</column>
            <column name="TargetName">GYF domain of protein CD2BP2</column>
            <column name="TargetSynonyms">Protein CD2BP2 alternative name(s):
CD2 antigen cytoplasmic tail-binding protein 2
CD2 cytoplasmic domain-binding protein 2
CD2 tail-binding protein 2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O95400 [280-338]</column>
            <column name="TargetStructure">1GYF, 1L2Z, 1SYX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">91</column>
            <column name="TargetName">GYF domain of protein PERQ2</column>
            <column name="TargetSynonyms">Protein PERQ2 alternative name(s):
PERQ amino acid-rich with GYF domain-containing protein 2
GRB10-interacting GYF protein 2
Trinucleotide repeat-containing gene 15 protein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q6Y7W6 [533-581]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">92</column>
            <column name="TargetName">GYF domain of protein SMY2</column>
            <column name="TargetSynonyms">Protein SMY2 alternative name(s):
Suppressor of MYO2-66 protein</column>
            <column name="TargetSource">Saccharomyces cerevisiae (Baker's yeast):4932</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P32909 [205-261]</column>
            <column name="TargetStructure">3FMA, 3K3V</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">93</column>
            <column name="TargetName">GYF domain of protein SYH1</column>
            <column name="TargetSynonyms">Protein SYH1 alternative name(s):
Uncharacterized protein YPL105C</column>
            <column name="TargetSource">Saccharomyces cerevisiae (Baker's yeast):4932</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q02875 [149-205]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">94</column>
            <column name="TargetName">GYF domain of protein PR-SYH1</column>
            <column name="TargetSynonyms">Protein SYH1 alternative name(s):
Uncharacterized protein YPL105C</column>
            <column name="TargetSource">Saccharomyces cerevisiae (Baker's yeast):4932</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q02875 [140-205]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">95</column>
            <column name="TargetName">GYF domain of protein GYN4</column>
            <column name="TargetSynonyms">Protein GYN4 alternative name(s):
Gb|AAC80623.1</column>
            <column name="TargetSource">Arabidopsis thaliana (Mouse-ear cress):3702</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9FMM3</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">96</column>
            <column name="TargetName">Integrin alpha-5-beta-1, integrin α5β1</column>
            <column name="TargetSynonyms">Integrin alpha-5 alternative name(s):
Fibronectin receptor subunit alpha
Integrin alpha-F
VLA-5
CD49 antigen-like family member E
CD_antigen=CD49e

Integrin beta-1 alternative name(s):
Fibronectin receptor subunit beta
VLA-4 subunit beta
CD_antigen=CD29</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Integrin alpha-5: P08648, Integrin beta-1: P05556</column>
            <column name="TargetStructure">Integrin alpha-5: 3VI3, 3VI4                
Integrin beta-1: 3G9W, 3T9K, 3VI3, 3VI4, 4DX9
</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">97</column>
            <column name="TargetName">Neutrophil cytosol factor 2, NCF-2</column>
            <column name="TargetSynonyms">Neutrophil NADPH oxidase factor 2
NADPH oxidase activator 2
67 kDa neutrophil oxidase factor
p67-phox</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P19878</column>
            <column name="TargetStructure">1E96, 1HH8, 1K4U, 1OEY, 1WM5, 2DMO</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">98</column>
            <column name="TargetName">Anti-lactotransferrin monoclonal antibody mAbRWL1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Monoclonal IgM antibody mAbRWL1 was produced from a cord blood B cell hybridoma and originally characterized as binding to a fraction of human lactoferrin. This mAb recognize a conformational epitope present in a CNBr digestion fraction of lactoferrin.</column>
        </table>
        <table name="target">
            <column name="TargetID">99</column>
            <column name="TargetName">Anti-lactotransferrin monoclonal antibody mAbRWL2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Monoclonal IgM antibody mAbRWL2 was produced from a cord blood B cell hybridoma and originally characterized as binding to a fraction of human lactoferrin. This mAb recognize a conformational epitope present in a CNBr digestion fraction of lactoferrin.</column>
        </table>
        <table name="target">
            <column name="TargetID">100</column>
            <column name="TargetName">Human gastric cancer cells GC9811-P</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">101</column>
            <column name="TargetName">Anti-parvalbumin polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Parvalbumin-specific antibodies IgE were purified from serum samples of 16 fish-allergic patients.</column>
        </table>
        <table name="target">
            <column name="TargetID">102</column>
            <column name="TargetName">Anti-Nipah virus polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">103</column>
            <column name="TargetName">Pancreatic triacylglycerol lipase</column>
            <column name="TargetSynonyms">Pancreatic lipase, PL
EC=3.1.1.21
EC=3.1.1.3</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00591</column>
            <column name="TargetStructure">1ETH</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">104</column>
            <column name="TargetName">Anti-EcA polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">105</column>
            <column name="TargetName">Anti-NPS polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">New Zealand rabbits were immunized with an NPS fraction of M. tuberculosis. After three immunizations, the hyperimmune antiserum mainly includes the antibodies reacting against non-protein components from the NPS fraction of M. tuberculosis.</column>
        </table>
        <table name="target">
            <column name="TargetID">106</column>
            <column name="TargetName">Langerhans cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">107</column>
            <column name="TargetName">Anti-lycoprotein G monoclonal antibody MnAb1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">108</column>
            <column name="TargetName">Anti-lycoprotein G monoclonal antibody MnAb2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">109</column>
            <column name="TargetName">Anti-ACTH monoclonal antibody A2H8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">110</column>
            <column name="TargetName">Anti-ACTH monoclonal antibody 57</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">111</column>
            <column name="TargetName">Anti-ACTH monoclonal antibody FZ10-A32</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">112</column>
            <column name="TargetName">Geminin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O75496</column>
            <column name="TargetStructure">1T6F, 1UII, 2LP0, 2WVR</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">113</column>
            <column name="TargetName">Anti-GPIIIa49-66 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">114</column>
            <column name="TargetName">Vascular endothelial growth factor receptor 1, VEGFR-1</column>
            <column name="TargetSynonyms">Vascular permeability factor receptor
Tyrosine-protein kinase receptor FLT
Tyrosine-protein kinase FRT
Fms-like tyrosine kinase 1, FLT-1
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P17948</column>
            <column name="TargetStructure">1FLT, 1QSV, 1QSZ, 1QTY, 1RV6, 2XAC, 3HNG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">115</column>
            <column name="TargetName">Bacillus anthracis Spore</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bacillus anthracis:1392</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">116</column>
            <column name="TargetName">Lipopolysaccharide, LPS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli:562</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">117</column>
            <column name="TargetName">Cardiac glycoside digoxin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Cardiac glycoside digoxin is a kind of large rigid hydrophobic hapten without charged groups.</column>
        </table>
        <table name="target">
            <column name="TargetID">118</column>
            <column name="TargetName">16-acetylgitoxin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">16-acetylgitoxin is a kind of large rigid hydrophobic hapten without charged groups and C-16 substituted analogue of digoxin.</column>
        </table>
        <table name="target">
            <column name="TargetID">119</column>
            <column name="TargetName">Gitoxin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Gitoxin is a kind of large rigid hydrophobic hapten without charged groups and C-16 substituted analogue of digoxin.</column>
        </table>
        <table name="target">
            <column name="TargetID">120</column>
            <column name="TargetName">16-formylgitoxin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">16-formylgitoxin is a kind of large rigid hydrophobic hapten without charged groups and C-16 substituted analogue of digoxin.</column>
        </table>
        <table name="target">
            <column name="TargetID">121</column>
            <column name="TargetName">Furin</column>
            <column name="TargetSynonyms">Paired basic amino acid residue-cleaving enzyme, PACE
Dibasic-processing enzyme
Prohormone convertase 3
EC=3.4.21.75</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P23188</column>
            <column name="TargetStructure">1P8J</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">122</column>
            <column name="TargetName">Fibronectin type-II 1 domain of MMP-2</column>
            <column name="TargetSynonyms">MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08253 [228-276]</column>
            <column name="TargetStructure">1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">123</column>
            <column name="TargetName">Fibronectin type-II 2 domain of MMP-2</column>
            <column name="TargetSynonyms">MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08253 [286-334]</column>
            <column name="TargetStructure">1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">124</column>
            <column name="TargetName">Fibronectin type-II 3 domain of MMP-2</column>
            <column name="TargetSynonyms">MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08253 [344-392]</column>
            <column name="TargetStructure">1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">125</column>
            <column name="TargetName">Fibronectin type-II 1-3 domain of MMP-2</column>
            <column name="TargetSynonyms">MMP-2 alternative name(s):
72 kDa type IV collagenase
72 kDa gelatinase
Matrix metalloproteinase-2
Gelatinase A
TBE-1
EC=3.4.24.24</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08253 [228-392]</column>
            <column name="TargetStructure">1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">126</column>
            <column name="TargetName">Anti-colicin-A monoalonal antibody 1C11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">127</column>
            <column name="TargetName">Integrin alpha-M, integrin </column>
            <column name="TargetSynonyms">Cell surface glycoprotein MAC-1 subunit alpha
CR-3 alpha chain
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD11 antigen-like family member B
CD_antigen=CD11b</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P11215</column>
            <column name="TargetStructure">1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">128</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody 17b</column>
            <column name="TargetSynonyms">Mab 17b (1.7b, sCD4-17b, 1.7B)</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:12084266, GI:12084267</column>
            <column name="TargetStructure">1G9M, 1G9N, 1GC1, 1RZ8, 1RZJ, 1RZK, 1YYL, 1YYM, 2I5Y, 2I60, 2NXY, 2NXZ, 2NY0, 2NY1, 2NY2, 2NY3, 2NY4, 2NY5, 2NY6</column>
            <column name="TargetComments">The monoclonal antibody 17b is a human IgG1κ generated with an Epstein-Barr virus immortalized B-cell clone isolated from an HIV-1-infected individual by the laboratory of James Robinson (Tulaine University).</column>
        </table>
        <table name="target">
            <column name="TargetID">129</column>
            <column name="TargetName">Anti-P24 monoclonal antibody 13b5</column>
            <column name="TargetSynonyms">Mab 13b5</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:12084541 , GI:12084542 </column>
            <column name="TargetStructure">1E6J, 1E6O</column>
            <column name="TargetComments">The monoclonal antibody 13B5 is derived from immunization of mice with a 243-residue recombinant P24 protein of HIV-1 strain HXB2 (which is designated RH24 ). Mab 13b5 is a mouse monoclonal IgG1κ antibody, which is available from bioMérieux.</column>
        </table>
        <table name="target">
            <column name="TargetID">130</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody CG10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">131</column>
            <column name="TargetName">T-cell surface glycoprotein YE1/48</column>
            <column name="TargetSynonyms">T lymphocyte antigen A1
Lymphocyte antigen 49a, Ly-49a</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P20937</column>
            <column name="TargetStructure">1QO3</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">132</column>
            <column name="TargetName">Anti-LPS monoclonal monoclonal MoAb 9-2-L3,7,9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MoAb 9-2-L3,7,9 is mouse immunoglobulin
(Ig)G2A and reactive against Neisseria meningococcal LPS immunotype L3,7,9.</column>
        </table>
        <table name="target">
            <column name="TargetID">133</column>
            <column name="TargetName">Anti-LPS monoclonal monoclonal MoAb 1-6-C</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MoAb 1-6-C is mouse immunoglobulin
IgG1 and reactive against Neisseria meningococci group-C PS.</column>
        </table>
        <table name="target">
            <column name="TargetID">134</column>
            <column name="TargetName">Anti-LPS monoclonal monoclonal MoAb 4-2-C</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MoAb 1-6-C is mouse immunoglobulin
IgG3 and reactive against Neisseria meningococci group-C PS.</column>
        </table>
        <table name="target">
            <column name="TargetID">135</column>
            <column name="TargetName">Anti-LPS monoclonal monoclonal MoAbR3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MoAb 1-6-C is mouse immunoglobulin
IgM and reactive against C1qR(P).</column>
        </table>
        <table name="target">
            <column name="TargetID">136</column>
            <column name="TargetName">Matrix metalloproteinase-9, MMP-9</column>
            <column name="TargetSynonyms">92 kDa type IV collagenase
92 kDa gelatinase
Gelatinase B, GELB
EC=3.4.24.35</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P14780</column>
            <column name="TargetStructure">1GKC, 1GKD, 1ITV, 1L6J, 2OVX, 2OVZ, 2OW0, 2OW1, 2OW2, 4H1Q, 4H2E, 4H3X, 4H82, 4HMA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">137</column>
            <column name="TargetName">Anti-ferritin polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Polyclonal mouse antisera against recombinant SjFer were collected after the third immunization. Specific IgG was purified by saturated ammonium sulphate precipitation.</column>
        </table>
        <table name="target">
            <column name="TargetID">138</column>
            <column name="TargetName">Anti-FASLG receptor monoclonal antibody SA-7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">139</column>
            <column name="TargetName">Anti-FASLG receptor monoclonal antibody SA-8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">140</column>
            <column name="TargetName">Synapsin-1</column>
            <column name="TargetSynonyms">Synapsin I</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P17599</column>
            <column name="TargetStructure">1AUV, 1AUX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">141</column>
            <column name="TargetName">Anti-GD2 monoclonal antibody 14G2a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">142</column>
            <column name="TargetName">96-well immunoassay plate (polystyrene, PS)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">143</column>
            <column name="TargetName">Anti-M. hyopneumoniae polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IgG was purified from antiserum by a modified protein-A method.</column>
        </table>
        <table name="target">
            <column name="TargetID">144</column>
            <column name="TargetName">Galectin-1, Gal-1</column>
            <column name="TargetSynonyms">Lectin galactoside-binding soluble 1
Beta-galactoside-binding lectin L-14-I
Lactose-binding lectin 1
S-Lac lectin 1
Galaptin
14 kDa lectin
HPL
HBL
Putative MAPK-activating protein PM12
14 kDa laminin-binding protein, HLBP14</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P09382</column>
            <column name="TargetStructure">1GZW, 1W6M, 1W6N, 1W6O, 1W6P, 1W6Q, 2KM2, 2ZKN, 3OY8, 3OYW, 3T2T</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">145</column>
            <column name="TargetName">16 kDa beta-galactoside-binding lectin</column>
            <column name="TargetSynonyms">C-16
Galectin CG-16</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P23668</column>
            <column name="TargetStructure">1QMJ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">146</column>
            <column name="TargetName">Calpain-1 catalytic subunit</column>
            <column name="TargetSynonyms">Calpain-1 large subunit
Calcium-activated neutral proteinase 1, CANP 1
Calpain mu-type
Micromolar-calpain, muCANP
Cell proliferation-inducing gene 30 protein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07384</column>
            <column name="TargetStructure">1ZCM, 2ARY</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">147</column>
            <column name="TargetName">Anti-P25-LHRH polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The specificities of immunoglobulin G antibodies were obtained from the sera of dogs inoculated with totally synthetic immunocontraceptive vaccine candidates based on P25 (KLIPNASLIENCTKAEL) and luteinising hormone releasing hormone (LHRH: amino acid sequence HWSYGLRPG).</column>
        </table>
        <table name="target">
            <column name="TargetID">148</column>
            <column name="TargetName">Anti-P27-LHRH polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The specificities of immunoglobulin G antibodies were obtained from the sera of dogs inoculated with totally synthetic immunocontraceptive vaccine candidates based on P27 (AELGEYEKLLNSVLEPI) and luteinising hormone releasing hormone (LHRH: amino acid sequence HWSYGLRPG).</column>
        </table>
        <table name="target">
            <column name="TargetID">149</column>
            <column name="TargetName">Anti-P35-LHRH polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The specificities of immunoglobulin G antibodies were obtained from the sera of dogs inoculated with totally synthetic immunocontraceptive vaccine candidates based on P35 (TAAQITAGIALHQSNLN) and luteinising hormone releasing hormone (LHRH: amino acid sequence HWSYGLRPG).</column>
        </table>
        <table name="target">
            <column name="TargetID">150</column>
            <column name="TargetName">NeutrAvidin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">151</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P1 (2C3D4)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">152</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P2 (8C6C4A12)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">153</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P4 (2D2A12G3)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">154</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P5 (15BC2G1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">155</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P6 (1B4D3F10)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">156</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P7 (16B1C9H7)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">157</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P9 (4A2D5D6)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">158</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P10 (1A4B10E1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">159</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P17 (8C1E11)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">160</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody F11 (9B4C1D8)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">161</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody F20 (9A4G1A8)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">162</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody F21 (9A5A11A11)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">163</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody P20 (7A5F12)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">164</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody LD5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">165</column>
            <column name="TargetName">Anti-leptospira monoclonal antibody LF9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">166</column>
            <column name="TargetName">Anti-leptospira polyclonal antibody 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">167</column>
            <column name="TargetName">Anti-leptospira polyclonal antibody 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">168</column>
            <column name="TargetName">Anti-leptospira polyclonal antibody 3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">169</column>
            <column name="TargetName">Anti-leptospira polyclonal antibody 4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">170</column>
            <column name="TargetName">Anti-ManLAM monoclonal antibody CS40</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">171</column>
            <column name="TargetName">Anti-RAPs polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-RAPs antibodies were purified by applying the sera to an affinity column (rProteinA FF resin, Amersham Pharmacia) according to the manufacturers instructions. Antibodies were eluted with 0.2M Gly-HCl (pH 3.0).</column>
        </table>
        <table name="target">
            <column name="TargetID">172</column>
            <column name="TargetName">Anti-PDC-E2 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The sera used were from individuals with typical PBC. IgG was prepared from the sera by affinity purification on protein A Sepharose (Pharmacia, Uppsala, Sweden).</column>
        </table>
        <table name="target">
            <column name="TargetID">173</column>
            <column name="TargetName">Anti-Gb3 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">174</column>
            <column name="TargetName">Recombinant protein N36(L8)C34</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human immunodeficiency virus 1:11676</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">N36(L8)C34 is a model of the  HIV-1gp41 core, , a six-helix bundle formed between the N- and C-terminal heptad repeats. For expression of N36(L8)C34, the gene fragments coding for N36 (spanning residues 546-581 in gp41) and C34 (spanning 628-661 in gp41) were PCR-amplified, respectively, from the corresponding plasmid coding gp160 with the primers.</column>
        </table>
        <table name="target">
            <column name="TargetID">175</column>
            <column name="TargetName">Polyglutamine containing 62 consecutive glutamines</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">176</column>
            <column name="TargetName">UDP-N-acetylmuramoylalanine--D-glutamate ligase</column>
            <column name="TargetSynonyms">UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase
D-glutamic acid-adding enzyme
EC=6.3.2.9</column>
            <column name="TargetSource">Pseudomonas aeruginosa:287</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q9HVZ9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">177</column>
            <column name="TargetName">Trisialogangliosides (GT1b), NGF-differentiated PC12 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">178</column>
            <column name="TargetName">XGC9811-L cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The human gastric carcinoma cell line XGC9811 was inoculated into nude mice by tail vein injection. After 3-4 weeks, the mice were killed and a few liver-metastatic nodules were harvested aseptically. Single cell suspensions were made by mincing and trypsinization and were cultured in vitro. The cells in this culture were designated as XGC9811-L1. The same procedure was repeated using XGC9811-L1 cells and the XGC9811-L cell line was established upon the fourth cycle of stepwise selection.</column>
        </table>
        <table name="target">
            <column name="TargetID">179</column>
            <column name="TargetName">Integrin alpha-X-beta-2, integrin αxβ2</column>
            <column name="TargetSynonyms">Integrin alpha-X alternative name(s):
Leukocyte adhesion glycoprotein p150,95 alpha chain
Leukocyte adhesion receptor p150,95
Leu M5
CD11 antigen-like family member C
CD_antigen=CD11c

Integrin beta-2 alternative name(s):
Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
Complement receptor C3 subunit beta
CD_antigen=CD18</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-X: P20702, Integrin beta-2: P05107</column>
            <column name="TargetStructure">Integrin alpha-X: 1N3Y, 2LUV, 3K6S, 3K71, 3K72
Integrin beta-2: 1L3Y, 1YUK, 2JF1, 2P26, 2P28, 2V7D, 3K6S, 3K71, 3K72</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">180</column>
            <column name="TargetName">Integrin alpha-M-beta-2, integrin αmβ2</column>
            <column name="TargetSynonyms">Integrin alpha-M alternative name(s):
Cell surface glycoprotein MAC-1 subunit alpha
CR-3 alpha chain
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD11 antigen-like family member B
CD_antigen=CD11b

Integrin beta-2 alternative name(s):
Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
Complement receptor C3 subunit beta
CD_antigen=CD18</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-M: P11215, Integrin beta-2: P05107</column>
            <column name="TargetStructure">Integrin alpha-M: 1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3
Integrin beta-2: 1L3Y, 1YUK, 2JF1, 2P26, 2P28, 2V7D, 3K6S, 3K71, 3K72</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">181</column>
            <column name="TargetName">DNA topoisomerase 1</column>
            <column name="TargetSynonyms">DNA topoisomerase I
EC=5.99.1.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P11387</column>
            <column name="TargetStructure">1A31, 1A35, 1A36, 1EJ9, 1K4S, 1K4T, 1LPQ, 1NH3, 1R49, 1RR8, 1RRJ, 1SC7, 1SEU, 1T8I, 1TL8</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">182</column>
            <column name="TargetName">Anthrax toxin receptor 1</column>
            <column name="TargetSynonyms">Tumor endothelial marker 8</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q9H6X2</column>
            <column name="TargetStructure">3N2N</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">183</column>
            <column name="TargetName">Anthrax toxin receptor 2</column>
            <column name="TargetSynonyms">Capillary morphogenesis gene 2 protein, CMG-2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P58335</column>
            <column name="TargetStructure">1SHT, 1SHU, 1T6B, 1TZN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">184</column>
            <column name="TargetName">Hepatoma cell line SMMC-7721</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">185</column>
            <column name="TargetName">RNA-directed RNA polymerase NS5B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Hepatitis C virus:11103</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">186</column>
            <column name="TargetName">Plasmodium falciparum-infected red blood cells (iRBCs)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">187</column>
            <column name="TargetName">Nontypeable Haemophilus influenzae, strain R2866</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Haemophilus influenzae (strain R2866):262728</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Nontypeable Haemophilus influenzae (NTHi) is an obligate parasite of the oropharynx of humans, in whom it commonly causes mucosal infections such as otitis media, sinusitis, and bronchitis.</column>
        </table>
        <table name="target">
            <column name="TargetID">188</column>
            <column name="TargetName">Anti-sperm polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">189</column>
            <column name="TargetName">Newcastle disease virus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Newcastle disease virus:11176</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">190</column>
            <column name="TargetName">Anti-NS4A monoclonal antibody 2E3C2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">191</column>
            <column name="TargetName">Hepatocellular carcinoma cell lines BEL-7402</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">192</column>
            <column name="TargetName">Monoclonal antibody CM22 IgM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">193</column>
            <column name="TargetName">Silver nanowires</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">194</column>
            <column name="TargetName">Anti-tenascin-C monoclonal antibody ST2146</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Production of ST2146 was carried out through cultivation of cST2146 hybridoma cells in protein-free medium, in a 2 L perfusion MD2 bioreactor.</column>
        </table>
        <table name="target">
            <column name="TargetID">195</column>
            <column name="TargetName">Anti-MC-LR monoclonal antibody MC10E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">196</column>
            <column name="TargetName">Anti-dsDNA polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">197</column>
            <column name="TargetName">Endothelial protein C receptor</column>
            <column name="TargetSynonyms">Endothelial cell protein C receptor
Activated protein C receptor, APC receptor
CD_antigen=CD201</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q9UNN8</column>
            <column name="TargetStructure">1L8J, 1LQV, 3JTC</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">198</column>
            <column name="TargetName">Anti-CCR5 monoclonal antibody 3A9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">199</column>
            <column name="TargetName">PreS domain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Hepatitis B virus (HBV):10407</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">200</column>
            <column name="TargetName">Pesticidal crystal protein cry11Aa</column>
            <column name="TargetSynonyms">Insecticidal delta-endotoxin CryXIA(a)
Crystaline entomocidal protoxin
72 kDa crystal protein</column>
            <column name="TargetSource">Bacillus thuringiensis subsp. israelensis:1430</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P21256</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">201</column>
            <column name="TargetName">Anti-GD2 monoclonal antibody ch14.18</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606, Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mouse-human chimeric antibody ch14.18, a chimeric IgG antibody, directed against the disialoganglioside GD2, was constructed by joining the cDNA for the variable region of the murine monoclonal antibody 14.18 with human gamma 1 constant region.</column>
        </table>
        <table name="target">
            <column name="TargetID">202</column>
            <column name="TargetName">Anti-tumor monoclonal antibody BAT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">203</column>
            <column name="TargetName">Human pancreatic adenocarcinoma cell line Capan-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">204</column>
            <column name="TargetName">C-C motif chemokine 2</column>
            <column name="TargetSynonyms">Small-inducible cytokine A2
Monocyte chemoattractant protein 1
Monocyte chemotactic protein 1, MCP-1
Monocyte chemotactic and activating factor, MCAF
Monocyte secretory protein JE
HC11</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P13500</column>
            <column name="TargetStructure">1DOK, 1DOL, 1DOM, 1DON, 1ML0, 2BDN, 2NZ1, 3IFD, 4DN4</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">205</column>
            <column name="TargetName">Trisialogangliosides (GT1b)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">206</column>
            <column name="TargetName">Anti-EGF monoclonal antibody EGF-10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">207</column>
            <column name="TargetName">Src SH2-GST fused protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">208</column>
            <column name="TargetName">PTP-alpha-GST fused protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">209</column>
            <column name="TargetName">PTP1B-GST fused protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">210</column>
            <column name="TargetName">Anti-gE monoclonal antibody 14B11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">211</column>
            <column name="TargetName">Anti-gE monoclonal antibody 13E8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">212</column>
            <column name="TargetName">Anti-gE monoclonal antibody 17C9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">213</column>
            <column name="TargetName">Anti-gE monoclonal antibody 8G11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">214</column>
            <column name="TargetName">Amino acid 27-135 of SLAM</column>
            <column name="TargetSynonyms">Signaling lymphocytic activation molecule
IPO-3
CDw150
CD_antigen=CD150</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q13291</column>
            <column name="TargetStructure">1D4T, 1D4W, 1KA6, 1KA7, 1M27</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">215</column>
            <column name="TargetName">Anti-phl p 5a monoclonal antibody IgE</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Phl p 5a-specific IgE was purified from patient sera by means of affinity chromatography.</column>
        </table>
        <table name="target">
            <column name="TargetID">216</column>
            <column name="TargetName">Long neurotoxin 1</column>
            <column name="TargetSynonyms">Neurotoxin 3
Alpha-cobratoxin, Alpha-CbT, Cbtx</column>
            <column name="TargetSource">Naja kaouthia (Monocled cobra) (Naja siamensis):8649</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01391</column>
            <column name="TargetStructure">1CTX, 1LXG, 1LXH, 1YI5, 4AEA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">217</column>
            <column name="TargetName">Anti-MBP monoclonal antibody MK16 Fab</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MK16 is a murine antibody directed against the multiple sclerosis associated human MHC class II molecule HLA-DR2b (DR2b) in complex with a myelin basic protein (MBP)-derived peptide corresponding to residues 85-99 (MBP 85-99).</column>
        </table>
        <table name="target">
            <column name="TargetID">218</column>
            <column name="TargetName">Cerebellar granule neurons</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">219</column>
            <column name="TargetName">Self-assembled monolayer (SAM) of a Gb3 mimic</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">220</column>
            <column name="TargetName">Anti-collagen alpha-1(II) chain monoclonal antibody CB268</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">221</column>
            <column name="TargetName">Anti-collagen alpha-1(II) chain monoclonal antibody CII-C1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:170292415; GI:170292416</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">CII-C1 was derived from a mouse of the DBA/1 strain, susceptible to collagen-induced arthritis, after immunization with native chicken type II collagen; it reacts with native helical type II collagen but not with the isolated chains of denatured collagen. Isotype: IgG2a, kappa.</column>
        </table>
        <table name="target">
            <column name="TargetID">222</column>
            <column name="TargetName">Anti-nucleosome monoclonal antibody #32</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">223</column>
            <column name="TargetName">GST A1-1 fused protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">224</column>
            <column name="TargetName">GST P1-1 fused protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">225</column>
            <column name="TargetName">GST M2-2 fused protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">226</column>
            <column name="TargetName">Anti-MCPS monoclonal antibody 1E4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">227</column>
            <column name="TargetName">psi RNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human immunodeficiency virus 1:11676</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">228</column>
            <column name="TargetName">Silicon dioxide, SiO2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">229</column>
            <column name="TargetName">Laminin-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">230</column>
            <column name="TargetName">Heat shock protein HSP 90-beta, HSP 90</column>
            <column name="TargetSynonyms">Heat shock 84 kDa, HSP 84, HSP84</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P08238</column>
            <column name="TargetStructure">1QZ2, 1UYM, 3NMQ, 3PRY</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">231</column>
            <column name="TargetName">E3 ubiquitin-protein ligase NEDD4</column>
            <column name="TargetSynonyms">Neural precursor cell expressed developmentally down-regulated protein 4, NEDD-4
Cell proliferation-inducing gene 53 protein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P46934</column>
            <column name="TargetStructure">2KPZ, 2KQ0, 2XBB, 2XBF, 3B7Y, 4BBN, 4BE8</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">232</column>
            <column name="TargetName">Death-associated protein kinase 3</column>
            <column name="TargetSynonyms">DAP kinase 3
DAP-like kinase, Dlk
ZIP-kinase
EC=2.7.11.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">O43293</column>
            <column name="TargetStructure">1YRP, 2J90, 3BHY, 3BQR</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">233</column>
            <column name="TargetName">E3 ubiquitin-protein ligase Mdm2</column>
            <column name="TargetSynonyms">p53-binding protein Mdm2
Oncoprotein Mdm2
Double minute 2 protein, Hdm2
EC=6.3.2.-</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q00987</column>
            <column name="TargetStructure">1RV1, 1T4E, 1T4F, 1YCR, 1Z1M, 2AXI, 2C6A, 2C6B, 2F1Y, 2FOP, 2GV2, 2HDP, 2LZG, 2M86, 2RUH, 2VJE, 2VJF, 3EQS, 3G03, 3IUX, 3IWY, 3JZK, 3JZR, 3JZS, 3LBK, 3LBL, 3LNJ, 3LNZ, 3MQS, 3TJ2, 3TPX, 3TU1, 3V3B, 3VBG, 3VZV, 3W69, 4DIJ, 4ERE, 4ERF, 4HBM, 4HFZ, 4HG7, 4JV7, 4JV9, 4JVE, 4JVR, 4JWR, 4MDN, 4MDQ, 4OAS, 4OBA, 4OCC, 4ODE, 4ODF, 4OGN, 4OGT, 4OGV, 4OQ3, 4QO4, 4QOC, 4UMN, 4WT2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">234</column>
            <column name="TargetName">Anti-LAM monoclonal antibody CS-35</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">An immunoglobulin G3 (IgG3) anti-LAM mouse MAb, MAb CS-35, was acquired as a tissue culture supernatant in RPMI medium containing 10% fetal calf serum.</column>
        </table>
        <table name="target">
            <column name="TargetID">235</column>
            <column name="TargetName">Anti-BCG polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Rabbits were similarly immunized with heat-killed whole M. bovis BCG cells, and a panel of sera which should contain polyclonal antibodies that mainly recognize surface-exposed mycobacterial antigens was thus raised.</column>
        </table>
        <table name="target">
            <column name="TargetID">236</column>
            <column name="TargetName">Anti-p22 monoclonal antibody NS1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">237</column>
            <column name="TargetName">Anti-p22 monoclonal antibody NS2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">238</column>
            <column name="TargetName">Anti-p22 monoclonal antibody NS5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">239</column>
            <column name="TargetName">Anti-p22 monoclonal antibody CS6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">240</column>
            <column name="TargetName">Anti-p22 monoclonal antibody CS8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">241</column>
            <column name="TargetName">Anti-p22 monoclonal antibody CS9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">242</column>
            <column name="TargetName">Mouse pancreas</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">243</column>
            <column name="TargetName">Human gastric cancer cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">244</column>
            <column name="TargetName">C57Bl/6 female mice muscle</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">245</column>
            <column name="TargetName">C57Bl/6 female mice pancreas</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">246</column>
            <column name="TargetName">C57Bl/6 female mice brain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">247</column>
            <column name="TargetName">C57Bl/6 female mice kidney</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">248</column>
            <column name="TargetName">C57Bl/6 female mice uterus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">249</column>
            <column name="TargetName">C57Bl/6 female mice bowel</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">250</column>
            <column name="TargetName">Vascular cell adhesion protein 1, V-CAM 1, VCAM-1</column>
            <column name="TargetSynonyms">CD_antigen=CD106</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P29533</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">251</column>
            <column name="TargetName">Mouse abdominal skin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">252</column>
            <column name="TargetName">V-type proton ATPase 116 kDa subunit a isoform 4</column>
            <column name="TargetSynonyms">V-ATPase 116 kDa isoform a4
Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4
Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9HBG4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">253</column>
            <column name="TargetName">Vascular endothelial growth factor A, VEGF-A</column>
            <column name="TargetSynonyms">Vascular permeability factor, VPF</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P15692</column>
            <column name="TargetStructure">1BJ1, 1CZ8, 1FLT, 1KAT, 1KMX, 1MJV, 1MKG, 1MKK, 1QTY, 1TZH, 1TZI, 1VGH, 1VPF, 1VPP, 2FJG, 2FJH, 2QR0, 2VGH, 2VPF, 3BDY, 3P9W, 3QTK, 3S1B, 3S1K, 3V2A, 4DEQ, 4GLN, 4GLS, 4KZN, 4QAF, 4WPB</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">254</column>
            <column name="TargetName">Mouse brain microvasculature</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">255</column>
            <column name="TargetName">Phenoxibenzoic acid-polyclonal antibody complex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">256</column>
            <column name="TargetName">Umbilical endothelial cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">257</column>
            <column name="TargetName">Proteinase K</column>
            <column name="TargetSynonyms">Tritirachium alkaline proteinase
Endopeptidase K
EC=3.4.21.64</column>
            <column name="TargetSource">Tritirachium album (Engyodontium album):37998</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P06873</column>
            <column name="TargetStructure">1BJR, 1CNM, 1EGQ, 1HT3, 1IC6, 1OYO, 1P7V, 1P7W, 1PEK, 1PFG, 1PJ8, 1PTK, 2DP4, 2DQK, 2DUJ, 2G4V, 2HD4, 2HPZ, 2ID8, 2PKC, 2PQ2, 2PRK, 2PWA, 2PWB, 2PYZ, 2V8B, 3AJ8, 3AJ9, 3D9Q, 3DDZ, 3DE0, 3DE1, 3DE2, 3DE3, 3DE4, 3DE5, 3DE6, 3DE7, 3DVQ, 3DVR, 3DVS, 3DW1, 3DW3, 3DWE, 3DYB, 3GT3, 3GT4, 3I2Y, 3I30, 3I34, 3I37, 3L1K, 3OSZ, 3PRK, 3PTL, 3Q40, 3Q5G, 3QMP, 4B5L, 4DJ5, 4FON</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">258</column>
            <column name="TargetName">Cathepsin S</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P25326</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">259</column>
            <column name="TargetName">Hronchial epithelial cells (16HBE14o-)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">260</column>
            <column name="TargetName">EGTA-treated 16HBE14o- cell monolayers</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">261</column>
            <column name="TargetName">A disintegrin and metalloproteinase with thrombospondin motifs 4</column>
            <column name="TargetSynonyms">ADAMTS-4, ADAM-TS 4, ADAM-TS4
Aggrecanase-1
ADMP-1
EC=3.4.24.82</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">O75173</column>
            <column name="TargetStructure">2RJP, 3B2Z</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">262</column>
            <column name="TargetName">Human primary atherosclerotic tissues</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">263</column>
            <column name="TargetName">Melanin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">264</column>
            <column name="TargetName">HBJ127</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">265</column>
            <column name="TargetName">Kasumi-1 acute myeloid leukemia cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">266</column>
            <column name="TargetName">Hepatocellular carcinoma cell line HCCLM3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">267</column>
            <column name="TargetName">Human epidermoid carcinoma A431 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">268</column>
            <column name="TargetName">Genhance 680, GH680</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">269</column>
            <column name="TargetName">HT-1376 human bladder tumor cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">270</column>
            <column name="TargetName">Anti-HAV polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">271</column>
            <column name="TargetName">Non-small cell lung cancer (CL1-5)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">272</column>
            <column name="TargetName">Seam 3 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Seam-3 is a protective monoclonal antibody agaimst Neisseria meningitidis serogroup B capsular polysaccharide.</column>
        </table>
        <table name="target">
            <column name="TargetID">273</column>
            <column name="TargetName">Peroxisome proliferator-activated receptor gamma, PPAR-gamma</column>
            <column name="TargetSynonyms">Nuclear receptor subfamily 1 group C member 3</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P37231</column>
            <column name="TargetStructure">1FM6, 1FM9, 1I7I, 1K74, 1KNU, 1NYX, 1PRG, 1RDT, 1WM0, 1ZEO, 1ZGY, 2ATH, 2F4B, 2FVJ, 2G0G, 2G0H, 2GTK, 2HFP, 2HWQ, 2HWR, 2I4J, 2I4P, 2I4Z, 2OM9, 2P4Y, 2POB, 2PRG, 2Q59, 2Q5P, 2Q5S, 2Q61, 2Q6R, 2Q6S, 2Q8S, 2QMV, 2VSR, 2VST, 2VV0, 2VV1, 2VV2, 2VV3, 2VV4, 2XKW, 2YFE, 2ZK0, 2ZK1, 2ZK2, 2ZK3, 2ZK4, 2ZK5, 2ZK6, 2ZNO, 2ZVT, 3ADS, 3ADT, 3ADU, 3ADV, 3ADW, 3ADX, 3AN3, 3AN4, 3B0Q, 3B0R, 3B1M, 3B3K, 3BC5, 3CDP, 3CDS, 3CS8, 3CWD, 3D6D, 3DZU, 3DZY, 3E00, 3ET0, 3ET3, 3FEJ, 3FUR, 3G9E, 3GBK, 3H0A, 3HO0, 3HOD, 3IA6, 3K8S, 3KMG, 3LMP, 3NOA, 3OSI, 3OSW, 3PBA, 3PO9, 3PRG, 3QT0, 3R5N, 3R8A, 3R8I, 3S9S, 3SZ1, 3T03, 3TY0, 3U9Q, 3V9T, 3V9V, 3V9Y, 3VJH, 3VJI, 3VN2, 3VSO, 3VSP, 4A4V, 4A4W, 4E4K, 4E4Q, 4EM9, 4EMA, 4F9M, 4FGY, 4PRG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">274</column>
            <column name="TargetName">Anti-MUC1 monoclonal antibody PR81</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PR81 MAb is a murine IgG1 kappa light chain monoclonal antibody raised against human MUC1.</column>
        </table>
        <table name="target">
            <column name="TargetID">275</column>
            <column name="TargetName">Gamma-aminobutyric acid receptor-associated protein</column>
            <column name="TargetSynonyms">GABA(A) receptor-associated protein
MM46</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O95166</column>
            <column name="TargetStructure">1GNU, 1KLV, 1KM7, 1KOT, 3D32, 3DOW, 3WIM, 4XC2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">276</column>
            <column name="TargetName">Anti-HGF-cMET monoclonal antibody SFN68</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986, Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">SFN68 is derived from a rabbit/human chimeric Fab library constructed using phage display after immunization with HGF-cMet complex. Its isotype is IgG1. SFN68 Fab was immobilized to the microtiter plates via mouse anti-HA antibody and then used for panning.</column>
        </table>
        <table name="target">
            <column name="TargetID">277</column>
            <column name="TargetName">Anti-GMDP monoclonal antibody E6/1.2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">278</column>
            <column name="TargetName">Beta amyloid peptide (12-28)</column>
            <column name="TargetSynonyms">Amyloid beta A4 protein
Alzheimer disease amyloid protein
ABPP
APPI, APP
PreA4
Cerebral vascular amyloid peptide, CVAP
Protease nexin-II, PN-II</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05067 [12-28]</column>
            <column name="TargetStructure">1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">279</column>
            <column name="TargetName">Beta amyloid peptide (25-35)</column>
            <column name="TargetSynonyms">Amyloid beta A4 protein
Alzheimer disease amyloid protein
ABPP
APPI, APP
PreA4
Cerebral vascular amyloid peptide, CVAP
Protease nexin-II, PN-II</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05067 [25-35]</column>
            <column name="TargetStructure">1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">280</column>
            <column name="TargetName">Beta-amyloid protein 42</column>
            <column name="TargetSynonyms">Beta-APP42</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05067 [672-713]</column>
            <column name="TargetStructure">1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">281</column>
            <column name="TargetName">Beta amyloid peptide (1-20)</column>
            <column name="TargetSynonyms">Amyloid beta A4 protein
Alzheimer disease amyloid protein
ABPP
APPI, APP
PreA4
Cerebral vascular amyloid peptide, CVAP
Protease nexin-II, PN-II</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05067 [1-20]</column>
            <column name="TargetStructure">1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">282</column>
            <column name="TargetName">Anti-PYANPSL polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-PYANPSL IgG was purified from serum of mice immunized with KLH-PYANPSL conjugate. Anti-KLH mouse IgG were used in panning to remove either anti-peptide IgG allotype/isotype-matched IgG or anti-KLH Ig-specific phage particles.</column>
        </table>
        <table name="target">
            <column name="TargetID">283</column>
            <column name="TargetName">Anti-WAANPSM polyclonal antibody  IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-WAANPSM IgG was purified from serum of mice immunized with KLH-WAANPSM conjugate. Anti-KLH mouse IgG were used in panning to remove either anti-peptide IgG allotype/isotype-matched IgG or anti-KLH Ig-specific phage particles.</column>
        </table>
        <table name="target">
            <column name="TargetID">284</column>
            <column name="TargetName">Tumor-associated glycoprotein (TAG-72)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human tumor-associated glycoprotein (TAG-72) is a mucin-like molecules that is expressed on a variety of epithelial malignancies.</column>
        </table>
        <table name="target">
            <column name="TargetID">285</column>
            <column name="TargetName">Nasopharyngeal carcinoma cell CEN-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">286</column>
            <column name="TargetName">l,2-Dioleoyl-sn-glycero-3-phosphatidylserine</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Phosphatidylserine (PS) is a well-characterized biomarker for apoptosis.</column>
        </table>
        <table name="target">
            <column name="TargetID">287</column>
            <column name="TargetName">Mouse inflammatory small bowel</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The bowel was removed from 8-week-old male C57BL/6Ncrj mice. The reaction mixture was first incubated with normal small bowel for 10 min at 37a</column>
        </table>
        <table name="target">
            <column name="TargetID">288</column>
            <column name="TargetName">Human blood outgrowth endothelial cells, HBOEC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">289</column>
            <column name="TargetName">Beta-nerve growth factor, Beta-NGF</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01138</column>
            <column name="TargetStructure">1SG1, 1WWW, 2IFG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">290</column>
            <column name="TargetName">Gonadotropin-releasing hormone promoter (GP) </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">291</column>
            <column name="TargetName">Human rotavirus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rotavirus:10912</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">292</column>
            <column name="TargetName">Hepatocellular carcinoma cell line HepG2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">293</column>
            <column name="TargetName">Colon cancer cell line SW480</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">294</column>
            <column name="TargetName">Hepatocyte growth factor receptor</column>
            <column name="TargetSynonyms">HGF receptor
Scatter factor receptor, SF receptor
HGF/SF receptor
Tyrosine-protein kinase Met
Proto-oncogene c-Met
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P08581</column>
            <column name="TargetStructure">1FYR, 1R0P, 1R1W, 1SHY, 1SSL, 2G15, 2RFN, 2RFS, 2UZX, 2UZY, 2WD1, 2WGJ, 2WKM, 3A4P, 3BUX, 3C1X, 3CCN, 3CD8, 3CE3, 3CTH, 3CTJ, 3DKC, 3DKF, 3DKG, 3EFJ, 3EFK, 3F66, 3F82, 3I5N, 3L8V, 3LQ8, 3Q6U, 3Q6W, 3QTI, 3R7O, 3RHK, 3U6H, 3U6I, 3VW8, 3ZBX, 3ZC5, 3ZCL, 3ZXZ, 3ZZE, 4AOI, 4AP7, 4DEG, 4DEH, 4DEI, 4EEV, 4GG5, 4GG7, 4IWD, 4K3J, 4KNB, 4MXC, 4O3T, 4O3U, 4R1V, 4R1Y, 4XMO, 4XYF</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">295</column>
            <column name="TargetName">Thyroid follicular carcinoma cell line FRO82-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">296</column>
            <column name="TargetName">Arabidopsis Fip1 ortholog encoded by At5g58040 (AtFip1[V])</column>
            <column name="TargetSynonyms">Genomic DNA, chromosome 5, TAC clone:K21L19</column>
            <column name="TargetSource">Arabidopsis thaliana (Mouse-ear cress):3702</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9FGU0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">297</column>
            <column name="TargetName">Glioma cell line 9L</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">298</column>
            <column name="TargetName">Anti-ACE monoclonal antibody CG1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">299</column>
            <column name="TargetName">Anti-B-subtype HIV-1 polyclonal antibody pre-HAART IgG from Patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">300</column>
            <column name="TargetName">Anti-B-subtype HIV-1 polyclonal antibody  post-HAART IgG from Patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">301</column>
            <column name="TargetName">Anti-B-subtype HIV-1 polyclonal antibody pre-HAART IgG from Patient 3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">302</column>
            <column name="TargetName">Vascular endothelial growth factor receptor 3, VEGFR-3</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase receptor FLT4
Fms-like tyrosine kinase 4, FLT-4
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P35916</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">303</column>
            <column name="TargetName">Anti-mycobacterial HSP60 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">304</column>
            <column name="TargetName">Paracetamol(4-acetamidophenol, 4AAP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">305</column>
            <column name="TargetName">Anti-CD4 monoclonal antibody 5145A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">306</column>
            <column name="TargetName">Anti-A. paragallinarum strain 0083 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">307</column>
            <column name="TargetName">serine repeat antigen 5, SERA5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Plasmodium falciparum:5833</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">308</column>
            <column name="TargetName">Acute myeloid leukemia cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human acute myeloid leukemia cells are freshly obtained from AML from patients.</column>
        </table>
        <table name="target">
            <column name="TargetID">309</column>
            <column name="TargetName">Sin Nombre virus (SNV) strain SN77734</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sin Nombre virus:37705</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">310</column>
            <column name="TargetName">Cysteine-rich protein 1, CRP-1</column>
            <column name="TargetSynonyms">Cysteine-rich intestinal protein, CRIP
Cysteine-rich heart protein, CRHP, hCRHP</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P50238</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">311</column>
            <column name="TargetName">Fresh human colonic adenomas</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">312</column>
            <column name="TargetName">Anti-ErbB2 monoclonal antibody A21</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">313</column>
            <column name="TargetName">Anti-SHIV polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Macaca mulatta (Rhesus macaque):9544</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">314</column>
            <column name="TargetName">Colon cancer cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">315</column>
            <column name="TargetName">Kallikrein-1</column>
            <column name="TargetSynonyms">Tissue kallikrein
Kidney/pancreas/salivary gland kallikrein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P06870</column>
            <column name="TargetStructure">1SPJ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">316</column>
            <column name="TargetName">Kallikrein-6</column>
            <column name="TargetSynonyms">Protease M
Neurosin
Zyme
SP59
Serine protease 9
Serine protease 18
EC=3.4.21.-</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q92876</column>
            <column name="TargetStructure">1GVL, 1L2E, 1LO6, 3VFE, 4D8N</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">317</column>
            <column name="TargetName">Large intestinal cancer cell line LoVo</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">318</column>
            <column name="TargetName">Claudin-4</column>
            <column name="TargetSynonyms">Clostridium perfringens enterotoxin receptor, CPE-receptor, CPE-R</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">O35054</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">319</column>
            <column name="TargetName">Hepatocellular carcinoma line Mahlavu</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">320</column>
            <column name="TargetName">HEK293 cells transfected with hFcRn and hβ2m (293c11)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">321</column>
            <column name="TargetName">Acute T-lymphoblastic leukemia Molt-4 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">322</column>
            <column name="TargetName">Chymotrypsinogen A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00766</column>
            <column name="TargetStructure">1AB9, 1ACB, 1AFQ, 1CA0, 1CBW, 1CGI, 1CGJ, 1CHG, 1CHO, 1DLK, 1EX3, 1GCD, 1GCT, 1GG6, 1GGD, 1GHA, 1GHB, 1GL0, 1GL1, 1GMC, 1GMD, 1GMH, 1HJA, 1K2I, 1MTN, 1N8O, 1OXG, 1P2M, 1P2N, 1P2O, 1P2Q, 1T7C, 1T8L, 1T8M, 1T8N, 1T8O, 1VGC, 1YPH, 2CGA, 2CHA, 2GCH, 2GCT, 2GMT, 2P8O, 2VGC, 2Y6T, 3BG4, 3GCH, 3GCT, 3RU4, 3T62, 3VGC, 4CHA, 4GCH, 4VGC, 5CHA, 5GCH, 6CHA, 6GCH, 7GCH, 8GCH</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">323</column>
            <column name="TargetName">Chitinase A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Serratia marcescens:615</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07254</column>
            <column name="TargetStructure">1CTN, 1EHN, 1EIB, 1FFQ, 1FFR, 1K9T, 1NH6, 1RD6, 1X6L, 1X6N, 2WK2, 2WLZ, 2WM0</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">324</column>
            <column name="TargetName">Chitinase B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Serratia marcescens:615</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P11797</column>
            <column name="TargetStructure">1E6N, 1GOI, 1H0G, 1H0I, 1O6I, 1OGB, 1OGG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">325</column>
            <column name="TargetName">Low affinity immunoglobulin gamma Fc region receptor II-a, IgG Fc receptor II-a</column>
            <column name="TargetSynonyms">Fc-gamma RII-a, Fc-gamma-RIIa, FcRII-a
CDw32
CD_antigen=CD32</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P12318</column>
            <column name="TargetStructure">1FCG, 1H9V, 3D5O, 3RY4, 3RY5, 3RY6</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">326</column>
            <column name="TargetName">Human B cell Burkitt lymphoma cell line Raji</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">327</column>
            <column name="TargetName">Cadherin-2</column>
            <column name="TargetSynonyms">Neural cadherin, N-cadherin
CDw325
CD_antigen=CD325</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P19022</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">328</column>
            <column name="TargetName">Platelet glycoprotein Ib alpha chain</column>
            <column name="TargetSynonyms">Glycoprotein Ibalpha, GP-Ib alpha, GPIb-alpha, GPIbA
Antigen CD42b-alpha
CD_antigen=CD42b</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07359</column>
            <column name="TargetStructure">1GWB, 1M0Z, 1M10, 1OOK, 1P8V, 1P9A, 1QYY, 1SQ0, 1U0N, 2BP3, 3P72, 3PMH, 4C2A, 4C2B, 4CH2, 4CH8, 4MGX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">329</column>
            <column name="TargetName">Tetragonal BaTiO3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">330</column>
            <column name="TargetName">Rat small intestinal mucosal tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">331</column>
            <column name="TargetName">Secretion chaperone</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Agrobacterium tumefaciens (strain C58 / ATCC 33970):176299</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">A9CI62</column>
            <column name="TargetStructure">2Q2H, 2Q2I</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">332</column>
            <column name="TargetName">Mouse digestive tract</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">333</column>
            <column name="TargetName">Ischemic stroke tissue from transient middle cerebral artery occlusion model</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">334</column>
            <column name="TargetName">FVIII inhibitor positive plasma samples before rituximab treatment</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">335</column>
            <column name="TargetName">FVIII inhibitor positive plasma samples after rituximab treatment</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">336</column>
            <column name="TargetName">Carbon Black FW-18</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">337</column>
            <column name="TargetName">Long fibrous cellulose</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">338</column>
            <column name="TargetName">Denuded cartilage grafts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">339</column>
            <column name="TargetName">Magnetic particles (BacMPs)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Magnetospirillum magneticum:84159</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">340</column>
            <column name="TargetName">Anti-H5N1 virus monoclonal antibody 8H5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The monoclonal antibody 8H5 (IgG2a) was generated by successively immunizing Balb/c mice with five strains of H5N1 avian influenza virus representing different major genetic subgroups of the virus prevalent since 2002 and found to have caused human infection. The antibody has been shown to be reactive against all of the major genetic groups of H5N1 viruses prevalent since 1997, and it was found to neutralize different H5N1 virus exhibiting broad but distinct H5 specificity.</column>
        </table>
        <table name="target">
            <column name="TargetID">341</column>
            <column name="TargetName">Implantation serine proteinase complex (Serine protease 28, 29)</column>
            <column name="TargetSynonyms">Serine protease 28 alternative name(s):
Implantation serine proteinase 1, ISP-1
Strypsin
Tryptase-like proteinase
EC=3.4.21.-

Serine protease 29 alternative name(s):
Implantation serine proteinase 2, ISP-2
Strypsin-2
Strypsin-related protein
Tryptase-like proteinase
EC=3.4.21.-</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Serine protease 28: Q924N9, Serine protease 29: Q99MS4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">342</column>
            <column name="TargetName">Monoclonal antibody ME361</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">ME361 is a mouse IgG2a monoclonal antibody against GD2 ganglioside. The 15mer phage library was reacted with biotinylated mAb ME361 immobilized on streptavidin-coated polystyrene f100 mm Petri dishes.</column>
        </table>
        <table name="target">
            <column name="TargetID">343</column>
            <column name="TargetName">Highly metastatic prostate carcinoma cell line PC-3M-1E8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">344</column>
            <column name="TargetName">Mouse thymus vasculature</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Female BALB/c mice ages 6 to 8 weeks were used.</column>
        </table>
        <table name="target">
            <column name="TargetID">345</column>
            <column name="TargetName">Mouse kidney</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Female BALB/c mice ages 6 to 8 weeks were used.</column>
        </table>
        <table name="target">
            <column name="TargetID">346</column>
            <column name="TargetName">Angiopoietin-1 receptor</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase receptor TIE-2, hTIE2
Tyrosine-protein kinase receptor TEK
Tunica interna endothelial cell kinase
p140 TEK
CD_antigen=CD202b
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q02763</column>
            <column name="TargetStructure">1FVR, 2GY5, 2GY7, 2OO8, 2OSC, 2P4I, 2WQB, 3BEA, 3L8P, 4K0V</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">347</column>
            <column name="TargetName">Hematite particles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">348</column>
            <column name="TargetName">Anti-LPS monoclonal antibody 9D5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">9D5 is an IgG3 monoclonal antiobody specific to lipopolysaccharide (LPS) of pathogenic Burkholderia pseudomallei strains. It showed partial protection against melioidosis in BALB/c mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">349</column>
            <column name="TargetName">Anti-EPS monoclonal antibody 4B11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">4B11 is an IgG2 monoclonal antiobody specific to exopolysaccharide (EPS) of pathogenic Burkholderia pseudomallei strains. It showed partial protection against melioidosis in BALB/c mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">350</column>
            <column name="TargetName">Monoclonal antibody BPA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BPA is an IgA monoclonal antiobody against proteins of pathogenic Burkholderia pseudomallei strains.</column>
        </table>
        <table name="target">
            <column name="TargetID">351</column>
            <column name="TargetName">Monoclonal antibody BPM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BPM is an IgM monoclonal antiobody against proteins of pathogenic Burkholderia pseudomallei strains.</column>
        </table>
        <table name="target">
            <column name="TargetID">352</column>
            <column name="TargetName">Anti-Pru p 3 polyclonal antibody IgE (from OSA-pool)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">353</column>
            <column name="TargetName">Anti-Pru p 3 polyclonal antibody IgE (from SYS-pool)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">354</column>
            <column name="TargetName">Anti-catalase monoclonal antibody C001</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C001 was an IgG1(κ) monoclonal antibody produced by the hybridoma technique using recombinant Catalase-GST as the immunogen.</column>
        </table>
        <table name="target">
            <column name="TargetID">355</column>
            <column name="TargetName">Anti-nucleoprotein monoclonal antibody N1H5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">N1H5 (IgG) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Nipah virus (NiV) expressed in E. coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">356</column>
            <column name="TargetName">Anti-nucleoprotein monoclonal antibody N4E2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">N4E2 (IgG) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Nipah virus (NiV) expressed in E. coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">357</column>
            <column name="TargetName">Anti-nucleoprotein monoclonal antibody H2F5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">H2F5 (IgM) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Hendra virus (HeV) expressed in E. coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">358</column>
            <column name="TargetName">Anti-nucleoprotein monoclonal antibody H3G5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">H3G5 (IgG) was generated by immunizing BALB/C mice with recombinant nucleocapsid protein (N) of Hendra virus (HeV) expressed in E. coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">359</column>
            <column name="TargetName">Enterotoxin type B</column>
            <column name="TargetSynonyms">SEB</column>
            <column name="TargetSource">Staphylococcus aureus:1280</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01552</column>
            <column name="TargetStructure">1D5M, 1D5X, 1D5Z, 1D6E, 1GOZ, 1SBB, 1SE3, 1SE4, 1SEB, 2SEB, 3GP7, 3R8B, 3SEB</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">360</column>
            <column name="TargetName">L-alpha-phosphatidylserine</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">361</column>
            <column name="TargetName">Anti-blood group A antigen monclonal antibody NaM87-1F6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NaM87-1F6 was bought from BD Biosciences. It is an monoclonal antibody of isotype (IgG3, κ) against blood group A antigen.</column>
        </table>
        <table name="target">
            <column name="TargetID">362</column>
            <column name="TargetName">Anti-HSP90 monoclonal antibody AC88</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">AC88 is an IgG1 monoclonal antibody, generated by immunizing mice with HSP90 of Achlya ambisexualis.</column>
        </table>
        <table name="target">
            <column name="TargetID">363</column>
            <column name="TargetName">Anti-DnaK monoclonal antibody 8E2/2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">8E2/2 is an IgG1 monoclonal antibody, generated by immunizing mice with DnaK of E. coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">364</column>
            <column name="TargetName">Pooled typhoid patients' sera (TPS)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Ten TPS were pooled together.</column>
        </table>
        <table name="target">
            <column name="TargetID">365</column>
            <column name="TargetName">U87MG glioblastoma cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">366</column>
            <column name="TargetName">Thioredoxin-1, Trx-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0AA25</column>
            <column name="TargetStructure">1F6M, 1KEB, 1M7T, 1OAZ, 1SKR, 1SKS, 1SKW, 1SL0, 1SL1, 1SL2, 1SRX, 1T7P, 1T8E, 1THO, 1TK0, 1TK5, 1TK8, 1TKD, 1TXX, 1X9M, 1X9S, 1X9W, 1XOA, 1XOB, 1ZCP, 1ZYQ, 1ZZY, 2AJQ, 2BTO, 2EIO, 2EIQ, 2EIR, 2FCH, 2FD3, 2H6X, 2H6Y, 2H6Z, 2H70, 2H71, 2H72, 2H73, 2H74, 2H75, 2H76, 2O8V, 2TIR, 2TRX, 3DYR</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">367</column>
            <column name="TargetName">Anti-cathepsin L1/L2 IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">368</column>
            <column name="TargetName">Omalizumab</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606, Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Omalizumab (Xolair) is a humanized IgG1κ monoclonal antibody against IgE approved for treatment of moderate to severe asthma. Omalizumab tightly binds to free circulating IgE molecules and prevents binding of these molecules to FcεRI on mast cells and basophils and FcεRII on various cell types.</column>
        </table>
        <table name="target">
            <column name="TargetID">369</column>
            <column name="TargetName">Heparin-binding growth factor 2, HBGF-2</column>
            <column name="TargetSynonyms">Basic fibroblast growth factor, BFGF</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P09038</column>
            <column name="TargetStructure">1BAS, 1BFB, 1BFC, 1BFF, 1BFG, 1BLA, 1BLD, 1CVS, 1EV2, 1FGA, 1FQ9, 1II4, 1IIL, 2BFH, 2FGF, 4FGF</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">370</column>
            <column name="TargetName">High affinity immunoglobulin gamma Fc receptor I, IgG Fc receptor I</column>
            <column name="TargetSynonyms">Fc-gamma RIA, FcgammaRIa
Fc-gamma RI, FcRI
CD_antigen=CD64</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P12314</column>
            <column name="TargetStructure">3RJD</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">371</column>
            <column name="TargetName">Serum of a pars planitis patient</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The pars planitis patient is on an active phase of the disease. Patients with PP were considered to be in the active phase of the disease if they had moderate or severe vitritis (with pars plana snowbanks).</column>
        </table>
        <table name="target">
            <column name="TargetID">372</column>
            <column name="TargetName">Anti-hstone H1 monoclonal antibody 16G9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target 16G9 is an IgM monoclonal antibody against histone H1 with MLR-inhibitory activity.</column>
        </table>
        <table name="target">
            <column name="TargetID">373</column>
            <column name="TargetName">CD40 ligand, CD40-L</column>
            <column name="TargetSynonyms">Tumor necrosis factor ligand superfamily member 5
TNF-related activation protein, AP
T-cell antigen Gp39
CD_antigen=CD154</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P29965</column>
            <column name="TargetStructure">1ALY, 1I9R, 3LKJ, 3QD6</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">374</column>
            <column name="TargetName">Agglutinin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Helix pomatia (Roman snail) (Edible snail):6536</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q2F1K8</column>
            <column name="TargetStructure">2CCV, 2CE6, 2CGY, 2CGZ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">375</column>
            <column name="TargetName">Semiconductor crystalline surface GaAs(100)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">376</column>
            <column name="TargetName">Semiconductor crystalline surface InAs(100)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">377</column>
            <column name="TargetName">Semiconductor crystalline surface GaN(0001)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">378</column>
            <column name="TargetName">Semiconductor crystalline surface ZnSe(100)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">379</column>
            <column name="TargetName">Semiconductor crystalline surface ZnTe(100)</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">380</column>
            <column name="TargetName">Semiconductor crystalline surface GaAs(111)A
</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">381</column>
            <column name="TargetName">Semiconductor crystalline surface GaSb(100)
</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">382</column>
            <column name="TargetName">Semiconductor crystalline surface CdSe(100)
</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">383</column>
            <column name="TargetName">Glycoprotein Gn, glycoprotein G1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Andes virus:46607</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">GI:30313865</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">384</column>
            <column name="TargetName">Glycoprotein Gc, glycoprotein G2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Andes virus:46607</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">GI:30313865</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">385</column>
            <column name="TargetName">S-ribosylhomocysteine lyase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Streptococcus suis:1307</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">B2CMA5</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">386</column>
            <column name="TargetName">Anti-hCXCR1 monoclonal antibody 5A12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This mouse monoclonal antibody (clone 5A12; isotype: IgG2b, kappa) is against human CXCR1.</column>
        </table>
        <table name="target">
            <column name="TargetID">387</column>
            <column name="TargetName">Anti-hCXCR2 monoclonal antibody 6C6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This mouse monoclonal antibody (clone 6C6; isotype: IgG1, lamda) is against human CXCR2.</column>
        </table>
        <table name="target">
            <column name="TargetID">388</column>
            <column name="TargetName">Platelet glycoprotein VI, GPVI</column>
            <column name="TargetSynonyms">Glycoprotein 6</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9HCN6</column>
            <column name="TargetStructure">2GI7</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">389</column>
            <column name="TargetName">Commercially pure titanium, cp-Ti</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">390</column>
            <column name="TargetName">Avian influenza virus (H9N2) particles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Avian influenza virus strain A/Chicken/Iran/16/2000(H9N2):566362</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">391</column>
            <column name="TargetName">Streptavidin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Streptomyces avidinii:1895</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P22629</column>
            <column name="TargetStructure">1DF8, 1HQQ, 1HXL, 1HXZ, 1HY2, 1I9H, 1KFF, 1KL3, 1KL4, 1KL5, 1LCV, 1LCW, 1LCZ, 1LUQ, 1MEP, 1MK5, 1MM9, 1MOY, 1N43, 1N4J, 1N7Y, 1N9M, 1N9Y, 1NBX, 1NC9, 1NDJ, 1NQM, 1PTS, 1RST, 1RSU, 1RXH, 1RXJ, 1RXK, 1SLD, 1SLE, 1SLF, 1SLG, 1SRE, 1SRF, 1SRG, 1SRH, 1SRI, 1SRJ, 1STP, 1STR, 1STS, 1SWA, 1SWB, 1SWC, 1SWD, 1SWE, 1SWF, 1SWG, 1SWH, 1SWJ, 1SWK, 1SWL, 1SWN, 1SWO, 1SWP, 1SWQ, 1SWR, 1SWS, 1SWT, 1SWU, 1VWA, 1VWB, 1VWC, 1VWD, 1VWE, 1VWF, 1VWG, 1VWH, 1VWI, 1VWJ, 1VWK, 1VWL, 1VWM, 1VWN, 1VWO, 1VWP, 1VWQ, 1VWR, 2BC3, 2F01, 2G5L, 2GH7, 2IZA, 2IZB, 2IZC, 2IZD, 2IZE, 2IZF, 2IZG, 2IZH, 2IZI, 2IZJ, 2IZK, 2IZL, 2QCB, 2RTA, 2RTB, 2RTC, 2RTD, 2RTE, 2RTF, 2RTG, 2RTH, 2RTI, 2RTJ, 2RTK, 2RTL, 2RTM, 2RTN, 2RTO, 2RTP, 2RTQ, 2RTR, 2WPU, 2Y3E, 2Y3F, 3MG5, 3PK2, 3RDM, 3RDO, 3RDQ, 3RDS, 3RDU, 3RDX, 3RE5, 3RE6, 3RY1, 3RY2, 3T6F, 3T6L, 4DNE, 4EKV, 4GJS, 4GJV, 4JO6</column>
            <column name="TargetComments">Streptavidin is a tetrameric protein purified from the bacterium Streptomyces avidinii. It has an extraordinarily high affinity for biotin; the dissociation constant of the biotin-streptavidin complex is about 10(-14) M, making it one of the strongest non-covalent interactions known in nature.</column>
        </table>
        <table name="target">
            <column name="TargetID">392</column>
            <column name="TargetName">Anti-cEG95 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-cEG95 are purified polyclonal antibodies against conformational epitopes on EG95.</column>
        </table>
        <table name="target">
            <column name="TargetID">393</column>
            <column name="TargetName">Protein SMG7</column>
            <column name="TargetSynonyms">SMG-7 homolog, hSMG-7
EST1-like protein C</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q92540</column>
            <column name="TargetStructure">1YA0</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">394</column>
            <column name="TargetName">Polystyrene/polyurethane magnetic beads</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The beads are made of polystyrene coated with a surface layer of polyurethane.</column>
        </table>
        <table name="target">
            <column name="TargetID">395</column>
            <column name="TargetName">Anti-neuwiedase polyclonal antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">These polyclonal antibodies are protective against NEU activity.</column>
        </table>
        <table name="target">
            <column name="TargetID">396</column>
            <column name="TargetName">Anti-SPACc polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">397</column>
            <column name="TargetName">Cadherin-1</column>
            <column name="TargetSynonyms">Epithelial cadherin, E-cadherin
Uvomorulin
CAM 120/80
CD_antigen=CD324</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P12830</column>
            <column name="TargetStructure">1O6S, 2O72, 2OMT, 2OMU, 2OMV, 2OMX, 2OMY, 2OMZ, 3FF7, 3FF8, 3L6X, 3L6Y</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">398</column>
            <column name="TargetName">Anti-rabies virus polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibodies were purified from a healthymale volunteer immunized with Rabipur®.</column>
        </table>
        <table name="target">
            <column name="TargetID">399</column>
            <column name="TargetName">Anti-MrkD monoclonal antibody E01</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">400</column>
            <column name="TargetName">Anti-CTGF monoclonal antibody 7G2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">401</column>
            <column name="TargetName">Phytophthora capsici extract</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Phytophthora capsici:4784</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">402</column>
            <column name="TargetName">UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase</column>
            <column name="TargetSynonyms">UDP-MurNAc-L-Ala-D-Glu:meso-diaminopimelate ligase
Meso-diaminopimelate-adding enzyme
Meso-A2pm-adding enzyme
UDP-N-acetylmuramyl-tripeptide synthetase
UDP-MurNAc-tripeptide synthetase
EC=6.3.2.13</column>
            <column name="TargetSource">Pseudomonas aeruginosa:287</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q59650</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">403</column>
            <column name="TargetName">Anti-GA4 monoclonal antibody 8/E9-Gibberellin A4 complex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">GI:24158782, GI:24158783</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">404</column>
            <column name="TargetName">The idiosyncratic pseudoknot structure (h18) formed by the segment 500–545 of 16S rRNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bacillus anthracis:1392</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A synthetic 59-nt RNA/DNA hybrid was composed of a 49-nt RNA segment representing h18 of Bacillus anthracis 16S rRNA followed by a 10-nt poly-dA tail with biotin attached at the 3' end.</column>
        </table>
        <table name="target">
            <column name="TargetID">405</column>
            <column name="TargetName">MMP-2-processed pepsin-extracted collagen IV from human placenta</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">406</column>
            <column name="TargetName">Hp-AS-pwk RNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli:562</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hp-AS-pwk RNA was taken as a bacterial (Escherichia coli) A-site rRNA model.</column>
        </table>
        <table name="target">
            <column name="TargetID">407</column>
            <column name="TargetName">Human breast cancer cell line MDA-MB-231</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">408</column>
            <column name="TargetName">Human breast cancer cell line MCF-7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">409</column>
            <column name="TargetName">Human IgG-Fc acid conformer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In therapeutic antibody preparation, acidic pH conditions are generally used for elution from Protein A affinity column of IgG or for its viral inactivation. Exposing IgG to low pH conditions induces conformational changes, leading to the non-native conformer (acid conformer) of human IgG. The acid conformer was easily generated at acidic pH (&lt;pH 3.0) and at moderate temperatures (20-40 °C). The conformer was present in a monomeric form functionally maintaining antigen or Fc receptor binding, but showed a tendency to aggregate with a long incubation time at neutral pH (&gt;25 °C).</column>
        </table>
        <table name="target">
            <column name="TargetID">410</column>
            <column name="TargetName">Anti-BoNT monoclonal antibody F1-40</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:193783174; GI:257348218</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">F1-40 is a mouse-derived, IgG1 kappa monoclonal antibody that binds the light chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection.</column>
        </table>
        <table name="target">
            <column name="TargetID">411</column>
            <column name="TargetName">PDZ10 domain of Multiple PDZ domain protein</column>
            <column name="TargetSynonyms">Multiple PDZ domain protein alternative name(s):
Multi-PDZ domain protein 1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O75970 [1629-1712]</column>
            <column name="TargetStructure">2FCF, 2FNE, 2IWN, 2IWO, 2IWP, 2IWQ, 2O2T, 2OPG, 2QG1</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">412</column>
            <column name="TargetName">PDZ3 domain of Postsynaptic density protein 95 (PSD-95)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P78352 [313-393]</column>
            <column name="TargetStructure">1KEF, 3I4W, 3K82, 3ZRT</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">413</column>
            <column name="TargetName">Embryonal Rhabdomyosarcoma cell line RD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">414</column>
            <column name="TargetName">Ouabain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">415</column>
            <column name="TargetName">Disintegrin domain of ADAM 15</column>
            <column name="TargetSynonyms">ADAM 15 alternative name(s):
Disintegrin and metalloproteinase domain-containing protein 15
Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15, MDC-15
Metalloprotease RGD disintegrin protein
Metargidin
EC=3.4.24.-</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q13444 [421-508]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">416</column>
            <column name="TargetName">Natriuretic peptides B</column>
            <column name="TargetSynonyms">Gamma-brain natriuretic peptide</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P16860</column>
            <column name="TargetStructure">1YK1, 3N56</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">417</column>
            <column name="TargetName">Anti-Human KGF monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">418</column>
            <column name="TargetName">Anti-BoNT monoclonal antibody F1-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:224830459</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">F1-2 is a mouse-derived, IgG1 kappa monoclonal antibody that binds the heavy chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection. The sequence of the kappa light chain used by F1-2 remain undetermined.</column>
        </table>
        <table name="target">
            <column name="TargetID">419</column>
            <column name="TargetName">Anti-BoNT monoclonal antibody F1-5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:224830461</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">F1-5 is a mouse-derived, IgG1 kappa monoclonal antibody that binds the heavy chain of BoNT serotype A (BoNT/A) and is used in a sensitive immunoassay for toxin detection. The sequence of the kappa light chain used by F1-5 remain undetermined.</column>
        </table>
        <table name="target">
            <column name="TargetID">420</column>
            <column name="TargetName">Anti-RBD of SARS-CoV spike protein monoclonal antibody S1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was produced by the hybridoma technique using recombinant receptor-binding domain (RBD) of spike protein (249-667) of SARS-CoV strain BJ01 as the immunogen. It had an IgG1 isotype and showed high specificity to SARSCoV.</column>
        </table>
        <table name="target">
            <column name="TargetID">421</column>
            <column name="TargetName">Anti-RBD of SARS-CoV spike protein monoclonal antibody S2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was produced by the hybridoma technique using recombinant receptor-binding domain (RBD) of spike protein (249-667) of SARS-CoV strain BJ01 as the immunogen. It had an IgG1 isotype and showed high specificity to SARSCoV.</column>
        </table>
        <table name="target">
            <column name="TargetID">422</column>
            <column name="TargetName">Anti-RBD of SARS-CoV spike protein monoclonal antibody S3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was produced by the hybridoma technique using recombinant receptor-binding domain (RBD) of spike protein (249-667) of SARS-CoV strain BJ01 as the immunogen. It had an IgG1 isotype and showed high specificity to SARSCoV.</column>
        </table>
        <table name="target">
            <column name="TargetID">423</column>
            <column name="TargetName">Bone-like mineral (BLM) films; Hydroxyapatite (HA) disks</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">424</column>
            <column name="TargetName">Rat nose-to-brain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">425</column>
            <column name="TargetName">Monocyte differentiation antigen CD14</column>
            <column name="TargetSynonyms">Myeloid cell-specific leucine-rich glycoprotein
CD_antigen=CD14</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P08571</column>
            <column name="TargetStructure">4GLP</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">426</column>
            <column name="TargetName">Zinc oxide, ZnO</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">427</column>
            <column name="TargetName">NCI-H1299 non-small cell lung cancer cell line </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">428</column>
            <column name="TargetName">Concanavalin-A, Con A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canavalia ensiformis (Jack bean) (Horse bean):3823</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02866</column>
            <column name="TargetStructure">1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">429</column>
            <column name="TargetName">ConA and Lentil lectin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canavalia ensiformis (Jack bean) (Horse bean):3823, Lens culinaris (Lentil, Cicer lens):3864</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02866; P02870</column>
            <column name="TargetStructure">ConA: 1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA
Lectin: 1LEM, 1LEN, 1LES, 2LAL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">430</column>
            <column name="TargetName">ConA, LCA and Pea lectin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canavalia ensiformis (Jack bean) (Horse bean):3823, Pisum sativum (Garden pea):3888</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02866, P02870, P02867</column>
            <column name="TargetStructure">ConA: 1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA
Lectin: 1LEM, 1LEN, 1LES, 2LAL
Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">431</column>
            <column name="TargetName">LCA and Pea lectin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Lens culinaris (Lentil, Cicer lens):3864, Pisum sativum (Garden pea):3888</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02870; P02867</column>
            <column name="TargetStructure">Lectin: 1LEM, 1LEN, 1LES, 2LAL
Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">432</column>
            <column name="TargetName">ConA and Pea lectin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canavalia ensiformis (Jack bean) (Horse bean):3823, Lens culinaris (Lentil, Cicer lens):3864, Pisum sativum (Garden pea):3888</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02866, P02867</column>
            <column name="TargetStructure">ConA: 1APN, 1BXH, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 2CNA, 2CTV, 2ENR, 2UU8, 3CNA, 3D4K, 3ENR, 3NWK, 5CNA
Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">433</column>
            <column name="TargetName">Pea lectin and Lentil lectin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Pisum sativum (Garden pea):3888, Lens culinaris (Lentil, Cicer lens):3864</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02867, P02870</column>
            <column name="TargetStructure">Lectin:1BQP, 1HKD, 1OFS, 1RIN, 2BQP, 2LTN
Lectin: 1LEM, 1LEN, 1LES, 2LAL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">434</column>
            <column name="TargetName">Anti-NAV polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Equus caballus (Horse)9796</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">435</column>
            <column name="TargetName">Anti-enteroaggregative Escherichia coli (EAEC) polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">436</column>
            <column name="TargetName">Anti-serine protease pet autotransporter polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">437</column>
            <column name="TargetName">Anti-serine protease pic autotransporter polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">438</column>
            <column name="TargetName">Anti-PfMIF monoclonal antibody B9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">439</column>
            <column name="TargetName">Anti-lipid-transfer protein polyclonal antibody IgE</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">440</column>
            <column name="TargetName">Serine-aspartate repeat-containing protein G</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Staphylococcus epidermidis:1282</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9KI13</column>
            <column name="TargetStructure">1R17, 1R19, 2RAL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">441</column>
            <column name="TargetName">Serine-aspartate repeat-containing protein C</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Staphylococcus aureus (strain Newman):426430</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O86487</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">442</column>
            <column name="TargetName">GTPase HRas</column>
            <column name="TargetSynonyms">Transforming protein p21
p21ras
H-Ras-1
c-H-ras
Ha-Ras</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01112</column>
            <column name="TargetStructure">121P, 1AA9, 1AGP, 1BKD, 1CLU, 1CRP, 1CRQ, 1CRR, 1CTQ, 1GNP, 1GNQ, 1GNR, 1HE8, 1IAQ, 1IOZ, 1JAH, 1JAI, 1K8R, 1LF0, 1LF5, 1LFD, 1NVU, 1NVV, 1NVW, 1NVX, 1P2S, 1P2T, 1P2U, 1P2V, 1PLJ, 1PLK, 1PLL, 1Q21, 1QRA, 1RVD, 1WQ1, 1XCM, 1XD2, 1XJ0, 1ZVQ, 1ZW6, 221P, 2C5L, 2CE2, 2CL0, 2CL6, 2CL7, 2CLC, 2CLD, 2EVW, 2LCF, 2Q21, 2QUZ, 2RGA, 2RGB, 2RGC, 2RGD, 2RGE, 2RGG, 2UZI, 2VH5, 2X1V, 3DDC, 3I3S, 3K8Y, 3K9L, 3K9N, 3KKM, 3KKN, 3KUD, 3L8Y, 3L8Z, 3LBH, 3LBI, 3LBN, 3LO5, 3OIU, 3OIV, 3OIW, 3RRY, 3RRZ, 3RS0, 3RS2, 3RS3, 3RS4, 3RS5, 3RS7, 3RSL, 3RSO, 3TGP, 421P, 4DLR, 4DLS, 4DLT, 4DLU, 4DLV, 4DLW, 4DLX, 4DLY, 4DLZ, 4DST, 4DSU, 4EFL, 4EFM, 4EFN, 4Q21, 521P, 5P21, 621P, 6Q21, 721P, 821P</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">443</column>
            <column name="TargetName">Tyrosine-protein kinase Lck</column>
            <column name="TargetSynonyms">Proto-oncogene Lck
Lymphocyte cell-specific protein-tyrosine kinase
p56-LCK
LSK
T cell-specific protein-tyrosine kinase
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P06239</column>
            <column name="TargetStructure">1BHF, 1BHH, 1CWD, 1CWE, 1FBZ, 1H92, 1IJR, 1KIK, 1LCJ, 1LCK, 1LKK, 1LKL, 1Q68, 1Q69, 1QPC, 1QPD, 1QPE, 1QPJ, 1X27, 2IIM, 2OF2, 2OF4, 2OFU, 2OFV, 2OG8, 2PL0, 2ZM1, 2ZM4, 2ZYB, 3AC1, 3AC2, 3AC3, 3AC4, 3AC5, 3AC8, 3ACJ, 3ACK, 3AD4, 3AD5, 3AD6, 3B2W, 3BRH, 3BYM, 3BYO, 3BYS, 3BYU, 3KMM, 3KXZ, 3LCK, 3MPM, 4D8K</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">444</column>
            <column name="TargetName">IgE of melon-allergic patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">445</column>
            <column name="TargetName">Brain (brain endothelium)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">446</column>
            <column name="TargetName">Anti-Toxoplasma gondii tachyzoites monoclonal antibody A4D12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The A4D12 monoclonal antibody was produce by immunized mice with toxoplasma gondii tachyzoites and it was isotyped as IgG1 isotype, kappa light chain.</column>
        </table>
        <table name="target">
            <column name="TargetID">447</column>
            <column name="TargetName">Anti-chCD132 monoclonal antibody C10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody C10 exhibited strong binding of chCD132 on the surface of Con A-activated splenic mononuclear cells and inhibited the lymphocyte proliferation induced by rchIL-2 in dose-dependent manner.</column>
        </table>
        <table name="target">
            <column name="TargetID">448</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 7G5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 7G5 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">449</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 6G5</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">The antibody 6G5 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">450</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 2F9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 2F9 is a neutralizing monoclonal antibody of IgG2b isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">451</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 7B7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 7B7 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">452</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 2G11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 2G11 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">453</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 3E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 3E7 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">454</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 8H8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 8H8 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">455</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 4F3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 4F3 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">456</column>
            <column name="TargetName">Anti-chicken IL-2 monoclonal antibody 6H10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody 6H10 is a neutralizing monoclonal antibody of IgG1 isotype.</column>
        </table>
        <table name="target">
            <column name="TargetID">457</column>
            <column name="TargetName">Human embryonic stem cell line H9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">458</column>
            <column name="TargetName">Human embryo carcinoma cell line NCCIT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">459</column>
            <column name="TargetName">Anti-TSOL18 monoclonal antibody 17E1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The monoclonal antibody 17E1 was produced using purified glycosylated TSOL18 produced in Pichia pastoris as the immunogen. It belonged to IgG2a, with kappa light chain.</column>
        </table>
        <table name="target">
            <column name="TargetID">460</column>
            <column name="TargetName">Prostate carcinoma cell line PC3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The PC3 (CRL-1435) cells were derived from a bone metastasis of grade IV prostatic adenocarcinoma.</column>
        </table>
        <table name="target">
            <column name="TargetID">461</column>
            <column name="TargetName">Heart of the normotensive Wistar Kyoto rat (WKY)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">462</column>
            <column name="TargetName">Heart of the stroke prone spontaneously hypertensive rat (SHRSP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">463</column>
            <column name="TargetName">von Willebrand factor, vWF</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04275</column>
            <column name="TargetStructure">1AO3, 1ATZ, 1AUQ, 1FE8, 1FNS, 1IJB, 1IJK, 1M10, 1OAK, 1SQ0, 1U0N, 1UEX, 2ADF, 3GXB, 3HXO, 3HXQ, 3PPV, 3PPW, 3PPX, 3PPY, 3ZQK, 4DMU</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">464</column>
            <column name="TargetName">Lipopolysaccharide (LPS)-activated alveolar macrophages (AMs)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">465</column>
            <column name="TargetName">Interleukin 2</column>
            <column name="TargetSynonyms">Interleukin-2</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O42288</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">466</column>
            <column name="TargetName">IL-2 alpha receptor</column>
            <column name="TargetSynonyms">Interleukin-2 alpha receptor</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q90WJ4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">467</column>
            <column name="TargetName">Bevacizumab-treated tumor vasculature in nude mice</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">468</column>
            <column name="TargetName">Mitochondrial fission 1 protein</column>
            <column name="TargetSynonyms">FIS1 homolog, hFis1
Tetratricopeptide repeat protein 11, TPR repeat protein 11</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9Y3D6</column>
            <column name="TargetStructure">1NZN, 1PC2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">469</column>
            <column name="TargetName">Troponin I, cardiac muscle</column>
            <column name="TargetSynonyms">Cardiac troponin I</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P19429</column>
            <column name="TargetStructure">1J1D, 1J1E, 1LXF, 1MXL, 1OZS, 2KGB, 2KRD, 2L1R</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">470</column>
            <column name="TargetName">Troponin I, cardiac muscle</column>
            <column name="TargetSynonyms">Cardiac troponin I</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P23693</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">471</column>
            <column name="TargetName">Tumor necrosis factor receptor superfamily member 10B</column>
            <column name="TargetSynonyms">Death receptor 5
TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2
CD_antigen=CD262</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">O14763</column>
            <column name="TargetStructure">1D0G, 1D4V, 1DU3, 1ZA3, 2H9G, 4I9X</column>
            <column name="TargetComments">Death receptor 5, also known as TNFRSF10B, is a receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis.</column>
        </table>
        <table name="target">
            <column name="TargetID">472</column>
            <column name="TargetName">Receptor tyrosine-protein kinase erbB-2</column>
            <column name="TargetSynonyms">p185erbB2
Proto-oncogene c-ErbB-2
Proto-oncogene Neu
Tyrosine kinase-type cell surface receptor HER2
Metastatic lymph node gene 19 protein, MLN 19
CD_antigen=CD340
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P04626</column>
            <column name="TargetStructure">1MFG, 1MFL, 1MW4, 1N8Z, 1QR1, 1S78, 2A91, 2JWA, 2KS1, 2L4K, 3BE1, 3H3B, 3MZW, 3N85, 3PP0, 3RCD</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">473</column>
            <column name="TargetName">Breast cancer cell line BT-474</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">474</column>
            <column name="TargetName">Pea aphid guts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Pea aphid (Acyrthosiphon pisum):7029</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">475</column>
            <column name="TargetName">Purified serum IgG from ankylosing spondylitis patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">476</column>
            <column name="TargetName">Gap junction alpha-1 protein</column>
            <column name="TargetSynonyms">Connexin-43, Cx43
Gap junction 43 kDa heart protein</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P08050</column>
            <column name="TargetStructure">1R5S, 3CYY</column>
            <column name="TargetComments">In fact, the target is recombinant Cx43CT (amino acids 255 to 382 of rCx43).</column>
        </table>
        <table name="target">
            <column name="TargetID">477</column>
            <column name="TargetName">Capsid protein p24, CA</column>
            <column name="TargetSynonyms">Gag-Pol polyprotein
Pr160Gag-Pol</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03366</column>
            <column name="TargetStructure">1A9M, 1AJV, 1AJX, 1AXA, 1BQM, 1BQN, 1D4H, 1D4I, 1D4J, 1DLO, 1DW6, 1EBK, 1EBW, 1EBY, 1EBZ, 1EC0, 1EC1, 1EC2, 1EC3, 1EET, 1G35, 1GNM, 1GNN, 1GNO, 1HAR, 1HBV, 1HEF, 1HEG, 1HIH, 1HMV, 1HNI, 1HNV, 1HOS, 1HPS, 1HPZ, 1HQE, 1HQU, 1HRH, 1HTE, 1HTF, 1HTG, 1HVI, 1HVK, 1HVU, 1HYS, 1IKV, 1IKW, 1IKX, 1IKY, 1J5O, 1KJH, 1MER, 1MES, 1MET, 1MEU, 1N5Y, 1N6Q, 1NPA, 1NPV, 1NPW, 1QE1, 1QMC, 1R0A, 1RDH, 1RTD, 1S6P, 1S6Q, 1S9E, 1S9G, 1SBG, 1SUQ, 1SV5, 1T03, 1T05, 1T7K, 1TV6, 1TVR, 1UWB, 1W5V, 1W5W, 1W5X, 1W5Y, 1YT9, 1ZP8, 1ZPA, 1ZSF, 1ZSR, 2AQU, 2B5J, 2B6A, 2BAN, 2BBB, 2BE2, 2EXF, 2G69, 2HB3, 2HMI, 2HNZ, 2HS1, 2HS2, 2I4D, 2I4U, 2I4V, 2I4W, 2I4X, 2I5J, 2IAJ, 2IC3, 2IDW, 2IEO, 2L45, 2L46, 2L4L, 2UXZ, 2UY0, 2VG5, 2VG6, 2VG7, 2X4U, 2YKM, 2YKN, 2ZD1, 2ZE2, 3AVI, 3BGR, 3DLK, 3GGA, 3GGV, 3GGX, 3HVT, 3IG1, 3IRX, 3IS9, 3ISN, 3ITH, 3JSM, 3JYT, 3K2P, 3K4V, 3KLE, 3KLF, 3KLG, 3KLH, 3KLI, 3NDT, 3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO, 3OK9, 3PSU, 3QAA, 3QLH, 3QO9, 3TKG, 3TKW, 3TL9, 3TLH, 3V4I, 3V6D, 3V81, 4DG1, 4G1Q, 4G8G, 4G8I, 4G9D, 4G9F, 4H4M, 4H4O, 4I2P, 4I2Q, 4ICL, 4ID5, 4IDK, 4IFV, 4IFY, 4IG0, 4IG3, 4KFB, 4KFB</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">478</column>
            <column name="TargetName">C-CANC</column>
            <column name="TargetSynonyms">Gag-Pol polyprotein
Pr160Gag-Pol</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03366</column>
            <column name="TargetStructure">1A9M, 1AJV, 1AJX, 1AXA, 1BQM, 1BQN, 1D4H, 1D4I, 1D4J, 1DLO, 1DW6, 1EBK, 1EBW, 1EBY, 1EBZ, 1EC0, 1EC1, 1EC2, 1EC3, 1EET, 1G35, 1GNM, 1GNN, 1GNO, 1HAR, 1HBV, 1HEF, 1HEG, 1HIH, 1HMV, 1HNI, 1HNV, 1HOS, 1HPS, 1HPZ, 1HQE, 1HQU, 1HRH, 1HTE, 1HTF, 1HTG, 1HVI, 1HVK, 1HVU, 1HYS, 1IKV, 1IKW, 1IKX, 1IKY, 1J5O, 1KJH, 1MER, 1MES, 1MET, 1MEU, 1N5Y, 1N6Q, 1NPA, 1NPV, 1NPW, 1QE1, 1QMC, 1R0A, 1RDH, 1RTD, 1S6P, 1S6Q, 1S9E, 1S9G, 1SBG, 1SUQ, 1SV5, 1T03, 1T05, 1T7K, 1TV6, 1TVR, 1UWB, 1W5V, 1W5W, 1W5X, 1W5Y, 1YT9, 1ZP8, 1ZPA, 1ZSF, 1ZSR, 2AQU, 2B5J, 2B6A, 2BAN, 2BBB, 2BE2, 2EXF, 2G69, 2HB3, 2HMI, 2HNZ, 2HS1, 2HS2, 2I4D, 2I4U, 2I4V, 2I4W, 2I4X, 2I5J, 2IAJ, 2IC3, 2IDW, 2IEO, 2L45, 2L46, 2L4L, 2UXZ, 2UY0, 2VG5, 2VG6, 2VG7, 2X4U, 2YKM, 2YKN, 2ZD1, 2ZE2, 3AVI, 3BGR, 3DLK, 3GGA, 3GGV, 3GGX, 3HVT, 3IG1, 3IRX, 3IS9, 3ISN, 3ITH, 3JSM, 3JYT, 3K2P, 3K4V, 3KLE, 3KLF, 3KLG, 3KLH, 3KLI, 3NDT, 3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO, 3OK9, 3PSU, 3QAA, 3QLH, 3QO9, 3TKG, 3TKW, 3TL9, 3TLH, 3V4I, 3V6D, 3V81, 4DG1, 4G1Q, 4G8G, 4G8I, 4G9D, 4G9F, 4H4M, 4H4O, 4I2P, 4I2Q, 4ICL, 4ID5, 4IDK, 4IFV, 4IFY, 4IG0, 4IG3, 4KFB, 4KFB</column>
            <column name="TargetComments">The protein C-CANC comprises the C-CA region, SP1 and NC.</column>
        </table>
        <table name="target">
            <column name="TargetID">479</column>
            <column name="TargetName">Murine bone marrow</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">480</column>
            <column name="TargetName">Murine hematopoietic stem cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">481</column>
            <column name="TargetName">Chlorine-doped polypyrrole, PPyCl</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">482</column>
            <column name="TargetName">Human glioma cell lines</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">483</column>
            <column name="TargetName">Undifferentiated P19 embryonic carcinoma stem cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">484</column>
            <column name="TargetName">Quinoprotein glucose dehydrogenase</column>
            <column name="TargetSynonyms">Glucose dehydrogenase [pyrroloquinoline-quinone]
Pyrroloquinoline quinone glucose dehydrogenase, PQQGDH, PQQ-glucose dehydrogenase
EC=1.1.5.2</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P15877</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">485</column>
            <column name="TargetName">Human saphenous vein vascular smooth muscle cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">486</column>
            <column name="TargetName">Gastrointestinal tract tissue, GIT tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">487</column>
            <column name="TargetName">Integrase, IN</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03366 [1160-1447]</column>
            <column name="TargetStructure">1A9M, 1AJV, 1AJX, 1AXA, 1BQM, 1BQN, 1D4H, 1D4I, 1D4J, 1DLO, 1DW6, 1EBK, 1EBW, 1EBY, 1EBZ, 1EC0, 1EC1, 1EC2, 1EC3, 1EET, 1G35, 1GNM, 1GNN, 1GNO, 1HAR, 1HBV, 1HEF, 1HEG, 1HIH, 1HMV, 1HNI, 1HNV, 1HOS, 1HPS, 1HPZ, 1HQE, 1HQU, 1HRH, 1HTE, 1HTF, 1HTG, 1HVI, 1HVK, 1HVU, 1HYS, 1IKV, 1IKW, 1IKX, 1IKY, 1J5O, 1KJH, 1MER, 1MES, 1MET, 1MEU, 1N5Y, 1N6Q, 1NPA, 1NPV, 1NPW, 1QE1, 1QMC, 1R0A, 1RDH, 1RTD, 1S6P, 1S6Q, 1S9E, 1S9G, 1SBG, 1SUQ, 1SV5, 1T03, 1T05, 1T7K, 1TV6, 1TVR, 1UWB, 1W5V, 1W5W, 1W5X, 1W5Y, 1YT9, 1ZP8, 1ZPA, 1ZSF, 1ZSR, 2AQU, 2B5J, 2B6A, 2BAN, 2BBB, 2BE2, 2EXF, 2G69, 2HB3, 2HMI, 2HNZ, 2HS1, 2HS2, 2I4D, 2I4U, 2I4V, 2I4W, 2I4X, 2I5J, 2IAJ, 2IC3, 2IDW, 2IEO, 2L45, 2L46, 2L4L, 2UXZ, 2UY0, 2VG5, 2VG6, 2VG7, 2X4U, 2YKM, 2YKN, 2ZD1, 2ZE2, 3AVI, 3BGR, 3DLK, 3GGA, 3GGV, 3GGX, 3HVT, 3IG1, 3IRX, 3IS9, 3ISN, 3ITH, 3JSM, 3JYT, 3K2P, 3K4V, 3KLE, 3KLF, 3KLG, 3KLH, 3KLI, 3NDT, 3NU3, 3NU4, 3NU5, 3NU6, 3NU9, 3NUJ, 3NUO, 3OK9, 3PSU, 3QAA, 3QLH, 3QO9, 3TKG, 3TKW, 3TL9, 3TLH, 3V4I, 3V6D, 3V81, 4DG1, 4G1Q, 4G8G, 4G8I, 4G9D, 4G9F, 4H4M, 4H4O, 4I2P, 4I2Q, 4ICL, 4ID5, 4IDK, 4IFV, 4IFY, 4IG0, 4IG3, 4KFB, 4KFB</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">488</column>
            <column name="TargetName">Bovine serum albumin (BSA)</column>
            <column name="TargetSynonyms">Allergen=Bos d 6</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02769</column>
            <column name="TargetStructure">2L7U, 3V03, 4F5S</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">489</column>
            <column name="TargetName">Harpin hrpZ</column>
            <column name="TargetSynonyms">HrpZ-Psph protein
Harpin-Psph</column>
            <column name="TargetSource">Pseudomonas syringae pv. phaseolicola:319</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9F0B0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">490</column>
            <column name="TargetName">Aluminum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">491</column>
            <column name="TargetName">Mild steel</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">492</column>
            <column name="TargetName">Anti-phomopsin A monoclonal antibody C3C11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">493</column>
            <column name="TargetName">Anti-AMA-1 monoclonal antibody 5G8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">494</column>
            <column name="TargetName">Anti-apical membrane protein 1 monoclone antibody 1F9</column>
            <column name="TargetSynonyms">monoclone antibody 1F9 against AMA-1</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">495</column>
            <column name="TargetName">Apical membrane antigen 1</column>
            <column name="TargetSynonyms">Merozoite surface antigen</column>
            <column name="TargetSource">Plasmodium chabaudi:5825</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P16445</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">496</column>
            <column name="TargetName">Mitochondrial import receptor subunit TOM70</column>
            <column name="TargetSynonyms">Mitochondrial precursor proteins import receptor
Translocase of outer membrane 70 kDa subunit</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">O94826</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">497</column>
            <column name="TargetName">Anti-Nef antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">498</column>
            <column name="TargetName">Protein Nef</column>
            <column name="TargetSynonyms">Negative factor, F-protein
3'ORF</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BH10) (HIV-1):11678</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03404</column>
            <column name="TargetStructure">1ZEC, 3TB8</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">499</column>
            <column name="TargetName">1,3-diketones 1-BSA and 2-BSA</column>
            <column name="TargetSynonyms">Bovine serum albumin</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02769</column>
            <column name="TargetStructure">2L7U, 3V03, 4F5S</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">500</column>
            <column name="TargetName">Phosphatidylserine, PS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Phosphatidylserine (PS) is involved in a variety of cellular events, including blood coagulation, phagocytic elimination of aged or pathological red blood cells, intracellular membrane fusion, and activation of protein kinase C.</column>
        </table>
        <table name="target">
            <column name="TargetID">501</column>
            <column name="TargetName">Tom20 missing residues 2-28</column>
            <column name="TargetSynonyms">Mitochondrial import receptor subunit TOM20 homolog
Mitochondrial 20 kDa outer membrane protein
Outer mitochondrial membrane receptor Tom20</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q15388</column>
            <column name="TargetStructure">4APO</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">502</column>
            <column name="TargetName">[PA63]7 complex</column>
            <column name="TargetSynonyms">(Protective antigen)7</column>
            <column name="TargetSource">Bacillus anthracis:1392</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P13423</column>
            <column name="TargetStructure">1ACC, 1T6B, 1TZN, 1TZO, 3ETB, 3INO, 3KWV, 3MHZ, 3Q8A, 3Q8B, 3Q8C, 3Q8E, 3Q8F, 3TEW, 3TEX, 3TEY, 3TEZ, 4EE2</column>
            <column name="TargetComments">Bacillus anthracis secretes a three-component toxin that assembles into complexes after the individual proteins are released by the bacterium. Protective antigen (PA) is the toxin component that targets mammalian cells by binding to the cellular receptors ANTXR1 and ANTXR2. PA is processed by proteases, either in the blood or on the cell surface, into a 63 kDa fragment that can self-associate into ring-shaped heptamers, referred to as [PA63]7.</column>
        </table>
        <table name="target">
            <column name="TargetID">503</column>
            <column name="TargetName">Isotactic poly(methyl methacrylate), st-PMMA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">504</column>
            <column name="TargetName">SH3 domain of tyrosine-protein kinase Lck</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase Lck alternative name(s):
Proto-oncogene Lck
Lymphocyte cell-specific protein-tyrosine kinase
p56-LCK
LSK
T cell-specific protein-tyrosine kinase
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P06239 [61-121]</column>
            <column name="TargetStructure">1BHF, 1BHH, 1CWD, 1CWE, 1FBZ, 1H92, 1IJR, 1KIK, 1LCJ, 1LCK, 1LKK, 1LKL, 1Q68, 1Q69, 1QPC, 1QPD, 1QPE, 1QPJ, 1X27, 2IIM, 2OF2, 2OF4, 2OFU, 2OFV, 2OG8, 2PL0, 2ZM1, 2ZM4, 2ZYB, 3AC1, 3AC2, 3AC3, 3AC4, 3AC5, 3AC8, 3ACJ, 3ACK, 3AD4, 3AD5, 3AD6, 3B2W, 3BRH, 3BYM, 3BYO, 3BYS, 3BYU, 3KMM, 3KXZ, 3LCK, 3MPM, 4D8K</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">505</column>
            <column name="TargetName">HUVECs co-cultured with gastric cancer cells</column>
            <column name="TargetSynonyms">Human umbilical vein endothelial cells co-cultured with gastric cancer cells
Co-HUVECs</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">506</column>
            <column name="TargetName">Paclitaxel (Taxol)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Paclitaxel (Taxol), an effective anticancer agent, is known to bind to tubulin and induce tubulin polymerization.</column>
        </table>
        <table name="target">
            <column name="TargetID">507</column>
            <column name="TargetName">Anti-N domain of human ACE monoclonal antibody 5F1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">508</column>
            <column name="TargetName">Wistar Kyoto (WKY) rats' kidney</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">509</column>
            <column name="TargetName">Tumor endothelial cells, TEC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">510</column>
            <column name="TargetName">Human melanoma cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">511</column>
            <column name="TargetName">Titanium dioxide, TiO2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">512</column>
            <column name="TargetName">Complement receptor type 2, Cr2</column>
            <column name="TargetSynonyms">Complement C3d receptor
Epstein-Barr virus receptor, EBV receptor
CD_antigen=CD21</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P20023</column>
            <column name="TargetStructure">1GHQ, 1LY2, 1W2R, 1W2S, 2GSX, 3OED</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">513</column>
            <column name="TargetName">Glutathione S-transferase Mu 2</column>
            <column name="TargetSynonyms">GSTM2-2
GST class-mu 2
EC=2.5.1.18</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P28161</column>
            <column name="TargetStructure">1HNA, 1HNB, 1HNC, 1XW5, 1YKC, 2AB6, 2C4J, 2GTU, 3GTU, 3GUR</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">514</column>
            <column name="TargetName">Anti-gp91-phox Monoclonal antibody CL5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">515</column>
            <column name="TargetName">HPV-16 E7 oncoprotein (28-LNDSSEEEDEI-38)</column>
            <column name="TargetSynonyms">Protein E7</column>
            <column name="TargetSource">Human papillomavirus type 16:333760</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03129 [28-38]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">516</column>
            <column name="TargetName">PreS region of the large surface antigen (LHB)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979) (HBV-D):490133</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03138 [2-63]</column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">517</column>
            <column name="TargetName">TG1 Escherichia coli cells, E.coli</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli:562</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">518</column>
            <column name="TargetName">Integrin alpha-IIb-beta-3, integrin αIIbβ3</column>
            <column name="TargetSynonyms">Integrin alpha-IIb alternative name(s):
Platelet membrane glycoprotein IIb
GPalpha IIb, GPIIb
CD_antigen=CD41

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa, GPIIIa
CD_antigen=CD61</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Integrin alpha-IIb: P08514, Integrin beta-3: P05106</column>
            <column name="TargetStructure">Integrin alpha-IIb: 1DPK, 1DPQ, 1KUP, 1KUZ, 1M8O, 1S4W, 1TYE, 2K1A, 2K9J, 2KNC, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3NID, 3NIF, 3NIG, 3T3M, 3T3P
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2L91, 2LJD, 2LJE, 2LJF, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG, 3T3M, 3T3P, 4G1E, 4G1M</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">519</column>
            <column name="TargetName">Kallikrein-14, hK14</column>
            <column name="TargetSynonyms">Kallikrein-like protein 6, KLK-L6</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9P0G3</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">520</column>
            <column name="TargetName">Ligand-binding domain of androgen receptor(AR)</column>
            <column name="TargetSynonyms">Dihydrotestosterone receptor
Nuclear receptor subfamily 3 group C member 4</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P10275 [690-919]</column>
            <column name="TargetStructure">1E3G, 1GS4, 1T5Z, 1T63, 1T65, 1XJ7, 1XOW, 1XQ3, 1Z95, 2AM9, 2AMA, 2AMB, 2AO6, 2AX6, 2AX7, 2AX8, 2AX9, 2AXA, 2HVC, 2OZ7, 2PIO, 2PIP, 2PIQ, 2PIR, 2PIT, 2PIU, 2PIV, 2PIW, 2PIX, 2PKL, 2PNU, 2Q7I, 2Q7J, 2Q7K, 2Q7L, 2YHD, 2YLO, 2YLP, 2YLQ, 2Z4J, 3B5R, 3B65, 3B66, 3B67, 3B68, 3BTR, 3L3X, 3L3Z, 3RLJ, 3RLL, 3V49, 3V4A, 3ZQT, 4HLW</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">521</column>
            <column name="TargetName">Interferon-binding domain of human p300</column>
            <column name="TargetSynonyms">IBD of p300</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">522</column>
            <column name="TargetName">Anti-VP2 monoclonal antibody 2F2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">523</column>
            <column name="TargetName">Kinase domain of VEGFR2</column>
            <column name="TargetSynonyms">VEGFR2 alternative name(s):
Vascular endothelial growth factor receptor 2
Kinase insert domain receptor
Protein-tyrosine kinase receptor flk-1
Fetal liver kinase 1, FLK-1
CD_antigen=CD309
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P35968 [834-1162]</column>
            <column name="TargetStructure">1VR2, 1Y6A, 1Y6B, 1YWN, 2OH4, 2P2H, 2P2I, 2QU5, 2QU6, 2RL5, 2X1W, 2X1X, 2XIR, 3B8Q, 3B8R, 3BE2, 3C7Q, 3CJF, 3CJG, 3CP9, 3CPB, 3CPC, 3DTW, 3EFL, 3EWH, 3KVQ, 3S35, 3S36, 3S37, 3U6J, 3VHE, 3VHK, 3VID, 3VNT, 3VO3, 4AG8, 4AGC, 4AGD, 4ASD, 4ASE</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">524</column>
            <column name="TargetName">Anti-human VEGF monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">525</column>
            <column name="TargetName">Estrogen receptor, ER</column>
            <column name="TargetSynonyms">Estradiol receptor
ER-alpha
Nuclear receptor subfamily 3 group A member 1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P03372</column>
            <column name="TargetStructure">1A52, 1ERE, 1ERR, 1G50, 1GWQ, 1GWR, 1HCP, 1HCQ, 1L2I, 1PCG, 1QKT, 1QKU, 1R5K, 1SJ0, 1UOM, 1X7E, 1X7R, 1XP1, 1XP6, 1XP9, 1XPC, 1XQC, 1YIM, 1YIN, 1ZKY, 2AYR, 2B1V, 2B1Z, 2B23, 2BJ4, 2FAI, 2G44, 2G5O, 2I0J, 2IOG, 2IOK, 2JF9, 2JFA, 2LLO, 2LLQ, 2OCF, 2OUZ, 2P15, 2POG, 2Q6J, 2Q70, 2QA6, 2QA8, 2QAB, 2QE4, 2QGT, 2QGW, 2QH6, 2QR9, 2QSE, 2QXM, 2QXS, 2QZO, 2R6W, 2R6Y, 2YAT, 2YJA, 3CBM, 3CBO, 3CBP, 3DT3, 3ERD, 3ERT, 3HLV, 3HM1, 3L03, 3OS8, 3OS9, 3OSA, 3Q95, 3Q97, 3UU7, 3UUA, 3UUC, 3UUD, 4AA6, 4DMA, 4IU7, 4IUI, 4IV2, 4IV4, 4IVW, 4IVY, 4IW6, 4IW8, 4IWC, 4IWF, 4JC3, 4JDD</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">526</column>
            <column name="TargetName">60 kDa chaperonin</column>
            <column name="TargetSynonyms">Protein Cpn60
GroEL protein</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0A6F5</column>
            <column name="TargetStructure">1AON, 1DK7, 1DKD, 1FY9, 1FYA, 1GR5, 1GRL, 1GRU, 1J4Z, 1JON, 1KID, 1KP8, 1KPO, 1LA1, 1MNF, 1OEL, 1PCQ, 1PF9, 1SS8, 1SVT, 1SX3, 1SX4, 1XCK, 2C7C, 2C7D, 2C7E, 2CGT, 2EU1, 2NWC, 2YEY, 3C9V, 3CAU, 4AAQ, 4AAR, 4AAS, 4AAU, 4AB2, 4AB3</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">527</column>
            <column name="TargetName">Anti-Cyt b monoclonal antibodies 7D5</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">528</column>
            <column name="TargetName">Collagenase 3</column>
            <column name="TargetSynonyms">Matrix metalloproteinase-13, MMP-13
EC=3.4.24.-</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P45452</column>
            <column name="TargetStructure">1EUB, 1FLS, 1FM1, 1PEX, 1XUC, 1XUD, 1XUR, 1YOU, 1ZTQ, 2D1N, 2E2D, 2OW9, 2OZR, 2PJT, 2YIG, 3ELM, 3I7G, 3I7I, 3KEC, 3KEJ, 3KEK, 3KRY, 3LJZ, 3O2X, 3TVC, 3ZXH, 456C, 4A7B, 830C</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">529</column>
            <column name="TargetName">Human spermatozoa</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">530</column>
            <column name="TargetName">Envelope glycoprotein gp120 (SU)</column>
            <column name="TargetSynonyms">Glycoprotein 120, gp120</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 (isolate HXB2 group M subtype B) (HIV-1):11706</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04578 [33-511]</column>
            <column name="TargetStructure">1AIK, 1DF4, 1DF5, 1DLB, 1G9M, 1GC1, 1GZL, 1K33, 1K34, 1RZJ, 2CMR, 2NY7, 2PV6, 2XRA, 3DNL, 3DNN, 3DNO, 3IDX, 3IDY, 3TYG, 3VIE, 4JPJ, 4JPK</column>
            <column name="TargetComments">The surface protein gp120 (SU) attaches the virus to the host lymphoid cell by binding to the primary receptor CD4. This interaction induces a structural rearrangement creating a high affinity binding site for a chemokine coreceptor like CXCR4 and/or CCR5. This peculiar 2 stage receptor-interaction strategy allows gp120 to maintain the highly conserved coreceptor-binding site in a cryptic conformation, protected from neutralizing antibodies. Surface protein gp120 (SU) may target the virus to gut-associated lymphoid tissue (GALT) by binding host ITGA4/ITGB7 (alpha-4/beta-7 integrins), a complex that mediates T-cell migration to the GALT. The surface protein gp120 is also a ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on endothelial cells of liver sinusoids and lymph node sinuses. These interactions allow capture of viral particles at mucosal surfaces by these cells and subsequent transmission to permissive cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">531</column>
            <column name="TargetName">Mosquito salivary gland</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Anopheles gambiae (African malaria mosquito):7165</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">532</column>
            <column name="TargetName">Mosquito midgut lumen</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Anopheles gambiae (African malaria mosquito):7165</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">533</column>
            <column name="TargetName">TrpE protein</column>
            <column name="TargetSynonyms">Anthranilate synthase component 1
Anthranilate synthase component I</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00895</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">534</column>
            <column name="TargetName">p85-N-SH2 domain</column>
            <column name="TargetSynonyms">p85 alternative name(s):
Phosphatidylinositol 3-kinase regulatory subunit beta
PtdIns-3-kinase regulatory subunit beta
PI3-kinase regulatory subunit beta
PI3K regulatory subunit beta
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta
PtdIns-3-kinase regulatory subunit p85-beta
PI3-kinase subunit p85-beta</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O00459 [330-425]</column>
            <column name="TargetStructure">2KT1, 2XS6, 3MTT, 3O5Z</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">535</column>
            <column name="TargetName">p85-C-SH2 domain</column>
            <column name="TargetSynonyms">p85 alternative name(s):
Phosphatidylinositol 3-kinase regulatory subunit beta
PtdIns-3-kinase regulatory subunit beta
PI3-kinase regulatory subunit beta
PI3K regulatory subunit beta
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta
PtdIns-3-kinase regulatory subunit p85-beta
PI3-kinase subunit p85-beta</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">O00459 [622-716]</column>
            <column name="TargetStructure">2KT1, 2XS6, 3MTT, 3O5Z</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">536</column>
            <column name="TargetName">PLCγ1-N-SH2 domain</column>
            <column name="TargetSynonyms">PLCγ1 alternative name(s):
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1
Phosphoinositide phospholipase C-gamma-1
Phospholipase C-gamma-1
PLC-gamma-1
Phospholipase C-II, PLC-II
PLC-148
EC=3.1.4.11</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P19174 [550-657]</column>
            <column name="TargetStructure">1HSQ, 2HSP, 4EY0, 4FBN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">537</column>
            <column name="TargetName">PLCγ1-C-SH2 domain</column>
            <column name="TargetSynonyms">PLCγ1 alternative name(s):
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1
Phosphoinositide phospholipase C-gamma-1
Phospholipase C-gamma-1
PLC-gamma-1
Phospholipase C-II, PLC-II
PLC-148
EC=3.1.4.11</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P19174 [668-756]</column>
            <column name="TargetStructure">1HSQ, 2HSP, 4EY0, 4FBN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">538</column>
            <column name="TargetName">GAP-N-SH2 domain</column>
            <column name="TargetSynonyms">GAP alternative name(s):
Ras GTPase-activating protein 1, RasGAP
GTPase-activating protein
Ras p21 protein activator
p120GAP</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P20936 [181-272]</column>
            <column name="TargetStructure">1WER, 1WQ1, 2GQI, 2GSB, 2J05, 2J06, 2M51, 4FSS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">539</column>
            <column name="TargetName">GAP-C-SH2 domain</column>
            <column name="TargetSynonyms">GAP alternative name(s):
Ras GTPase-activating protein 1, RasGAP
GTPase-activating protein
Ras p21 protein activator
p120GAP</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P20936 [351-441]</column>
            <column name="TargetStructure">1WER, 1WQ1, 2GQI, 2GSB, 2J05, 2J06, 2M51, 4FSS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">540</column>
            <column name="TargetName">GAP-N+C-SH2 (includes SH3 domain)</column>
            <column name="TargetSynonyms">GAP alternative name(s):
Ras GTPase-activating protein 1, RasGAP
GTPase-activating protein
Ras p21 protein activator
p120GAP</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P20936 [181-441]</column>
            <column name="TargetStructure">1WER, 1WQ1, 2GQI, 2GSB, 2J05, 2J06, 2M51, 4FSS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">541</column>
            <column name="TargetName">Integrin alpha-V-beta-6, integrin αVβ6</column>
            <column name="TargetSynonyms">Integrin alpha-V alternative name(s):
Vitronectin receptor subunit alpha
CD_antigen=CD51</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-V: P06756, Integrin beta-6: P18564</column>
            <column name="TargetStructure">Integrin alpha-V: 1JV2, 1L5G, 1M1X, 1U8C, 3IJE, 4G1E, 4G1M</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">542</column>
            <column name="TargetName">Integrin alpha-V-beta-3, integrin αvβ3</column>
            <column name="TargetSynonyms">Integrin alpha-V alternative name(s):
Vitronectin receptor subunit alpha
CD_antigen=CD51

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa, GPIIIa
CD_antigen=CD61</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-V: P06756, Integrin beta-3: P05106</column>
            <column name="TargetStructure">Integrin alpha-V: 1JV2, 1L5G, 1M1X, 1U8C, 3IJE
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">543</column>
            <column name="TargetName">Hyaluronan, HA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Hyaluronan (HA), a high molecular weight glycosaminoglycan, is expressed abundantly in the extracellular matrix and on cell surfaces.</column>
        </table>
        <table name="target">
            <column name="TargetID">544</column>
            <column name="TargetName">Transferrin receptor protein 1</column>
            <column name="TargetSynonyms">TfR1, TfR, TR, Trfr
T9
p90
CD_antigen=CD71</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P02786</column>
            <column name="TargetStructure">1CX8, 1DE4, 1SUV, 2NSU, 3KAS, 3S9L, 3S9M, 3S9N</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">545</column>
            <column name="TargetName">M protein from patient 3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">546</column>
            <column name="TargetName">M protein from patient 6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">547</column>
            <column name="TargetName">Hhydroxyethyl radical-modified bovine serum albumin, BSA-HER</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02769</column>
            <column name="TargetStructure">2L7U, 3V03, 4F5S</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">548</column>
            <column name="TargetName">Acetaldehyde-modified bovine serum albumin, BSA-AcH</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02769</column>
            <column name="TargetStructure">2L7U, 3V03, 4F5S</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">549</column>
            <column name="TargetName">HIV-1 protease, HIV-1 PR</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human immunodeficiency virus:12721</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q9YQ34</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">550</column>
            <column name="TargetName">Matrix metalloproteinase-14, MMP-14</column>
            <column name="TargetSynonyms">Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1
Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP
MMP-X1
EC=3.4.24.80</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P50281</column>
            <column name="TargetStructure">1BQQ, 1BUV, 3C7X, 3MA2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">551</column>
            <column name="TargetName">Protein Rev</column>
            <column name="TargetSynonyms">Regulator of expression of viral proteins
Anti-repression transactivator
ART/TRS</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate HXB3) (HIV-1):11707</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P69718</column>
            <column name="TargetStructure">3LPH</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">552</column>
            <column name="TargetName">Anti-BLG polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Two eight-week old White New Zealand rabbits were immunised by injection at multiple subcutaneous sites with beta lactoglobulin B.</column>
        </table>
        <table name="target">
            <column name="TargetID">553</column>
            <column name="TargetName">Protein Nef</column>
            <column name="TargetSynonyms">Negative factor, F-protein
3'ORF</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1):11686</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03406</column>
            <column name="TargetStructure">1AVV, 1AVZ, 1EFN, 4D8D</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">554</column>
            <column name="TargetName">Protein NefR90</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1):11686</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NefR90 a Nef variant containing an engineered F90R mutation that interferes
with docking of the native Hck RT-loop.</column>
        </table>
        <table name="target">
            <column name="TargetID">555</column>
            <column name="TargetName">Anti-NTX monoclonal antibody BNTX18</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">556</column>
            <column name="TargetName">Cucumber mosaic virus, CMV</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Cucumber mosaic virus (cucumber mosaic cucumovirus):12305</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">557</column>
            <column name="TargetName">PDZ2 domain of hPTPE1</column>
            <column name="TargetSynonyms">hPTPE1 Alternative name(s):
Tyrosine-protein phosphatase non-receptor type 13
Protein-tyrosine phosphatase 1E, PTP-E1
PTP-BAS
Protein-tyrosine phosphatase PTPL1
Fas-associated protein-tyrosine phosphatase 1, FAP-1
EC=3.1.3.48</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q12923 [1368-1452]</column>
            <column name="TargetStructure">1D5G, 1Q7X, 1WCH, 3LNX, 3LNY, 3PDZ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">558</column>
            <column name="TargetName">Anti-GAD65 monoclonal antibody MICA3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">559</column>
            <column name="TargetName">Anti-GAD65 monoclonal antibody MICA4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">560</column>
            <column name="TargetName">Anti-E1 protein polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">561</column>
            <column name="TargetName">HrNMT</column>
            <column name="TargetSynonyms">N terminal fused His6 NMT</column>
            <column name="TargetSource">Saccharomyces cerevisiae (Baker's yeast):4932</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">562</column>
            <column name="TargetName">Glycylpeptide N-tetradecanoyltransferase</column>
            <column name="TargetSynonyms">Peptide N-myristoyltransferase
Myristoyl-CoA:protein N-myristoyltransferase, NMT
Cell division control protein 72
EC=2.3.1.97</column>
            <column name="TargetSource">Saccharomyces cerevisiae (Baker's yeast):4932</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P14743</column>
            <column name="TargetStructure">1IIC, 1IID, 2NMT, 2P6E, 2P6F, 2P6G</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">563</column>
            <column name="TargetName">14-3-3 protein theta</column>
            <column name="TargetSynonyms">14-3-3 protein tau
14-3-3 protein T-cell
Protein HS1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P27348</column>
            <column name="TargetStructure">2BTP</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">564</column>
            <column name="TargetName">Anti-human SP-A monoclonal antibody  PE10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">565</column>
            <column name="TargetName">Anti-human SP-A monoclonal antibody PC6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">566</column>
            <column name="TargetName">Human neutrophil cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">567</column>
            <column name="TargetName">Anti-Bet v 1 polyclonal antibody IgE</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">568</column>
            <column name="TargetName">Anti-gpIIIa monoclonal antibody Y2/51</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">569</column>
            <column name="TargetName">Anti-gpIIb/IIIa monoclonal antibody 5B12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">570</column>
            <column name="TargetName">Anti-human platelet polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">571</column>
            <column name="TargetName">Anti-chlamydia pneumoniae monoclonal antibody RR-402</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">572</column>
            <column name="TargetName">Polyclonal sera from patients with C. pneumoniae infection</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">573</column>
            <column name="TargetName">Anti-SHP-1 monoclonal antibody 6D41</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">574</column>
            <column name="TargetName">Anti-SHP-1 monoclonal antibody 3E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">575</column>
            <column name="TargetName">Anti-SHP-1 monoclonal antibody 4E6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">576</column>
            <column name="TargetName">Texas red fluorophore dye</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">577</column>
            <column name="TargetName">Rhodamine red fluorophore dye</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">578</column>
            <column name="TargetName">Oregon green 514 fluorophore dye</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">579</column>
            <column name="TargetName">Fluorescein fluorophore dye</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">580</column>
            <column name="TargetName">U1 small nuclear RNA, U1 snRNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">581</column>
            <column name="TargetName">Anticodon stem and loop of yeast tRNA(Phe) (tRNA(ACPhe))</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Saccharomyces cerevisiae (Baker's yeast):4932</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">582</column>
            <column name="TargetName">Anti-gG2 monoclonal antibody H5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">583</column>
            <column name="TargetName">Anti-gG2 monoclonal antibody H7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">584</column>
            <column name="TargetName">Anti-gG2 monoclonal antibody F11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">585</column>
            <column name="TargetName">Anti-gG2 monoclonal antibody E5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">586</column>
            <column name="TargetName">Anti-MAPS monoclonal antibody 9C10 </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">587</column>
            <column name="TargetName">Pancreatic alpha-amylase, PA</column>
            <column name="TargetSynonyms">1,4-alpha-D-glucan glucanohydrolase
EC=3.2.1.1</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00690</column>
            <column name="TargetStructure">1BVN, 1DHK, 1HX0, 1JFH, 1KXQ, 1KXT, 1KXV, 1OSE, 1PIF, 1PIG, 1PPI, 1UA3, 1VAH, 1WO2, 3L2L, 3L2M</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">588</column>
            <column name="TargetName">Anti-c-myc protein monoclonal antibody 9E10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">589</column>
            <column name="TargetName">pFc' fragments of HAT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">590</column>
            <column name="TargetName">Anti-GPIb monoclonal antibody 6B4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">591</column>
            <column name="TargetName">Anti-GPIb monoclonal antibody 12G1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">592</column>
            <column name="TargetName">Anti-GPIb monoclonal antibody 12E4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">593</column>
            <column name="TargetName">Anti-GPIb monoclonal antibody 27A10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">594</column>
            <column name="TargetName">HLA class II histocompatibility antigen, DRB1-1 beta chain</column>
            <column name="TargetSynonyms">MHC class II antigen DRB1*1, DR-1, DR1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04229</column>
            <column name="TargetStructure">1AQD, 1DLH, 1FYT, 1HXY, 1JWM, 1JWS, 1JWU, 1KG0, 1KLG, 1KLU, 1LO5, 1PYW, 1R5I, 1SEB, 1SJE, 1SJH, 1T5W, 1T5X, 2FSE, 2G9H, 2IAM, 2IAN, 2ICW, 2IPK, 2OJE, 2XN9, 3L6F, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 3S4S, 3S5L, 4AEN, 4AH2, 4E41, 4FQX, 4GBX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">595</column>
            <column name="TargetName">High molecular mass serum fraction</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">596</column>
            <column name="TargetName">Madin-Darby canine kidney cells strain II, MDCKII</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">597</column>
            <column name="TargetName">Tobacco plasmodesmal-enriched cell wall fraction, W2 cell fraction</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Nicotiana tabacum (Common tobacco):4097</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">598</column>
            <column name="TargetName">Human foetal tracheal epithelial cell line CFT-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">599</column>
            <column name="TargetName">Rabbit hyperimmune serum against peptide (MSESHVKISRTIIRGTSPST)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">600</column>
            <column name="TargetName">Anti-peptide (MSESHVKISRTIIRGTSPST) polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">601</column>
            <column name="TargetName">Anti-CA monoclonal antibody A-56.36</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">602</column>
            <column name="TargetName">Anti-Myohemerythrin monoclonal antibody A2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was generated against the MHr peptide fragment EVVPHKKMHKDFLEKIGGL(69-87), binding to myohemerythrin strongly with a dissociation constants of 50nM.</column>
        </table>
        <table name="target">
            <column name="TargetID">603</column>
            <column name="TargetName">Anti-Myohemerythrin monoclonal antibody M33</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was generated against the myohemerythrin (MHr) pprotein, binding to MHr with a dissociation constants of 640nM.</column>
        </table>
        <table name="target">
            <column name="TargetID">604</column>
            <column name="TargetName">Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab001</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</column>
        </table>
        <table name="target">
            <column name="TargetID">605</column>
            <column name="TargetName">Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab003</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</column>
        </table>
        <table name="target">
            <column name="TargetID">606</column>
            <column name="TargetName">Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab004</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</column>
        </table>
        <table name="target">
            <column name="TargetID">607</column>
            <column name="TargetName">Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab005</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</column>
        </table>
        <table name="target">
            <column name="TargetID">608</column>
            <column name="TargetName">Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab006</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</column>
        </table>
        <table name="target">
            <column name="TargetID">609</column>
            <column name="TargetName">Chronic Lymphocytic Leukemia Fragment Antigen-Binding (Fab) Fragments Fab007</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BCRs from 8 randomly chosen patients with CLL were expressed as Fab fragments, termed &quot;Fab&quot; followed by a patient-specific number.</column>
        </table>
        <table name="target">
            <column name="TargetID">610</column>
            <column name="TargetName">Tyrosine-protein kinase Yes</column>
            <column name="TargetSynonyms">p61-Yes
EC=2.7.10.2</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P09324</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">611</column>
            <column name="TargetName">Anti-HIV-l isotype MN gp120 monoclonal antibody 58.2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:4558278, GI:4558277</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">612</column>
            <column name="TargetName">Anti-ovarian carcinoma monoclonal antibody OV-TL3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:693814, GI:693815</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">OV-TL3, raised after immunization with an extract of an endometrioid cancer biopsy, has a reactivity pattern highly restricted to ovarian carcinomas and was shown to react with a surface glycoprotein by molecular cloning of the antigen. Isotype: IgG1, kappa.</column>
        </table>
        <table name="target">
            <column name="TargetID">613</column>
            <column name="TargetName">Anti-ovarian carcinoma monoclonal antibody OV-TL16</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:693816, GI:693817</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">OV-TL16 was raised after immunization with cyst fluid obtained from a poorly differentiated ovarian carcinoma. Isotype: IgG1, kappa.</column>
        </table>
        <table name="target">
            <column name="TargetID">614</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363160</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">615</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363159</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">616</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE13</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363153</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">617</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE14</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:854291</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">618</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE15</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363160</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">619</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE19</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363164</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">620</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE20</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363166</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">621</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE21</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363167</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">622</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE22</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363168</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">623</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE23</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363169</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">624</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE24</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363170</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">625</column>
            <column name="TargetName">Anti-proenkephalin monoclonal antibody PE25</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:1363171</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody was raised against human proenkephalin-beta-galactosidase fusion protein synthesized in Escherichia coli.</column>
        </table>
        <table name="target">
            <column name="TargetID">626</column>
            <column name="TargetName">Anti-beta-endorphin monoclonal antibody 3-E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This antibody was first described by Gramsch C. et al. on J Neurochem (PMID: 6187900). Its immunogen was a fragment of synthetic human beta-endorphin (YGGF) coupled with polylysine or thyroglobulin. Its isotype: IgG2a.</column>
        </table>
        <table name="target">
            <column name="TargetID">627</column>
            <column name="TargetName">Interleukin-1 receptor type 1</column>
            <column name="TargetSynonyms">IL-1RT-1, IL-1RT1, IL-1R-1
Interleukin-1 receptor type I
Interleukin-1 receptor alpha, IL-1R-alpha
p80
CD121 antigen-like family member A
CD_antigen=CD121a</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P14778</column>
            <column name="TargetStructure">1G0Y, 1IRA, 1ITB, 4DEP, 4GAF</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">628</column>
            <column name="TargetName">E-selectin</column>
            <column name="TargetSynonyms">Endothelial leukocyte adhesion molecule 1, ELAM-1
Leukocyte-endothelial cell adhesion molecule 2, LECAM2
CD62 antigen-like family member E
CD_antigen=CD62E</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P16581</column>
            <column name="TargetStructure">1ESL, 1G1T</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">629</column>
            <column name="TargetName">Anti-P53 monoclonal antibody PAb240</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PAb240 is a mouse monoclonal IgG1 derived by fusion of Sp2 myeloma cells with spleen cells from a mouse immunized with a beta-galactosidase fusion protein containing a p53 domain corresponding to amino acids 156-214 of mammalian origin.</column>
        </table>
        <table name="target">
            <column name="TargetID">630</column>
            <column name="TargetName">Anti-P53 monoclonal antibody DO-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">DO-1 is a mouse monoclonal IgG2a derived by fusion of X63Ag 8.653 mouse myeloma cells with spleen cells from a BALB/C mouse immunized with recombinant wild type p53 protein. The epitope maps to amino acids 11-25 of wt and mutant p53 of human origin.</column>
        </table>
        <table name="target">
            <column name="TargetID">631</column>
            <column name="TargetName">Anti-P53 monoclonal antibody DO-7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">DO-7 is a mouse monoclonal IgG2b derived from mouse immunized with recombinant wild type p53 protein. The epitope maps to amino acids 20-25 of p53 of human origin.</column>
        </table>
        <table name="target">
            <column name="TargetID">632</column>
            <column name="TargetName">Anti-P53 monoclonal antibody Bp53-11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Bp53-11 is a mouse monoclonal IgG2a derived from mouse immunized with recombinant human p53 protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">633</column>
            <column name="TargetName">Anti-P53 monoclonal antibody Bp53-12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Bp53-12 is a mouse monoclonal IgG2a derived from mouse immunized with recombinant human p53 protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">634</column>
            <column name="TargetName">Anti-P53 monoclonal antibody Bp53-19</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Bp53-19 is a mouse monoclonal IgG derived from mouse immunized with recombinant human p53 protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">635</column>
            <column name="TargetName">Anti-P53 monoclonal antibody PAb421</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PAb421 is a mouse monoclonal IgG2a derived from mouse immunized with synthetic peptide corresponding to aa 371-380 of human p53.</column>
        </table>
        <table name="target">
            <column name="TargetID">636</column>
            <column name="TargetName">Anti-P53 monoclonal antibody PAb122</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PAb122 is a mouse monoclonal IgG2b, kappa.</column>
        </table>
        <table name="target">
            <column name="TargetID">637</column>
            <column name="TargetName">Protein S100-B</column>
            <column name="TargetSynonyms">S100 calcium-binding protein B
S-100 protein subunit beta
S-100 protein beta chain</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02638</column>
            <column name="TargetStructure">1CFP, 1MHO, 1PSB, 3CR2, 3CR4, 3CR5, 3GK1, 3GK2, 3GK4, 3IQO, 3IQQ, 3LK0, 3LK1, 3LLE, 3RLZ, 3RM1, 4FQO</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">638</column>
            <column name="TargetName">Antigen-presenting glycoprotein CD1d1</column>
            <column name="TargetSynonyms">CD_antigen=CD1d.1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P11609</column>
            <column name="TargetStructure">1CD1, 1Z5L, 1ZHN, 2AKR, 2FIK, 2GAZ, 2Q7Y, 3ARB, 3ARD, 3ARE, 3ARF, 3ARG, 3AU1, 3G08, 3GML, 3GMM, 3GMN, 3GMO, 3GMP, 3GMQ, 3GMR, 3HE6, 3HE7, 3ILP, 3ILQ, 3MA7, 3O8X, 3O9W, 3QI9, 3QUX, 3QUY, 3QUZ, 3RUG, 3RZC, 3SCM, 3SDA, 3SDC, 3SDD, 3T1F, 3TA3, 3TN0, 3TO4, 3TVM, 3UBX, 4APQ, 4EI5, 4ELM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">639</column>
            <column name="TargetName">Anti-keratin 19 monoclonal antibody BM19.21</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BM19.21 is a subclone of Ks19.2 (Achtstatter, 1988), also monospecific for keratin 19.</column>
        </table>
        <table name="target">
            <column name="TargetID">640</column>
            <column name="TargetName">Anti-keratin 19 monoclonal antibody LE64</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">LE64 is a mouse monoclonal IgG2a, generated against detergent insoluble cytoskeleton extracts from a cultured simple epithelium derived cell line, PtK, cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">641</column>
            <column name="TargetName">Anti-keratin 19 monoclonal antibody KM4.62</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">KM4.62 was reported to be monospecific for keratin 19.</column>
        </table>
        <table name="target">
            <column name="TargetID">642</column>
            <column name="TargetName">Anti-keratin 19 monoclonal antibody LP2K</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">LP2K was reported to be monospecific for keratin 19.</column>
        </table>
        <table name="target">
            <column name="TargetID">643</column>
            <column name="TargetName">Anti-keratin 19 monoclonal antibody BA16</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BA16 is a mouse monoclonal IgG1 derived by fusion of X63Ag 8.653 mouse myeloma cells with spleen cells from a BALB/C mouse immunized with detergent-insoluble extract of human mammary epithelial organoids. BA16 was reported to be monospecific for keratin 19.</column>
        </table>
        <table name="target">
            <column name="TargetID">644</column>
            <column name="TargetName">MAR DNA Affinity Column</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Multimeric wild-type MAR DNA (25)5 (top strand of the monomer sequence: 59-TCTTTAATTTCTAATATATTTAGAAttc-39) was used in the experiment.</column>
        </table>
        <table name="target">
            <column name="TargetID">645</column>
            <column name="TargetName">Purified IgM lamda receptor of the human Burkitt lymphoma cell line SUP-B8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">646</column>
            <column name="TargetName">Anti-p22phox monoclonal antibody 44.1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was produced against the Triton X-100-solubilized wheat germ agglutinin and heparin-Ultrogel-purified cytochrome b protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">647</column>
            <column name="TargetName">Anti-gp91phox monoclonal antibody 54.1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This monoclonal antibody was produced against the Triton X-100-solubilized wheat germ agglutinin and heparin-Ultrogel-purified cytochrome b protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">648</column>
            <column name="TargetName">Stromelysin-1, SL-1</column>
            <column name="TargetSynonyms">Matrix metalloproteinase-3, MMP-3
Transin-1
EC=3.4.24.17</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08254</column>
            <column name="TargetStructure">1B3D, 1B8Y, 1BIW, 1BM6, 1BQO, 1C3I, 1C8T, 1CAQ, 1CIZ, 1CQR, 1D5J, 1D7X, 1D8F, 1D8M, 1G05, 1G49, 1G4K, 1HFS, 1HY7, 1OO9, 1QIA, 1QIC, 1SLM, 1SLN, 1UEA, 1UMS, 1UMT, 1USN, 2D1O, 2JNP, 2JT5, 2JT6, 2SRT, 2USN, 3OHL, 3OHO, 3USN, 4DPE, 4JA1</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">649</column>
            <column name="TargetName">Matrilysin</column>
            <column name="TargetSynonyms">Pump-1 protease
Uterine metalloproteinase
Matrix metalloproteinase-7, MMP-7
Matrin
EC=3.4.24.23</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P09237</column>
            <column name="TargetStructure">1MMP, 1MMQ, 1MMR, 2DDY, 2Y6C, 2Y6DY</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">650</column>
            <column name="TargetName">Urokinase plasminogen activator surface receptor</column>
            <column name="TargetSynonyms">U-PAR, uPAR
Monocyte activation antigen Mo3
CD_antigen=CD87</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q03405</column>
            <column name="TargetStructure">1YWH, 2FD6, 2I9B, 3BT1, 3BT2, 3U73, 3U74, 4K24, 4QTI</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">651</column>
            <column name="TargetName">Biotin</column>
            <column name="TargetSynonyms">Vitamin B7, Vitamin H
Coenzyme R, Biopeiderm
PDB component identifier: BTN</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">CID: 171548
SMILES: O=C1N[C@@H]2[C@@H](SC[C@@H]2N1)CCCCC(=O)O</column>
            <column name="TargetStructure">1AVD,1BDO,1BIB,1DF8,1F27,1HXD,1KQS,1LUQ,1MEP,1MK5,1N43,1N9M,1NDJ,1NQM,1STP,1SWD,1SWE,1SWG,1SWK,1SWN,1SWP,1SWR,1SWT,1WBI,1WPY,1XNY,1Y52,1Y55,2AVI,2B8G,2BDO,2C1Q,2C4I,2DTH,2DTO,2DXT,2EJ9,2EJF,2EJG,2F01,2FYK,2GH7,2IZF,2IZG,2IZH,2IZI,2IZJ,2JGS,2RTD,2RTE,2RTF,2RTG,2UYW,2UZ2,2Y3F,2ZGW,2ZSC,3EFR,3EFS,3EW2,3G8C,3IB9,3MG5,3O34,3RDM,3RDO</column>
            <column name="TargetComments">Biotin is a water-soluble B-complex vitamin discovered by Bateman in 1916. The Empirical formula of Biotin is C10H16O3N2S, with an unusual structure composed of a ureido (tetrahydroimidizalone) ring fused with a tetrahydrothiophene ring. Biotin is necessary for cell growth, the production of fatty acids, and the metabolism of fats and amino acids. It plays a role in the citric acid cycle, which is the process by which biochemical energy is generated during aerobic respiration. Biotin not only assists in various metabolic reactions but also helps to transfer carbon dioxide. Biotin may also be helpful in maintaining a steady blood sugar level. </column>
        </table>
        <table name="target">
            <column name="TargetID">652</column>
            <column name="TargetName">Proto-oncogene tyrosine-protein kinase Src</column>
            <column name="TargetSynonyms">Proto-oncogene c-Src
pp60c-src, p60-Src</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00523</column>
            <column name="TargetStructure">1F1W, 1F2F, 1NLO, 1NLP, 1P13, 1PRL, 1PRM, 1RLP, 1RLQ, 1SRL, 1SRM, 2HWO, 2HWP, 2OIQ, 2PTK, 2QI8, 2QLQ, 2QQ7, 3D7T, 3D7U, 3DQW, 3DQX, 3EL7, 3EL8, 3EN4, 3EN5, 3EN6, 3EN7, 3F3T, 3F3U, 3F3V, 3F3W, 3F6X, 3FJ5, 3G5D, 3G6G, 3G6H, 3GEQ, 3LOK, 3OEZ, 3OF0, 3QLF, 3QLG, 3SVV, 3TZ7, 3TZ8, 3TZ9, 3U4W, 3U51, 3UQF, 3UQG, 4AGW, 4DGG, 4FIC, 4HVU, 4HVV, 4HVW</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">653</column>
            <column name="TargetName">Brain blood vessels</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">654</column>
            <column name="TargetName">Kidney blood vessels</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">655</column>
            <column name="TargetName">Anti-G(o) monoclonal antibody 3E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">3E7 is a mouse monoclonal IgG1 derived by fusion of Sp2 myeloma cells with spleen cells from a mouse immunized with purified brain G-proteins from either human or bovine.</column>
        </table>
        <table name="target">
            <column name="TargetID">656</column>
            <column name="TargetName">Erythropoietin receptor</column>
            <column name="TargetSynonyms">EPO-R</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P19235</column>
            <column name="TargetStructure">1CN4, 1EBA, 1EBP, 1EER, 1ERN, 2JIX, 2MV6, 4Y5V, 4Y5X, 4Y5Y</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">657</column>
            <column name="TargetName">Tyrosine-protein kinase Blk</column>
            <column name="TargetSynonyms">B lymphocyte kinase
p55-Blk
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P51451</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">658</column>
            <column name="TargetName">Tyrosine-protein kinase SYK</column>
            <column name="TargetSynonyms">Spleen tyrosine kinase
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P43405</column>
            <column name="TargetStructure">1A81, 1CSY, 1CSZ, 1XBA, 1XBB, 1XBC, 3BUW, 3EMG, 3FQE, 3FQH, 3FQS, 3SRV, 3TUB, 3TUC, 3TUD, 3VF8, 3VF9, 4DFL, 4DFN, 4F4P, 4FL1, 4FL2, 4FL3, 4FYN, 4FYO, 4FZ6</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">659</column>
            <column name="TargetName">Toxic shock syndrome toxin-1, TSST-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Staphylococcus aureus:1280</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P06886</column>
            <column name="TargetStructure">1AW7, 1QIL, 1TS2, 1TS3, 1TS4, 1TS5, 2QIL, 2TSS, 3TSS, 4TSS, 5TSS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">660</column>
            <column name="TargetName">Anti-HBsAg polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Chimpanzee:9598</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">661</column>
            <column name="TargetName">Tyrosine-protein kinase ITK/TSK</column>
            <column name="TargetSynonyms">T-cell-specific kinase
IL-2-inducible T-cell kinase
Kinase EMT
Kinase TLK
EC=2.7.10.2</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q03526</column>
            <column name="TargetStructure">1AWJ, 1LUI, 1LUK, 1LUM, 1LUN, 2ETZ, 2EU0, 2K79, 2K7A, 2RN8, 2RNA, 3S9K</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">662</column>
            <column name="TargetName">HLA class II histocompatibility antigen DR13</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01903, Q5Y7A7</column>
            <column name="TargetStructure">MHC class II antigen DRA: 1A6A, 1AQD, 1BX2, 1D5M, 1D5X, 1D5Z, 1D6E, 1DLH, 1FV1, 1FYT, 1H15, 1HQR, 1HXY, 1J8H, 1JWM, 1JWS, 1JWU, 1KG0, 1KLG, 1KLU, 1LO5, 1PYW, 1R5I, 1SEB, 1SJE, 1SJH, 1T5W, 1T5X, 1YMM, 1ZGL, 2FSE, 2G9H, 2IAM, 2IAN, 2ICW, 2IPK, 2OJE, 2Q6W, 2SEB, 2WBJ, 2XN9, 3C5J, 3L6F, 3O6F, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 3S4S, 3S5L, 3T0E, 4AEN, 4AH2, 4E41, 4FQX, 4GBX, 4H1L</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">663</column>
            <column name="TargetName">Integrin alpha-6-beta-1, integrin α6β1</column>
            <column name="TargetSynonyms">Integrin alpha-6 alternative name(s):
VLA-6
CD49 antigen-like family member F
CD_antigen=CD49f

Integrin beta-1 alternative name(s):
Fibronectin receptor subunit beta
VLA-4 subunit beta
CD_antigen=CD29</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-6: P23229, Integrin beta-1: P05556</column>
            <column name="TargetStructure">Integrin beta-1: 3G9W, 3T9K, 3VI3, 3VI4, 4DX9</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">664</column>
            <column name="TargetName">Intercellular adhesion molecule 1, ICAM-1</column>
            <column name="TargetSynonyms">Major group rhinovirus receptor
CD_antigen=CD54</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P05362</column>
            <column name="TargetStructure">1D3E, 1D3I, 1D3L, 1IAM, 1IC1, 1MQ8, 1P53, 1Z7Z, 2OZ4, 3TCX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">665</column>
            <column name="TargetName">Anti-CD80 monoclonal antibody L307.4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IgG1, kappa</column>
        </table>
        <table name="target">
            <column name="TargetID">666</column>
            <column name="TargetName">Alpha-bungarotoxin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bungarus multicinctus (Many-banded krait):8616</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P60615, P60616</column>
            <column name="TargetStructure">Alpha-BTX A31: 1ABT, 1BXP, 1HAA, 1HAJ, 1HC9, 1HOY, 1IDG, 1IDH, 1IDI, 1IDL, 1IK8, 1IKC, 1JBD, 1KC4, 1KFH, 1KL8, 1L4W, 1LJZ, 1RGJ, 2ABX, 2BTX
Alpha-BTX V31:1HC9, 2QC1</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">667</column>
            <column name="TargetName">Anti-MSP1 monoclonal antibody D14-3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">D14-3 is a monoclonal antibody raised against the the Mr 42000 C-terminal fragment (Pv42) of Plasmodium vivax merozoite surface protein 1 (PvMSPl).</column>
        </table>
        <table name="target">
            <column name="TargetID">668</column>
            <column name="TargetName">Calmodulin, CaM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Spinacia oleracea (Spinach):3562</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04353</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">669</column>
            <column name="TargetName">Aequorin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Aequorea victoria (Jellyfish):6100</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07164, P02592</column>
            <column name="TargetStructure">1SL8, 1EJ3, 1UHH, 1UHI, 1UHJ, 1UHK
 </column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">670</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody GV1A8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GV1A8 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gp120/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</column>
        </table>
        <table name="target">
            <column name="TargetID">671</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody GV4D3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GV4D3 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gp120/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</column>
        </table>
        <table name="target">
            <column name="TargetID">672</column>
            <column name="TargetName">Anti-GXM monoclonal antibody 2E9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">2E9 is a human monoclonal antibody (IgM, lamda) elicited by the investigational cryptococcal capsular polysaccharide vaccine glucuronoxylomannan-tetanus toxoid (GXM-TT).</column>
        </table>
        <table name="target">
            <column name="TargetID">673</column>
            <column name="TargetName">Anti-dystrophin monoclonal antibody MANDYS142</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MANDYS142 was raised against the central rod region of dystrophin.</column>
        </table>
        <table name="target">
            <column name="TargetID">674</column>
            <column name="TargetName">Anti-DNA monoclonal antibody F14.6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">F14.6 is a monoclonal IgG2a polyreactive antibody obtained from the splenocytes of an 8-month-old (NZB x NZW)Fl mouse that spontaneously developed a lupus-like syndrome, after fusion with X63 myeloma cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">675</column>
            <column name="TargetName">Anti-DNA monoclonal antibody J20.8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">J20.8 is a monoclonal IgG2a polyreactive antibody obtained from the splenocytes of an 8-month-old (NZB x NZW)Fl mouse that spontaneously developed a lupus-like syndrome, after fusion with X63 myeloma cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">676</column>
            <column name="TargetName">Tissue-type plasminogen activator</column>
            <column name="TargetSynonyms">t-plasminogen activator, t-PA, tPA
INN=Alteplase
INN=Reteplase</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00750</column>
            <column name="TargetStructure">1A5H, 1BDA, 1PK2, 1PML, 1RTF, 1TPG, 1TPK, 1TPM, 1TPN</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">677</column>
            <column name="TargetName">Anti-PSM monoclonal antibody 7E11-C5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">7E11-C5 is a monoclonal antibody (IgG2a, kappa) against prostate-specific membrane antigen (PSMA).</column>
        </table>
        <table name="target">
            <column name="TargetID">678</column>
            <column name="TargetName">Calmodulin, CaM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P62157</column>
            <column name="TargetStructure">1A29, 1AK8, 1CDM, 1CM1, 1CM4, 1CMF, 1CMG, 1DEG, 1FW4, 1LIN, 1PRW, 1QIV, 1QIW, 1XA5, 2F2O, 2F2P, 2FOT, 3IF7</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">679</column>
            <column name="TargetName">Thomsen-Friedenreich antigen (T antigen, TF antigen)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The Thomsen-Friedenreich (TF) antigen is a precursor structure of MN blood group antigens and is also expressed by about 90% of human carcinomas. The immunodominant group of TF antigen is β-galactosyl(1-3)-α-N-acetylglactosamine.</column>
        </table>
        <table name="target">
            <column name="TargetID">680</column>
            <column name="TargetName">Protease precursor, pPR</column>
            <column name="TargetSynonyms">Capsid protein P40
Virion structural protein UL26</column>
            <column name="TargetSource">Human herpesvirus 1 (strain 17) (HHV-1) (Human herpes simplex virus 1):10299</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P10210</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">681</column>
            <column name="TargetName">Anti-Hantaan virus glycoprotein G2 monoclonal antibody mAbGDO5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">682</column>
            <column name="TargetName">Anti-P53 monoclonal antibody mAbBp53-11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">683</column>
            <column name="TargetName">Phosphoenolpyruvate-protein phosphotransferase</column>
            <column name="TargetSynonyms">Phosphotransferase system, enzyme I
EC=2.7.3.9</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08839</column>
            <column name="TargetStructure">1EZA, 1EZB, 1EZC, 1EZD, 1ZYM, 2EZA, 2EZB, 2EZC, 2HWG, 2KX9, 2L5H, 2MP0, 2XDF, 3EZA, 3EZB, 3EZE</column>
            <column name="TargetComments">General (non sugar-specific) component of the phosphoenolpyruvate-dependent sugar phosphotransferase system (sugar PTS). This major carbohydrate active-transport system catalyzes the phosphorylation of incoming sugar substrates concomitantly with their translocation across the cell membrane. Enzyme I transfers the phosphoryl group from phosphoenolpyruvate (PEP) to the phosphoryl carrier protein (HPr).</column>
        </table>
        <table name="target">
            <column name="TargetID">684</column>
            <column name="TargetName">Anti-preS1 monoclonal antibody MA18/7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MA18/7 is a monoclonal mouse IgG1 produced after immunization of mice with HBV virions of the ay subtype.</column>
        </table>
        <table name="target">
            <column name="TargetID">685</column>
            <column name="TargetName">Anti-C5a monoclonal antibody 2925</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb 2925 was raised against the nonapeptide ISHKDMQLG of C5a(65-73).</column>
        </table>
        <table name="target">
            <column name="TargetID">686</column>
            <column name="TargetName">Anti-c-myc monoclonal antibody MYC-X-5/1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MYC-X-5/1 is a monoclonal antibody (IgG2a, kappa) derived by fusion of SP2/0 mouse myeloma cells with spleen cells from a Balb/c mouse immunized with recombinant human c-myc protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">687</column>
            <column name="TargetName">Caveolin-1</column>
            <column name="TargetSynonyms">Vesicular integral-membrane protein VIP21</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P33724</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">688</column>
            <column name="TargetName">Anti-FIV monoclonal antibody 3e3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The 3e3 monoclonal antibody was derived by fusion of mouse myeloma cells with spleen cells from a Balb/c mouse immunized with a synthetic peptide from the surface glycoprotein (396-415) of the feline immunodeficiency virus coupled to BSA.</column>
        </table>
        <table name="target">
            <column name="TargetID">689</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody A32</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb A32 is a monoclonal human IgG1 obtained from immortalized antibody-producing peripheral cell clones from individuals infected with HIV-1. Human MAb A32 was shown to recognize gpl20 derived from most (&gt;93%) HIV-1 clade B isolates.</column>
        </table>
        <table name="target">
            <column name="TargetID">690</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody 19b</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb 19b is a monoclonal human IgG1 obtained from immortalized antibody-producing peripheral cell clones from individuals infected with HIV-1. The ability of MAb 19b to neutralize laboratory-adapted strains of HIV-1, neutralize primary isolates of HIV-1, bind display phage with sequences mimicking the noncontiguous determinant in gpl20 V3 region, and to interfere in the interaction of gpl20 and CCR5 in infectivity of CD4+ cells has been reported.</column>
        </table>
        <table name="target">
            <column name="TargetID">691</column>
            <column name="TargetName">HMG box 1 domain of high mobility group protein B1</column>
            <column name="TargetSynonyms">High mobility group protein B1 alternative name(s):
High mobility group protein 1, HMG-1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P09429[9-79]</column>
            <column name="TargetStructure">2LY4, 2YRQ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">692</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody 447-52D</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb 447-52D (IgG3, lamda) recognizes the most prevalent clade B V3 region apex sequence, GPXR.</column>
        </table>
        <table name="target">
            <column name="TargetID">693</column>
            <column name="TargetName">Anti-gp41 monoclonal antibody 50-69</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IgG2 kappa</column>
        </table>
        <table name="target">
            <column name="TargetID">694</column>
            <column name="TargetName">Mice carrying human MDA-MB-435 breast carcinoma xenografts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">695</column>
            <column name="TargetName">Protein Vpr</column>
            <column name="TargetSynonyms">Viral protein R
R ORF protein</column>
            <column name="TargetSource">Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1):11686</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05928</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">696</column>
            <column name="TargetName">CD81 antigen</column>
            <column name="TargetSynonyms">26 kDa cell surface protein TAPA-1
Target of the antiproliferative antibody 1
Tetraspanin-28, Tspan-28
CD_antigen: CD81</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P60033</column>
            <column name="TargetStructure">1G8Q, 1IV5</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">697</column>
            <column name="TargetName">Chaperone surA</column>
            <column name="TargetSynonyms">Peptidyl-prolyl cis-trans isomerase surA, PPIase surA
Rotamase surA
Survival protein A</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0ABZ6</column>
            <column name="TargetStructure">1M5Y, 2PV1, 2PV2, 2PV3</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">698</column>
            <column name="TargetName">SurA (delta-P2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0ABZ6</column>
            <column name="TargetStructure">1M5Y, 2PV1, 2PV2, 2PV3</column>
            <column name="TargetComments">An expression vector for a SurA deletion lacking the second P2 parvulin-like domain (SurA(delta P2), residues 21-281 and 390-428) was created using the overlap-extension methodology.</column>
        </table>
        <table name="target">
            <column name="TargetID">699</column>
            <column name="TargetName">Anti-b558 monoclonal antibody NL7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">700</column>
            <column name="TargetName">Monoclonal antibody 5E8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MoAb 5E8 (IgG1 subclass) is against an antigen presenton the bile canalicular membrane of rat hepatocytes.</column>
        </table>
        <table name="target">
            <column name="TargetID">701</column>
            <column name="TargetName">Anti-GXM monoclonal antibody 2H1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:2914305; GI:2914304</column>
            <column name="TargetStructure">2H1P</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">702</column>
            <column name="TargetName">Proximal convoluted tubules, PCT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">703</column>
            <column name="TargetName">Atherosclerotic lesion surfaces</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">704</column>
            <column name="TargetName">Anti-estradiol monoclonal antibody E2-15</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">705</column>
            <column name="TargetName">Anti-BTx-A monoclonal antibody BT57-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">706</column>
            <column name="TargetName">Anti-BTx-A monoclonal antibody BT150-3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">707</column>
            <column name="TargetName">Anti-glutamic acid decarboxylase monoclonal antibody GAD-6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GAD-6, a murine IgG2a monoclonal antibody (mAb) specific for the 65 kDa isoform of glutamic acid decarboxylase (GAD65) (Chang and Gottlieb, 1988)</column>
        </table>
        <table name="target">
            <column name="TargetID">708</column>
            <column name="TargetName">Anti-glutamic acid decarboxylase monoclonal antibody N-mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">N-mAb (GC3208, clone 11) is a murine IgG1 mAb that specifically recognises resi-dues 4-17 of GAD65 (Ziegler et al., 1994).</column>
        </table>
        <table name="target">
            <column name="TargetID">709</column>
            <column name="TargetName">Anti-glutamic acid decarboxylase monoclonal antibody C-mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C-mAb (GC3108, clone 111) is a murine IgG1 mAb that recognises the C-terminus of GAD65 and GAD67 (residues 572-585 of GAD65) (Ziegler et al., 1996).</column>
        </table>
        <table name="target">
            <column name="TargetID">710</column>
            <column name="TargetName">Vascular smooth muscle cells, VSMC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">711</column>
            <column name="TargetName">Murine microglial cell line EOC 20</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">712</column>
            <column name="TargetName">LNCaP prostate carcinoma cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">713</column>
            <column name="TargetName">Fibroblast growth factor receptor 1, FGFR-1</column>
            <column name="TargetSynonyms">Basic fibroblast growth factor receptor 1 (BFGFR or bFGF-R-1)
Fms-like tyrosine kinase 2 (FLT-2)
N-sam
Proto-oncogene c-Fgr
CD_antigen: CD331</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P11362</column>
            <column name="TargetStructure">1AGW, 1CVS, 1EVT, 1FGI, 1FGK, 1FQ9, 1XR0, 2CR3, 2FGI, 3C4F, 3DPK, 3GQI, 3GQL, 3JS2, 3KRJ, 3KRL, 3KXX, 3KY2, 3OJV, 3RHX, 3TT0, 4F63, 4F64, 4F65, 4NK9, 4NKA, 4NKS, 4RWI, 4RWJ, 4RWK, 4RWL, 4UWB, 4UWC, 4UWY, 4V01, 4V04, 4V05, 4WUN, 4ZSA, 5A46, 5A4C, 5AM6, 5AM7, 5B7V, 5EW8, 5FLF, 5O49, 5O4A, 5UQ0, 5UR1, 5VND, 5W21, 5W59, 5ZV2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">714</column>
            <column name="TargetName">Anti-PSA monoclonal antibody 5E4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">715</column>
            <column name="TargetName">Anti-PSA monoclonal antibody 5E4 and H117</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">716</column>
            <column name="TargetName">Anti-PSA monoclonal antibody H117</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">717</column>
            <column name="TargetName">Anti-PSA monoclonal antibody 5A10 and 4G10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">718</column>
            <column name="TargetName">Anti-PSA monoclonal antibody 4G10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">719</column>
            <column name="TargetName">Anti-PSA monoclonal antibody H50</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">720</column>
            <column name="TargetName">Anti-PSA monoclonal antibody H50 and 9C5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">721</column>
            <column name="TargetName">Anti-PSA monoclonal antibody 9C5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">722</column>
            <column name="TargetName">Capsid protein</column>
            <column name="TargetSynonyms">Core protein
Core antigen
HBcAg
p21.5</column>
            <column name="TargetSource">Hepatitis B virus genotype A2 subtype adw2 (strain Rutter 1979) (HBV-A):480116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03148</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">723</column>
            <column name="TargetName">Fibroblast growth factor receptor 2, FGFR-2</column>
            <column name="TargetSynonyms">Keratinocyte growth factor receptor
K-sam
CD_antigen=CD332</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P21802</column>
            <column name="TargetStructure">1DJS, 1E0O, 1EV2, 1GJO, 1II4, 1IIL, 1NUN, 1OEC, 1WVZ, 2FDB, 2PSQ, 2PVF, 2PVY, 2PWL, 2PY3, 2PZ5, 2PZP, 2PZR, 2Q0B, 3B2T, 3CAF, 3CLY, 3CU1, 3DAR, 3EUU, 3OJ2, 3OJM, 3RI1, 4J23, 4J95, 4J96, 4J97, 4J98, 4J99</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">724</column>
            <column name="TargetName">Alzheimer's disease specific monoclonal antibody MN423</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">725</column>
            <column name="TargetName">Anti-LOS polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">726</column>
            <column name="TargetName">Monoclonal antibody HC-10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb HC-10 (IgG2a) which recognizes a determinant preferentially expressed on all β2m-free HLA-B and -C HC and on β2m-free HLA-A3, A10, A28, A29, A30, A31, A32, and A33 HC.</column>
        </table>
        <table name="target">
            <column name="TargetID">727</column>
            <column name="TargetName">Zinc ion, Zn(2+)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">728</column>
            <column name="TargetName">Integrin alpha-M-beta-2, integrin αMβ2</column>
            <column name="TargetSynonyms">Integrin alpha-M alternative name(s):
Cell surface glycoprotein MAC-1 subunit alpha
CR-3 alpha chain
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD11 antigen-like family member B
CD_antigen=CD11b

Integrin beta-2 alternative name(s):
Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta
Complement receptor C3 subunit beta
CD_antigen=CD18</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-M: P11215, Integrin beta-2: P05107</column>
            <column name="TargetStructure">Integrin alpha-M: 1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3
Integrin beta-2: 1L3Y, 1YUK, 2JF1, 2P26, 2P28, 2V7D, 3K6S, 3K71, 3K72</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">729</column>
            <column name="TargetName">Cortical collecting duct, CCD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">730</column>
            <column name="TargetName">Mouse skeletal muscles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">731</column>
            <column name="TargetName">Anti-C.pneumoniae monoclonal antibody 8A6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">732</column>
            <column name="TargetName">Human submucosal-gland carcinoma, Calu-3 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">733</column>
            <column name="TargetName">Cell division protein ftsA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0ABH0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">734</column>
            <column name="TargetName">Human urothelial cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">735</column>
            <column name="TargetName">Allergen-specific IgE-mimicking monoclonal antibody 2A1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Six-week-old BALB/c mice were each injected intraperitoneally with 50 μg of an equal mixture of total proteins from rye, Bermuda and timothy grass pollens in Hunter\'s Titermax adjuvant (CytRx, Athens, GA, USA). Then mAb 2A1 was puri¢ed by protein G chromatography.</column>
        </table>
        <table name="target">
            <column name="TargetID">736</column>
            <column name="TargetName">RG2 rat glioma cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">737</column>
            <column name="TargetName">Integrin alpha-V-beta-5, integrin αvβ5</column>
            <column name="TargetSynonyms">Integrin alpha-V alternative name(s):
Vitronectin receptor subunit alpha
CD_antigen=CD51</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-V: P06756, Integrin beta-5: P18084</column>
            <column name="TargetStructure">Integrin alpha-V: 1JV2, 1L5G, 1M1X, 1U8C, 3IJE, 4G1E, 4G1M
</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">738</column>
            <column name="TargetName">Peripheral-type benzodiazepine receptor</column>
            <column name="TargetSynonyms">Putative uncharacterized protein
Translocator protein</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q541E3</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">739</column>
            <column name="TargetName">Chaperone protein hscA</column>
            <column name="TargetSynonyms">Hsc66</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0A6Z1</column>
            <column name="TargetStructure">1U00</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">740</column>
            <column name="TargetName">Serum antibodies with Lyme disease</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">741</column>
            <column name="TargetName">Beta-lactamase TEM</column>
            <column name="TargetSynonyms">TEM-1
TEM-2
TEM-3
TEM-4
TEM-5
TEM-6
TEM-8/CAZ-2
TEM-16/CAZ-7
TEM-24/CAZ-6
IRT-4
Penicillinase</column>
            <column name="TargetSource">Escherichia coli:562</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P62593</column>
            <column name="TargetStructure">1AXB, 1BT5, 1BTL, 1CK3, 1ERM, 1ERO, 1ERQ, 1ESU, 1FQG, 1JTD, 1JTG, 1JVJ, 1JWP, 1JWV, 1JWZ, 1LHY, 1LI0, 1LI9, 1M40, 1NXY, 1NY0, 1NYM, 1NYY, 1PZO, 1PZP, 1S0W, 1TEM, 1XPB, 1XXM, 1YT4, 1ZG4, 1ZG6, 2B5R, 2V1Z, 2V20, 3C7U, 3C7V, 3CMZ, 3DTM, 3JYI, 3TOI, 4DXB, 4DXC, 4GKU, 4IBR, 4IBX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">742</column>
            <column name="TargetName">BAG family molecular chaperone regulator 1</column>
            <column name="TargetSynonyms">BAG-1
Bcl-2-associated athanogene 1
HAP46
</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q99933</column>
            <column name="TargetStructure">1HX1, 1WXV, 3FZF, 3FZH, 3FZK, 3FZL, 3FZM, 3LDQ, 3M3Z</column>
            <column name="TargetComments">BAG family molecular chaperone regulator 1 is a protein that inhibits the chaperone activity of HSP70/HSC70 by promoting substrate release. It has anti-apoptotic activity through inhibiting the pro-apoptotic function of PPP1R15A.</column>
        </table>
        <table name="target">
            <column name="TargetID">743</column>
            <column name="TargetName">Polarized human umbilical vein endothelial (HUVE) cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">744</column>
            <column name="TargetName">C-C chemokine receptor type 3</column>
            <column name="TargetSynonyms">C-C CKR-3, CC-CKR-3, CCR-3, CCR3, CKR3Eosinophil eotaxin receptor
CD_antigen=CD193</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P51677</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">745</column>
            <column name="TargetName">Eotaxin</column>
            <column name="TargetSynonyms">C-C motif chemokine 11
Small-inducible cytokine A11
Eosinophil chemotactic protein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P51671</column>
            <column name="TargetStructure">1EOT, 2EOT</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">746</column>
            <column name="TargetName">Botulinum neurotoxin A light chain</column>
            <column name="TargetSynonyms">Botulinum neurotoxin A alternative name(s):
Botulinum neurotoxin type A, BoNT/A
Bontoxilysin-A, BOTOX</column>
            <column name="TargetSource">Clostridium botulinum:1491</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P18645 [2-448]</column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">747</column>
            <column name="TargetName">Botulinum neurotoxin B light chain</column>
            <column name="TargetSynonyms">Botulinum neurotoxin B alternative name(s):
Botulinum neurotoxin type B, BoNT/B
Bontoxilysin-B
</column>
            <column name="TargetSource">Clostridium botulinum:1491</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P10844 [2-441]</column>
            <column name="TargetStructure">1EPW, 1F31, 1F82, 1G9A, 1G9B, 1G9C, 1G9D, 1I1E, 1S0B, 1S0C, 1S0D, 1S0E, 1S0F, 1S0G, 1Z0H, 2ETF, 2NM1, 2NP0, 2XHL, 3ZUQ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">748</column>
            <column name="TargetName">Botulinum neurotoxin C1 light chain</column>
            <column name="TargetSynonyms">Botulinum neurotoxin C1 alternative name(s):
Botulinum neurotoxin type C1, BoNT/C1
Bontoxilysin-C1
</column>
            <column name="TargetSource">Clostridium botulinum:1491</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P18640 [2-449]</column>
            <column name="TargetStructure">2QN0, 3DEB, 3N7K, 3R4S, 3R4U</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">749</column>
            <column name="TargetName">Cellulose-binding domain (CBD)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">750</column>
            <column name="TargetName">DNA topoisomerase 1</column>
            <column name="TargetSynonyms">DNA topoisomerase I
EC=5.99.1.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P11387</column>
            <column name="TargetStructure">1A31, 1A35, 1A36, 1EJ9, 1K4S, 1K4T, 1LPQ, 1NH3, 1R49, 1RR8, 1RRJ, 1SC7, 1SEU, 1T8I, 1TL8</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">751</column>
            <column name="TargetName">Anti-JL1 leukemia-specific monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">752</column>
            <column name="TargetName">Purified IgGs from serum of prostate cancer patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">753</column>
            <column name="TargetName">Purified IgGs from serum of prostate cancer patient 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">754</column>
            <column name="TargetName">Purified IgGs from serum of prostate cancer patient 3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">755</column>
            <column name="TargetName">Mycobacterium paratuberculosis</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mycobacterium paratuberculosis:1770</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">756</column>
            <column name="TargetName">Deoxyribonuclease-2</column>
            <column name="TargetSynonyms">Deoxyribonuclease-2-alpha alternative name(s):
Deoxyribonuclease II alpha, DNase II alpha
Acid DNase
Lysosomal DNase II
R31240_2
EC=3.1.22.1

Deoxyribonuclease-2-beta alternative name(s):
Deoxyribonuclease II beta, DNase II beta
DNase2-like acid DNase
DNase II-like acid DNase
Endonuclease DLAD
EC=3.1.22.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">O00115, Q8WZ79</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">757</column>
            <column name="TargetName">Anti-human IFN-b monoclonal antibody YSB-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">758</column>
            <column name="TargetName">P-selectin</column>
            <column name="TargetSynonyms">Granule membrane protein 140, GMP-140
Platelet activation dependent granule-external membrane protein, PADGEM
Leukocyte-endothelial cell adhesion molecule 3, LECAM3
CD62 antigen-like family member P
CD_antigen=CD62P</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P16109</column>
            <column name="TargetStructure">1FSB, 1G1Q, 1G1R, 1G1S, 1HES</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">759</column>
            <column name="TargetName">Anti-L2/HNK-1 monoclonal antibody L2-412</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">760</column>
            <column name="TargetName">Cholesteryl ester transfer protein</column>
            <column name="TargetSynonyms">Lipid transfer protein I</column>
            <column name="TargetSource">Macaca fascicularis (Crab eating macaque) (Cynomolgus monkey):9541</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P47896</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">761</column>
            <column name="TargetName">IgG from the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">762</column>
            <column name="TargetName">Anti-syndecan-1 monoclonal antibody B-B2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The isotype of B-B2 is IgG2b.</column>
        </table>
        <table name="target">
            <column name="TargetID">763</column>
            <column name="TargetName">Anti-syndecan-1 monoclonal antibody B-B4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The isotype of B-B2 is IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">764</column>
            <column name="TargetName">MDDQRDLISNNEQLK peptide</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04233 [17-30]</column>
            <column name="TargetStructure">1A6A, 1ICF, 1IIE, 1L3H, 1MUJ, 3PDO, 3PGC, 3PGD, 3QXA, 3QXD, 4AEN, 4AH2</column>
            <column name="TargetComments">MDDQRDLISNNEQLK is a synthetic peptide derived from the cytosolic tail of MHC class II associated invariant chain (Ii, HLA class II histocompatibility antigen gamma chain, CD74). This peptide contained a leucine class endosomal sorting signal (LI), known to be recognised as an autonomous functional unit during targeting of class II complexes to antigen processing compartments. The C-terminal lysine was included to allow biotinylation at both ends, as biotin is attached to free amino groups.</column>
        </table>
        <table name="target">
            <column name="TargetID">765</column>
            <column name="TargetName">HMG box 2 domain of high mobility group protein B1</column>
            <column name="TargetSynonyms">High mobility group protein B1 alternative name(s):
High mobility group protein 1, HMG-1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P09429 [95-163]</column>
            <column name="TargetStructure">2LY4, 2YRQ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">766</column>
            <column name="TargetName">Anti-chicken GAD monoclonal antibody GAD1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GAD1 was derived from a mouse immunized with glutamate decarboxylase (GAD) from chicken brain. It reacts with a conformational epitope of GAD, and does not react by Western blotting.</column>
        </table>
        <table name="target">
            <column name="TargetID">767</column>
            <column name="TargetName">Constant region of humanized anti-Tac monoclonal antibody (HAT)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">768</column>
            <column name="TargetName">Anti-mucin monoclonal antibody C595</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C595 is a murine IgG3 subclass monoclonal antibody which was raised by immunisation of BALB/c mice with human urinary mucin obtained by affinity purification.</column>
        </table>
        <table name="target">
            <column name="TargetID">769</column>
            <column name="TargetName">IgG fraction of anti-EHV-1 serum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Equus caballus (Horse)9796</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Selecting equine antiserum (F19) was from a gnotobiotic foal infected with EHV-1 strain RAC-H.</column>
        </table>
        <table name="target">
            <column name="TargetID">770</column>
            <column name="TargetName">WW-EF-ZZ fusion protein from utrophin</column>
            <column name="TargetSynonyms">Utrophin alternative name(s):
Dystrophin-related protein 1, DRP-1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P46939</column>
            <column name="TargetStructure">1BHD, 1QAG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">771</column>
            <column name="TargetName">Human dendritic cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">772</column>
            <column name="TargetName">Carbon nanotubes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">773</column>
            <column name="TargetName">SEM-5 SH3 domain</column>
            <column name="TargetSynonyms">SEM-5 alternative name(s):
Sex muscle abnormal protein 5</column>
            <column name="TargetSource">Caenorhabditis elegans:6239</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P29355 [154-213]</column>
            <column name="TargetStructure">1K76, 1KFZ, 1SEM, 2SEM, 3SEM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">774</column>
            <column name="TargetName">Anti-mouse CD45 monoclonal antibody IBL-8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">775</column>
            <column name="TargetName">Immunoglobulin fractions obtained from vitiligo patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">776</column>
            <column name="TargetName">Anti-WNV E protein monoclonal antibody E16</column>
            <column name="TargetSynonyms">Mab E16</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:78101113, GI:78101114</column>
            <column name="TargetStructure">1ZTX</column>
            <column name="TargetComments">The monoclonal antibody E16 is an mouse IgG2bκ that can neutralize 10 different strains in vitro and have shown therapeutic efficacy in mice even when administered as a single dose 5 days after West Nile virus (WNV) infection. The construction of the hybridoma producing E16 monocloanl antibody is described briefly in the following sentences. BALB/c mice were primed and boosted at 3-week intervals with insect cell-generated, purified, recombinant WNV E protein (25 μg) that was complexed with adjuvant. Approximately 1 month after the last boost, serum was harvested and tested for immunoreactivity against solid-phase purified E protein. Mice with high titers (&gt;1/10,000) were boosted intravenously with purified E protein (5 μg) in PBS. Three days later, splenocytes were harvested and fused to P3X63Ag8.653 myeloma cells to generate hybridomas.</column>
        </table>
        <table name="target">
            <column name="TargetID">777</column>
            <column name="TargetName">Anti-H Fer monoclonal antibody H107</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">778</column>
            <column name="TargetName">Anti-PTX S1 monoclonal antibody 1B7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">779</column>
            <column name="TargetName">Anti-capsid protein 1 monoclonal antibody C4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb C4 belongs to the IgG1 subclass and has κ type light chains.</column>
        </table>
        <table name="target">
            <column name="TargetID">780</column>
            <column name="TargetName">Mouse cardiac tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">781</column>
            <column name="TargetName">Nucleocapsid protein</column>
            <column name="TargetSynonyms">Nucleocapsid protein N</column>
            <column name="TargetSource">Porcine reproductive and respiratory syndrome virus (PRRSV):28344</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">B5A495</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">782</column>
            <column name="TargetName">Mouse embryonic stem cell line M9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">783</column>
            <column name="TargetName">Anti-ARD1A polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-ARD1A polyclonal antibody purified from colon cancer patient serum belongs to the IgG class.</column>
        </table>
        <table name="target">
            <column name="TargetID">784</column>
            <column name="TargetName">Primary cardiac myocytes (PCM)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">785</column>
            <column name="TargetName">Campylobacter jejuni </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Campylobacter jejuni:197</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">786</column>
            <column name="TargetName">Toxin A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Clostridium difficile:1496</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P16154</column>
            <column name="TargetStructure">2F6E, 2G7C, 2QJ6, 3HO6, 4DMV, 4DMW</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">787</column>
            <column name="TargetName">Phakopsora pachyrhizi urediniospores</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Phakopsora pachyrhizi:170000</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">788</column>
            <column name="TargetName">MLV/HIV 89.6 pseudovirions</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human immunodeficiency virus 1:11676</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">CD4-activated retroviral particles carrying Env from the R5X4 HIV-1 89.6 strain, MLV Gag Pol particles pseudotyped with HIV-1 R5X4 89.6 Env in the presence of sCD4.</column>
        </table>
        <table name="target">
            <column name="TargetID">789</column>
            <column name="TargetName">B16F10-Nex2 melanoma cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">790</column>
            <column name="TargetName">Extracellular domain of TβR1 (TβR1-ED) </column>
            <column name="TargetSynonyms">TβR1 alternative name(s):
TGF-beta receptor type-1, TGFR-1
Activin receptor-like kinase 5, ALK-5
Serine/threonine-protein kinase receptor R4, SKR4
TGF-beta type I receptor
Transforming growth factor-beta receptor type I, TGF-beta receptor type I, TbetaR-I</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P36897 [25-125]</column>
            <column name="TargetStructure">1B6C, 1IAS, 1PY5, 1RW8, 1VJY, 2L5S, 2PJY, 2WOT, 2WOU, 2X7O, 3FAA, 3GXL, 3HMM, 3KCF, 3KFD, 3TZM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">791</column>
            <column name="TargetName">Anti-E(rns) glycoprotein monoclonal antibody M2172</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb M2172 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">792</column>
            <column name="TargetName">Anti-E(rns) glycoprotein monoclonal antibody M2171</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb M2171 belongs to the IgG2b subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">793</column>
            <column name="TargetName">Anti-E(rns) glycoprotein monoclonal antibody M2165</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb M2165 belongs to the IgG2b subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">794</column>
            <column name="TargetName">Anti-E(rns) glycoprotein monoclonal antibody M2180</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb M2180 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">795</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 1H4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">796</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 2B3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">797</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 5F6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">798</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 4G12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">799</column>
            <column name="TargetName">Anti-HIV1 plasma IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">800</column>
            <column name="TargetName">Adherent primary cardiac myocytes, APCM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">APCM cells are freshly isolated by the same procedure as the non-adherent PCM but are then allowed to adhere to tissue culture wells coated with laminin.</column>
        </table>
        <table name="target">
            <column name="TargetID">801</column>
            <column name="TargetName">Mouse embryonic stem (ES) cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">802</column>
            <column name="TargetName">Anti-LBP monoclonal antibody M392-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">803</column>
            <column name="TargetName">Rat lactating mammary gland</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">804</column>
            <column name="TargetName">Rhipicephalus microplus eggs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Boophilus microplus (Cattle tick):6941</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">805</column>
            <column name="TargetName">Intact oocytes surrounded by ZP proteins</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">806</column>
            <column name="TargetName">Anti-larval proteins of R. microplus polyclonal antibodies IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">807</column>
            <column name="TargetName">Anti-tick subolesin polyclonal antibody (S2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sheep IgG were obtained from sheep immunized and protected against tick infestations.</column>
        </table>
        <table name="target">
            <column name="TargetID">808</column>
            <column name="TargetName">Anti-tick subolesin polyclonal antibody (S9)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sheep IgG were obtained from sheep immunized and protected against tick infestations.</column>
        </table>
        <table name="target">
            <column name="TargetID">809</column>
            <column name="TargetName">Anti-mosquito subolesin polyclonal antibody (S4)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sheep IgG were obtained from sheep immunized and protected against tick infestations.</column>
        </table>
        <table name="target">
            <column name="TargetID">810</column>
            <column name="TargetName">Anti-mosquito subolesin polyclonal antibody (S5)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sheep IgG were obtained from sheep immunized and protected against tick infestations.</column>
        </table>
        <table name="target">
            <column name="TargetID">811</column>
            <column name="TargetName">Anti-Ap[17-30] polyconal antibody from patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">812</column>
            <column name="TargetName">Anti-Ap[17-30] polyconal antibody from patient 8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">813</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 2E6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">814</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 3A1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">815</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 3B3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">816</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 5A9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">817</column>
            <column name="TargetName">Anti-IL-2 monoclonal antibody 5C3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">818</column>
            <column name="TargetName">Beta-amyloid protein 42 (Beta-APP42)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P12023 [672-713]</column>
            <column name="TargetStructure">2ROZ, 2YSZ, 2YT0, 2YT1</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">819</column>
            <column name="TargetName">Glycine receptor subunit alpha-1</column>
            <column name="TargetSynonyms">Glycine receptor 48 kDa subunit
Glycine receptor strychnine-binding subunit</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P07727</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">820</column>
            <column name="TargetName">Anti-EGFR monoclonal antibody 12H23</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">12H23 is a murine monoclonal antibody that can recognize the CC16 epitope.</column>
        </table>
        <table name="target">
            <column name="TargetID">821</column>
            <column name="TargetName">Human 143B osteosarcoma cell lines</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">822</column>
            <column name="TargetName">GaAs semi-insulating substrate</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">823</column>
            <column name="TargetName">Anti-SEB monoclonal antibody ab53981</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">824</column>
            <column name="TargetName">Anti-S100A4 monoclonal antibody 22.3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb 22.3 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">825</column>
            <column name="TargetName">Anti-S100A4 monoclonal antibody 22.1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb 22.1 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">826</column>
            <column name="TargetName">Na+ Montmorillonite (MMT)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">827</column>
            <column name="TargetName">Primary Ammonium C18 Modified Montmorillonite (MMT)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">828</column>
            <column name="TargetName">Quaternary Ammonium C18 Modified Montmorillonite (MMT)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">829</column>
            <column name="TargetName">Chymase</column>
            <column name="TargetSynonyms">Alpha-chymase
Mast cell protease I
EC=3.4.21.39</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P21842</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">830</column>
            <column name="TargetName">Breast cancer tumors</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">831</column>
            <column name="TargetName">Mixed liver/kidney tissue extracts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">832</column>
            <column name="TargetName">Pd wire</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">833</column>
            <column name="TargetName">TIMREX SLP30 Primary Synthetic Potato graphite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">834</column>
            <column name="TargetName">AFM standard highly ordered pyrolytic graphite (HOPG)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">835</column>
            <column name="TargetName">N006 nano graphene platelets</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">836</column>
            <column name="TargetName">Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1</column>
            <column name="TargetSynonyms">Glucosaminyl N-deacetylase/N-sulfotransferase 1, NDST-1
N-heparan sulfate sulfotransferase 1, N-HSST 1
[Heparan sulfate]-glucosamine N-sulfotransferase 1, HSNST 1
EC=2.8.2.8</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q3UHN9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">837</column>
            <column name="TargetName">Human OE33 (esophageal adenocarcinoma) cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">838</column>
            <column name="TargetName">Lupus-derived monoclonal antibody BT164</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BT164 is a lupus-derived monoclonal antibody that was recently established by selection on apoptotic chromatin (van Bavel et al, unpublished data).</column>
        </table>
        <table name="target">
            <column name="TargetID">839</column>
            <column name="TargetName">Hyperbranched poly(phenylene vinylene) (hypPPV)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">840</column>
            <column name="TargetName">Linear poly(phenylene vinylene) (linPPV)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">841</column>
            <column name="TargetName">Apoptosis regulator Bcl-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P10415</column>
            <column name="TargetStructure">1G5M, 1GJH, 1YSW, 2O21, 2O22, 2O2F, 2W3L, 2XA0, 4AQ3</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">842</column>
            <column name="TargetName">Anti-urease B monoclonal antibody U001</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">843</column>
            <column name="TargetName">Indium nitride (InN) semiconductor (SC) material</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">844</column>
            <column name="TargetName">Fibrosarcoma cell line NG4TL4-tk</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">845</column>
            <column name="TargetName">Human leukemia cells MOLT-4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">846</column>
            <column name="TargetName">Macrophages isolated from primary human lung squamous carcinoma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">847</column>
            <column name="TargetName">Peptide SLGLSFYQPPEGDNALC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target is a peptide corresponding to the N-terminal half of the human PMCA1 exdom 1 (exdom 1X) consisting of residues 121-137 (SLGLSFYQPPEGDNALC, Protein bank P20020). The PMCA1 sequence is identical in rabbit, man, rat, mouse, pig and cow.</column>
        </table>
        <table name="target">
            <column name="TargetID">848</column>
            <column name="TargetName">In vitro M cell coculture system</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A human colon carcinoma cell line, Caco-2, and a human Burkitt's lymphoma cell line, Raji, were purchased from the American Type Culture Collection (Manassas, VA). The in vitro M cell coculture model was assembled as described by Kerne′is et al. and modified by Gullberg et al. Briefiy, 0.1 and 1.5 ml DMEM supplemented with 10% FBS were added to the apical and basolateral sides of the transwell, respectively, and the transwells then were preincubated for 30 min in a CO2 incubator. The Caco-2 cells then were spread to the apical side of the transwell. After incubation for 3 h, the medium at the apical side was changed, and the upper medium was changed every other day for the next 14 d of culture. Raji cells suspended in RPMI 1640/DMEM (1:2) mixture then were added to the basolateral chamber of the transwell, and the coculture was maintained for 2 d. Caco-2 cells cultured alone by this procedure, without the Raji cells, served as a control.</column>
        </table>
        <table name="target">
            <column name="TargetID">849</column>
            <column name="TargetName">PC-3 human prostate carcinoma cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">850</column>
            <column name="TargetName">Soluble 37/48kDa oligomer formation of Aβ(1-42)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">851</column>
            <column name="TargetName">Virulent isolate of Paracoccidioides brasiliensis (Pb18)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Paracoccidioides brasiliensis:121759</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">852</column>
            <column name="TargetName">Primary rat lung alveolar epithelial primary cell cultures</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">853</column>
            <column name="TargetName">Ganglioside GM3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">854</column>
            <column name="TargetName">Germania</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">855</column>
            <column name="TargetName">Extracellular domain of Tie2</column>
            <column name="TargetSynonyms">Tie2 alternative name(s):
Angiopoietin-1 receptor
Tyrosine-protein kinase receptor TIE-2, hTIE2
Tyrosine-protein kinase receptor TEK
Tunica interna endothelial cell kinase
p140 TEK
CD_antigen=CD202b</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q02763 [23-745]</column>
            <column name="TargetStructure">1FVR, 2GY5, 2GY7, 2OO8, 2OSC, 2P4I, 2WQB, 3BEA, 3L8P, 4K0V</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">856</column>
            <column name="TargetName">Anti-M2e monoclonal antibody 8C6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">857</column>
            <column name="TargetName">Doxorubicin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Doxorubicin is a kind of multidrug-resistance (MDR) drugs.</column>
        </table>
        <table name="target">
            <column name="TargetID">858</column>
            <column name="TargetName">Anti-FMDV Asia1 antigen monoclonal antibody 3E11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb 3E11 belongs to the IgG1 subclass and has κ type light chains.</column>
        </table>
        <table name="target">
            <column name="TargetID">859</column>
            <column name="TargetName">Methylmalonic aciduria and homocystinuria type C protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9Y4U1</column>
            <column name="TargetStructure">3SBY, 3SBZ, 3SC0, 3SOM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">860</column>
            <column name="TargetName">Glutathione S-transferase, GST</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">861</column>
            <column name="TargetName">Cytoplasmic domain of CORYNE</column>
            <column name="TargetSynonyms">CORYNE alternative name(s):
Inactive leucine-rich repeat receptor-like protein kinase CORYNE
Protein SUPPRESSOR OF OVEREXPRESSION OF LLP1 2</column>
            <column name="TargetSource">Arabidopsis thaliana (Mouse-ear cress):3702</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q9LYU7 [84-401]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">862</column>
            <column name="TargetName">Dry degummed silk fibroin fibers</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bombyx mori (Silk moth):7091</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">863</column>
            <column name="TargetName">Anti-HIV-1 gp41 MPER monoclonal antibody 2F5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">864</column>
            <column name="TargetName">Anti-DENV2 monoclonal antibody 2A10G6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb 2A10G6 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">865</column>
            <column name="TargetName">Unmodified helix 31 of bacterial 16S ribosomal RNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The sequence of unmodified helix 31 is 5'-GUUCGAUGCAACGCGAAC-3'.</column>
        </table>
        <table name="target">
            <column name="TargetID">866</column>
            <column name="TargetName">Modified helix 31 of bacterial 16S ribosomal RNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The sequence of modified helix 31 is 5'-GUUCGAU-m(2)G-m(5)C-AACGCGAAC-3'.</column>
        </table>
        <table name="target">
            <column name="TargetID">867</column>
            <column name="TargetName">Anti-WNV C protein monoclonal antibody 6D3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">868</column>
            <column name="TargetName">Gliadin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Triticum aestivum (Wheat):4565</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">869</column>
            <column name="TargetName">Single-crystal hydroxyapatite (HAP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">870</column>
            <column name="TargetName">Polycrystalline hydroxyapatite (HAP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">871</column>
            <column name="TargetName">Amino acid (160)REVPYAYIREGHEKQ(174) of MMP-14</column>
            <column name="TargetSynonyms">MMP-14 alternative name(s):
Matrix metalloproteinase-14
Membrane-type matrix metalloproteinase 1, MT-MMP 1, MTMMP1
Membrane-type-1 matrix metalloproteinase, MT1-MMP, MT1MMP
MMP-X1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P50281 [160-174]</column>
            <column name="TargetStructure">1BQQ, 1BUV, 3C7X, 3MA2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">872</column>
            <column name="TargetName">Myelin basic protein, MBP</column>
            <column name="TargetSynonyms">Myelin A1 protein
Myelin membrane encephalitogenic protein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02686</column>
            <column name="TargetStructure">1BX2, 1FV1, 1HQR, 1YMM, 1ZGL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">873</column>
            <column name="TargetName">Excised murine peripheral nerves</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">874</column>
            <column name="TargetName">Nerve tissue (sciatic, brachial plexus, cranial nerves)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">875</column>
            <column name="TargetName">Ischemic region of left ventricular (LV) </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">876</column>
            <column name="TargetName">Non-ischemic region of left ventricular (LV) </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">877</column>
            <column name="TargetName">Right ventricular (RV) </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">878</column>
            <column name="TargetName">Intact matrices (Integra ®)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">879</column>
            <column name="TargetName">Solubilized matrices (Integra ®)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">880</column>
            <column name="TargetName">Cryostat-sectioned matrices (Integra ®)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">881</column>
            <column name="TargetName">Anti-human TGF-β1 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">882</column>
            <column name="TargetName">Candida albicans, C. albicans</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Candida albicans (Yeast):5476</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">883</column>
            <column name="TargetName">Patient CA502 ascitic IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">884</column>
            <column name="TargetName">Mouse colonic dysplasia</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">885</column>
            <column name="TargetName">Purified lgG of tuberculosis serum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">886</column>
            <column name="TargetName">Protein E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human papillomavirus type 16:333760</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03129</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">887</column>
            <column name="TargetName">Anti-gastric cancer antigen monoclonal antibody MGb1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">888</column>
            <column name="TargetName">Anti-CCR5 monoclonal antibody 5C7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">889</column>
            <column name="TargetName">Concanavalin-A, Con A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canavalia ensiformis (Jack bean) (Horse bean):3823</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02866</column>
            <column name="TargetStructure">1APN, 1BXH, 1C57, 1CES, 1CJP, 1CN1, 1CON, 1CVN, 1DQ0, 1DQ1, 1DQ2, 1DQ4, 1DQ5, 1DQ6, 1ENQ, 1ENR, 1ENS, 1GIC, 1GKB, 1HQW, 1I3H, 1JBC, 1JN2, 1JOJ, 1JUI, 1JW6, 1JYC, 1JYI, 1NLS, 1NXD, 1ONA, 1QGL, 1QNY, 1SCR, 1SCS, 1TEI, 1VAL, 1VAM, 1XQN, 2CNA, 2CTV, 2ENR, 2UU8, 2YZ4, 3CNA, 3D4K, 3ENR, 5CNA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">890</column>
            <column name="TargetName">Anti-fiber tail monoclonal antibody 4D2.5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">891</column>
            <column name="TargetName">Anti-penton base monoclonal antibody 20G1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">892</column>
            <column name="TargetName">Penton capsomer</column>
            <column name="TargetSynonyms">Penton base-fiber complex</column>
            <column name="TargetSource">Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03275, P03276</column>
            <column name="TargetStructure">2C9F</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">893</column>
            <column name="TargetName">Penton protein</column>
            <column name="TargetSynonyms">Penton base protein
Virion component III
pIII</column>
            <column name="TargetSource">Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03276</column>
            <column name="TargetStructure">1X9P, 1X9T, 2C6S, 2C9F, 2C9G, 4V4U</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">894</column>
            <column name="TargetName">Fiber protein</column>
            <column name="TargetSynonyms">pIV</column>
            <column name="TargetSource">Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03275</column>
            <column name="TargetStructure">1QHV, 1QIU, 1V1H, 1V1I, 2BLD, 2C9F, 4AR2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">895</column>
            <column name="TargetName">Head domain of fiber protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03275 [399-582]</column>
            <column name="TargetStructure">1QHV, 1QIU, 1V1H, 1V1I, 1X9T, 2C9F, 4AR2, 4V4U</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">896</column>
            <column name="TargetName">Shaft domain of fiber protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2):10515</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03275 [45-392]</column>
            <column name="TargetStructure">1QHV, 1QIU, 1V1H, 1V1I, 2BLD, 2C9F, 4AR2</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">897</column>
            <column name="TargetName">PEA10 mouse fibroblast cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">898</column>
            <column name="TargetName">Anti-DENV1 envelope protein monoclonal antibody 4E11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">899</column>
            <column name="TargetName">Anti-WNV E protein monoclonal antibody E24</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">900</column>
            <column name="TargetName">Anti-WNV E protein monoclonal antibody E60</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">901</column>
            <column name="TargetName">Anti-WNV E protein monoclonal antibody E113</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">902</column>
            <column name="TargetName">Anti-WNV E protein monoclonal antibody E121</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">903</column>
            <column name="TargetName">Anti-WNV polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">904</column>
            <column name="TargetName">Anti-HBsAg polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">905</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody GV4H3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GV4H3 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gpl2O/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</column>
        </table>
        <table name="target">
            <column name="TargetID">906</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody GV1G2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GV1G2 is a mouse monoclonal antibody derived by fusion of NS-O mouse myeloma cells with spleen cells from a Balb/c mouse immunized with gpl2O/M77 immunocomplex. M77 is a monoclonal antibody specific for the V3-loop of HIV-1 (IIIB).</column>
        </table>
        <table name="target">
            <column name="TargetID">907</column>
            <column name="TargetName">Anti-HIV-1 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">908</column>
            <column name="TargetName">Anti-HER-2 extracellular domain polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">909</column>
            <column name="TargetName">Anti-HER-2 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mice were immunized with plasmids expressing either the full length protein (HER-2).</column>
        </table>
        <table name="target">
            <column name="TargetID">910</column>
            <column name="TargetName">Anti-HER-2 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mice were inoculated with TUBO tumors, which express rat HER-2.</column>
        </table>
        <table name="target">
            <column name="TargetID">911</column>
            <column name="TargetName">α, β-tubulins from bovine brain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">912</column>
            <column name="TargetName">Anti-CD6 monoclonal antibody ior t1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-human CD6 MAb ior t1 (IgG2a, κ) was obtained after immunization of BALB/c mice with peripheral blood mononuclear cells (PBMC) from a Sezary\'s syndrome patient.</column>
        </table>
        <table name="target">
            <column name="TargetID">913</column>
            <column name="TargetName">Anti-Der p 1 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">914</column>
            <column name="TargetName">Anti-Der p 2 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">915</column>
            <column name="TargetName">Synthetic ligand for FK506-binding protein, SLF</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">916</column>
            <column name="TargetName">Irinotecan, Iri</column>
            <column name="TargetSynonyms">CPT-11</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">917</column>
            <column name="TargetName">Anti-transferrin monoclonal antibody hTf345</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">918</column>
            <column name="TargetName">Anti-b558 monoclonal antibody 7A2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">919</column>
            <column name="TargetName">Anti-b558 monoclonal antibody 8G11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">920</column>
            <column name="TargetName">Anti-E. coli K1 monoclonal antibody HmenB1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</column>
        </table>
        <table name="target">
            <column name="TargetID">921</column>
            <column name="TargetName">Anti-E. coli K1 monoclonal antibody HmenB3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</column>
        </table>
        <table name="target">
            <column name="TargetID">922</column>
            <column name="TargetName">Anti-E. coli K1 monoclonal antibody HmenB13</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</column>
        </table>
        <table name="target">
            <column name="TargetID">923</column>
            <column name="TargetName">Anti-E. coli K1 monoclonal antibody HmenB14</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From mice immunized with Escherichia coli K1 bacteria, immunoglobulin M hybridomas secreting monoclonal antibodies (MAbs) was produced, which bind to Neisseria meningitidis group B (NMGB). The MAbs also bound the capsular polysaccharide (PS) of E. coli K1 [which, like NMGB, is α(2-8)-linked polysialic acid (PSA)] and bound to EV36, a nonpathogenic E. coli K-12 strain producing α(2-8) PSA.</column>
        </table>
        <table name="target">
            <column name="TargetID">924</column>
            <column name="TargetName">Polyclonal antibody IgE from birch pollen-allergic patient #1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">925</column>
            <column name="TargetName">Polyclonal antibody IgE from birch pollen-allergic patient #2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">926</column>
            <column name="TargetName">Polyclonal antibody IgE from birch pollen-allergic patient #3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">927</column>
            <column name="TargetName">Polyclonal antibody IgE from birch pollen-allergic patient #4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">928</column>
            <column name="TargetName">Polyclonal antibody IgE from birch pollen-allergic patient #5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">929</column>
            <column name="TargetName">Estrogen receptor beta, ER-beta</column>
            <column name="TargetSynonyms">ESR2
ESTRB
NR3A2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q92731</column>
            <column name="TargetStructure">1L2J, 1NDE, 1QKM, 1U3Q, 1U3R, 1U3S, 1U9E, 1X76, 1X78, 1X7B, 1X7J, 1YY4, 1YYE, 1ZAF, 2FSZ, 2GIU, 2I0G, 2JJ3, 2NV7, 2QTU, 2YJD, 2YLY, 2Z4B, 3OLL, 3OLS, 3OMO, 3OMP, 3OMQ, 4J24, 4J26</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">930</column>
            <column name="TargetName">Anti-FPR monoclonal antibody NFPR1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">931</column>
            <column name="TargetName">Anti-FPR monoclonal antibody NFPR2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">932</column>
            <column name="TargetName">Silver nanoparticles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">933</column>
            <column name="TargetName">Cobalt nanoparticles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">934</column>
            <column name="TargetName">Interleukin-6, IL-6</column>
            <column name="TargetSynonyms">B-cell stimulatory factor 2, BSF-2
CTL differentiation factor, CDF
Hybridoma growth factor
Interferon beta-2, IFN-beta-2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05231</column>
            <column name="TargetStructure">1ALU, 1IL6, 1P9M, 2IL6</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">935</column>
            <column name="TargetName">Banana streak virus, BSV</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Banana streak virus:69577</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">936</column>
            <column name="TargetName">Anti-gp120 monoclonal antibody F105</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">F105 is a human IgG1 MAb directed against the envelope glycoprotein gp120.</column>
        </table>
        <table name="target">
            <column name="TargetID">937</column>
            <column name="TargetName">Anti-rhodopsin monoclonal antibody 4B4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">938</column>
            <column name="TargetName">Anti-cytochrome b-245 monoclonal antibody 449</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb 449 is a mouse IgG1 against human neutrophil flavocytochrome b.</column>
        </table>
        <table name="target">
            <column name="TargetID">939</column>
            <column name="TargetName">Anti-MOMP monoclonal antibody GZD1E8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GZD1E8 is a major outer membrane protein of C. pneumoniae.</column>
        </table>
        <table name="target">
            <column name="TargetID">940</column>
            <column name="TargetName">Anti-PSA monoclpnal antibody 30H12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Monoclonal anti-PSA Ab of the IgG2a isotype was directed to Neisseria meningitidis B capsular polysaccharide.</column>
        </table>
        <table name="target">
            <column name="TargetID">941</column>
            <column name="TargetName">Octyltrimethoxysilane</column>
            <column name="TargetSynonyms">C8 ink</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">942</column>
            <column name="TargetName">Anti-TNF-α polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">943</column>
            <column name="TargetName">Anti-acetylcholine receptor monoclonal antibody 35</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">944</column>
            <column name="TargetName">Anti-HBsAg monoclonal antibody H166</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">945</column>
            <column name="TargetName">Anti-HBsAg monoclonal antibody H5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">946</column>
            <column name="TargetName">Anti-HBsAg monoclonal antibody H35</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">947</column>
            <column name="TargetName">Anti-HBsAg monoclonal antibody H53</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">948</column>
            <column name="TargetName">Anti-HCV core protein monoclonal antibody 14-153-462</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">949</column>
            <column name="TargetName">Anti-V3 loop of HIV gp120 monoclonal antibody 1001</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">950</column>
            <column name="TargetName">Anti-CMV CP polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">951</column>
            <column name="TargetName">Anti-PSV-J polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">952</column>
            <column name="TargetName">Anti-TAV-V polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">953</column>
            <column name="TargetName">Anti-TAV-C polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">954</column>
            <column name="TargetName">Anti-F-actin polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">955</column>
            <column name="TargetName">Ig gamma-1 chain C region</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">P01857</column>
            <column name="TargetStructure">1AJ7, 1AQK, 1BEY, 1D5B, 1D5I, 1D6V, 1DFB, 1DN2, 1E4K, 1FC1, 1FC2, 1FCC, 1GAF, 1H3T, 1H3U, 1H3V, 1H3W, 1H3Y, 1HKL, 1HZH, 1I7Z, 1L6X, 1OP3, 1OQO, 1OQX, 1T83, 1T89, 1VGE, 2DTS, 2GJ7, 2I5Y, 2IWG, 2J6E, 2JB5, 2JB6, 2O5X, 2O5Y, 2O5Z, 2OSL, 2QAD, 2QL1, 2QQK, 2QQL, 2QQN, 2QR0, 2R56, 2RCS, 2VXQ, 3AGV, 3AVE, 3AY4, 3B2U, 3B2V, 3BDY, 3BE1, 3BKY, 3BN9, 3BQU, 3C08, 3C09, 3C2S, 3CFJ, 3CFK, 3CSY, 3D0L, 3D0V, 3D6G, 3D85, 3DJ9, 3DNK, 3DO3, 3DRO, 3DRQ, 3DVG, 3DVN, 3EYF, 3EYO, 3EYQ, 3RY6, 3S7G, 3SGJ, 3SGK, 3TV3, 3TWC, 3TYG, 3U0W, 3U7W, 3U7Y, 3V7M, 3V8C, 3V95, 4ACP, 4B7I, 4DZ8, 4EOW, 4J12</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">956</column>
            <column name="TargetName">Anti-lymphotoxin polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">957</column>
            <column name="TargetName">ICR male mice brain parenchyma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">958</column>
            <column name="TargetName">Anti-β-1,2-linked mannoside monoclonal antibody DJ2.8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">959</column>
            <column name="TargetName">Insulin-like growth factor-binding protein 1, IGFBP-1</column>
            <column name="TargetSynonyms">IBP-1, IGF-binding protein 1
Placental protein 12, PP12</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P08833</column>
            <column name="TargetStructure">1ZT3, 1ZT5, 2DSQ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">960</column>
            <column name="TargetName">Human serum albumin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02768</column>
            <column name="TargetStructure">1AO6, 1BJ5, 1BKE, 1BM0, 1E78, 1E7A, 1E7B, 1E7C, 1E7E, 1E7F, 1E7G, 1E7H, 1E7I, 1GNI, 1GNJ, 1H9Z, 1HA2, 1HK1, 1HK2, 1HK3, 1HK4, 1HK5, 1N5U, 1O9X, 1TF0, 1UOR, 1YSX, 2BX8, 2BXA, 2BXB, 2BXC, 2BXD, 2BXE, 2BXF, 2BXG, 2BXH, 2BXI, 2BXK, 2BXL, 2BXM, 2BXN, 2BXO, 2BXP, 2BXQ, 2ESG, 2I2Z, 2I30, 2VDB, 2VUE, 2VUF, 2XSI, 2XVQ, 2XVU, 2XVV, 2XVW, 2XW0, 2XW1, 2YDF, 3A73, 3B9L, 3B9M, 3CX9, 3JQZ, 3JRY, 3LU6, 3LU7, 3LU8, 3SQJ, 3TDL, 3UIV, 4E99, 4EMX, 4HGK, 4HGM, 4IW1, 4IW2, 4K2C</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">961</column>
            <column name="TargetName">Rabbit serum albumin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P49065</column>
            <column name="TargetStructure">3V09</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">962</column>
            <column name="TargetName">Rat serum albumin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02770</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">963</column>
            <column name="TargetName">Anti-ATPase alpha-1 subunit monoclonal antibody M8-P1-A3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">964</column>
            <column name="TargetName">Anti-sperm whale myoglobin polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">965</column>
            <column name="TargetName">Anti-TPO monoclomal antibody T13</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">966</column>
            <column name="TargetName">A549 bronchial epithelial cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">967</column>
            <column name="TargetName">Anti-p34 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A subgenomic fragment-encoding amino-acid 167-298 (p34-cx) was expressed in E. coli as described in Materials and methods. The recombinant p-34cx fragment was used to immunize calves.</column>
        </table>
        <table name="target">
            <column name="TargetID">968</column>
            <column name="TargetName">Anti-PRRSV neutralizing monoclonal antibody ISU25-C1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">ISU25-C1 is an IgG1(λ) anti-PRRSV KY-35 isolate MAb directed against a sequential epitope on GP5, as demonstrated by the recognition of the protein electrophoresed under denaturing conditions by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difiuoride membrane. It has neutralization activity against several PRRSV isolates.</column>
        </table>
        <table name="target">
            <column name="TargetID">969</column>
            <column name="TargetName">Anti-PRRSV polycolonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">970</column>
            <column name="TargetName">Anti-peptide SGSGANNSSSSHFQSIYNC polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-peptide SGSGANNSSSSHFQSIYNC antibodies were affinity purified from anti-PRRSV pooled precipitated antibodies.</column>
        </table>
        <table name="target">
            <column name="TargetID">971</column>
            <column name="TargetName">Rhesus monkey neural stem cells (R-NS cells)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Macaca mulatta (Rhesus macaque):9544</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Neural stem (NS) cells are derived from embryonic stem (ES) cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">972</column>
            <column name="TargetName">Bacillus cereus ATCC 4342</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bacillus cereus ATCC 4342:526977</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">973</column>
            <column name="TargetName">β-galactosidase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">974</column>
            <column name="TargetName">Bovine fibrinogen</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">975</column>
            <column name="TargetName">Single-walled carbon nanotubes, SWNTs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">976</column>
            <column name="TargetName">Hydroxyapatite, HA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">977</column>
            <column name="TargetName">ICR male mice brain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">978</column>
            <column name="TargetName">AC3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Tomato leaf curl Kerala virus:551531</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">B5B3X0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">979</column>
            <column name="TargetName">The first and second extracellular loops of CCR5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The amino acid sequences of the first and second extracellular loops of CCR5 (YAANEWVFGNI, RSQKEGFHYTCSPHFPHTQYHFWKSFQTLK) were synthesized by GLS Company (Shanghai, China).</column>
        </table>
        <table name="target">
            <column name="TargetID">980</column>
            <column name="TargetName">Anti-PSA monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">981</column>
            <column name="TargetName">Human ovarian tumor cell line SK-OV-3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">982</column>
            <column name="TargetName">Lead Ion, Pb(2+)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">983</column>
            <column name="TargetName">Anti-HMW-MAA monoclonal antibody VT80.12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">984</column>
            <column name="TargetName">Anti-HMW-MAA monoclonal antibody VF1-TP43</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">985</column>
            <column name="TargetName">Major outer membrane protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Leptospira noguchii serovar Pomona:280502</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q6J0N9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">986</column>
            <column name="TargetName">Anti-VSG LiTat 1.5 monoclonal antibody H12H3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb H12H3 belongs to the IgG3 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">987</column>
            <column name="TargetName">Anti-VSG LiTat 1.3 monoclonal antibody H13F7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb H13F7 belongs to the IgG3 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">988</column>
            <column name="TargetName">Anti-VSG LiTat 1.3 monoclonal antibody H18C11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb H18C11 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">989</column>
            <column name="TargetName">Human antimicrobial peptide LL-37</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">LL-37 is the only member of the human cathelicidin antimicrobial peptide family and is commonly expressed in various tissues, including epithelium. The sequence of LL-37 is LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES.</column>
        </table>
        <table name="target">
            <column name="TargetID">990</column>
            <column name="TargetName">Rabbit chondrocyte</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">991</column>
            <column name="TargetName">Heparan sulfate, HS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">992</column>
            <column name="TargetName">3-O-sulfated heparan sulfate, 3-OS HS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">993</column>
            <column name="TargetName">Mouse adipose stromal cells, ASCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">994</column>
            <column name="TargetName">Mouse lung stromal cells, LSCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">995</column>
            <column name="TargetName">Etoposide, VP-16</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Etoposide (VP-16) is a semi-synthetic derivative of podophyllotoxin that was originally isolated from the herbaceous perennial plant Podophyllum peltatum. This compound stabilizes DNA-topoisomerase II (top II) cleavage complexes and arrests cell cycle in S or G2/M phase, which results in apoptotic cell death.</column>
        </table>
        <table name="target">
            <column name="TargetID">996</column>
            <column name="TargetName">Lipoate-protein ligase A</column>
            <column name="TargetSynonyms">Lipoate--protein ligase
EC=2.7.7.63</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P32099</column>
            <column name="TargetStructure">1X2G, 1X2H, 3A7A, 3A7R</column>
            <column name="TargetComments">E. coli lipoic acid ligase (LplA) catalyzes ATP-dependent covalent ligation of lipoic acid onto specific lysine sidechains of three acceptor proteins involved in oxidative metabolism.</column>
        </table>
        <table name="target">
            <column name="TargetID">997</column>
            <column name="TargetName">CSF samples from neurocysticercosis patient #1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">998</column>
            <column name="TargetName">CSF samples from neurocysticercosis patient #2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">999</column>
            <column name="TargetName">Melanoma-derived growth regulatory protein</column>
            <column name="TargetSynonyms">Melanoma inhibitory activity protein</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q16674</column>
            <column name="TargetStructure">1HJD, 1I1J, 1K0X</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1000</column>
            <column name="TargetName">Anti-JEV E protein monoclonal antibody E3.3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1001</column>
            <column name="TargetName">Deoxyribonucleotides, DNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Double-stranded oligodeoxyribonucleotides (duplex ODNs) is composed of 36 base pairs and contains the 5'-TCGA-3' recognition sequence.</column>
        </table>
        <table name="target">
            <column name="TargetID">1002</column>
            <column name="TargetName">Single stranded oligonucleotides consisting of cytosine</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1003</column>
            <column name="TargetName">Anti-LOS monoclonal antibody 9-2-L379</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb 9-2-L379 belongs to the IgG2a subclass</column>
        </table>
        <table name="target">
            <column name="TargetID">1004</column>
            <column name="TargetName">Anti-HIV-1 monoclonal antibdoy 2G12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1005</column>
            <column name="TargetName">Hsp70-peptide complexes, Hsp70-PCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1006</column>
            <column name="TargetName">Peptide NNYDDISLRARP</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1007</column>
            <column name="TargetName">Peptide TMGFTAPREPHY</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1008</column>
            <column name="TargetName">Peptide IERPLHESVLAT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1009</column>
            <column name="TargetName">Human adipose stem cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1010</column>
            <column name="TargetName">Mouse 3T3-L1 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">3T3-L1 is a cell line derived from 3T3 cells that is used in biological research on adipose tissue. Differentiation of 3T3-L1 postconfluent preadipocytes was induced by treatment with insulin, dexamethasone, and isobutylmethylxanthine in DMEM/FCS.</column>
        </table>
        <table name="target">
            <column name="TargetID">1011</column>
            <column name="TargetName">Quartz</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1012</column>
            <column name="TargetName">SiO2 wafer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1013</column>
            <column name="TargetName">L1(0) phase of FePt, L1(0) FePt</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1014</column>
            <column name="TargetName">Anti-beta-endorphin monoclonal antibody 3-E7 Fab</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">This antibody was first described by Gramsch C. et al. on J Neurochem (PMID: 6187900). Its immunogen was a fragment of synthetic human beta-endorphin (YGGF) coupled with polylysine or thyroglobulin. Its isotype: IgG2a.</column>
        </table>
        <table name="target">
            <column name="TargetID">1015</column>
            <column name="TargetName">Anti-HCV polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1016</column>
            <column name="TargetName">Human neuroblastoma cell line WAC 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">WAC 2 cell line is a derivative of neuroblastoma cell line SH-EP and expresses high levels of the MYCN gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1017</column>
            <column name="TargetName">CD19+ cells from patient #16</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1018</column>
            <column name="TargetName">CD19+ cells from patient #25</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1019</column>
            <column name="TargetName">CD19+ cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1020</column>
            <column name="TargetName">Anti-CPS monoclonal antibody 13D9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb 13D9 belongs to the IgG2a subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">1021</column>
            <column name="TargetName">Neuropilin-1</column>
            <column name="TargetSynonyms">Vascular endothelial cell growth factor 165 receptor
CD_antigen=CD304</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">O14786</column>
            <column name="TargetStructure">1KEX, 2QQI, 2QQM, 2QQN, 3I97, 4DEQ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1022</column>
            <column name="TargetName">Anti-NSP2 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1023</column>
            <column name="TargetName">Semiconductor InP(001) surface</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1024</column>
            <column name="TargetName">Semiconductor InP(111) surface</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1025</column>
            <column name="TargetName">Anti-EG95 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1026</column>
            <column name="TargetName">H1299 cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1027</column>
            <column name="TargetName">Anti-DENV2 monoclonal antibody Ab4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb Ab4 belongs to the IgG1 subclass.</column>
        </table>
        <table name="target">
            <column name="TargetID">1028</column>
            <column name="TargetName">Mouse prostate</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1029</column>
            <column name="TargetName">Anti-phosphotyrosine monoclonal antibody PY20</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1030</column>
            <column name="TargetName">Peptide  IDQYRMQRDKEFRLKQ</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q96LB4 [44-59]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1031</column>
            <column name="TargetName">Trinitrotoluene, TNT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1032</column>
            <column name="TargetName">2,4-dinitrotoluene, DNT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1033</column>
            <column name="TargetName">Human lewis lung carcinoma, LLC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1034</column>
            <column name="TargetName">Mouse GL261 glioblastoma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1035</column>
            <column name="TargetName">Semiconductor GaN(0001) surface</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1036</column>
            <column name="TargetName">Anti-DON monoclonal antibody 6F5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1037</column>
            <column name="TargetName">B-cell lymphoma/leukemia 10</column>
            <column name="TargetSynonyms">B-cell CLL/lymphoma 10, Bcl-10
CARD-containing molecule enhancing NF-kappa-B
CARD-like apoptotic protein, hCLAP
CED-3/ICH-1 prodomain homologous E10-like regulator, CIPER
Cellular homolog of vCARMEN, cCARMEN
Cellular-E10, c-E10
Mammalian CARD-containing adapter molecule E10, mE10</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O95999</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Bcl-X(L), an antiapoptotic member of the Bcl-2 family, is a mitochondrial protein that inhibits activation of Bax and Bak, which commit the cell to apoptosis, and it therefore represents a potential target for drug discovery.</column>
        </table>
        <table name="target">
            <column name="TargetID">1038</column>
            <column name="TargetName">Anti-p53 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1039</column>
            <column name="TargetName">Internal ribosomal entry site, IRES</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Hepatitis C virus:11103</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hepatitis C virus (HCV) is a positive strand RNA flavivirus that is a major causative agent of serious liver disease, making new treatment modalities an urgent priority. Because HCV translation initiation occurs by a mechanism that is fundamentally distinct from that of host mRNAs, it is an attractive target for drug discovery. The translation of HCV mRNA is initiated from an internal ribosomal entry site (IRES), independent of cap and poly(A) recognition and bypassing eIF4F complex formation.</column>
        </table>
        <table name="target">
            <column name="TargetID">1040</column>
            <column name="TargetName">Thymidylate synthase mRNA, TS </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">GI:186972144</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Thymidylate synthase (TS), an essential enzyme for catalyzing the biosynthesis of thymidylate, is a critical therapeutic target in cancer therapy.</column>
        </table>
        <table name="target">
            <column name="TargetID">1041</column>
            <column name="TargetName">Calmodulin, CaM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P62158</column>
            <column name="TargetStructure">1CDL, 1CLL, 1CTR, 1IWQ, 1J7O, 1J7P, 1K90, 1K93, 1L7Z, 1LVC, 1NKF, 1PK0, 1S26, 1SK6, 1SW8, 1WRZ, 1XFU, 1XFV, 1XFW, 1XFX, 1XFY, 1XFZ, 1Y6W, 1YR5, 1YRT, 1YRU, 1ZOT, 1ZUZ, 2BE6, 2F3Y, 2F3Z, 2HF5, 2I08, 2JZI, 2K0E, 2K0F, 2K0J, 2K61, 2KNE, 2KUG, 2KUH, 2L53, 2L7L, 2LGF, 2LL6, 2LL7, 2LQC, 2LQP, 2LV6, 2M55, 2R28, 2V01, 2V02, 2VAY, 2W73, 2WEL, 2X0G, 2Y4V, 3BYA, 3DVE, 3DVJ, 3DVK, 3DVM, 3EWT, 3EWV, 3G43, 3HR4, 3O77, 3O78, 3OXQ, 3SUI, 3UCT, 3UCW, 3UCY, 4DCK, 4DJC, 4GOW</column>
            <column name="TargetComments">Calmodulin mediates the control of a large number of enzymes and other proteins by Ca(2+). Among the enzymes to be stimulated by the calmodulin-Ca(2+) complex are a number of protein kinases and phosphatases. Together with CEP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis.</column>
        </table>
        <table name="target">
            <column name="TargetID">1042</column>
            <column name="TargetName">Botulinum neurotoxin A light chain</column>
            <column name="TargetSynonyms">Botulinum neurotoxin A alternative name(s):
Botulinum neurotoxin type A, BoNT/A
Bontoxilysin-A, BOTOX</column>
            <column name="TargetSource">Clostridium botulinum:1491</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q45894 [2-448]</column>
            <column name="TargetStructure">1E1H, 2G7K, 2G7N, 2G7P, 2G7Q</column>
            <column name="TargetComments">Botulinum neurotoxins (BoNTs) are extremely toxic.</column>
        </table>
        <table name="target">
            <column name="TargetID">1043</column>
            <column name="TargetName">Anti-polyhistidine monoclonal antibody HIS-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The antibody recognizes synthetic polyHistidine, as well as native or denatured, reduced forms of proteins tagged with 6X histidines, expressed in selected vectors.</column>
        </table>
        <table name="target">
            <column name="TargetID">1044</column>
            <column name="TargetName">Guanine nucleotide-binding protein G(i) subunit alpha-1</column>
            <column name="TargetSynonyms">Adenylate cyclase-inhibiting G alpha protein</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P10824</column>
            <column name="TargetStructure">1AGR, 1AS0, 1AS2, 1AS3, 1BH2, 1BOF, 1CIP, 1GDD, 1GFI, 1GG2, 1GIA, 1GIL, 1GIT, 1GP2, 1SHZ, 1SVK, 1SVS, 2BCJ, 2ZJY, 2ZJZ, 3AH8, 3D7M, 3FFA, 3FFB, 3V00</column>
            <column name="TargetComments">Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. The G(i) proteins are involved in hormonal regulation of adenylate cyclase: they inhibit the cyclase in response to beta-adrenergic stimuli. The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane.</column>
        </table>
        <table name="target">
            <column name="TargetID">1045</column>
            <column name="TargetName">Penicillin binding protein 2a, PBP2a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Staphylococcus aureus:1280</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q7DHH4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1046</column>
            <column name="TargetName">Prothrombin</column>
            <column name="TargetSynonyms">EC=3.4.21.5</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00734 [328-622]</column>
            <column name="TargetStructure">1A2C, 1A3B, 1A3E, 1A46, 1A4W, 1A5G, 1A61, 1ABI, 1ABJ, 1AD8, 1AE8, 1AFE, 1AHT, 1AI8, 1AIX, 1AWF, 1AWH, 1AY6, 1B5G, 1B7X, 1BA8, 1BB0, 1BCU, 1BHX, 1BMM, 1BMN, 1BTH, 1C1U, 1C1V, 1C1W, 1C4U, 1C4V, 1C4Y, 1C5L, 1C5N, 1C5O, 1CA8, 1D3D, 1D3P, 1D3Q, 1D3T, 1D4P, 1D6W, 1D9I, 1DE7, 1DIT, 1DM4, 1DOJ, 1DWB, 1DWC, 1DWD, 1DWE, 1DX5, 1E0F, 1EB1, 1EOJ, 1EOL, 1FPC, 1FPH, 1G30, 1G32, 1G37, 1GHV, 1GHW, 1GHX, 1GHY, 1GJ4, 1GJ5, 1H8D, 1H8I, 1HAG, 1HAH, 1HAI, 1HAO, 1HAP, 1HBT, 1HDT, 1HGT, 1HLT, 1HUT, 1HXE, 1HXF, 1IHS, 1IHT, 1JMO, 1JOU, 1JWT, 1K21, 1K22, 1KTS, 1KTT, 1LHC, 1LHD, 1LHE, 1LHF, 1LHG, 1MH0, 1MU6, 1MU8, 1MUE, 1NM6, 1NO9, 1NRN, 1NRO, 1NRP, 1NRQ, 1NRR, 1NRS, 1NT1, 1NU7, 1NU9, 1NY2, 1NZQ, 1O0D, 1O2G, 1O5G, 1OOK, 1OYT, 1P8V, 1PPB, 1QBV, 1QHR, 1QJ1, 1QJ6, 1QJ7, 1QUR, 1RD3, 1RIW, 1SB1, 1SFQ, 1SG8, 1SGI, 1SHH, 1SL3, 1SR5, 1T4U, 1T4V, 1TA2, 1TA6, 1TB6, 1TBZ, 1THP, 1THR, 1THS, 1TMB, 1TMT, 1TMU, 1TOM, 1TQ0, 1TQ7, 1TWX, 1UMA, 1UVS, 1VR1, 1VZQ, 1W7G, 1WAY, 1WBG, 1XM1, 1XMN, 1YPE, 1YPG, 1YPJ, 1YPK, 1YPL, 1YPM, 1Z71, 1Z8I, 1Z8J, 1ZGI, 1ZGV, 1ZRB, 2A0Q, 2A2X, 2A45, 2AFQ, 2ANK, 2ANM, 2B5T, 2BDY, 2BVR, 2BVS, 2BVX, 2BXT, 2BXU, 2C8W, 2C8X, 2C8Y, 2C8Z, 2C90, 2C93, 2CF8, 2CF9, 2CN0, 2FEQ, 2FES, 2GDE, 2GP9, 2H9T, 2HGT, 2HNT, 2HPP, 2HPQ, 2HWL, 2JH0, 2JH5, 2JH6, 2OD3, 2PGB, 2PGQ, 2PKS, 2PW8, 2R2M, 2THF, 2UUF, 2UUJ, 2UUK, 2V3H, 2V3O, 2ZC9, 2ZDA, 2ZDV, 2ZF0, 2ZFF, 2ZFP, 2ZFQ, 2ZFR, 2ZG0, 2ZGB, 2ZGX, 2ZHE, 2ZHF, 2ZHQ, 2ZHW, 2ZI2, 2ZIQ, 2ZNK, 2ZO3, 3B23, 3B9F, 3BEF, 3BEI, 3BF6, 3BIU, 3BIV, 3BV9, 3C1K, 3C27, 3D49, 3DA9, 3DD2, 3DHK, 3DT0, 3DUX, 3E6P, 3EE0, 3EGK, 3EQ0, 3F68, 3GIC, 3GIS, 3HAT, 3HKJ, 3HTC, 3JZ1, 3JZ2, 3K65, 3LDX, 3LU9, 3NXP, 3P17, 3P6Z, 3P70, 3PMH, 3PO1, 3QDZ, 3QGN, 3QLP, 3QTO, 3QTV, 3QWC, 3QX5, 3R3G, 3RLW, 3RLY, 3RM0, 3RM2, 3RML, 3RMM, 3RMN, 3RMO, 3S7H, 3S7K, 3SHA, 3SHC, 3SI3, 3SI4, 3SQE, 3SQH, 3SV2, 3T5F, 3TU7, 3U69, 3U8O, 3U8R, 3U8T, 3U98, 3U9A, 3UTU, 3UWJ, 4AX9, 4AYV, 4AYY, 4AZ2, 4BAH, 4BAK, 4BAM, 4BAN, 4BAO, 4BAQ, 4DIH, 4DII, 4DT7, 4DY7, 4E05, 4E06, 4E7R, 4H6S, 4H6T, 4HFP, 4HFY, 4HTC, 4THN, 5GDS, 7KME, 8KME</column>
            <column name="TargetComments">Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.</column>
        </table>
        <table name="target">
            <column name="TargetID">1047</column>
            <column name="TargetName">Three RNA targets (λ-boxBR, GNRA tetraloop, and P22 boxBL)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Three different RNA targets differs only in their loop structures.</column>
        </table>
        <table name="target">
            <column name="TargetID">1048</column>
            <column name="TargetName">Cationic trypsin</column>
            <column name="TargetSynonyms">Beta-trypsin</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00760</column>
            <column name="TargetStructure">1AQ7, 1AUJ, 1AZ8, 1BJU, 1BJV, 1BTP, 1BTW, 1BTX, 1BTY, 1BTZ, 1C1N, 1C1O, 1C1P, 1C1Q, 1C1R, 1C1S, 1C1T, 1C2D, 1C2E, 1C2F, 1C2G, 1C2H, 1C2I, 1C2J, 1C2K, 1C2L, 1C2M, 1C5P, 1C5Q, 1C5R, 1C5S, 1C5T, 1C5U, 1C5V, 1C9T, 1CE5, 1D6R, 1EB2, 1EJM, 1EZX, 1F0T, 1F0U, 1F2S, 1G36, 1G3B, 1G3C, 1G3D, 1G3E, 1G9I, 1GBT, 1GHZ, 1GI0, 1GI1, 1GI2, 1GI3, 1GI4, 1GI5, 1GI6, 1GJ6, 1HJ9, 1J8A, 1JIR, 1JRS, 1JRT, 1K1I, 1K1J, 1K1L, 1K1M, 1K1N, 1K1O, 1K1P, 1LQE, 1MAX, 1MAY, 1MTS, 1MTU, 1MTV, 1MTW, 1N6X, 1N6Y, 1NC6, 1NTP, 1O2H, 1O2I, 1O2J, 1O2K, 1O2L, 1O2M, 1O2N, 1O2O, 1O2P, 1O2Q, 1O2R, 1O2S, 1O2T, 1O2U, 1O2V, 1O2W, 1O2X, 1O2Y, 1O2Z, 1O30, 1O31, 1O32, 1O33, 1O34, 1O35, 1O36, 1O37, 1O38, 1O39, 1O3A, 1O3B, 1O3C, 1O3D, 1O3E, 1O3F, 1O3G, 1O3H, 1O3I, 1O3J, 1O3K, 1O3L, 1O3M, 1O3N, 1O3O, 1OPH, 1OX1, 1OYQ, 1P2I, 1P2J, 1P2K, 1PPC, 1PPE, 1PPH, 1QA0, 1QB1, 1QB6, 1QB9, 1QBN, 1QBO, 1QCP, 1QL7, 1QL8, 1RXP, 1S0Q, 1S0R, 1SBW, 1SFI, 1SMF, 1TAB, 1TAW, 1TGB, 1TGC, 1TGN, 1TGS, 1TGT, 1TIO, 1TLD, 1TNG, 1TNH, 1TNI, 1TNJ, 1TNK, 1TNL, 1TPA, 1TPO, 1TPP, 1TPS, 1TX7, 1TX8, 1TYN, 1UTN, 1UTO, 1UTP, 1UTQ, 1V2J, 1V2K, 1V2L, 1V2M, 1V2N, 1V2O, 1V2P, 1V2Q, 1V2R, 1V2S, 1V2T, 1V2U, 1V2V, 1V2W, 1XUF, 1XUG, 1XUH, 1XUI, 1XUJ, 1XUK, 1Y3U, 1Y3V, 1Y3W, 1Y3X, 1Y3Y, 1Y59, 1Y5A, 1Y5B, 1Y5U, 1YP9, 1YYY, 1ZR0, 1ZZZ, 2A7H, 2AGE, 2AGG, 2AGI, 2AH4, 2AYW, 2BLV, 2BLW, 2BTC, 2BY5, 2BY6, 2BY7, 2BY8, 2BY9, 2BYA, 2BZA, 2CMY, 2D8W, 2F3C, 2FI3, 2FI4, 2FI5, 2FTL, 2FTM, 2FX4, 2FX6, 2G55, 2G5N, 2G5V, 2G81, 2G8T, 2ILN, 2J9N, 2O9Q, 2OTV, 2OXS, 2PLX, 2PTC, 2PTN, 2QN5, 2QYI, 2TGA, 2TGD, 2TGP, 2TGT, 2TIO, 2TLD, 2TPI, 2UUY, 2XTT, 2ZDK, 2ZDL, 2ZDM, 2ZDN, 2ZFS, 2ZFT, 2ZHD, 2ZQ1, 2ZQ2, 3A7T, 3A7V, 3A7W, 3A7X, 3A7Y, 3A7Z, 3A80, 3A81, 3A82, 3A83, 3A84, 3A85, 3A86, 3A87, 3A88, 3A89, 3A8A, 3A8B, 3A8C, 3A8D, 3AAS, 3AAU, 3AAV, 3ATI, 3ATK, 3ATL, 3ATM, 3BTD, 3BTE, 3BTF, 3BTG, 3BTH, 3BTK, 3BTM, 3BTQ, 3BTT, 3BTW, 3D65, 3E8L, 3GY2, 3GY3, 3GY4, 3GY5, 3GY6, 3GY7, 3GY8, 3I29, 3ITI, 3LJJ, 3LJO, 3M35, 3M7Q, 3MFJ, 3MI4, 3NK8, 3NKK, 3OTJ, 3PLB, 3PLK, 3PLP, 3PM3, 3PMJ, 3PTB, 3PTN, 3PWB, 3PWC, 3PYH, 3Q00, 3QK1, 3RDZ, 3RU4, 3RXA, 3RXB, 3RXC, 3RXD, 3RXE, 3RXF, 3RXG, 3RXH, 3RXI, 3RXJ, 3RXK, 3RXL, 3RXM, 3RXO, 3RXP, 3RXQ, 3RXR, 3RXS, 3RXT, 3RXU, 3RXV, 3T25, 3T26, 3T27, 3T28, 3T29, 3TPI, 3UNQ, 3UNR, 3UNS, 3UOP, 3UPE, 3UQO, 3UQV, 3UUZ, 3UWI, 3UY9, 3V0X, 3V12, 3V13, 3VEQ, 3VPK, 4AB8, 4AB9, 4ABA, 4ABB, 4ABD, 4ABE, 4ABF, 4ABG, 4ABH, 4ABI, 4ABJ, 4AOQ, 4AOR, 4B1T, 4B2A, 4B2B, 4B2C, 4I8G, 4I8H, 4I8J, 4I8K, 4I8L, 4J2Y, 4TPI, 5PTP</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1049</column>
            <column name="TargetName">Anti-c-myc monoclonal antibody 9E10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The 9E10 monoclonal antibody recognizes the amino acid sequence EQKLISEEDL, which is a specific portion of the human c-myc gene product. This antibody is highly specific and is unlikely to alter the activity of the cloned sequence.</column>
        </table>
        <table name="target">
            <column name="TargetID">1050</column>
            <column name="TargetName">Prepilin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Salmonella typhi:90370</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q8Z1L1</column>
            <column name="TargetStructure">3FHU, 3FHV</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1051</column>
            <column name="TargetName">Model membranes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1052</column>
            <column name="TargetName">Cobalt(II) complex, Co(II)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1053</column>
            <column name="TargetName">Anti-FLAG M2 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-FLAG M2 monoclonal antibody is a purified IgG1 monoclonal antibody isolated from a murine cell culture that binds to FLAG fusion proteins. Unlike anti-FLAG M1 antibody, the M2 antibody will recognize the FLAG sequence at the N-terminus, Met-N-terminus or C-terminus of FLAG fusion proteins. Anti-FLAG M2 monoclonal antibody is useful for identification of FLAG fusion proteins by common immunological procedures. It is also useful for affinity purification of FLAG fusion proteins when bound to a solid support.</column>
        </table>
        <table name="target">
            <column name="TargetID">1054</column>
            <column name="TargetName">Anti-β-cat monoclonal antibody 36a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1055</column>
            <column name="TargetName">Anti-β-cat monoclonal antibody 48a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1056</column>
            <column name="TargetName">Envelope glycoprotein E2</column>
            <column name="TargetSynonyms">NS1
gp68
gp70</column>
            <column name="TargetSource">Hepatitis C virus genotype 1a (isolate H) (HCV):11108</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P27958 [384-746]</column>
            <column name="TargetStructure">1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2XI2, 2XI3</column>
            <column name="TargetComments">Envelope glycoprotein E2 is a chain of genome polyprotein.</column>
        </table>
        <table name="target">
            <column name="TargetID">1057</column>
            <column name="TargetName">C-reactive protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02741</column>
            <column name="TargetStructure">1B09, 1GNH, 1LJ7, 3L2Y, 3PVN, 3PVO</column>
            <column name="TargetComments">Displays several functions associated with host defense: it promotes agglutination, bacterial capsular swelling, phagocytosis and complement fixation through its calcium-dependent binding to phosphorylcholine. Can interact with DNA and histones and may scavenge nuclear material released from damaged circulating cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1058</column>
            <column name="TargetName">Surface protein gp120, SU</column>
            <column name="TargetSynonyms">Glycoprotein 120, gp120</column>
            <column name="TargetSource">Human immunodeficiency virus 1:11676</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1059</column>
            <column name="TargetName">Anti-T7·Tag monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The T7·Tag® Antibody is a mouse monoclonal antibody (IgG2b) directed against the 11 amino acid gene 10 leader peptide expressed by many of the pET translation vectors as well as pSCREEN and pRSET vectors. Because the peptide is the natural amino terminal end of the T7 major capsid protein, the antibody also recognizes T7 bacteriophage.</column>
        </table>
        <table name="target">
            <column name="TargetID">1060</column>
            <column name="TargetName">Human breast ductal carcinoma cell line, ZR-75-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1061</column>
            <column name="TargetName">Cuprous oxide, Cu(2)O</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1062</column>
            <column name="TargetName">Human red blood cells, RBCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1063</column>
            <column name="TargetName">Heparin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1064</column>
            <column name="TargetName">IgG from human, mouse, rat, rabbit and goat</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606, Mus musculus (Mouse):10090, Rattus norvegicus (Rat):10116, Oryctolagus cuniculus (Rabbit):9986, Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1065</column>
            <column name="TargetName">C crystalline face of synthetic sapphire, α-Al(2)O(3)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1066</column>
            <column name="TargetName">A crystalline face of synthetic sapphire, α-Al(2)O(3)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1067</column>
            <column name="TargetName">R crystalline face of synthetic sapphire, α-Al(2)O(3)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1068</column>
            <column name="TargetName">Zinc sufide, ZnS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1069</column>
            <column name="TargetName">Lead sulphide, PbS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1070</column>
            <column name="TargetName">Cadmium sulfide, CdS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1071</column>
            <column name="TargetName">6Al-4V Ti</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1072</column>
            <column name="TargetName">(001)-oriented TiO2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1073</column>
            <column name="TargetName">(100)-oriented TiO2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1074</column>
            <column name="TargetName">(110)-oriented TiO2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1075</column>
            <column name="TargetName">Silica, Si</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1076</column>
            <column name="TargetName">Gold</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1077</column>
            <column name="TargetName">Titanium, Ti</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1078</column>
            <column name="TargetName">Stainless steel</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1079</column>
            <column name="TargetName">Bulk steel (edges)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1080</column>
            <column name="TargetName">Iridium oxide, IrO2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1081</column>
            <column name="TargetName">Anti-RESA monoclonal antibody MAb 18/2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1082</column>
            <column name="TargetName">Grass carp hemorrhage virus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Grass carp hemorrhagic virus:128986</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Grass carp hemorrhage virus (GCHV), a member of Reoviridae, causes severe hemorrhagic disease of grass carp (Ctenopharyngodon idellus) in China</column>
        </table>
        <table name="target">
            <column name="TargetID">1083</column>
            <column name="TargetName">Newcastle disease virus, NDV</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Newcastle disease virus (isolate AF2240) (NDV):351071</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Newcastle disease virus (NDV) which causes a major disease in poultry, is grouped under the family of Paramyxoviridae.</column>
        </table>
        <table name="target">
            <column name="TargetID">1084</column>
            <column name="TargetName">Apical membrane antigen 1, AMA1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Plasmodium falciparum (isolate 3D7):36329</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q7KQK5</column>
            <column name="TargetStructure">1Z40, 2Q8A, 2Q8B, 2Z8V, 2Z8W, 3SRJ, 3ZWZ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1085</column>
            <column name="TargetName">Regulatory protein E2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Human papillomavirus type 16:333760</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03120</column>
            <column name="TargetStructure">1BY9, 1DTO, 1R8P, 1ZZF, 2NNU, 2Q79, 3MI7</column>
            <column name="TargetComments">Plays an accessory role in initiation of DNA replication. A dimer of E2 interacts with a dimer of E1 in order to improve specificity of E1 DNA binding activity. Once the complex recognizes and binds DNA at specific sites, the E2 dimer is removed from DNA. E2 also regulates viral transcription through binding to the E2RE response element (5'-ACCNNNNNNGGT-3') present in multiple copies in the regulatory regions of the viral genome. Activates or represses transcription depending on E2RE's position with regards to proximal promoter elements including the TATA-box. Repression occurs by sterically hindering the assembly of the transcription initiation complex.</column>
        </table>
        <table name="target">
            <column name="TargetID">1086</column>
            <column name="TargetName">Human antibodies eluted from the surface of infected red blood cell (iRBC)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1087</column>
            <column name="TargetName">Large envelope protein</column>
            <column name="TargetSynonyms">L glycoprotein
L-HBsAg, LHB
Large S protein
Large surface protein
Major surface antigen</column>
            <column name="TargetSource">Hepatitis B virus genotype D subtype adw (isolate United Kingdom/adyw/1979) (HBV-D):10419</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03139</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The large envelope protein exists in two topological conformations, one which is termed 'external' or Le-HBsAg and the other 'internal' or Li-HBsAg. In its external conformation the protein attaches the virus to cell receptors and thereby initiating infection. This interaction determines the species specificity and liver tropism. This attachment induces virion internalization predominantly through caveolin-mediated endocytosis. The large envelope protein also assumes fusion between virion membrane and endosomal membrane.</column>
        </table>
        <table name="target">
            <column name="TargetID">1088</column>
            <column name="TargetName">Interferon alpha/beta receptor 2, IFN-R-2</column>
            <column name="TargetSynonyms">IFN-alpha binding protein, IFN-alpha/beta receptor 2
Interferon alpha binding protein
Type I interferon receptor 2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P48551</column>
            <column name="TargetStructure">1N6U, 1N6V, 2HYM, 2KZ1, 2LAG, 3S8W, 3S9D, 3SE3, 3SE4</column>
            <column name="TargetComments">Associates with IFNAR1 to form the type I interferon receptor. Receptor for interferons alpha and beta. Involved in IFN-mediated STAT1, STAT2 and STAT3 activation.</column>
        </table>
        <table name="target">
            <column name="TargetID">1089</column>
            <column name="TargetName">Envelope glycoprotein E2</column>
            <column name="TargetSynonyms">NS1
gp68
gp70</column>
            <column name="TargetSource">Hepatitis C virus genotype 2a (isolate JFH-1) (HCV):356411</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q99IB8 [384-750]</column>
            <column name="TargetStructure">2KZQ, 2LIF, 2XXD, 2XYM, 3I5K, 4AEP, 4AEX, 4E76, 4E78, 4E7A</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1090</column>
            <column name="TargetName">Interleukin-10, IL-10</column>
            <column name="TargetSynonyms">Cytokine synthesis inhibitory factor, CSIF</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P22301</column>
            <column name="TargetStructure">1ILK, 1INR, 1J7V, 1LK3, 1Y6K, 2H24, 2ILK</column>
            <column name="TargetComments">Inhibits the synthesis of a number of cytokines, including IFN-gamma, IL-2, IL-3, TNF and GM-CSF produced by activated macrophages and by helper T-cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1091</column>
            <column name="TargetName">Ganglioside GM1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GM1 (monosialotetrahexosylganglioside) the &quot;prototype&quot; ganglioside, is a member of the ganglio series of gangliosides which contain one sialic acid residue. GM1 has important physiological properties and impacts neuronal plasticity and repair mechanisms, and the release of neurotrophins in the brain. Besides its function in the physiology of the brain, GM1 acts as the site of binding for both Cholera toxin and E. coli heat-labile enterotoxin.</column>
        </table>
        <table name="target">
            <column name="TargetID">1092</column>
            <column name="TargetName">Hemagglutinin, HA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Influenza A virus (strain A/Puerto Rico/8/1934 H1N1):211044</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">1RU7, 1RVX, 1RVZ</column>
            <column name="TargetComments">Hemagglutinin (HA) in the membrane of type A influenza viruses recognizes sialylglycoconjugate receptors on the host cell surface at an initial step in the infection process; consequently, HA inhibitors are considered potential candidates for antiviral drugs.</column>
        </table>
        <table name="target">
            <column name="TargetID">1093</column>
            <column name="TargetName">Hemagglutinin, HA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Influenza A virus (A/Wuhan/359/1995(H3N2)):63106</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O40714</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Hemagglutinin (HA) in the membrane of type A influenza viruses recognizes sialylglycoconjugate receptors on the host cell surface at an initial step in the infection process; consequently, HA inhibitors are considered potential candidates for antiviral drugs.</column>
        </table>
        <table name="target">
            <column name="TargetID">1094</column>
            <column name="TargetName">α form of poly(L-lactide) crystalline films</column>
            <column name="TargetSynonyms">???</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PLLA is one of the most commonly used synthetic polymers in the biomedical field because of its many excellent physical properties such as thermal stability, mechanical properties, biocompatibility, and biodegradability to nontoxic products.</column>
        </table>
        <table name="target">
            <column name="TargetID">1095</column>
            <column name="TargetName">Anti-biotin polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-biotin antibody was obtained from Sigma(B3640), which was produced in goat with Biotin-KLH conjugate as immunogen.</column>
        </table>
        <table name="target">
            <column name="TargetID">1096</column>
            <column name="TargetName">GSI-B4 isolectin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Griffonia simplicifolia:3850</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q8W1R6</column>
            <column name="TargetStructure">1GNZ, 1HQL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1097</column>
            <column name="TargetName">Anti-pig Xenoreactive Natural Antibodies, XNAs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human anti-pig XNAs, primarily of IgM isotype, were eluted from porcine aortic endothelial cell. They were captured to be the target of biopanning by biotinylated mouse anti-human IgM, which was imobilized by streptavidin coated on the surface of the culture plates.</column>
        </table>
        <table name="target">
            <column name="TargetID">1098</column>
            <column name="TargetName">Fc domain of IgG (IGHG1,IGHG2,IGHG3,IGHG4)</column>
            <column name="TargetSynonyms">Ig gamma chain C region, Human IgG Fc fragment</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01857, P01859, P01860, P01861</column>
            <column name="TargetStructure">IGHG1: 1AJ7, 1AQK, 1BEY, 1D5B, 1D5I, 1D6V, 1DFB, 1DN2, 1E4K, 1FC1, 1FC2, 1FCC, 1GAF, 1H3T, 1H3U, 1H3V, 1H3W, 1H3X, 1H3Y, 1HKL, 1HZH, 1I7Z, 1L6X, 1N7M, 1OP3, 1OQO, 1OQX, 1T83, 1T89, 1VGE, 2DTS, 2GJ7, 2I5Y, 2IWG, 2J6E, 2JB5, 2JB6, 2O5X, 2O5Y, 2O5Z, 2OSL, 2QAD, 2QL1, 2QQK, 2QQL, 2QQN, 2QR0, 2R56, 2RCJ, 2RCS, 2VXQ, 2WAH, 3AGV, 3AVE, 3AY4, 3B2U, 3B2V, 3BDY, 3BE1, 3BKY, 3BN9, 3BQU, 3C08, 3C09, 3C2S, 3CFJ, 3CFK, 3CSY, 3D0L, 3D0V, 3D6G, 3D85, 3DJ9, 3DNK, 3DO3, 3DRO, 3DRQ, 3DVG, 3DVN, 3EYF, 3EYO, 3EYQ, 3FJT, 3O11, 3RY6, 3S7G, 3SGJ, 3SGK, 3TV3, 3TWC, 3TYG, 3U0W, 3U7W, 3U7Y, 3V7M, 3V8C, 3V95, 3WJJ, 3WJL, 3WKN, 3WN5, 4ACP, 4B7I, 4BM7, 4BSV, 4BSW, 4BYH, 4CDH, 4D9Q, 4D9R, 4DAG, 4DZ8, 4EOW, 4J12, 4KU1, 4LLD, 4LLM, 4LLQ, 4N0U, 4NQS, 4NQT, 4NQU, 4NWT, 4NWU, 4O4Y, 4O51, 4Q6Y, 4Q74, 4Q7D, 4W4N, 4W4O, 4X4M
IGHG2: 2QSC, 4HAF, 4HAG, 4L4J
IGHG4: 1ADQ, 1BBJ, 2FL5, 4B53, 4C54, 4C55, 4D2N</column>
            <column name="TargetComments">Defects in IGHG1 are a cause of multiple myeloma, which is a malignant tumor of plasma cells usually arising in the bone marrow and characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria and anemia. Complications of multiple myeloma are bone pain, hypercalcemia, renal failure and spinal cord compression. The aberrant antibodies that are produced lead to impaired humoral immunity and patients have a high prevalence of infection.</column>
        </table>
        <table name="target">
            <column name="TargetID">1099</column>
            <column name="TargetName">Anti-IgE polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The polyclonal antibody was isolated from the serum of an asthma patient with high titre of IgG1 anti-IgE.</column>
        </table>
        <table name="target">
            <column name="TargetID">1100</column>
            <column name="TargetName">SB-365579</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">SB-365579 is a biotinylated derivative of SB-236057 (biotin conjugated to the spiropiperidine moiety). The compound SB-236057 is a serotonin receptor 1B (5-HT1B) inverse agonist that has been identified to be teratogenic in rats, rabbits and mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">1101</column>
            <column name="TargetName">SB-365580</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">SB-365580 is a biotinylated derivative of SB-236057 (biotin conjugate in lieu of the oxadiazole ring). The compound SB-236057 is a serotonin receptor 1B (5-HT1B) inverse agonist that has been identified to be teratogenic in rats, rabbits and mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">1102</column>
            <column name="TargetName">70 kDa heat shock cognate protein 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Vigna radiata (Mung bean):157791</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q5QHT4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1103</column>
            <column name="TargetName">Cobalt ion, Co(2+)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1104</column>
            <column name="TargetName">Microcystin-LR, MC-LR</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Cyanobacteria:1117</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Microcystins are a group of stable cyclic heptapeptide toxins produced by cyanobacterial blooms, which cause environmental contamination.</column>
        </table>
        <table name="target">
            <column name="TargetID">1105</column>
            <column name="TargetName">Anti-E2 protein monoclonal antibody HQ06</column>
            <column name="TargetSynonyms">mAb HQ06</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb HQ06 directed against the E2 protein of Classical swine fever virus (CSFV) was generated by immunization of BALB/c mice with the recombinant truncated E2 protein (aa 754-881) of CSFV Shimen/HVRI strain (GenBank accession no. AY775178) expressed in Escherichia coli. The mAb showed reactivity and neutralizing activity with Shimen/HVRI strain in infected PK15 cells in virus neutralization test.</column>
        </table>
        <table name="target">
            <column name="TargetID">1106</column>
            <column name="TargetName">Sulfated Lewis X</column>
            <column name="TargetSynonyms">HSO3-LeX, HSO3LeX</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The sulfated Lewis X is widely distributed in tumor mucin.</column>
        </table>
        <table name="target">
            <column name="TargetID">1107</column>
            <column name="TargetName">Sulfated Lewis A</column>
            <column name="TargetSynonyms">HSO3-LeA, HSO3LeA</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The sulfated Lewis A is widely distributed in tumor mucin.</column>
        </table>
        <table name="target">
            <column name="TargetID">1108</column>
            <column name="TargetName">Anti-human DAF monoclonal antibody DG3</column>
            <column name="TargetSynonyms">Mab DG3</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The IgG1 mAbs DG3 are specific to the human DAF.</column>
        </table>
        <table name="target">
            <column name="TargetID">1109</column>
            <column name="TargetName">p53-binding domains of MDM2</column>
            <column name="TargetSynonyms">MDM2 alternative name(s):
E3 ubiquitin-protein ligase Mdm2
Double minute 2 protein
Oncoprotein Mdm2
p53-binding protein Mdm2
EC=6.3.2.-</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q00987 [25-109]</column>
            <column name="TargetStructure">1RV1, 1T4E, 1T4F, 1YCR, 1Z1M, 2AXI, 2C6A, 2C6B, 2F1Y, 2FOP, 2GV2, 2HDP, 2LZG, 2M86, 2RUH, 2VJE, 2VJF, 3EQS, 3G03, 3IUX, 3IWY, 3JZK, 3JZR, 3JZS, 3LBK, 3LBL, 3LNJ, 3LNZ, 3MQS, 3TJ2, 3TPX, 3TU1, 3V3B, 3VBG, 3VZV, 3W69, 4DIJ, 4ERE, 4ERF, 4HBM, 4HFZ, 4HG7, 4JV7, 4JV9, 4JVE, 4JVR, 4JWR, 4MDN, 4MDQ, 4OAS, 4OBA, 4OCC, 4ODE, 4ODF, 4OGN, 4OGT, 4OGV, 4OQ3, 4QO4, 4QOC, 4UMN, 4WT2</column>
            <column name="TargetComments">E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as an ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways.</column>
        </table>
        <table name="target">
            <column name="TargetID">1110</column>
            <column name="TargetName">p53-binding domains of MDMX</column>
            <column name="TargetSynonyms">MDMX alternative name(s):
Protein Mdm4
Double minute 4 protein
Mdm2-like p53-binding protein
Protein Mdmx
p53-binding protein Mdm4</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O15151 [24-108]</column>
            <column name="TargetStructure">2CR8, 2VJE, 2VJF, 2VYR, 3DAB, 3EQY, 3FDO, 3FE7, 3FEA, 3JZO, 3JZP, 3JZQ, 3LBJ, 3MQR, 3U15</column>
            <column name="TargetComments">Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1111</column>
            <column name="TargetName">Monoclonal antibody 3-4B</column>
            <column name="TargetSynonyms">MAb 3-4B</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb 3-4B is a mouse monoclonal IgM that reacts with the large subunit of Caenorhabditis elegans RNA polymerase II and with a fusion protein containing 148 residues of that polypeptide.</column>
        </table>
        <table name="target">
            <column name="TargetID">1112</column>
            <column name="TargetName">Insulin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Insulin normally binds a cell surface receptor, although it has also been shown to bind a hexapeptide.</column>
        </table>
        <table name="target">
            <column name="TargetID">1113</column>
            <column name="TargetName">Interleukin-2 receptor subunit alpha</column>
            <column name="TargetSynonyms">IL-2 receptor subunit alpha, IL-2-RA, IL-2R subunit alpha, IL2-RA
TAC antigen
p55
CD_antigen=CD25</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P01589</column>
            <column name="TargetStructure">1Z92, 2B5I, 2ERJ, 3IU3, 3NFP</column>
            <column name="TargetComments">IL-2Rα is the extracellular binding domain of the small (α) subunit of the IL-2 receptor; it binds the polypeptide hormone IL-2 without the large subunit.</column>
        </table>
        <table name="target">
            <column name="TargetID">1114</column>
            <column name="TargetName">Syndiotactic polystyrene film</column>
            <column name="TargetSynonyms">sPS film</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">sPS adopts TTGG helical conformations (T and G indicate trans and gauche conformations, respectively) when films are appropriately prepared with suitable solvents such as xylene and toluene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1115</column>
            <column name="TargetName">Petri dish (polystyrene, PS)</column>
            <column name="TargetSynonyms">Petri plate
Cell culture dish</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A Petri dish (or Petri plate or cell culture dish) is a shallow glass or plastic cylindrical lidded dish that biologists use to culture cells or small moss plants.</column>
        </table>
        <table name="target">
            <column name="TargetID">1116</column>
            <column name="TargetName">Mouse pooled sera immunized with VHBL plasmid DNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1117</column>
            <column name="TargetName">Anti-mut-II monoclonal antibody LmmAbB2D4</column>
            <column name="TargetSynonyms">Mab LmmAbB2D4</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1118</column>
            <column name="TargetName">Rat synovial tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1119</column>
            <column name="TargetName">Anti-CAEV polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IgG fraction was purified from serum at 12-week post-infection (pi).</column>
        </table>
        <table name="target">
            <column name="TargetID">1120</column>
            <column name="TargetName">Recombinant 4e5 domain of human stabilin-2</column>
            <column name="TargetSynonyms">Stabilin-2 alternative name(s):
FAS1 EGF-like and X-link domain-containing adhesion molecule 2
Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2, FEEL-2
Hyaluronan receptor for endocytosis</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q8WWQ8</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Recombinant 4e5 domain of human stabilin-2 was constructed with the fourth FAS domain, the third EGF repeat domain, and the fifth FAS domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">1121</column>
            <column name="TargetName">Plasmodium berghei ookinetes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Plasmodium berghei (strain Anka):5823</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The ookinete is a motile stage of malaria parasites that forms in the midgut lumen of the mosquito vector within the infective bloodmeal bolus.</column>
        </table>
        <table name="target">
            <column name="TargetID">1122</column>
            <column name="TargetName">Membrane primary amine oxidase</column>
            <column name="TargetSynonyms">EC=1.4.3.21
Copper amine oxidase
HPAO
Semicarbazide-sensitive amine oxidase, SSAO
Vascular adhesion protein 1, VAP-1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q16853</column>
            <column name="TargetStructure">1PU4, 1US1, 2C10, 2C11, 2Y73, 2Y74, 3ALA</column>
            <column name="TargetComments">Vascular adhesion protein-1 (VAP-1/AOC3) is an endothelial cell molecule that is rapidly translocated from the intracellular storage granules to the endothelial cell surface on inflammation. It contributes to several steps in the extravasation cascade and controls trafficking of lymphocytes, granulocytes, and monocytes to sites of inflammation.</column>
        </table>
        <table name="target">
            <column name="TargetID">1123</column>
            <column name="TargetName">Soluble ectodomain of APP isoform sAPPα695</column>
            <column name="TargetSynonyms">APP alternative name(s):
ABPP
APPI
Alzheimer disease amyloid protein
Cerebral vascular amyloid peptide, CVAP
PreA4
Protease nexin-II, PN-II</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05067</column>
            <column name="TargetStructure">1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</column>
            <column name="TargetComments">The amyloid precursor protein (APP) is well known for giving rise to the amyloid-β peptide and for its role in Alzheimer's disease. Much less is known, however, on the physiological roles of APP in the development and plasticity of the central nervous system.</column>
        </table>
        <table name="target">
            <column name="TargetID">1124</column>
            <column name="TargetName">Human thymic CD4+CD25+ T cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Thymic CD4+CD25+ cells play an important role in immune regulation and are continuously developed in the thymus as an independent lineage.</column>
        </table>
        <table name="target">
            <column name="TargetID">1125</column>
            <column name="TargetName">PreS1 protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Hepatitis B virus (HBV):10407</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1126</column>
            <column name="TargetName">Anti-Li venom monoclonal antibody LimAb7</column>
            <column name="TargetSynonyms">Mab LimAb7</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The monoclonal antibody LimAb7 can neutralize the dermonecrotic activity of crude Li venom.</column>
        </table>
        <table name="target">
            <column name="TargetID">1127</column>
            <column name="TargetName">Influenza A virus (A/goose/Jilin/hb/2003(H5N1))</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Influenza A virus (A/goose/Jilin/hb/2003(H5N1)):404186</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Influenza A virus causes influenza in birds and some mammals and is the only species of influenzavirus A. Influenzavirus A is a genus of the Orthomyxoviridae family of viruses.</column>
        </table>
        <table name="target">
            <column name="TargetID">1128</column>
            <column name="TargetName">Porcine skin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1129</column>
            <column name="TargetName">Porcine dermis</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1130</column>
            <column name="TargetName">Ig-like C2-type 1-3 domain of c-kit</column>
            <column name="TargetSynonyms">c-kit alternative name(s):
Mast/stem cell growth factor receptor Kit, SCFR
Piebald trait protein, PBT
Proto-oncogene c-Kit
Tyrosine-protein kinase Kit
p145 c-kit
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
CD_antigen=CD117
EC=2.7.10.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P10721 [27-308]</column>
            <column name="TargetStructure">1PKG, 1T45, 1T46, 2E9W, 2EC8, 2VIF, 3G0E, 3G0F, 4HVS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1131</column>
            <column name="TargetName">The tegument of schistosoma japonicum schistosomula</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Schistosoma japonicum (Blood fluke):6182</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1132</column>
            <column name="TargetName">BH3 motif of Mcl-1 protein</column>
            <column name="TargetSynonyms">Mcl-1 protein alternative name(s):
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog
Bcl-2-related protein EAT/mcl1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P97287</column>
            <column name="TargetStructure">1WSX, 2JM6, 2NL9, 2NLA, 2ROC, 2ROD, 3IO9, 4G35</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1133</column>
            <column name="TargetName">Goat anti-mouse IgG (Fc) polycloanl antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1134</column>
            <column name="TargetName">Anti-CEA monoclonal antibody Col-1</column>
            <column name="TargetSynonyms">Mab Col-1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Monoclonal anti-CEA anitbody Col-1 monoclonalis is an IgG2a made from BALB/C mice immunized with extract of colon carcinoma cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1135</column>
            <column name="TargetName">Human DA-MB-435eb.1 tumor xenografts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1136</column>
            <column name="TargetName">Pancreatic phospholipase A2 </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Vipera ammodytes ammodytes (Western sand viper):8705</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Pancreatic phospholipase (neurotoxin found in the venom glands of long-nosed viper, Vipera ammodytes ammodytes) belongs to a group of secretory phospholipases A2 (EC 3.1.1.4) that catalyze the hydrolysis of the sn-2 ester bond of phospholipids.</column>
        </table>
        <table name="target">
            <column name="TargetID">1137</column>
            <column name="TargetName">Phospholipase A2, ammodytoxin C</column>
            <column name="TargetSynonyms">Phosphatidylcholine 2-acylhydrolase
EC=3.1.1.4</column>
            <column name="TargetSource">Vipera ammodytes ammodytes (Western sand viper):8705</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P11407</column>
            <column name="TargetStructure">3G8H</column>
            <column name="TargetComments">Ammodytoxin C (neurotoxin found in the venom glands of long-nosed viper, Vipera ammodytes ammodytes) belongs to a group of secretory phospholipases A2 (EC 3.1.1.4) that catalyze the hydrolysis of the sn-2 ester bond of phospholipids.</column>
        </table>
        <table name="target">
            <column name="TargetID">1138</column>
            <column name="TargetName">Rabbit anti-PrV polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1139</column>
            <column name="TargetName">Rabbit anti-PRRSV polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1140</column>
            <column name="TargetName">CD44 antigen protein</column>
            <column name="TargetSynonyms">CDw44
Epican
Extracellular matrix receptor III, ECMR-III
GP90 lymphocyte homing/adhesion receptor
HUTCH-I
Heparan sulfate proteoglycan
Hermes antigen
Hyaluronate receptor
Phagocytic glycoprotein 1, PGP-1
CD_antigen=CD44</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P16070</column>
            <column name="TargetStructure">1POZ, 1UUH, 2I83</column>
            <column name="TargetComments">CD44, a cancer-associated membrane glycoprotein involved in cell adhesion and tumor progression, has been implicated as a cancer stem cell antigen in several cancers including breast cancer.</column>
        </table>
        <table name="target">
            <column name="TargetID">1141</column>
            <column name="TargetName">Rat visceral adipose tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1142</column>
            <column name="TargetName">Alanine aminotransferase 1, ALT1</column>
            <column name="TargetSynonyms">Glutamate pyruvate transaminase 1, GPT 1
Glutamic--alanine transaminase 1
Glutamic--pyruvic transaminase 1
EC=2.6.1.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P24298</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">ALT catalyzes the reversible transamination of L-alanine and a-ketoglutarate to pyruvate and L-glutamate with pyridoxal 59-phosphate as a coenzyme. ALT is found mainly in the liver, but is also found in red blood cells, heart cells, muscle tissue and other organs, such as the pancreas and kidneys.</column>
        </table>
        <table name="target">
            <column name="TargetID">1143</column>
            <column name="TargetName">Anti-SP1 polyclonal antibody IgGs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1144</column>
            <column name="TargetName">Anti-SP2 polyclonal antibody IgGs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1145</column>
            <column name="TargetName">Mouse cardiomyocyte</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Cardiomyocytes derived from pluripotent stem cells (PSCs) offer a large source of cardiomyocytes.</column>
        </table>
        <table name="target">
            <column name="TargetID">1146</column>
            <column name="TargetName">Mouse mesenchymal stem cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1147</column>
            <column name="TargetName">Anti-CYR61 monoclonal antibody 093G9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1148</column>
            <column name="TargetName">Anti-CYR61 monoclonal antibody 096B7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1149</column>
            <column name="TargetName">Caspase recruitment domain (CARD) of APAF-1</column>
            <column name="TargetSynonyms">APAF-1 alternative name(s):
Apoptotic protease-activating factor 1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O14727 [1-90]</column>
            <column name="TargetStructure">1C15, 1CWW, 1CY5, 1Z6T, 2P1H, 2YGS, 3IZA, 3YGS</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1150</column>
            <column name="TargetName">Human renal carcinoma cell line A498</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1151</column>
            <column name="TargetName">Sera from early-stage primary HCC patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1152</column>
            <column name="TargetName">Human chronic myeloid leukemia (CML) cell lines KT-1/A3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1153</column>
            <column name="TargetName">Urease</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Helicobacter pylori (Campylobacter pylori):210</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1154</column>
            <column name="TargetName">Anti-CD11b monoclonal antibody 44a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1155</column>
            <column name="TargetName">MBP mouse Kelch protein (MBP-Kelch)</column>
            <column name="TargetSynonyms">Kelch-like ECH-associated protein 1
Cytosolic inhibitor of Nrf2, INrf2</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9Z2X8 [308-624]</column>
            <column name="TargetStructure">1X2J, 1X2R, 2DYH, 2Z32, 3ADE</column>
            <column name="TargetComments">MBP-Kelch is a fusion protein of the Kelch-repeat domain of mouse Keap1 (residues 308-624) and maltose-binding protein (MBP).</column>
        </table>
        <table name="target">
            <column name="TargetID">1156</column>
            <column name="TargetName">Anti-Bla g 2 monoclonal antibody 7C11</column>
            <column name="TargetSynonyms">Mab 7C11</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1157</column>
            <column name="TargetName">Clusterin</column>
            <column name="TargetSynonyms">Aging-associated gene 4 protein
Apolipoprotein J, Apo-J
Complement cytolysis inhibitor, CLI
Complement-associated protein SP-40,40
Ku70-binding protein 1
NA1/NA2
Testosterone-repressed prostate message 2, TRPM-2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P10909</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Clusterin (CLU) is a well-conserved glycoprotein, which is also known as dimeric acidic glycoprotein, testosterone repressed prostate message-2, sulfated glycoprotein-2 and complement lysis inhibitor.</column>
        </table>
        <table name="target">
            <column name="TargetID">1158</column>
            <column name="TargetName">Serine protease 28</column>
            <column name="TargetSynonyms">Implantation serine proteinase 1, ISP-1
Strypsin
Tryptase-like proteinase
EC=3.4.21.-</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q924N9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1159</column>
            <column name="TargetName">Tenascin, TN</column>
            <column name="TargetSynonyms">Hexabrachion
Tenascin-C, TN-C</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q80YX1</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1160</column>
            <column name="TargetName">Bovine rotavirus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bovine rotavirus:10927</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1161</column>
            <column name="TargetName">Anti-influenza A H2N2 monoclonal antibody C179</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1162</column>
            <column name="TargetName">Anti-influenza A H1N1 monoclonal antibody IV.C102</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1163</column>
            <column name="TargetName">Anti-influenza A H3N2 polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1164</column>
            <column name="TargetName">SIV sera from patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1165</column>
            <column name="TargetName">C-X-C chemokine receptor type 1, CXCR-1</column>
            <column name="TargetSynonyms">CXC-R1
CDw128a
High affinity interleukin-8 receptor A, IL-8R A
IL-8 receptor type 1
CD_antigen=CD181</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P25024</column>
            <column name="TargetStructure">1ILP, 1ILQ, 2LNL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1166</column>
            <column name="TargetName">C-X-C chemokine receptor type 2, CXCR-2</column>
            <column name="TargetSynonyms">CXC-R2
CDw128b
GRO/MGSA receptor
High affinity interleukin-8 receptor B, IL-8R B
IL-8 receptor type 2
CD_antigen=CD182</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P25025</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1167</column>
            <column name="TargetName">Interleukin-8, IL-8</column>
            <column name="TargetSynonyms">C-X-C motif chemokine 8
Emoctakin
Granulocyte chemotactic protein 1, GCP-1
Monocyte-derived neutrophil chemotactic factor, MDNCF
Monocyte-derived neutrophil-activating peptide, MONAP
Neutrophil-activating protein 1, NAP-1
Protein 3-10C
T-cell chemotactic factor</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P10145</column>
            <column name="TargetStructure">1ICW, 1IKL, 1IKM, 1IL8, 1ILP, 1ILQ, 1QE6, 1ROD, 2IL8, 3IL8</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1168</column>
            <column name="TargetName">Prestin</column>
            <column name="TargetSynonyms">Solute carrier family 26 member 5</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q99NH7</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Prestin is a bidirectional voltage-to-force converter, it can operate at microsecond rates. It uses cytoplasmic anions as extrinsic voltage sensors, probably chloride and bicarbonate. After binding to a site with millimolar affinity, these anions are translocated across the membrane in response to changes in the transmembrane voltage. They move towards the extracellular surface following hyperpolarization, and towards the cytoplasmic side in response to depolarization. As a consequence, this translocation triggers conformational changes in the protein that ultimately alter its surface area in the plane of the plasma membrane.</column>
        </table>
        <table name="target">
            <column name="TargetID">1169</column>
            <column name="TargetName">Graphite flakes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1170</column>
            <column name="TargetName">Purified immunoglobulin G (IgG) from sera of knee OA patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1171</column>
            <column name="TargetName">Gadolinium  oxide  (GdO)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1172</column>
            <column name="TargetName">Anti-gp75 monoclonal antibody 5E7C</column>
            <column name="TargetSynonyms">Mab 5E7C</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1173</column>
            <column name="TargetName">Low-density lipoprotein receptor</column>
            <column name="TargetSynonyms">LDL receptor</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P01130</column>
            <column name="TargetStructure">1AJJ, 1D2J, 1F5Y, 1F8Z, 1HJ7, 1HZ8, 1I0U, 1IJQ, 1LDL, 1LDR, 1N7D, 1XFE, 2FCW, 2KRI, 2LGP, 2W2M, 2W2N, 2W2O, 2W2P, 2W2Q, 3BPS, 3GCW, 3GCX, 3M0C, 3P5B, 3P5C, 3SO6</column>
            <column name="TargetComments">LDL receptor binds LDL, the major cholesterol-carrying lipoprotein of plasma, and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. In case of HIV-1 infection, functions as a receptor for extracellular Tat in neurons, mediating its internalization in uninfected cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1174</column>
            <column name="TargetName">Fibrin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1175</column>
            <column name="TargetName">Soluble fibrin fragment DD(E)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Prepared as previously described. 13 DD(E) used in this study contained subunits of 61 kD and 72 kD, assigned to fragments E1 and E2 and present in a roughly 1:1 ratio, and 180 kD (fragment DD).</column>
        </table>
        <table name="target">
            <column name="TargetID">1176</column>
            <column name="TargetName">Anti-RPV-H monoclonal antibody C1</column>
            <column name="TargetSynonyms">Mab C1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-RPV-H C1 mAb derived from a hybridoma line was purified from cell culture supernatant using the ImmunoPure (G) IgG Purification Kit (Pierce) according to the manufacturer's instructions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1177</column>
            <column name="TargetName">Phosphocarrier protein HPr</column>
            <column name="TargetSynonyms">Histidine-containing protein
EC=2.7.11.-</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P0AA04</column>
            <column name="TargetStructure">1CM2, 1CM3, 1GGR, 1HDN, 1J6T, 1OPD, 1PFH, 1POH, 1VRC, 2JEL, 2LRK, 2LRL, 2XDF, 3CCD, 3EZA, 3EZB, 3EZE</column>
            <column name="TargetComments">General (non sugar-specific) component of the phosphoenolpyruvate-dependent sugar phosphotransferase system (sugar PTS). This major carbohydrate active-transport system catalyzes the phosphorylation of incoming sugar substrates concomitantly with their translocation across the cell membrane. The phosphoryl group from phosphoenolpyruvate (PEP) is transferred to the phosphoryl carrier protein HPr by enzyme I. Phospho-HPr then transfers it to the permease (enzymes II/III).</column>
        </table>
        <table name="target">
            <column name="TargetID">1178</column>
            <column name="TargetName">Human bone marrow-derived mesenchymal stem cell, hBMMSCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1179</column>
            <column name="TargetName">Whole Mycobacterium bovis cells, WCA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mycobacterium bovis:1765</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1180</column>
            <column name="TargetName">Ethanol-extracted Mycobacterium bovis cell surface antigens, EEA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mycobacterium bovis:1765</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1181</column>
            <column name="TargetName">Cell surface lipoprotein MPB83</column>
            <column name="TargetSynonyms">Lipoprotein p23</column>
            <column name="TargetSource">Mycobacterium bovis:1765</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0CAX7</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1182</column>
            <column name="TargetName">Anti-LPS monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The LPS antibody (Abcam, Cambridge, MA, CAT# ab35654) was a monoclonal antibody, which was produced by vaccinating mice with whole Escherichia coli O111B4J5 cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1183</column>
            <column name="TargetName">Transcriptional regulatory protein devR (dosR)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mycobacterium tuberculosis:1773</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P95193</column>
            <column name="TargetStructure">1ZLJ, 1ZLK, 3C3W, 3C57</column>
            <column name="TargetComments">DevR is a key regulator of the dormancy response in Mycobacterium tuberculosis (M. tb).</column>
        </table>
        <table name="target">
            <column name="TargetID">1184</column>
            <column name="TargetName">Thiamethoxam, TMX</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Thiamethoxam (TMX) is an organic solid.</column>
        </table>
        <table name="target">
            <column name="TargetID">1185</column>
            <column name="TargetName">Anti-SapA monoclonal antibody A2D5</column>
            <column name="TargetSynonyms">Mab A2D5</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1186</column>
            <column name="TargetName">Anti-MSP1a monoclonal antibody 15D2</column>
            <column name="TargetSynonyms">Mab 15D2</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1187</column>
            <column name="TargetName">Human corneal epithelial cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1188</column>
            <column name="TargetName">Thiacloprid</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Thiacloprid is an insecticide of the neonicotinoid class. Its mechanism of action involves disruption of the insect's nervous system by inhibiting nicotinic acetylcholine receptors.</column>
        </table>
        <table name="target">
            <column name="TargetID">1189</column>
            <column name="TargetName">Imidacloprid</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Imidacloprid is a systemic insecticide which acts as an insect neurotoxin and belongs to a class of chemicals called the neonicotinoids which act on the central nervous system of insects with much lower toxicity to mammals. The chemical works by interfering with the transmission of stimuli in the insect nervous system. Specifically, it causes a blockage in the nicotinergic neuronal pathway. This blockage leads to the accumulation of acetylcholine, an important neurotransmitter, resulting in the insect's paralysis, and eventually death. It is effective on contact and via stomach action.</column>
        </table>
        <table name="target">
            <column name="TargetID">1190</column>
            <column name="TargetName">Extracellular domain of human carbonic anhydrase IX</column>
            <column name="TargetSynonyms">Carbonic anhydrase 9 alternative name(s):
Carbonate dehydratase IX
Carbonic anhydrase IX, CA-IX, CAIX
Membrane antigen MN
P54/58N
Renal cell carcinoma-associated antigen G250, RCC-associated antigen G250
pMW1
EC=4.2.1.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q16790 [38-414]</column>
            <column name="TargetStructure">2HKF, 3IAI</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1191</column>
            <column name="TargetName">Anti-D2NS1 monoclonal antibody DB16-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1192</column>
            <column name="TargetName">CD133 extracellular fraction</column>
            <column name="TargetSynonyms">CD133 alternative name(s):
Prominin-1
Antigen AC133 homolog
Prominin-like protein 1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O54990 [418-434]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1193</column>
            <column name="TargetName">Porcine ear skin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (pig):9823</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1194</column>
            <column name="TargetName">Chitin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Chitin, a poly-β-1,4-N-acetylglucosamine (GlcNAc), is one of most abundant biopolymers in nature, because it is the main component of the exoskeleton of arthropods, such as insects, arachnids and crustaceans, and is a structural polysaccharide in fungal cell walls.</column>
        </table>
        <table name="target">
            <column name="TargetID">1195</column>
            <column name="TargetName">Type IV secretion system protein virB8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Brucella suis biovar 1 (strain 1330):204722</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q7CEG3</column>
            <column name="TargetStructure">2BHM, 4AKY, 4AKZ</column>
            <column name="TargetComments">The virB system could be required for the establishment of the replication niche in the host.</column>
        </table>
        <table name="target">
            <column name="TargetID">1196</column>
            <column name="TargetName">Major prion protein, PrP</column>
            <column name="TargetSynonyms">ASCR
PrP27-30
PrP33-35C
CD_antigen=CD230</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04156</column>
            <column name="TargetStructure">1E1G, 1E1J, 1E1P, 1E1S, 1E1U, 1E1W, 1FKC, 1FO7, 1H0L, 1HJM, 1HJN, 1I4M, 1OEH, 1OEI, 1QLX, 1QLZ, 1QM0, 1QM1, 1QM2, 1QM3, 2IV4, 2IV5, 2IV6, 2K1D, 2KUN, 2LBG, 2LEJ, 2LFT, 2LSB, 2LV1, 2OL9, 2W9E, 3HAF, 3HAK, 3HEQ, 3HER, 3HES, 3HJ5, 3HJX, 3MD4, 3MD5, 3NHC, 3NHD, 3NVF, 4DGI, 4E1H, 4E1I</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1197</column>
            <column name="TargetName">Human gastric cancer specimens</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1198</column>
            <column name="TargetName">Cardiac phospholamban, PLB</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P26678</column>
            <column name="TargetStructure">1PLP, 1ZLL, 2HYN</column>
            <column name="TargetComments">Phospholamban has been postulated to regulate the activity of the calcium pump of cardiac sarcoplasmic reticulum.</column>
        </table>
        <table name="target">
            <column name="TargetID">1199</column>
            <column name="TargetName">Human osteosarcoma MG-63 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1200</column>
            <column name="TargetName">72 kDa type IV collagenase</column>
            <column name="TargetSynonyms">72 kDa gelatinase
Gelatinase A
Matrix metalloproteinase-2, MMP-2
TBE-1
EC=3.4.24.24</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08253</column>
            <column name="TargetStructure">1CK7, 1CXW, 1EAK, 1GEN, 1GXD, 1HOV, 1J7M, 1KS0, 1QIB, 1RTG, 3AYU</column>
            <column name="TargetComments">Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture.</column>
        </table>
        <table name="target">
            <column name="TargetID">1201</column>
            <column name="TargetName">IgGs purified from equine sera</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IgGs were purified from a pool comprised of 20 sera from animals naturally infected with equine infectious anemia virus.</column>
        </table>
        <table name="target">
            <column name="TargetID">1202</column>
            <column name="TargetName">Caspase-6, CASP-6</column>
            <column name="TargetSynonyms">Apoptotic protease Mch-2
EC=3.4.22.59</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P55212</column>
            <column name="TargetStructure">2WDP, 3K7E, 3NKF, 3NR2, 3OD5, 3P45, 3P4U, 3QNW, 3S70, 3S8E, 3V6L, 3V6M, 4EJF, 4FXO, 4HVA</column>
            <column name="TargetComments">Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves poly(ADP-ribose) polymerase in vitro, as well as lamins. Overexpression promotes programmed cell death.</column>
        </table>
        <table name="target">
            <column name="TargetID">1203</column>
            <column name="TargetName">Anti-MgPa polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1204</column>
            <column name="TargetName">Anti-VSG LiTat 1.3 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1205</column>
            <column name="TargetName">Anti-VSG LiTat 1.5 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1206</column>
            <column name="TargetName">Oxygen-terminated sides of single-crystalline ZnO (000-1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1207</column>
            <column name="TargetName">Zinc-terminated sides of single-crystalline ZnO (0001)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1208</column>
            <column name="TargetName">Helicase, Hel</column>
            <column name="TargetSynonyms">Nsp10
EC=3.6.4.12
EC=3.6.4.13</column>
            <column name="TargetSource">Porcine reproductive and respiratory syndrome virus (isolate Pig/United States/SD 01-08/2001) (PRRSV):857306</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">A0MD28 [3021-3462]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1209</column>
            <column name="TargetName">RNA-directed RNA polymerase, Pol, RdRp</column>
            <column name="TargetSynonyms">Nsp9
EC=2.7.7.48</column>
            <column name="TargetSource">Porcine reproductive and respiratory syndrome virus (isolate Pig/United States/SD 01-08/2001) (PRRSV):857306</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">A0MD28 [2335-3020]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1210</column>
            <column name="TargetName">Zirconia</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1211</column>
            <column name="TargetName">Amorphous spherical silica particles (15 nm diameter)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1212</column>
            <column name="TargetName">Amorphous spherical silica particles (82 nm diameter)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1213</column>
            <column name="TargetName">Amorphous spherical silica particles (450 nm diameter)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1214</column>
            <column name="TargetName">Anti-MDA-LDL monoclonal antibody LR04</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">LRO4 is a monoclonal IgM Ab that was cloned from the spleens of cholesterol-fed Ldlr -/-mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">1215</column>
            <column name="TargetName">Anti-VACV A33  monoclonal antidbody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb-1G10 was initially characterized as an A33-binding monoclonal antibody that could provide partial protection in vivo against an intranasal VACV-WR challenge in a mouse model, as well as block EV spread in cell culture.</column>
        </table>
        <table name="target">
            <column name="TargetID">1216</column>
            <column name="TargetName">Protein tyrosine phosphatases(PTPRJ-His6)</column>
            <column name="TargetSynonyms">DEP-1
HPTP???</column>
            <column name="TargetSource">Homo sapiens (Human) :9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P23470</column>
            <column name="TargetStructure">2H4V, 2HY3, 2NLK, 2PBN, 3JXH, 3QCB, 3QCC, 3QCD, 3QCE, 3QCF, 3QCG, 3QCH, 3QCI, 3QCJ, 3QCK, 3QCL, 3QCM, 3QCN </column>
            <column name="TargetComments">PTPRJ (also named DEP-1, HPTPη, or CD148) is down-regulated in mammary cancer cells, and its restoration blocks their proliferation.</column>
        </table>
        <table name="target">
            <column name="TargetID">1217</column>
            <column name="TargetName">Tomato-stained cotton swatches</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The real target is carotenoid.</column>
        </table>
        <table name="target">
            <column name="TargetID">1218</column>
            <column name="TargetName">Paprika-stained cotton swatches</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The real target is carotenoid.</column>
        </table>
        <table name="target">
            <column name="TargetID">1219</column>
            <column name="TargetName">Lens epithelium-derived growth factor (LEDGF)/p75</column>
            <column name="TargetSynonyms">LEDGF</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q5XXA9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">LEDGF/p75 is a chromatin-associated protein that tethers the preintegration complex to the host chromatin through its direct interaction with IN thereby supporting HIV replication.</column>
        </table>
        <table name="target">
            <column name="TargetID">1220</column>
            <column name="TargetName">Platelet-derived growth factor receptor β (PDGFRβ)</column>
            <column name="TargetSynonyms">Beta platelet-derived growth factor receptor
Beta-type platelet-derived growth factor receptor
CD140 antigen-like family member B
Platelet-derived growth factor receptor 1
</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P09619</column>
            <column name="TargetStructure">1GQ5, 1H9O, 2L6W, 3MJG </column>
            <column name="TargetComments">The platelet-derived growth factor receptor β (PDGFRβ) is a transmembrane glycoprotein that belongs to the receptor tyrosine kinase family.</column>
        </table>
        <table name="target">
            <column name="TargetID">1221</column>
            <column name="TargetName">Mouse gut</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1222</column>
            <column name="TargetName">Human immunoglobulin G (hIgG)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human immunoglobulin G (hIgG),the second most abundant protein in human serum,is usually removed using Protein A or G.</column>
        </table>
        <table name="target">
            <column name="TargetID">1223</column>
            <column name="TargetName">CD59</column>
            <column name="TargetSynonyms">1F5 antigen
20 kDa homologous restriction factor
MAC-inhibitory protein
MEM43 antigen
Membrane attack complex inhibition factor
Membrane inhibitor of reactive lysis
Protectin
CD_antigen=CD59</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P13987</column>
            <column name="TargetStructure">1CDQ, 1CDR, 1CDS, 1ERG, 1ERH, 2J8B, 2OFS, 2UWR, 2UX2, 4BIK</column>
            <column name="TargetComments">CD59 is a Mr 18-20kDa protein and anchored through glycanphosphatidylinositol to the cell membrane.The mature form of the CD59 polypeptide is consisting of 77 amino acids starting with Leu and terminating with Asn.</column>
        </table>
        <table name="target">
            <column name="TargetID">1224</column>
            <column name="TargetName">Ganglioside GM2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1225</column>
            <column name="TargetName">Ganglioside GD1a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1226</column>
            <column name="TargetName">Interleukin-10 receptor subunit alpha (IL-10RA)</column>
            <column name="TargetSynonyms">CDw210a
Interleukin-10 receptor subunit 1
CD_antigen=CD210</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q13651</column>
            <column name="TargetStructure">1J7V, 1LQS, 1Y6K, 1Y6M, 1Y6N </column>
            <column name="TargetComments">Defects in IL10RA are the cause of inflammatory bowel disease type 28 (IBD28).</column>
        </table>
        <table name="target">
            <column name="TargetID">1227</column>
            <column name="TargetName">Staphylococcus aureus, S.aureus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Staphylococcus aureus is an opportunistic pathogen causing disease in humans and animals.It has been found as part of normal flora on human skin and mucosal surfaces and account for large proportion of nosocomial infections and community-acquired infections.</column>
        </table>
        <table name="target">
            <column name="TargetID">1228</column>
            <column name="TargetName">cAb29</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">cAb29 is a chimeric antibody that was selected
from a large panel of PA-neutralizing monoclonal antibodies.</column>
        </table>
        <table name="target">
            <column name="TargetID">1229</column>
            <column name="TargetName">Boron nitride nanospheres,NNS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">BN has the advantage of a high biocompatibility, with easier cellular uptake and lower toxicity than carbon.</column>
        </table>
        <table name="target">
            <column name="TargetID">1230</column>
            <column name="TargetName">Mouse retina</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1231</column>
            <column name="TargetName">Human bone</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1232</column>
            <column name="TargetName">Human marrow</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1233</column>
            <column name="TargetName">Human fat</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1234</column>
            <column name="TargetName">Human skeletal muscle</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1235</column>
            <column name="TargetName">Human prostate</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1236</column>
            <column name="TargetName">Human skin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1237</column>
            <column name="TargetName">Human multiple organs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1238</column>
            <column name="TargetName">Nd2O3 nanocrystals</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1239</column>
            <column name="TargetName">Human mammary carcinoma cell line SK-BR-3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1240</column>
            <column name="TargetName">Human Platele</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1241</column>
            <column name="TargetName">G protein β1γ1 subunits</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Spodoptera frugiperda (Sf):7108</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1242</column>
            <column name="TargetName">Sera from RA patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1243</column>
            <column name="TargetName">Anti-LeY antigen monoclonal antibody B3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1244</column>
            <column name="TargetName">Mouse lung</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1245</column>
            <column name="TargetName">Mouse skin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1246</column>
            <column name="TargetName">Mouse intestine</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1247</column>
            <column name="TargetName">Mouse uterus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1248</column>
            <column name="TargetName">Human dermal microvascular endothelial cells, HDMECs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1249</column>
            <column name="TargetName">Mouse adrenal gland</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1250</column>
            <column name="TargetName">NG2</column>
            <column name="TargetSynonyms">Chondroitin sulfate proteoglycan NG2
Proteoglycan AN2</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q8VHY0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NG2 is the rat homologue of the human melanoma proteoglycan,also known as the high molecular weight melanoma-associated antigen. </column>
        </table>
        <table name="target">
            <column name="TargetID">1251</column>
            <column name="TargetName">KIX domain of p300/CBP</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1252</column>
            <column name="TargetName">HNSCC cell line MDA167Tu </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1253</column>
            <column name="TargetName">Dysplastic skin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1254</column>
            <column name="TargetName">The human cell lines  16HBE14o-</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1255</column>
            <column name="TargetName">LOX-1</column>
            <column name="TargetSynonyms">Oxidized low-density lipoprotein receptor 1
Ox-LDL receptor 1
Lectin-like oxidized LDL receptor 1
Lectin-like oxLDL receptor 1
Lectin-type oxidized LDL receptor 1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090 </column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q9EQ09</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">LOX-1 is a receptor normally expressed at low levels exclusively on venous and arterial vascular endothelial cells but strongly upregulated in dysfunctional endothelium associated with hypertension and atherogenesis.</column>
        </table>
        <table name="target">
            <column name="TargetID">1256</column>
            <column name="TargetName">PMCA398 </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">PM Ca2+ pumps are encoded by four plasma membrane Ca2+-ATPase (PMCA) genes, and their transcripts can be alternatively spliced.The isoform PMCA1b is most widely expressed. The PM Ca2+ pump protein models show ten transmembrane and five extracellular domains. The second putative extracellular domain of PMCA1b in rabbit contains the residues 401-413 (KRPWLAECTPIYI. Including additional amino acids flanking this sequence, replacing serine for cysteine, and adding a cysteine at the COOH terminus, the peptide PMCA398 (WVQKRPWLAESTPIYIQYFVKC) was synthesized.</column>
        </table>
        <table name="target">
            <column name="TargetID">1257</column>
            <column name="TargetName">U87-MG glioma cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1258</column>
            <column name="TargetName">Human melanoma cell line MeWo</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1259</column>
            <column name="TargetName">Bacterial cell wall precursor lipid I </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Phage display screens made use of lipid I inspired targets in both natural and enantiomeric forms.First,by doing so the amount of chemical space explored in the screen is effectively doubled.Secondly,it was considered that L-peptides selected in the screen that possess high affinity for natural lipidI/II might in fact be toxic towards the E.coli used in the amplification step of the phage display experiment ,so using enantiomeric forms  was viewed as a way of avoiding any such negative selection bias.</column>
        </table>
        <table name="target">
            <column name="TargetID">1260</column>
            <column name="TargetName">Anti-CK 8/18 complex monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">K94 monoclonal antibody, a tumor-associated autoantibody purified from another B-cell hybridoma clone derived from a mouse model of HCC, was analyzed and identified as an anti-cytokeratin (CK) 8/18 complex antibody. </column>
        </table>
        <table name="target">
            <column name="TargetID">1261</column>
            <column name="TargetName">Eukaryotic initiation factor (eIF)4E</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">eIF4E initiates cap-dependent translation by binding to the cap structure found at the 59 end of mRNA. eIF4E is part of the large  eIF4F complex which includes other proteins such as eIF4G and eIF4A. eIF4F forms a complex with the 40S ribosomal subunit and eIF3, which then shuttles along the 59-untranslated region (59-UTR) of the mRNA until it arrives at the AUG initiation codon.</column>
        </table>
        <table name="target">
            <column name="TargetID">1262</column>
            <column name="TargetName">Karilysin catalytic domain, Kly18</column>
            <column name="TargetSynonyms">Karilysin protease</column>
            <column name="TargetSource">Bacteroides forsythus (Tannerella forsythensis):28112 </column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">D0EM77</column>
            <column name="TargetStructure">2XS3, 2XS4, 4IN9</column>
            <column name="TargetComments">Karilysin, a newly identified metalloprotease isolated from T. forsythia is secreted as a 472-residue protein and has the following composition; a 20-residue signal sequence, a 14-residue pro-peptide, an 18 kDa catalytic peptidase domain and a 30 kDa C-terminal domain of unknown function.</column>
        </table>
        <table name="target">
            <column name="TargetID">1263</column>
            <column name="TargetName">Calretinin, CR</column>
            <column name="TargetSynonyms">29 kDa calbindin</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P22676</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Calretinin (CR), a Ca+2-binding protein highly expressed in subpopulations of neurons in thebrain, inhibits CDI and enhances CDF by binding directly to α12.1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1264</column>
            <column name="TargetName">Human IgA, hIgA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IgA is secreted in the mucus as a dimer (secretory form of IgA) connected by a joining chain via intermolecular disulfide bridges, whereas the major form of IgA in plasma is monomeric. IgA has two subclasses: IgA1 and IgA2.</column>
        </table>
        <table name="target">
            <column name="TargetID">1265</column>
            <column name="TargetName">Unphosphorylated ERα LBD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).</column>
        </table>
        <table name="target">
            <column name="TargetID">1266</column>
            <column name="TargetName">Phosphorylated ERβ LBD, ERβ LBD-P</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).  ERβ LBD-P contained a phosphorylated Y488.</column>
        </table>
        <table name="target">
            <column name="TargetID">1267</column>
            <column name="TargetName">Phosphorylated ERα LBD, ERα LBD-P</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).  ERa LBD-P  contained  a phosphorylated Y537.</column>
        </table>
        <table name="target">
            <column name="TargetID">1268</column>
            <column name="TargetName">Unphosphorylated ERβ  LBD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The Estrogen Receptor (ER) belongs to the Nuclear Receptor (NR) superfamily of ligand-inducible transcription factors that bind to DNA response elements and cofactor proteins to control gene transcription. There are two ER isoforms, ERα and ERβ, which both bind estradiol as a natural ligand and share the multidomain features of NRs, which includes a C-terminal Ligand Binding Domain (LBD) with significant homology (60%).</column>
        </table>
        <table name="target">
            <column name="TargetID">1269</column>
            <column name="TargetName">Anti-PI-LPS monoclonal antibody 1E4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1270</column>
            <column name="TargetName">Bone marrow-derived dendritic cells, BMDCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1271</column>
            <column name="TargetName">Mouse liver</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1272</column>
            <column name="TargetName">Mouse spleen</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1273</column>
            <column name="TargetName">Mouse visceral adipose tissues</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1274</column>
            <column name="TargetName">DOX-SAM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Doxorubicin, a commonly used cancer chemotherapy agent, elicits several potent biological effects, including synergistic-antitumor activity in combination with cisplatin. A derivative of doxorubicin underinvestigation is synthesized to form a self-assembled monolayer (SAM).</column>
        </table>
        <table name="target">
            <column name="TargetID">1275</column>
            <column name="TargetName">Monoclonal antibody 6D10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1276</column>
            <column name="TargetName">IgG from human</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1277</column>
            <column name="TargetName">Anti-OmpU polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1278</column>
            <column name="TargetName">Male Sprague-Dawley (SD) mouse brain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1279</column>
            <column name="TargetName">cGP antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1280</column>
            <column name="TargetName">Mink enteritis virus, MEV</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mink enteritis virus (MEV) is the causative pathogen of mink viral gastroenteritis, an acute, violent, and highly contagious disease that causes violent diarrhea as the main clinical symptom.</column>
        </table>
        <table name="target">
            <column name="TargetID">1281</column>
            <column name="TargetName">Extracellular domain of human ErbB-2, ErbB-2-ECD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The erbB-2 proto-oncogene, also known as HER-2 or neu, is frequently altered in human cancers. This gene encodes an 185 kDa protein, denoted p185, which is also referred to as ErbB-2. ErbB-2 along with three other known homologous proteins, ErbB-1 (epidermal growth factor receptor, EGFR), ErbB-3, and ErbB-4, form the ErbB family or subclass I of receptor tyrosine kinases (RTKs). ErbB-2-ECD is the recombinant extracellular domain of human ErbB-2.</column>
        </table>
        <table name="target">
            <column name="TargetID">1282</column>
            <column name="TargetName">B-lymphocyte WI-L2 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1283</column>
            <column name="TargetName">The breast cancer cell line SKBR3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1284</column>
            <column name="TargetName">Anti-MRP1 monoclonal antibody MRPr1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1285</column>
            <column name="TargetName">Glutamate carboxypeptidase 2
EC=3.4.17.21</column>
            <column name="TargetSynonyms">Cell growth-inhibiting gene 27 protein
Folate hydrolase 1
Folylpoly-gamma-glutamate carboxypeptidase
FGCP
Glutamate carboxypeptidase II
GCPII
Membrane glutamate carboxypeptidase
mGCP
N-acetylated-alpha-linked acidic dipeptidase I
NAALADase I
Prostate-specific membrane antigen
PSM
PSMA
Pteroylpoly-gamma-glutamate carboxypeptidase</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q04609</column>
            <column name="TargetStructure">1Z8L?</column>
            <column name="TargetComments">There are high frequencies of prostate-specific membrane antigen (PSMA) overexpression in all stages and grades of PCa patients. PSMA is a 100-kDa transmembrane glycoprotein with folate hydrolase activity (hydrolysis of the terminal glutamates fromclinked polyglutamates) as well as NAALADase activity (hydrolysis of the terminal glutamate from the neuropeptide NAAG), which was found not only in normal prostate epithelium but also in the central nervous system and the proximal gastrointestinal tract.</column>
        </table>
        <table name="target">
            <column name="TargetID">1286</column>
            <column name="TargetName">Human adenocarcinoma lung cancer cell line A549</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1287</column>
            <column name="TargetName">Human colon cancer cell line HT29</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1288</column>
            <column name="TargetName">Anti-CD18 monoclonal antibody MHM23</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1289</column>
            <column name="TargetName">The  ECs injured by ox-LDL</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1290</column>
            <column name="TargetName">Tumor-related antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1291</column>
            <column name="TargetName">Human MTC-derived TT cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1292</column>
            <column name="TargetName">Human MTC xenografts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1293</column>
            <column name="TargetName">Nasopharyngeal carcinoma (NPC) cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1294</column>
            <column name="TargetName">PED3 domain of PMCA1b</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit): 9986</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The plasma membrane Ca2+ pump (PMCA) is a Ca2+-Mg2+-ATPase that expels Ca2+ from cells to help them maintain low concentrations of cytosolic Ca2+ ([Ca2+]i). It contains five putative extracellular domains (PEDs).</column>
        </table>
        <table name="target">
            <column name="TargetID">1295</column>
            <column name="TargetName">Prostate Carcinoma Cell Line DU-145</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1296</column>
            <column name="TargetName">Extracellular domain 1 of plasma membrane Ca2+-pump isoform 4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The plasma membrane Ca2+-pump is a protein with 10 transmembrane  domains, 5 putative extracellular domains and 3 major cytosolic domains.</column>
        </table>
        <table name="target">
            <column name="TargetID">1297</column>
            <column name="TargetName">The ECV304 cells injured by ox-LDL</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1298</column>
            <column name="TargetName">Medullary thyroid carcinoma, MTC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1299</column>
            <column name="TargetName">PED1 of PMCA4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1300</column>
            <column name="TargetName">B lymphocyte A20 cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1301</column>
            <column name="TargetName">C8161 xenograft tumors</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1302</column>
            <column name="TargetName">Human breast cancer tumor</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1303</column>
            <column name="TargetName">B16-F10 tumors</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1304</column>
            <column name="TargetName">PC-3 human prostate cancer cell xenografts</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1305</column>
            <column name="TargetName">Mouse PDAC cells </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1306</column>
            <column name="TargetName">Anti-protein monoclonal antibody BPM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1307</column>
            <column name="TargetName">Anti-protein monoclonal antibody BPA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1308</column>
            <column name="TargetName">Anti-uPAR monoclonal antibody IIIF10 </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown </column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1309</column>
            <column name="TargetName">Anti-huPENK monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1310</column>
            <column name="TargetName">Aminopeptidase N</column>
            <column name="TargetSynonyms">Myeloid plasma membrane glycoprotein CD13
Microsomal aminopeptidase
Alanyl aminopeptidase
Aminopeptidase M
CD_antigen
gp150
AP-M
CD13</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P15144</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1311</column>
            <column name="TargetName">CNS endothelial cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1312</column>
            <column name="TargetName">Lewis  lung  carcinoma  (LLC)  tumor cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1313</column>
            <column name="TargetName">Human factor H</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1314</column>
            <column name="TargetName">Human CD4+CD25+ thymic cells </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1315</column>
            <column name="TargetName">Monoclonal antibody TP25.99</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mouse mAb TP25.99 is among the few mAb reacting with both β2m-associated and β2 m-free HLA class I heavy chains.</column>
        </table>
        <table name="target">
            <column name="TargetID">1316</column>
            <column name="TargetName">THP-1 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1317</column>
            <column name="TargetName">The embryonic progenitor cell line W10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The embryonic progenitor cell line, W10, expresses markers such as transcription factor, heart and neural crest derivatives-expressed 2 (HAND2) and distal HOX genes such as HOXA4 and HOXB7.</column>
        </table>
        <table name="target">
            <column name="TargetID">1318</column>
            <column name="TargetName">Primary cultured chondrocytes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Primary cultured chondrocytes secrete a large number of matrix proteins in native conformation to provide a rich array of possible targets for peptide binding.</column>
        </table>
        <table name="target">
            <column name="TargetID">1319</column>
            <column name="TargetName">Anti-topo-I antibodies, pt4 anti-Ap1-17 Abs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-topo-I antibodies (Abs) are associated with more diffuse cutaneous involvement, pulmonary fibrosis, renal involvement and, possibly, higher disease severity.</column>
        </table>
        <table name="target">
            <column name="TargetID">1320</column>
            <column name="TargetName">The cell surface of E. coli</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC):199310</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1321</column>
            <column name="TargetName">Tumor necrosis factor alpha, TNF-α</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9UBM5</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Tumor necrosis factor alpha (TNF-α) is a proinflammatory cytokine produced in many inflammatory and autoimmune diseases. Mature TNF-α is secreted as a 157-amino acid form with a molecular weight of 17kDa. Before being released from cells, TNF-α is anchored in the plasma membrane as a 26 kDa precursor containing both hydrophobic and hydrophilic regions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1322</column>
            <column name="TargetName">VPAC1 receptor</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpressed in the most frequently occurring malignant tumors and plays a major role in the progression and angiogenesis of a number of malignancies.</column>
        </table>
        <table name="target">
            <column name="TargetID">1323</column>
            <column name="TargetName">Anti-CFP10-ESAT-6 (CE) pAbs </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1324</column>
            <column name="TargetName">U251 glioma cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1325</column>
            <column name="TargetName">Serine/threonine-protein kinase StkP</column>
            <column name="TargetSynonyms">Eukaryotic-type Ser/Thr protein kinase
ESTPK</column>
            <column name="TargetSource">Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4):170187</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q8KY50</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">StkP and its orthologous Ser/Thr kinases contain an intracellular kinase domain and four environmentally responsive extracellular PASTA domains, in crystallographic studies, to bind to the ß-lactam cefuroxime. It has been shown that the extracellular PASTA-containing domain of StkP binds to both chemically synthesized fragments of cell wall peptidoglycan and to ß-lactam antibiotics that mimic the terminal portions of the peptidoglycan pentapeptide moiety.</column>
        </table>
        <table name="target">
            <column name="TargetID">1326</column>
            <column name="TargetName">Prostate adenocarcinoma cells, PC-3 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1327</column>
            <column name="TargetName">Recombinant serotype D NTNHA, rNTNHA-D</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1328</column>
            <column name="TargetName">Anti-human KGF mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1329</column>
            <column name="TargetName">Anti-rabies virus IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1330</column>
            <column name="TargetName">Fibroblast growth factor 8, FGF-8</column>
            <column name="TargetSynonyms">Androgen-induced growth factor
AIGF
Heparin-binding growth factor 8
HBGF-8
</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P55075</column>
            <column name="TargetStructure">2FDB</column>
            <column name="TargetComments">FGF8 belongs to the fibroblast growth factor family of at least 23 members. Alternative splicing of the human FGF8 gene allows transcription of four different isoforms designated FGF8a, FGF8b, FGF8e, and FGF8f. FGF8b is the real target. It has also been found to have a strongly angiogenic and transforming potential in comparison to FGF8a and FGF8e. FGF8b is expressed and secreted by the epithelium, and it signals directionally to mesenchyme by binding FGFR3c, FGFR4, FGFR2c, or FGFR1c. </column>
        </table>
        <table name="target">
            <column name="TargetID">1331</column>
            <column name="TargetName">NEP1–35</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NEP1-35 (NH2-SFRIYKGVIQAIQKSDEGHPFRAYLE-SEVAISEEL-COOH) was synthesized. It contained 1–33 residues of Nogo-66, covering two putative regions pivotal for the affinity of Nogo-66 to NgR1, residues 1–10 (RIYKGVIQAI) and 30–33 (SEEL).</column>
        </table>
        <table name="target">
            <column name="TargetID">1332</column>
            <column name="TargetName">The human colon carcinoma Caco-2 cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1333</column>
            <column name="TargetName">Protein S100-B</column>
            <column name="TargetSynonyms">S-100 protein beta chain
S-100 protein subunit beta
S100 calcium-binding protein B</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04271</column>
            <column name="TargetStructure">1MQ1, 1UWO, 2H61, 2PRU, 3CZT, 3D0Y, 3D10, 3HCM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1334</column>
            <column name="TargetName">BetaC1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Cotton leaf curl Multan betasatellite:649192</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">C5ICF8</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The βC1 protein was expressed in prokaryotic system as 6XHis-bC1 fusion protein and recombinant protein showed size- and sequence-specific DNA binding activity.</column>
        </table>
        <table name="target">
            <column name="TargetID">1335</column>
            <column name="TargetName">Brz2001</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Brz2001 is a specific DWARF4 inhibitor in plant hormone brassinosteroid biosynthesis. Brz2001 belongs to the triazole series of compound that
shows low solubility in solvents, as represented by antifungal agents such as fluconazole.</column>
        </table>
        <table name="target">
            <column name="TargetID">1336</column>
            <column name="TargetName">Epoxy</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Epoxies are advanced thermosetting polymers, which exhibit excellent electrical, mechanical, and chemical properties for awide variety of applications as adhesives, protective coatings, electrical encapsulants, pharmaceuticals, etc.</column>
        </table>
        <table name="target">
            <column name="TargetID">1337</column>
            <column name="TargetName">Anti-IL1β(163-171) monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mouse MAb was obtained by immunization with an oligopeptide of sequence VQGEESNDKDK.</column>
        </table>
        <table name="target">
            <column name="TargetID">1338</column>
            <column name="TargetName">Anti-TcTS Abs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1339</column>
            <column name="TargetName">E. acerulina sporozoites</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1340</column>
            <column name="TargetName">Polyclonal RRi-11 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Macaca mulatta (Rhesus macaque):9544</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1341</column>
            <column name="TargetName">Polyclonal RTr-11 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Macaca mulatta (Rhesus macaque):9544</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">RTr-11 showed anamnestic cellular immune responses compatible with cryptic infection.</column>
        </table>
        <table name="target">
            <column name="TargetID">1342</column>
            <column name="TargetName">Glyphosate</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Glyphosate (N-(phosphonomethyl)glycine) is a herbicide that is used to kill weeds in farms, parks, and gardens. Glyphosate is toxic to plants because it can interfere with the synthesis of aromatic amino acids such as phenylalanine, tyrosine, and tryptophan by inhibiting the enzyme activity of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).</column>
        </table>
        <table name="target">
            <column name="TargetID">1343</column>
            <column name="TargetName">Crystalline cellulose
nanowhiskers, CNWs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1344</column>
            <column name="TargetName">Metuximab</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Metuximab is the generic name of HAb18, a mouse monoclonal antibody of IgG1 class. The hybridoma producing HAb18 was made from mice immunized with a cell suspension of fresh human hepatocellular carcinoma tissues.</column>
        </table>
        <table name="target">
            <column name="TargetID">1345</column>
            <column name="TargetName">Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4</column>
            <column name="TargetSynonyms">Parvulin-17
Par17</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q9Y237</column>
            <column name="TargetStructure">1EQ3, 1FJD, 3UI4, 3UI5, 3UI6</column>
            <column name="TargetComments">Par17 is expressed in all human tissues and cell lines examined so far and originates from alternative transcription initiation. Thus, Par17 is N-terminally extended by 25 amino acids when compared with Par14.</column>
        </table>
        <table name="target">
            <column name="TargetID">1346</column>
            <column name="TargetName">Par17-GST</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GST-tagged Par17 protein was expressed as follows. The Par17 nucleotide sequence was cloned in-frame into the expression vector pET41-PreSc. The construct was transformed into E. coli BL21 competent cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1347</column>
            <column name="TargetName">Anti-PAP sera sample 1, PAP1</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1348</column>
            <column name="TargetName">Anti-PAP sera sample 2, PAP2</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1349</column>
            <column name="TargetName">Anti-PAP sera sample 3, PAP3</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1350</column>
            <column name="TargetName">Anti-PAP sera sample 4, PAP4</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1351</column>
            <column name="TargetName">BT483 breast cancer cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Breast cancer cell line BT483 was obtained from the American Type Culture Collection. BT483 cells were grown in DMEM (Invitrogen) containing 20 mM L-glutamine.</column>
        </table>
        <table name="target">
            <column name="TargetID">1352</column>
            <column name="TargetName">Siliceous spicules</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Suberites domuncula (Sponge):55567</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1353</column>
            <column name="TargetName">Gamma-irradiated Salmonella spp.</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Salmonella, a genus belonging to the Enterobacteriaceae family, is comprised of two species, bongori and enterica. Salmonella enterica is further classified into six subspecies with over 2500 serovars currently known, of which 1531 are part of the subspecies enterica and are the causative agents of more than 99% of human Salmonellosis cases.</column>
        </table>
        <table name="target">
            <column name="TargetID">1354</column>
            <column name="TargetName">Monocyte-derived immature DCs (iDCs)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Dendritic cells (DCs) are key regulators of T- and B-cell immunity, owing to their superior ability to capture, process, and present antigens compared to other antigen-presenting cells (APCs).</column>
        </table>
        <table name="target">
            <column name="TargetID">1355</column>
            <column name="TargetName">Norwalk virus virus-like particles, NV VLPs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NV VLPs were expressed and purified as reported previously. Briefly, the VP1 and VP2 capsid proteins were expressed from a baculovirus vector in Sf9 insect cells and purified using a cesium chloride gradient. Proper VLP structure was confirmed by electron microscopy.</column>
        </table>
        <table name="target">
            <column name="TargetID">1356</column>
            <column name="TargetName">Appetite-regulating hormone</column>
            <column name="TargetSynonyms">Growth hormone secretagogue
Growth hormone-releasing peptide
Motilin-related peptide
Protein M46
</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9UBU3</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Ghrelin, an orexigenic peptide hormone, is predominantly produced in the enteroendocrine cells in the stomach and hypothalamus. Approximately 90 % of the total plasma ghrelin is in the form of pharmacologically inactive des-acyl ghrelin, while the active form, octanoyl ghrelin, comprises approximately 10 %. The active form of ghrelin is a peptide of 28 amino acids esterified at the Ser3 residue with an octanoic fatty acid. Octanoylation is catalysed by ghrelin-O-acyltransferase (GOAT).</column>
        </table>
        <table name="target">
            <column name="TargetID">1357</column>
            <column name="TargetName">Serum from AS patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1358</column>
            <column name="TargetName">Granulocytic myeloid-derived suppressor cells, granulocytic MDSCs</column>
            <column name="TargetSynonyms">Toll/interleukin-1 receptor-like protein 4
CD_antigen
CD282</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1359</column>
            <column name="TargetName">NSCLC tumor cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1360</column>
            <column name="TargetName">Anti-SFV FLAG mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1361</column>
            <column name="TargetName">Anti-SFV V2 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1362</column>
            <column name="TargetName">Anti-SFV V3 mVAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1363</column>
            <column name="TargetName">Anti-SFV V7 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1364</column>
            <column name="TargetName">Anti-SFV V8 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1365</column>
            <column name="TargetName">Anti-SFV V10 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1366</column>
            <column name="TargetName">Anti-SFV V11 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The hybridoma cell line which secretes monoclonal antibodies (MCAs) against swine fever virus (SFV) strain Brescia was produced. The hybrid cells resulted from fusion of P3X63-Ag8.653 myeloma cells with splenocytes of Balb/c mice which had been immunized with purified SFV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1367</column>
            <column name="TargetName">Neural stem cells, NSC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NSC are undifferentiated multipotent stem cells found in the subventricular and subgranular zones of the mammalian adult brain. NSC represent a good cell type for neuroregenerative purposes not only because of their ability to differentiate into neurons, astrocytes and oligodendrocytes in vitro but also because they do not show tumorigenic potentials upon transplantation in different animal models of neurodegenerative diseases. Moreover, the neural differentiation of NSC can be modulated by specific peptide sequences present in extracellular matrices, in soluble molecules and/or in membrane-bound cell molecules.</column>
        </table>
        <table name="target">
            <column name="TargetID">1368</column>
            <column name="TargetName">Diamond-like carbon, DLC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Diamond like carbon (DLC) is an amorphous carbon material that is used as an extremely wear-resistant coating material. DLC coatings are chemically stable, optically transparent and have good mechanical properties due to their hardness, low friction coefficient, high wear and corrosion resistance, and smoothness.</column>
        </table>
        <table name="target">
            <column name="TargetID">1369</column>
            <column name="TargetName">Anti-DENV2-NS1 pAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1370</column>
            <column name="TargetName">Vitamin B12-binding protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P37028</column>
            <column name="TargetStructure">1N2Z, 1N4A, 1N4D, 2QI9, 4DBL, 4FI3</column>
            <column name="TargetComments">Periplasmic binding protein BtuF is a bilobed 28 kDa protein. Its two globular domains are connected by a single rigid R-helix, characteristic of class III periplasmic binding proteins. The N-terminal domain of BtuF extends from residues 1 to 106, and the C-terminal domain includes residues 130-244 of the mature protein. Cyanocobalamin is bound in a cleft between the globular domains making contact with residues in both domains.</column>
        </table>
        <table name="target">
            <column name="TargetID">1371</column>
            <column name="TargetName">Anti-FhuA Fhu4.1 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1372</column>
            <column name="TargetName">Anti-FhuA Fhu6.4 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1373</column>
            <column name="TargetName">Anti-FhuA Fhu6.6 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1374</column>
            <column name="TargetName">Aminopeptidase N</column>
            <column name="TargetSynonyms">AP-N
pAPN
Alanyl aminopeptidase
Aminopeptidase M
AP-M
Microsomal aminopeptidase
gp130
CD_antigen=CD13
EC=3.4.11.2</column>
            <column name="TargetSource">Sus scrofa (Pig): 9823</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P15145</column>
            <column name="TargetStructure">4F5C, 4FKE, 4FKH, 4FKK, 4H5H, 4HOL, 4HOM </column>
            <column name="TargetComments">Porcine aminopeptidase N (pAPN) is a cellular receptor of transmissible gastroenteritis virus (TGEV), a porcine coronavirus. Interaction between the spike (S) protein of TGEV and pAPN initiates cell infection.</column>
        </table>
        <table name="target">
            <column name="TargetID">1375</column>
            <column name="TargetName">MDR GC cells SGC7901/ADR or SGC7901/VCR</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1376</column>
            <column name="TargetName">Pancreatic metastasis</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1377</column>
            <column name="TargetName">HTLA-230-derived primary tumor</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1378</column>
            <column name="TargetName">GI-LI-N-derived primary tumor</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1379</column>
            <column name="TargetName">Anti-NS2 4D4 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1380</column>
            <column name="TargetName">Pb2+</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1381</column>
            <column name="TargetName">Anti-blood group A  antigen monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">1JV5</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1382</column>
            <column name="TargetName">Anti-TTPI 4H11D10B11 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1383</column>
            <column name="TargetName">Spike glycoprotein</column>
            <column name="TargetSynonyms">S glycoprotein
Peplomer protein
E2</column>
            <column name="TargetSource">Human SARS coronavirus (SARS-CoV) (Severe acute respiratory syndrome coronavirus):227859</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P59594</column>
            <column name="TargetStructure">1WNC, 1WYY, 1ZV7, 1ZV8, 1ZVB, 2AJF, 2BEQ, 2BEZ, 2DD8, 2FXP, 2GHV, 2GHW, 3BGF, 3D0G, 3D0H, 3D0I, 3SCI, 3SCJ, 3SCK, 3SCL</column>
            <column name="TargetComments">Spike glycoprotein cleaves into two proteins: S1 and S2. Spike protein S1 attaches the virion to the cell membrane by interacting with human ACE2 and CLEC4M/DC-SIGNR, initiating the infection. And spike protein S1 is used as the target in the panning.</column>
        </table>
        <table name="target">
            <column name="TargetID">1384</column>
            <column name="TargetName">Anti-CsdA A3G5 mAb</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1385</column>
            <column name="TargetName">Toll-like receptor 2</column>
            <column name="TargetSynonyms">Toll/interleukin-1 receptor-like protein 4
CD_antigen=CD282</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">O60603</column>
            <column name="TargetStructure">1FYW, 1FYX, 1O77, 2Z7X, 2Z80</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1386</column>
            <column name="TargetName">MD-2 mimic peptide, NH2-FSKGKYKCV-COOH</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The sequence of MD-2 from the report of Shimazu et al (NCBI sequence, BAA78717) was used in the study. MD-2 mimic peptides were synthesized.</column>
        </table>
        <table name="target">
            <column name="TargetID">1387</column>
            <column name="TargetName">Listeria monocytogenes serotype 4b</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">NCTC 4885</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Listeria monocytogenes is one of six species within the Listeriagenus. It is Gram positive, facultative anaerobic, non-spore-forming, rod-shaped bacteria 0.5 µm in width and 1-1.5 µm in length.</column>
        </table>
        <table name="target">
            <column name="TargetID">1388</column>
            <column name="TargetName">Amyloid β peptide, Aβ40</column>
            <column name="TargetSynonyms">ABPP
APPI
APP
Alzheimer disease amyloid protein
Cerebral vascular amyloid peptide
CVAP
PreA4
Protease nexin-II
PN-II</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">P05067</column>
            <column name="TargetStructure">1AAP, 1AMB, 1AMC, 1AML, 1BA4, 1BA6, 1BJB, 1BJC, 1BRC, 1CA0, 1HZ3, 1IYT, 1MWP, 1OWT, 1QCM, 1QWP, 1QXC, 1QYT, 1TAW, 1TKN, 1X11, 1Z0Q, 1ZE7, 1ZE9, 1ZJD, 2BEG, 2BP4, 2FJZ, 2FK1, 2FK2, 2FK3, 2FKL, 2FMA, 2G47, 2IPU, 2LFM, 2LLM, 2LMN, 2LMO, 2LMP, 2LMQ, 2LNQ, 2LOH, 2LP1, 2LZ3, 2LZ4, 2M4J, 2M9R, 2M9S, 2OTK, 2R0W, 2WK3, 2Y29, 2Y2A, 2Y3J, 2Y3K, 2Y3L, 3AYU, 3DXC, 3DXD, 3DXE, 3GCI, 3IFL, 3IFN, 3IFO, 3IFP, 3JTI, 3KTM, 3L33, 3L81, 3MOQ, 3MXC, 3MXY, 3NYJ, 3NYL, 3OVJ, 3OW9, 3SV1, 3U0T, 3UMH, 3UMI, 3UMK, 4HIX</column>
            <column name="TargetComments">The primary agent of neurodegeneration is a peptide of 39–43 amino acid residues known as amyloid peptide (Aβ). The majority of secreted Aβ is 40 amino acids long (Aβ40).</column>
        </table>
        <table name="target">
            <column name="TargetID">1389</column>
            <column name="TargetName">Transforming growth factor beta-1, TGF-beta-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01137</column>
            <column name="TargetStructure">1KLA, 1KLC, 1KLD, 3KFD</column>
            <column name="TargetComments">Transforming growth factor beta (TGFβ) belongs to a family of regulatory cytokines. Among them, isoforms TGFβ1, TGFβ2 and TGFβ3 participate in a large number of biological processes such as cell proliferation, embryonic development, immune-modulation, angiogenesis, tumorogenesis, and balance between cell mass and extracellular matrix.</column>
        </table>
        <table name="target">
            <column name="TargetID">1390</column>
            <column name="TargetName">Anti- FASN monoclonal antibody K1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Splenocytes from H-ras12V transgenic mice at about 10 months old were used for the construction of B-cell hybridoma cell pool producing tumor-associated autoantibodies. Cell fusion and selection of B-cell hybridoma were performed. The reactivity of antibodies produced by these B-cell clones was determined by intracellular staining of HepG2 or Hepa-1c1c7 cells with each autoantibody, followed by flow cytometric analysis as described below. The isotypes of each autoantibody were determined using an isotyping kit (Pierce). For preparation of K1 autoantibody, ascites fluid was produced and antibody was purified using protein L-agarose (Pierce).</column>
        </table>
        <table name="target">
            <column name="TargetID">1391</column>
            <column name="TargetName">Anti-PCV2 Cap polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Sus scrofa (Pig):9823</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Affinity-purified Cap-specific polyclonal antibodies served as ligands in this research to increase specificity and efficiency for the selection, and were produced from blood samples collected from swine of different ages (piglets, finishing pigs and sows) and of diverse health status (with subclinical or silent infections) at a PCV2-infected pig farm in Hunan province.</column>
        </table>
        <table name="target">
            <column name="TargetID">1392</column>
            <column name="TargetName">Rat mesenchymal stem cells, rMSCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116 </column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1393</column>
            <column name="TargetName">M2 macrophages</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1394</column>
            <column name="TargetName">Bacteriorhodopsin, BR</column>
            <column name="TargetSynonyms">Bacterioopsin
BO</column>
            <column name="TargetSource">Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) (Halobacterium halobium):64091</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">P02945</column>
            <column name="TargetStructure">1AP9, 1AT9, 1BCT, 1BHA, 1BHB, 1BM1, 1BRD, 1BRR, 1BRX, 1C3W, 1C8R, 1C8S, 1CWQ, 1DZE, 1E0P, 1F4Z, 1F50, 1FBB, 1FBK, 1IW6, 1IW9, 1IXF, 1JV6, 1JV7, 1KG8, 1KG9, 1KGB, 1KME, 1L0M, 1M0K, 1M0L, 1M0M, 1MGY, 1O0A, 1P8H, 1P8I, 1P8U, 1PXR, 1PXS, 1PY6, 1Q5I, 1Q5J, 1QHJ, 1QKO, 1QKP, 1QM8, 1R2N, 1R84, 1S51, 1S52, 1S53, 1S54, 1S8J, 1S8L, 1TN0, 1TN5, 1UCQ, 1VJM, 1X0I, 1X0K, 1X0S, 1XJI, 2AT9, 2BRD, 2I1X, 2I20, 2I21, 2NTU, 2NTW, 2WJK, 2WJL, 2ZFE, 2ZZL, 3COC, 3COD, 3HAN, 3HAO, 3HAP, 3HAQ, 3HAR, 3HAS, 3MBV, 3NS0, 3NSB, 3T45, 3UTV, 3UTW, 3UTX, 3UTY, 3VHZ, 3VI0, 4FPD, 4HWL, 4HYX</column>
            <column name="TargetComments">Just like GPCRs, which form the largest family of drug targets, BR possesses seven transmembrane helices connected by small loops. BR is also well characterized concerning its spectroscopic and biophysical properties. In previous works by Bayburt and his coworkers it was shown that BR can be assembled into nanodiscs in monomeric and oligomeric forms.</column>
        </table>
        <table name="target">
            <column name="TargetID">1395</column>
            <column name="TargetName">Nanodiscs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Nanodiscs are nanometer-sized phospholipid bilayers encircled by two copies of an amphipathicahelical protein, called membrane scaffold protein (MSP).</column>
        </table>
        <table name="target">
            <column name="TargetID">1396</column>
            <column name="TargetName">Membrane protein, M protein</column>
            <column name="TargetSynonyms">E1 glycoprotein
Matrix glycoprotein
Membrane glycoprotein</column>
            <column name="TargetSource">Porcine transmissible gastroenteritis coronavirus (strain Purdue) (TGEV):11151</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P04135</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The virus responsible for TGE (TGEV) has a glycoprotein surface envelope and positive-sense RNA genome of approximately 28.5 kb. The virus consists of four structural proteins: spike (S), small membrane (sM or E), membrane (M), and nucleocapsid (N) proteins. The M protein is the most abundant component of the coronavirus particle.</column>
        </table>
        <table name="target">
            <column name="TargetID">1397</column>
            <column name="TargetName">Protein-glutamine gamma-glutamyltransferase Z</column>
            <column name="TargetSynonyms">Transglutaminase Z
TG(Z)
TGZ
TGase Z
EC=2.3.2.13
Transglutaminase-7
TGase-7</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q96PF1</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Transglutaminases (TGs: E.C. 2.3.2.13) are an enzyme family comprising of eight members: FXIII and TG1-TG7. These enzymes catalyze cross-linking reactions via formation of an isopeptide bond between a peptide-bound glutamine and lysine residues, in a calcium-dependent manner. TGZ has been found in the skin epidermis.</column>
        </table>
        <table name="target">
            <column name="TargetID">1398</column>
            <column name="TargetName">Anti-SMN monoclonal antibody MANSMA1-21</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Monoclonal antibodies (MANSMA1-21) were produced by immunization of BALB/c mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">1399</column>
            <column name="TargetName">Bevacizumab (Avastin)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Bevacizumab (Avastin), which is a humanized monoclonal antibody that binds VEGF, has been approved for the treatment of cancer.</column>
        </table>
        <table name="target">
            <column name="TargetID">1400</column>
            <column name="TargetName">U-CLL mAb068</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:45439529</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL068's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 068 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1401</column>
            <column name="TargetName">M-CLL mAb169</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:215982737</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL169's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 169 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1402</column>
            <column name="TargetName">M-CLL mAb183 </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:3004685</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL183's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 183 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1403</column>
            <column name="TargetName">M-CLL mAb255</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:215982713</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL255's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 255 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1404</column>
            <column name="TargetName">M-CLL mAb412</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:45439545</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL412's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of M-CLL 412 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1405</column>
            <column name="TargetName">U-CLL mAb014</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:3004691</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL014's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 014 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1406</column>
            <column name="TargetName">U-CLL mAb114</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence"> GI:30407981</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL114's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 114 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1407</column>
            <column name="TargetName">U-CLL mAb270</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">GI:19848551</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In brief, ribonucleic acid (RNA) from  patient CLL270's blood mononuclear cells was reverse-transcribed into cDNA. The variable segments of rearranged immunoglobulin heavy (IGH) and immunoglobulin light (IGL) of U-CLL 270 were expressed as human IgG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1408</column>
            <column name="TargetName">Atherosclerotic plaques</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Carotid plaques used for panning were classified as AHA 5B/C (plaque with calcification and low lipid levels) and 5A (plaque with fibrous cap).</column>
        </table>
        <table name="target">
            <column name="TargetID">1409</column>
            <column name="TargetName">Ovarian cancer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1410</column>
            <column name="TargetName">Anti-Efb-C polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1411</column>
            <column name="TargetName">Ceramic fluorapatite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Ceramic fluorapatite (40μm particle size,600-800 Å pore size) was obtained from BioRad Laboratories (Hercules, California, USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1412</column>
            <column name="TargetName">Palladium powder</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1413</column>
            <column name="TargetName">Serine protease 29</column>
            <column name="TargetSynonyms">Implantation serine proteinase 2
ISP-2
Strypsin-2
Strypsin-related protein
Tryptase-like proteinase</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q99MS4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Implantation serine proteinase 2 (ISP2), a S1 family serine proteinase, is known for its role in the critical processes of embryo hatching and implantation in the mouse uterus.</column>
        </table>
        <table name="target">
            <column name="TargetID">1414</column>
            <column name="TargetName">Tumor necrosis factor receptor superfamily member 5</column>
            <column name="TargetSynonyms">B-cell surface antigen CD40
Bp50
CD40L receptor
CDw40
CD40</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P25942</column>
            <column name="TargetStructure">1CZZ, 1D00, 1FLL, 1LB6, 3QD6</column>
            <column name="TargetComments">The CD40/CD40L dyad is deemed to play a central role in several inflammatory processes, including atherosclerosis. As CD40 is overexpressed in atherosclerotic lesions, it constitutes a promising candidate for targeted imaging approaches.</column>
        </table>
        <table name="target">
            <column name="TargetID">1415</column>
            <column name="TargetName">Replication initiator protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Indian mungbean yellow mosaic virus:88774</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q91SC1</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The major player in geminiviral replication is a viralencoded factor, the replication initiator protein (Rep), which creates a site-specific nick in the conserved nonanucleotide sequence TAATATTa</column>
        </table>
        <table name="target">
            <column name="TargetID">1416</column>
            <column name="TargetName">Mast cell protease 4, mMCP-4</column>
            <column name="TargetSynonyms">EC=3.4.21.-
Mast cell protease IV
rMCP-IV</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P97592</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1417</column>
            <column name="TargetName">Thrombopoietin receptor, TPO-R</column>
            <column name="TargetSynonyms">Myeloproliferative leukemia protein
Proto-oncogene c-Mpl
CD_antigen=CD110</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P40238</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1418</column>
            <column name="TargetName">Anti-E-3-G monoclonal antibody 41551</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MAb41551 is a murine IgG1 antibody raised against E-3-G. It was prepared by conventional hybridoma technology.</column>
        </table>
        <table name="target">
            <column name="TargetID">1419</column>
            <column name="TargetName">Anti-MUC1 monoclonal antibody C595</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The murine anti-MUC1 monoclonal antibody  C595 (IgG3 subclass) was originally prepared by conventional hybridoma technology using spleen.</column>
        </table>
        <table name="target">
            <column name="TargetID">1420</column>
            <column name="TargetName">Gamma-gliadin and alpha/beta-gliadin</column>
            <column name="TargetSynonyms">Gliadin B-III
Prolamin</column>
            <column name="TargetSource">Triticum aestivum (Wheat):4565</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Gamma-gliadin: P04730, Alpha/beta-gliadin: P02863</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1421</column>
            <column name="TargetName">Anti-rTs-Pmy-N monoclonal antibody 8F12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-rTs-Pmy-N mAb 8F12 was established by using the conventional hybridoma technique. The mAb 8F12 isotype was determined to be IgG1κ.  Western blot analysis revealed that 8F12 not only recognized rTs-Pmy-N  (40 kDa) but also recognized the native Ts-Pmy (110 kDa) in crude somatic extracts of  T. spiralis adult worms, newborn larvae (NBL) and\r\nML.</column>
        </table>
        <table name="target">
            <column name="TargetID">1422</column>
            <column name="TargetName">FGFR-expressing Balb/c 3T3 cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Actually the real target is fibroblast growth factor receptor (FGFR).</column>
        </table>
        <table name="target">
            <column name="TargetID">1423</column>
            <column name="TargetName">Anti-SAH monoclonal antibody ab111903</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-SAH rabbit MAb (ab111903) was purchased from Abcam (Cambridge, MA, USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1424</column>
            <column name="TargetName">MA026</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MA026, a novel lipocyclodepsipeptide isolated from the fermentation broth of Pseudomonas sp. RtIB026, consists of a cyclodepsipeptide, a chain peptide, and an N-terminal (R)-3-hydroxydecanoic acid. The first subunit, side chain 2, was prepared by coupling fatty acid moiety 4 with tripeptide 5.</column>
        </table>
        <table name="target">
            <column name="TargetID">1425</column>
            <column name="TargetName">Mycobacterium Dleu/Dpan strain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mycobacterium Dleu/Dpan strain was used as a model target because it is easy to manipulate, as it can be grown outside a biosafety level 3 laboratory.</column>
        </table>
        <table name="target">
            <column name="TargetID">1426</column>
            <column name="TargetName">Ephrin type-A receptor 4</column>
            <column name="TargetSynonyms">EC=2.7.10.1
Tyrosine-protein kinase receptor MPK-3
Tyrosine-protein kinase receptor SEK-1</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q03137</column>
            <column name="TargetStructure">1B0X, 2HEL, 2XYU, 2Y6M, 2Y6O</column>
            <column name="TargetComments">The EphA4 receptor is expressed in neurons, where it promotes the repulsive guidance of developing axons. EphA4 receptor binds to both type A ephrins and most type B ephrins, but it also forms a hetero receptor complex with fibroblast growth factor receptor (FGFR). </column>
        </table>
        <table name="target">
            <column name="TargetID">1427</column>
            <column name="TargetName">HIV-1 CDC451 gp120</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Recombinant gp120 CDC451 protein was purchased from Advanced BioScience Labs, MA, USA.</column>
        </table>
        <table name="target">
            <column name="TargetID">1428</column>
            <column name="TargetName">Four- to five-week-old mdx mice heart</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1429</column>
            <column name="TargetName">Four- to five-week-old mdx mice muscle</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1430</column>
            <column name="TargetName">Mixtures of 13 anti-dystrophin monoclonal antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1431</column>
            <column name="TargetName">IgE of the peanut allergic patient no. 2205</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1432</column>
            <column name="TargetName">IgE of the peanut allergic patient no. 2208</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1433</column>
            <column name="TargetName">IgE of the peanut allergic patient no. 2209</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1434</column>
            <column name="TargetName">IgE of the peanut allergic patient no. 2304</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1435</column>
            <column name="TargetName">IgE of the peanut allergic patient no. 2305</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1436</column>
            <column name="TargetName">IgE of animal nr. 19</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1437</column>
            <column name="TargetName">IgE of animal nr. 49</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1438</column>
            <column name="TargetName">IgE of animal nr. 52</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1439</column>
            <column name="TargetName">IgE of animal nr. 53</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1440</column>
            <column name="TargetName">IgE of animal nr. 54</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1441</column>
            <column name="TargetName">Interferon-induced, double-stranded RNA-activated protein kinase</column>
            <column name="TargetSynonyms">EC=2.7.11.1
Eukaryotic translation initiation factor 2-alpha kinase 2
eIF-2A protein kinase 2
Interferon-inducible RNA-dependent protein kinase
P1/eIF-2A protein kinase
Protein kinase RNA-activated
PKR
Tyrosine-protein kinase EIF2AK2
EC=2.7.10.2
p68 kinase</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P19525</column>
            <column name="TargetStructure">1QU6, 2A19, 2A1A, 3UIU</column>
            <column name="TargetComments">Double-stranded RNA-dependent protein kinase (PKR, EC 2.7.11.1) is one of the best-characterized kinases. Structurally , PKR has two functional domains: an Nterminal double-stranded RNA (dsRNA)-binding regulatory domain and a C-terminal kinase catalytic domain. In the catalytic domain (a.a. 251-551) of PKR (named PKRcat), K296 acts as the binding site for ATP, and mutation of K296 (K296R) has a dominant negative effect on the ability of PKR to phosphorylate eIF2α.</column>
        </table>
        <table name="target">
            <column name="TargetID">1442</column>
            <column name="TargetName">Cyclosporin A, CsA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">CsA is a natural compound showing multiple biological activities, including an immunosuppressive function, anti-chaperone activity, inhibition of transporter activity and antiviral activity against human immunodeficiency virus and HCV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1443</column>
            <column name="TargetName">Serum of dogs with VL</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (Dog) (Canis lupus familiaris):9615</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The blood serum samples from animals with CVL were selected on the basis of two serological tests (IFAT [IFATLVC Bio-Manguinhos kit] and ELISA [EIE-LVC Bio-Manguinhos kit], both from Bio-Manguinhos, Fiocruz, Brazil) for Leishmania spp. Animals with an IFAT titer of &gt; 1:40 and an ELISA value over the cutoff were considered to be seropositive.</column>
        </table>
        <table name="target">
            <column name="TargetID">1444</column>
            <column name="TargetName">Anti-BDE47 monoclonal antibody 1H2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1445</column>
            <column name="TargetName">Mab 1H2-BDE47 immunocomplex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1446</column>
            <column name="TargetName">BDE47-polyclonal antibody immunocomplex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1447</column>
            <column name="TargetName">Proprotein convertase subtilisin/kexin type 9, PCSK9</column>
            <column name="TargetSynonyms">EC=3.4.21.-
Neural apoptosis-regulated convertase 1
NARC-1
Proprotein convertase 9
PC9
Subtilisin/kexin-like protease PC9</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q8NBP7</column>
            <column name="TargetStructure">2P4E, 2PMW, 2QTW, 2W2M, 2W2N, 2W2O, 2W2P, 2W2Q, 2XTJ, 3BPS, 3GCW, 3GCX, 3H42, 3M0C, 3P5B, 3P5C, 3SQO, 4K8R, 4NMX</column>
            <column name="TargetComments">PCSK9 is an ideal antibody target because it circulates in blood and has only modest binding affinity to cell surface LDL receptor and its main interaction site is an exposed 500-Å2 slightly convex region that is readily available for antibody binding.</column>
        </table>
        <table name="target">
            <column name="TargetID">1448</column>
            <column name="TargetName">Bovine insulin-Like growth factor-binding protein 2, bIGFbp-2</column>
            <column name="TargetSynonyms">IBP-2
IGF-binding protein 2
IGFBP-2</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P13384</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1449</column>
            <column name="TargetName">Death-associated protein kinase 1</column>
            <column name="TargetSynonyms">DAP kinase 1
EC=2.7.11.1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P53355</column>
            <column name="TargetStructure">1IG1, 1JKK, 1JKL, 1JKS, 1JKT, 1P4F, 1WVW, 1WVX, 1WVY, 1YR5, 2W4J, 2W4K, 2X0G, 2XUU, 2XZS, 2Y0A, 2Y4P, 2Y4V, 2YAK, 3DFC, 3DGK, 3EH9, 3EHA, 3F5G, 3F5U, 3GU4, 3GU5, 3GU6, 3GU7, 3GU8, 3GUB, 3ZXT, 4B4L, 4PF4</column>
            <column name="TargetComments">At the biochemical level DAPK-1 is composed of several functional domains, including its kinase domain, ankyrin repeat domain, calmodulin binding domain, and death domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">1450</column>
            <column name="TargetName">Globotriaosylceramide, Gb3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Globotriaosylceramide (Gb3) was purchased from Matreya LLC (Pleasant Gap, PA, USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1451</column>
            <column name="TargetName">The Domain III of the Japan Encephalitis Virus Envelope Protein, E DIII</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Japanese encephalitis virus:11072</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">1PJW</column>
            <column name="TargetComments">Japanese encephalitis virus (JEV) is a major cause of acute viral encephalitis in both humans and animals. Domain III of the virus envelope glycoprotein (E DIII) plays an important role in the interaction of viral particles with host cell receptors to facilitate viral entry. In addition, DIII has been proposed to act as the binding region for the cellular receptor.</column>
        </table>
        <table name="target">
            <column name="TargetID">1452</column>
            <column name="TargetName">BCR/ABL-expressing NIH3T3 mouse fibroblast cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1453</column>
            <column name="TargetName">Amorphous Ni3B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1454</column>
            <column name="TargetName">Crystalline Ni3B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1455</column>
            <column name="TargetName">Fibroblast growth factor 1, FGF-1</column>
            <column name="TargetSynonyms">Acidic fibroblast growth factor
aFGF
Endothelial cell growth factor
ECGF
Heparin-binding growth factor 1
HBGF-1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P05230</column>
            <column name="TargetStructure">1AXM, 1DJS ,1DZC ,1DZD ,1E0O ,1EVT ,1HKN ,1JQZ ,1JT3 ,1JT4 ,1JT5 ,1JT7 ,1JTC ,1JY0 ,1K5U ,1K5V ,1M16 ,1NZK ,1P63 ,1PZZ ,1Q03 ,1Q04 ,1RG8 ,1RML ,1RY7 ,1YTO ,1Z2V ,1Z4S ,2AFG ,2AQZ ,2AXM ,2ERM ,2HW9 ,2HWA ,2HWM ,2HZ9 ,2K43 ,2K4A ,2K8R ,2KI4 ,2KI6 ,2LDN ,2NTD ,2Q9X ,2RQ9 ,3B9U ,3BA4 ,3BA5 ,3BA7 ,3BAD ,3BAG ,3BAH ,3BAO ,3BAQ ,3BAU ,3BAV ,3BB2 ,3CQA ,3CRG ,3CRH ,3CRI ,3CU1 ,3FGM ,3FJ8 ,3FJ9 ,3FJA ,3FJB ,3FJC ,3FJD ,3FJE ,3FJF ,3FJH ,3FJI ,3FJJ ,3FJK ,3HOM ,3JUT ,3K1X ,3O3Q ,3OJ2 ,3OJM ,3OJV ,3UD7 ,3UD8 ,3UD9 ,3UDA ,4J23</column>
            <column name="TargetComments">Acidic fibroblast growth factor (aFGF) is a member of the fibroblast growth factor family, originally isolated as mitogens for fibroblasts from the brain and pituitary. AFGF executes its pleiotropic biological actions by binding, dimerizing, and activating cell surface FGF receptors (FGFRs). The extra-cellular ligand-binding portion of FGFRs is composed of three immunoglobulin-like (Ig-like) domains (D1-D3). The crystal structure of the ectodomain of the FGFR complex with FGF demonstrated that the ligand-binding domain of FGFR involves Ig-like domains II and III (D2 and D3, respectively), as well as the linker between D2 and D3.</column>
        </table>
        <table name="target">
            <column name="TargetID">1456</column>
            <column name="TargetName">Mixture of murine melanoma cell lines B16.F1 and B16.F10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1457</column>
            <column name="TargetName">Calcium silicate hydrate 0.66, C-S-H 0.66</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</column>
        </table>
        <table name="target">
            <column name="TargetID">1458</column>
            <column name="TargetName">Calcium silicate hydrate 1.0, C-S-H 1.0</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</column>
        </table>
        <table name="target">
            <column name="TargetID">1459</column>
            <column name="TargetName">Calcium silicate hydrate 1.5, C-S-H 1.5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</column>
        </table>
        <table name="target">
            <column name="TargetID">1460</column>
            <column name="TargetName">Calcium silicate hydrate 1.7, C-S-H 1.7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix.</column>
        </table>
        <table name="target">
            <column name="TargetID">1461</column>
            <column name="TargetName">Salivary  pellicle</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In the oral cavity, the salivary proteins and peptides are selectively adsorbed to the enamel surface to form a us film called the acquired salivary pellicle. This pellicle is composed of peptides and (glycosylated) proteins, such as statherin, histatins, proline-rich proteins and mucins.</column>
        </table>
        <table name="target">
            <column name="TargetID">1462</column>
            <column name="TargetName">Human umbilical vein endothelial cells, HUVECs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1463</column>
            <column name="TargetName">IGVH1 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1464</column>
            <column name="TargetName">IGVH3 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1465</column>
            <column name="TargetName">IGVH4 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1466</column>
            <column name="TargetName">IGVH6 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1467</column>
            <column name="TargetName">IGVK1 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1468</column>
            <column name="TargetName">IGVK2 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1469</column>
            <column name="TargetName">IGVK3 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1470</column>
            <column name="TargetName">IGVK4 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1471</column>
            <column name="TargetName">IGVK5 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1472</column>
            <column name="TargetName">IGVK6 template protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1473</column>
            <column name="TargetName">Ephrin type-A receptor 2</column>
            <column name="TargetSynonyms">EC=2.7.10.1
Epithelial cell kinase
Tyrosine-protein kinase receptor ECK
Tyrosine-protein kinase receptor MPK-5
Tyrosine-protein kinase receptor SEK-2</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q03145</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1474</column>
            <column name="TargetName">Colonic adenomas</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1475</column>
            <column name="TargetName">Envelope glycoprotein E2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Hepatitis C virus genotype 1a (isolate H) (HCV):11108</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P27958 [384-661]</column>
            <column name="TargetStructure">1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2QV1, 2XI2, 2XI3, 2XNI, 4CL1, 4JZN, 4JZO, 4MWF</column>
            <column name="TargetComments">Full-length E2 protein extends from amino acids 384 to 746 of the HCV polyprotein and contains regions of extreme variability. E2661 is the C-terminal truncation of E2 at residue 661 (E2661).</column>
        </table>
        <table name="target">
            <column name="TargetID">1476</column>
            <column name="TargetName">The anticodon stem and loop of human tRNA(Lys3), ASL(Lys3)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1477</column>
            <column name="TargetName">ASL(Lys3) (s2U34;Ψ39)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The modified ASL target is a 17 nucleotide, human ASL tRNA(Lys3) with s2U34 and Ψ39.</column>
        </table>
        <table name="target">
            <column name="TargetID">1478</column>
            <column name="TargetName">ASL(Lys3) (UUU-ms2t6A37;mcm5s2U34;Ψ39)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The htRNA(Lys3) (UUU) with the anticodon UUU is one of some 45 tRNAs. Mature htRNA(Lys3) (UUU) contains the naturally occurring post-transcriptional modifications 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U34) at wobble position 34 and 2-methylthio-N6-threonylcarbamoyladenosine (ms2t6A37) at position 37 within the tRNA\'s anticodon stem and loop domain. Pseudouridine, Ψ39 is locatet at position 39, 3′to the anticodon loop.</column>
        </table>
        <table name="target">
            <column name="TargetID">1479</column>
            <column name="TargetName">Anti-DENV E EDIII HuScFv</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human single-chain variable fragments (HuScFv) with inhibitory effect to DENV infection were generated. HuScFv molecules were screened and selected from the human antibody phage display library by using purified recombinant DENV EDII proteins as target antigens for biopanning.</column>
        </table>
        <table name="target">
            <column name="TargetID">1480</column>
            <column name="TargetName">Human breast carcinoma SKBR-3 (HER positive) cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1481</column>
            <column name="TargetName">Human synovium-derived mesenchymal stem cells, hSMSCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human SMSCs (hSMSCs) were isolated from eight patients (three males and five females, aged 60.38 ± 6.28 years with an age range of 50-73 years) who underwent total knee arthroplasty.</column>
        </table>
        <table name="target">
            <column name="TargetID">1482</column>
            <column name="TargetName">Anti-Claudin 18.2 monoclonal antibody IMAB362</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">IMAB362 (anti-Claudin 18.2) is a highly tumor-specific monoclonal IgG1 antibody currently in clinical development for the treatment of advanced gastro-esophageal and stomach cancer. The antibody is directed against the cancer-specific cell surface target Claudin 18 isoform 2 (CLDN18.2), a 27.7 kDa gastric differentiation protein that spans the cell membrane with four transmembrane helices. IMAB362 is derived from a murine monoclonal antibody, and has been chimerized to display the human IgG1 constant region. For clinical development, IMAB362 is produced in Chinese Hamster Ovary (CHO) cells by standard recombinant expression technology.</column>
        </table>
        <table name="target">
            <column name="TargetID">1483</column>
            <column name="TargetName">Fc region of human immunoglobulin G (IgG)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1484</column>
            <column name="TargetName">Human glioblastoma cell line A172</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1485</column>
            <column name="TargetName">IgG from cerebro spinal fluid of multiple sclerosis (MS) patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606 </column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1486</column>
            <column name="TargetName">IgG from cerebro spinal fluid of multiple sclerosis (MS) patient 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1487</column>
            <column name="TargetName">IgG from a mixture of 20 different CSF of multiple sclerosis (MS) patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1488</column>
            <column name="TargetName">Tyrosyl-tRNA synthetase, TyrRS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Tyrosyl-tRNA synthetase (TyrRS) from H. influenzae catalyzes the charging of the amino acid tyrosine to tRNA(Tyr).</column>
        </table>
        <table name="target">
            <column name="TargetID">1489</column>
            <column name="TargetName">Proline--tRNA ligase</column>
            <column name="TargetSynonyms">Global RNA synthesis factor
Prolyl-tRNA synthetase
ProRS
EC=6.1.1.15</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P16659</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Prolyl-tRNA synthetase (ProRS) from E. coli catalyzes the charging of the amino acid proline to tRNA(Pro).</column>
        </table>
        <table name="target">
            <column name="TargetID">1490</column>
            <column name="TargetName">Alcohol dehydrogenase 2</column>
            <column name="TargetSynonyms">Alcohol dehydrogenase II
EC=1.1.1.1
YADH-2</column>
            <column name="TargetSource">Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast):559292</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00331</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Alcohol dehydrogenase (ADH) from Saccharomyces cerevisiae catalyzes the conversion of ethanol to acetaldehyde using NAD+ as a cofactor.</column>
        </table>
        <table name="target">
            <column name="TargetID">1491</column>
            <column name="TargetName">β-glucosidase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">β-Glucosidase from  Agrobacterium faecalis catalyzes the hydrolysis of β-glucosides.</column>
        </table>
        <table name="target">
            <column name="TargetID">1492</column>
            <column name="TargetName">Hexokinase-1 and hexokinase-2</column>
            <column name="TargetSynonyms">Alternative name(s) of Hexokinase-1:
Hexokinase PI
Hexokinase-A
Alternative name(s) of Hexokinase-2:
Hexokinase PII
Hexokinase-B</column>
            <column name="TargetSource">Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast):559292</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Hexokinase-1: P04806, Hexokinase-2: P04807</column>
            <column name="TargetStructure">Hexokinase-1: 1HKG, 3B8A
Hexokinase-2: 1IG8, 2YHX</column>
            <column name="TargetComments">Hexokinase (HK) from S. cerevisiae catalyzes the phosphorylation of D-glucose by ATP to yield D-glucose 6-phosphate.</column>
        </table>
        <table name="target">
            <column name="TargetID">1493</column>
            <column name="TargetName">Glycogen phosphorylase, muscle form</column>
            <column name="TargetSynonyms">Myophosphorylase
EC=2.4.1.1</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00489</column>
            <column name="TargetStructure">1A8I, 1ABB, 1AXR, 1B4D, 1BX3, 1C50, 1C8K, 1C8L, 1E1Y, 1FS4, 1FTQ, 1FTW, 1FTY, 1FU4, 1FU7, 1FU8, 1GFZ, 1GG8, 1GGN, 1GPA, 1GPB, 1GPY, 1H5U, 1HLF, 1K06, 1K08, 1KTI, 1LWN, 1LWO, 1NOI, 1NOJ, 1NOK, 1P29, 1P2B, 1P2D, 1P2G, 1P4G, 1P4H, 1P4J, 1PYG, 1UZU, 1WUT, 1WUY, 1WV0, 1WV1, 1WW2, 1WW3, 1XC7, 1XKX, 1XL0, 1XL1, 1Z62, 1Z6P, 1Z6Q, 2AMV, 2F3P, 2F3Q, 2F3S, 2F3U, 2FET, 2FF5, 2FFR, 2G9Q, 2G9R, 2G9U, 2G9V, 2GJ4, 2GM9, 2GPA, 2GPB, 2GPN, 2IEG, 2IEI, 2OFF, 2PRI, 2PRJ, 2PYD, 2PYI, 2QLM, 2QLN, 2QN1, 2QN2, 2QN3, 2QN7, 2QN8, 2QN9, 2QNB, 2QRG, 2QRH, 2QRM, 2QRP, 2QRQ, 2SKC, 2SKD, 2SKE, 3AMV, 3BCR, 3BCS, 3BCU, 3BD6, 3BD7, 3BD8, 3BDA, 3CUT, 3CUU, 3CUV, 3CUW, 3E3L, 3E3N, 3E3O, 3EBO, 3EBP, 3G2H, 3G2I, 3G2J, 3G2K, 3G2L, 3G2N, 3GPB, 3L79, 3L7A, 3L7B, 3L7C, 3L7D, 3MQF, 3MRT, 3MRV, 3MRX, 3MS2, 3MS4, 3MS7, 3MSC, 3MT7, 3MT8, 3MT9, 3MTA, 3MTB, 3MTD, 3NC4, 3NP7, 3NP9, 3NPA, 3S0J, 3SYM, 3SYR, 3T3D, 3T3E, 3T3G, 3T3H, 3T3I, 3ZCP, 3ZCQ, 3ZCR, 3ZCS, 3ZCT, 3ZCU, 3ZCV, 4EJ2, 4EKE, 4EKY, 4EL0, 4EL5, 4GPB, 4MRA, 5GPB, 6GPB, 7GPB, 8GPB, 9GPB</column>
            <column name="TargetComments">Glycogen phosphorylase a (Pa) from rabbit muscle catalyzes the removal and phosphorylation of the terminal glucose residue of glycogen to generate glucose-1-phosphate.</column>
        </table>
        <table name="target">
            <column name="TargetID">1494</column>
            <column name="TargetName">Carboxypeptidase B</column>
            <column name="TargetSynonyms">EC=3.4.17.2</column>
            <column name="TargetSource">Sus scrofa (Pig):9823</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P09955</column>
            <column name="TargetStructure">1NSA, 1PBA, 1Z5R, 1ZG7, 1ZG8, 1ZG9, 2JEW, 2PIY, 2PIZ, 2PJ0, 2PJ1, 2PJ2, 2PJ3, 2PJ4, 2PJ5, 2PJ6, 2PJ7, 2PJ8, 2PJ9, 2PJA, 2PJB, 2PJC, 3GLJ, 3WAB, 3WC5, 3WC6, 3WC7</column>
            <column name="TargetComments">Carboxypeptidase B (CPB) is a metalloprotease that cleaves proteins adjacent to arginine and lysine residues.</column>
        </table>
        <table name="target">
            <column name="TargetID">1495</column>
            <column name="TargetName">MRNA of amyloid precursor protein (APP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target mRNA of amyloid precursor protein (APP) has 48 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</column>
        </table>
        <table name="target">
            <column name="TargetID">1496</column>
            <column name="TargetName">MRNA of hepatitis C virus (HCV)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target mRNA of hepatitis C virus (HCV) has 51 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</column>
        </table>
        <table name="target">
            <column name="TargetID">1497</column>
            <column name="TargetName">MRNA of insulin-like growth factor-1 (IGF-1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target mRNA of insulin-like growth factor-1 (IGF-1) has 61 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</column>
        </table>
        <table name="target">
            <column name="TargetID">1498</column>
            <column name="TargetName">MRNA of Rev Response Element (RRE)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target mRNA of Rev Response Element (RRE) has 47 nucleotides. Oligonucleotides for the mRNA pans were synthesized and used for the experiments after heat treatment and re-annealing (65° for 10' and slow cooling at room temperature).</column>
        </table>
        <table name="target">
            <column name="TargetID">1499</column>
            <column name="TargetName">RIP1-Tag2 tumors</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">RIP1-Tag2 mice develop multifocal angiogenic islet progenitors and then solid tumors in a stepwise manner, such that at 12 weeks of age, each mouse will typically have approximately 50 angiogenic islets and 2–6 small tumors. This circumstance allowed us to use 12-week-old mice to select for phage binding to angiogenic islet progenitors and/or tumors in the same mouse.</column>
        </table>
        <table name="target">
            <column name="TargetID">1500</column>
            <column name="TargetName">RIP1-Tag2 angiogenic islets</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">RIP1-Tag2 mice develop multifocal angiogenic islet progenitors and then solid tumors in a stepwise manner, such that at 12 weeks of age, each mouse will typically have approximately 50 angiogenic islets and 2–6 small tumors. This circumstance allowed us to use 12-week-old mice to select for phage binding to angiogenic islet progenitors and/or tumors in the same mouse.</column>
        </table>
        <table name="target">
            <column name="TargetID">1501</column>
            <column name="TargetName">Fibronectin type Ⅲ10(RGD)-containing fragments</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1502</column>
            <column name="TargetName">SAS-derived tumors</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">SAS cells were injected subcutaneously into the dorsolateral flank of 4–6-week-old SCID mice to produce oral cancer xenografts.</column>
        </table>
        <table name="target">
            <column name="TargetID">1503</column>
            <column name="TargetName">Phytophthora capsici zoospore</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Phytophthora capsici:4784</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Phytophthora capsici is a soilborne pathogenic protist (phylum Oomycota) that infects aerial and subterranean structures of many solanaceous plants. Diseases caused by P. capsici are polycyclic in that multiple cycles of infection and inoculum production occur in a single growing season. The pathogen survives unfavorable conditions in soil by forming thickwalled oospores, while dissemination and infection are achieved through the production of motile biflagellate zoospores from oospores. The zoospores swim through water in the soil and are chemotactically attracted to the exudates released by the roots of potential host plants. After the zoospores have adhered to the root surface, they encyst and produce a precisely oriented germ tube that grows into adjacent host plant tissue.</column>
        </table>
        <table name="target">
            <column name="TargetID">1504</column>
            <column name="TargetName">CD147</column>
            <column name="TargetSynonyms">Basigin
5F7
Collagenase stimulatory factor
Extracellular matrix metalloproteinase inducer
Leukocyte activation antigen M6
OK blood group antigen
Tumor cell-derived collagenase stimulatory factor</column>
            <column name="TargetSource">Homo sapiens (Human) :9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P35613</column>
            <column name="TargetStructure">3B5H , 3I84 , 3I85 , 3QQN , 3QR2</column>
            <column name="TargetComments">CD147 is a transmembrane glycoprotein of the immunoglobulin superfamily. It is highly enriched on the surface of cancer cells. Thus, it has been taken as a biomarker that can be used in cancer detection.</column>
        </table>
        <table name="target">
            <column name="TargetID">1505</column>
            <column name="TargetName">HIV-1 TAR</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The HIV-1 TAR is a 59 nucleotide long element present at the 5' end of the HIV-1 viral RNA and stimulates transcription when bound to protein ligands; the viral Tat protein complexed with the host positive Transcription Elongation Factor b (pTEFb, composed of Cyclin T1 and CDK9), associates to the TAR element with high affinity, and promotes the hyper-phosphorylation of the C-terminal Domain of RNA polymerase Ⅱ large subunit.</column>
        </table>
        <table name="target">
            <column name="TargetID">1506</column>
            <column name="TargetName">Human plasma clots</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Blood was anticoagulated with 0.4% sodium citrate and centrifuged at 2, 500 × g . The plasma was collected, spun again to remove remaining blood cells, and frozen at 80°C. Clotting was initiated by adding CaCl2 to 20 mM, and the clot was repeatedly washed with PBS.</column>
        </table>
        <table name="target">
            <column name="TargetID">1507</column>
            <column name="TargetName">Puumala virus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Puumala virus belongs to the genus Hantavirus, family Bunyaviridae. Hantaviruses are enveloped and have a trisegmented, single-stranded, negative-sense RNA genome. The large, medium, and small segments are packed into nucleocapsids separately. The large segment encodes the viral RNA polymerase-transcriptase, the medium segment encodes envelope glycoproteins G1 and G2, and the small segment encodes nucleocapsid protein. Each hantavirus is associated with a primary rodent host carrier in which it has evolved and for which it is apathogenic.</column>
        </table>
        <table name="target">
            <column name="TargetID">1508</column>
            <column name="TargetName">SH3 domain of tyrosine-protein kinase Yes</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase Yes alternative name(s):
EC=2.7.10.2
Proto-oncogene c-Yes
p61-Yes</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07947 [91-152]</column>
            <column name="TargetStructure">2HDA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1509</column>
            <column name="TargetName">SH3 domain of tyrosine-protein kinase ABL1</column>
            <column name="TargetSynonyms">Tyrosine-protein kinase ABL1 alternative name(s):
Abelson murine leukemia viral oncogene homolog 1
Abelson tyrosine-protein kinase 1
Proto-oncogene c-Abl
p150
EC=2.7.10.2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00519 [61-121]</column>
            <column name="TargetStructure">1AB2, 1AWO, 1BBZ, 1JU5, 1OPL, 1ZZP, 2ABL, 2E2B, 2F4J, 2FO0, 2G1T, 2G2F, 2G2H, 2G2I, 2GQG, 2HIW, 2HYY, 2HZ0, 2HZ4, 2HZI, 2O88, 2V7A, 3CS9, 3EG0, 3EG1, 3EG2, 3EG3, 3EGU, 3K2M, 3PYY, 3QRI, 3QRJ, 3QRK, 3T04, 3UE4, 3UYO, 4J9B, 4J9C, 4J9D, 4J9E, 4J9F, 4J9G, 4J9H, 4J9I, 4JJB, 4JJC, 4JJD</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1510</column>
            <column name="TargetName">SH3 domain of cortactin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1511</column>
            <column name="TargetName">SH3 domain of apoptosis-stimulating of p53 protein 2</column>
            <column name="TargetSynonyms">Apoptosis-stimulating of p53 protein 2 alternative name(s):
Bcl2-binding protein
Bbp
Renal carcinoma antigen NY-REN-51
Tumor suppressor p53-binding protein 2
53BP2
p53-binding protein 2
p53BP2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q13625 [1057-1119]</column>
            <column name="TargetStructure">1YCS, 2UWQ, 4A63, 4IRV</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1512</column>
            <column name="TargetName">SH3 domains of 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 and gamma-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">SH3 domain of PLC-gamma-1: P19174 [791-851], SH3 domain of PLC-gamma-2: P16885 [769-829]</column>
            <column name="TargetStructure">PLC-gamma-1: 1HSQ, 2HSP, 4EY0, 4FBN
PLC-gamma-2: 2K2J, 2W2W, 2W2X</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1513</column>
            <column name="TargetName">SH3 domain of Crk N</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1514</column>
            <column name="TargetName">SH3 domain of Grb2 N</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1515</column>
            <column name="TargetName">Troponin C, skeletal muscle</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02586</column>
            <column name="TargetStructure">1A2X, 1TCF, 1TN4, 2TN4</column>
            <column name="TargetComments">Troponin C, the major regulatory protein in striated muscle contraction, is the calcium-binding component of the ternary troponin complex. It regulates the actomyosin activity in a calcium-dependent manner, through its association with tropomyosin and actin.</column>
        </table>
        <table name="target">
            <column name="TargetID">1516</column>
            <column name="TargetName">Purified serum IgG from goat-1 (G1) infection with Map</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1517</column>
            <column name="TargetName">Purified serum IgG from goat-2 (G2) infection with Map</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1518</column>
            <column name="TargetName">Anti-EBV monoclonal antibody gp125</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-EBV MAbs were raised by immunizing mice with crude EBV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1519</column>
            <column name="TargetName">Anti-EBV monoclonal antibody F1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-EBV MAbs were raised by immunizing mice with crude EBV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1520</column>
            <column name="TargetName">Anti-EBV monoclonal antibody A2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-EBV MAbs were raised by immunizing mice with crude EBV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1521</column>
            <column name="TargetName">Anti-EBV monoclonal antibody A3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-EBV MAbs were raised by immunizing mice with crude EBV.</column>
        </table>
        <table name="target">
            <column name="TargetID">1522</column>
            <column name="TargetName">Purified serum IgG from an EBV-infected patient</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1523</column>
            <column name="TargetName">Purified serum IgG from an EBV-immunised rabbit</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1524</column>
            <column name="TargetName">Endoglucanase isozyme AgEGl, IsoA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Anoplophora glabripennis (Asian longhorn beetle) (Anoplophora nobilis):217634</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1525</column>
            <column name="TargetName">Anti-Lewis X monoclonal antibody MMA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1526</column>
            <column name="TargetName">Anti-Lewis X monoclonal antibody SSEA-1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1527</column>
            <column name="TargetName">Anti-Lewis X monoclonal antibody Pmn6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1528</column>
            <column name="TargetName">Anti-Lc4Cer monoclonal antibody AD117m</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1529</column>
            <column name="TargetName">Anti-nLc4Cer monoclonal antibody H11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1530</column>
            <column name="TargetName">Anti-GD1α monoclonal antibody KA17</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1531</column>
            <column name="TargetName">Anti-Lewis A monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1532</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody SA3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1533</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody Strep 9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1534</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody HGAC 39</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1535</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody HGAC 47</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1536</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody HGAC 101</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1537</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody SE155.4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1538</column>
            <column name="TargetName">Anti-GAS CWPS monoclonal antibody SYAJ/6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1539</column>
            <column name="TargetName">Hairpin DNA containing an altered Zif268 binding site GCG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 1 is TGT (5'-CCTGCGTGGTGTCCCTTTTGGGACACCACGCAGG-3'). The selection target site is GCG.</column>
        </table>
        <table name="target">
            <column name="TargetID">1540</column>
            <column name="TargetName">Hairpin DNA containing an altered Zif268 binding site TGT</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 1 is TGT (5'-CCTGCGTGGTGTCCCTTTTGGGACACCACGCAGG-3'). The selection target site is TGT.</column>
        </table>
        <table name="target">
            <column name="TargetID">1541</column>
            <column name="TargetName">Hairpin DNA containing an altered Zif268 binding site TGG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 2 is TTG (5 '-CCTGCGTTGCGCCCTTTTGGGCGCCAACGCAGG-3'). The selection target site is TGG.</column>
        </table>
        <table name="target">
            <column name="TargetID">1542</column>
            <column name="TargetName">Hairpin DNA containing an altered Zif268 binding site TTG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 2 is TTG (5 '-CCTGCGTTGCGCCCTTTTGGGCGCCAACGCAGG-3'). The selection target site is TTG.</column>
        </table>
        <table name="target">
            <column name="TargetID">1543</column>
            <column name="TargetName">Hairpin DNA containing an altered Zif268 binding site GCG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 3 is CTG (5'-CCTCTGTGGGCGCCCTTTTGGGCGCCCACAGAGG-3'). The selection target site is GCG.</column>
        </table>
        <table name="target">
            <column name="TargetID">1544</column>
            <column name="TargetName">Hairpin DNA containing an altered Zif268 binding site CTG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A 34-nucleotide hairpin DNA containing either the consensus or an altered Zif268 binding site was used for zinc-finger selection. The consensus binding site is denoted as Z268N (5'-CCTGCTGGGCCCCTTTTGGGCGCCCACGCAGG-3'). The altered site for finger 3 is CTG (5'-CCTCTGTGGGCGCCCTTTTGGGCGCCCACAGAGG-3'). The selection target site is CTG.</column>
        </table>
        <table name="target">
            <column name="TargetID">1545</column>
            <column name="TargetName">Hairpin DNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Hairpin target oligonucleotides had the sequence 5'-Biotin-GGACGCN'N'N'CGCGGGTTTTCCCGCGNNNGCGTCC-3', where NNN was the 3-nt finger-2 target sequence and N'N'N' its complement. </column>
        </table>
        <table name="target">
            <column name="TargetID">1546</column>
            <column name="TargetName">The SH2 domain of growth factor receptor-bound protein 2</column>
            <column name="TargetSynonyms">Growth factor receptor-bound protein 2 alternative name(s):
Adapter protein GRB2
Protein Ash
SH2/SH3 adapter GRB2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P62993 [60-152]</column>
            <column name="TargetStructure">1AZE, 1BM2, 1BMB, 1CJ1, 1FHS, 1FYR, 1GCQ, 1GFC, 1GFD, 1GHU, 1GRI, 1IO6, 1JYQ, 1JYR, 1JYU, 1QG1, 1TZE, 1X0N, 1ZFP, 2AOA, 2AOB, 2H46, 2H5K, 2HUW, 2VVK, 2VWF, 2W0Z, 3C7I, 3IMD, 3IMJ, 3IN7, 3IN8, 3KFJ, 3MXC, 3MXY, 3N7Y, 3N84, 3N8M, 3OV1, 3OVE, 3S8L, 3S8N, 3S8O, 3WA4</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1547</column>
            <column name="TargetName">DNA duplex containing an inverted repeat of the Zif12-binding site</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1548</column>
            <column name="TargetName">SH3 domain of endophilin-A1</column>
            <column name="TargetSynonyms">Endophilin-A1 alternative name(s):
EEN-B1
Endophilin-1
SH3 domain protein 2A
SH3 domain-containing GRB2-like protein 2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q99962 [290-349]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1549</column>
            <column name="TargetName">SH3 domain of endophilin-A2</column>
            <column name="TargetSynonyms">Endophilin-A2 alternative name(s):
EEN fusion partner of MLL
Endophilin-2
Extra eleven-nineteen leukemia fusion gene protein
EEN
SH3 domain protein 2B
SH3 domain-containing GRB2-like protein 1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q99961 [306-365]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1550</column>
            <column name="TargetName">SH3 domain of endophilin-A3</column>
            <column name="TargetSynonyms">Endophilin-A2 alternative name(s):
EEN-B2
Endophilin-3
SH3 domain protein 2C
SH3 domain-containing GRB2-like protein 3</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q99963 [285-344]</column>
            <column name="TargetStructure">2EW3, 2Z0V</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1551</column>
            <column name="TargetName">SH3 domain of amphiphysin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P49418 [622-695]</column>
            <column name="TargetStructure">1KY7, 1UTC, 3SOG, 4ATM</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1552</column>
            <column name="TargetName">Elongation factor Tu, EF-Tu</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1553</column>
            <column name="TargetName">Anti-Puumala virus envelope glycoprotein G1 monoclonal antibody 5A2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Myodes glareolus (Bank vole) (Clethrionomys glareolus)：447135</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1554</column>
            <column name="TargetName">Anti-Puumala virus envelope glycoprotein G2 monoclonal antibody 4G2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Myodes glareolus (Bank vole) (Clethrionomys glareolus)：447135</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1555</column>
            <column name="TargetName">Anti-Puumala virus envelope glycoprotein G2 monoclonal antibody 1C9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1556</column>
            <column name="TargetName">Estrogen receptor alpha, ERα</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The estrogen receptor (ER) is a member of the steroid family of nuclear receptors. Like other nuclear receptors, the ER is a ligand-dependent transcriptional activator. In the absence of hormone, the ER resides in the nucleus of target cells where it is associated with an inhibitory heat-shock protein complex. On binding ligand, the receptor is activated. This process permits the formation of stable receptor dimers and subsequent interaction with specific DNA response elements located within the regulatory region of target genes. The DNA-bound receptor can then either positively or negatively regulate target gene transcription.</column>
        </table>
        <table name="target">
            <column name="TargetID">1557</column>
            <column name="TargetName">Estrogen receptor beta, ERβ</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The estrogen receptor (ER) is a member of the steroid family of nuclear receptors. Like other nuclear receptors, the ER is a ligand-dependent transcriptional activator. In the absence of hormone, the ER resides in the nucleus of target cells where it is associated with an inhibitory heat-shock protein complex. On binding ligand, the receptor is activated. This process permits the formation of stable receptor dimers and subsequent interaction with specific DNA response elements located within the regulatory region of target genes. The DNA-bound receptor can then either positively or negatively regulate target gene transcription.</column>
        </table>
        <table name="target">
            <column name="TargetID">1558</column>
            <column name="TargetName">Mouse breast tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1559</column>
            <column name="TargetName">Angiogenic vessel</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">DAS model mice were prepared. In brief, highly metastatic murine B16BL6 melanoma cells (1.0e7 cells/ring) were loaded into a Millipore chamber ring. The chamber rings were dorsally implanted into 5-week-old C57BL/6 male mice. Five days after the implantation, these mice were used for in vivo biopanning.</column>
        </table>
        <table name="target">
            <column name="TargetID">1560</column>
            <column name="TargetName">Angiogenin</column>
            <column name="TargetSynonyms">ANG
RNASE5</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03950</column>
            <column name="TargetStructure">1A4Y, 1ANG, 1AWZ, 1B1E, 1B1I, 1B1J, 1GV7, 1H0D, 1H52, 1H53, 1HBY, 1K58, 1K59, 1K5A, 1K5B, 1UN3, 1UN4, 1UN5, 2ANG, 4AHD, 4AHE, 4AHF, 4AHG, 4AHH, 4AHI, 4AHJ, 4AHK, 4AHL, 4AHM, 4AHN, 4AOH, 4B36</column>
            <column name="TargetComments">Angiogenin is one of the most potent tumor-derived angiogenic factors. Recombinant human angiogenin, rhAng, is the target.</column>
        </table>
        <table name="target">
            <column name="TargetID">1561</column>
            <column name="TargetName">Extracellular domain of receptor tyrosine-protein kinase erbB-2</column>
            <column name="TargetSynonyms">Receptor tyrosine-protein kinase erbB-2 (EC:2.7.10.1) alternative name(s):
Proto-oncogene Neu
Proto-oncogene c-ErbB-2
p185erbB2
CD_antigen: CD340</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P70424[23-653]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The purified form of ECD-ErbB2 was fused to AP and purified from a mouse fibroblast cell line, referred to as ECDAP. ECDAP is the real target.</column>
        </table>
        <table name="target">
            <column name="TargetID">1562</column>
            <column name="TargetName">IA/IAA-enriched immunoglobulin G from REM-A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were obtained twice from a 6-year-old Caucasian boy with newly diagnosed Type 1 diabetes. The serum obtained at the onset of diabetes (prior to insulin treatment) was identified as REM-A. IA is short for insulin antibody; IAA insulin autoantibody.</column>
        </table>
        <table name="target">
            <column name="TargetID">1563</column>
            <column name="TargetName">IA/IAA-enriched immunoglobulin G from REM-B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were obtained twice from a 6-year-old Caucasian boy with newly diagnosed Type 1 diabetes. The serum obtained around 3 months after insulin therapy was identified as REM-B. IA is short for insulin antibody; IAA insulin autoantibody.</column>
        </table>
        <table name="target">
            <column name="TargetID">1564</column>
            <column name="TargetName">IA/IAA-enriched immunoglobulin G from NREM-A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were taken from a 9-year-old Caucasian boy who had not entered a honeymoon period. Serum taken at onset of diabetes was designated NREM-A. IA is short for insulin antibody; IAA insulin autoantibody.</column>
        </table>
        <table name="target">
            <column name="TargetID">1565</column>
            <column name="TargetName">IA/IAA-enriched immunoglobulin G from NREM-B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were taken from a 9-year-old Caucasian boy who had not entered a honeymoon period. Serum taken at 3 months after insulin initiation was designated as NREM-B. IA is short for insulin antibody; IAA insulin autoantibody.</column>
        </table>
        <table name="target">
            <column name="TargetID">1566</column>
            <column name="TargetName">RAR-DBD-LBD</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P15207 [538-902]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The abbreviations used are: AR, androgen receptor; rAR, rat androgen receptor; DBD, DNA-binding domain; LBD, ligand-binding domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">1567</column>
            <column name="TargetName">Vitellogenin estrogen response element (ERE)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknonw</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1568</column>
            <column name="TargetName">Anti-dsDNA monoclonal antibody R4A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">R4A, a mouse monoclonal IgG2b anti-dsDNA antibody, causes glomerulonephritis in nonautoimmune mice.</column>
        </table>
        <table name="target">
            <column name="TargetID">1569</column>
            <column name="TargetName">Anti-dsDNA monoclonal antibody 52b3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">52b3, one mutant of R4A which is a mouse monoclonal IgG2b anti-dsDNA antibody, has three amino acid substitutions in framework 3 of the H chain (arginine to glutamine at position 66, threonine to alanine at position 82b, and arginine to serine at position 83). 52b3 displays a 10-fold increase in its binding of dsDNA and a shift in tissue pathology from the predominantly glomerular deposition of the parental R4A antibody to tubular deposition.</column>
        </table>
        <table name="target">
            <column name="TargetID">1570</column>
            <column name="TargetName">Anti-the 0-Ag of the S. flexneri serotype 5a LPS monoclonal antibody C5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1571</column>
            <column name="TargetName">Anti-the 0-Ag of the S. flexneri serotype 5a LPS monoclonal antibody I3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1572</column>
            <column name="TargetName">Yorkie homolog</column>
            <column name="TargetSynonyms">65 kDa Yes-associated protein
YAP65</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P46937 [171-204, 230-263]</column>
            <column name="TargetStructure">1JMQ, 1K5R, 1K9Q, 1K9R, 2LAW, 2LAX, 2LAY, 2LTV, 2LTW, 3KYS, 3MHR</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1573</column>
            <column name="TargetName">Yorkie homolog</column>
            <column name="TargetSynonyms">65 kDa Yes-associated protein
YAP65</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P46938 [156-189, 215-248]</column>
            <column name="TargetStructure">3JUA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1574</column>
            <column name="TargetName">Anti-CTLA4 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1575</column>
            <column name="TargetName">White fat</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1576</column>
            <column name="TargetName">Integrin alpha-M-beta-3, integrin αmβ3</column>
            <column name="TargetSynonyms">Integrin alpha-M alternative name(s):
CD11 antigen-like family member B
CR-3 alpha chain
Cell surface glycoprotein MAC-1 subunit alpha
Leukocyte adhesion receptor MO1
Neutrophil adherence receptor
CD_antigen: CD11b

Integrin beta-3 alternative name(s):
Platelet membrane glycoprotein IIIa GPIIIa
CD_antigen=CD61</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Integrin alpha-M: P11215, Integrin beta-3: P05106</column>
            <column name="TargetStructure">Integrin alpha-M: 1BHO, 1BHQ, 1IDN, 1IDO, 1JLM, 1M1U, 1MF7, 1N9Z, 1NA5, 2LKE, 2LKJ, 3Q3G, 3QA3, 4M76
Integrin beta-3: 1JV2, 1KUP, 1KUZ, 1L5G, 1M1X, 1M8O, 1MK7, 1MK9, 1S4X, 1TYE, 1U8C, 2K9J, 2KNC, 2KV9, 2L1C, 2Q6W, 2RMZ, 2RN0, 2VC2, 2VDK, 2VDL, 2VDM, 2VDN, 2VDO, 2VDP, 2VDQ, 2VDR, 3FCS, 3FCU, 3IJE, 3NID, 3NIF, 3NIG</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1577</column>
            <column name="TargetName">Myeloperoxidase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P05164</column>
            <column name="TargetStructure">1CXP, 1D2V, 1D5L, 1D7W, 1DNU, 1DNW, 1MHL, 1MYP, 3F9P, 3ZS0, 3ZS1, 4C1M, 4DL1, 4EJX, 5FIW, 5MFA</column>
            <column name="TargetComments">Human myeloperoxidase (hMPO) is released by activated neutrophils and displays powerful pro-oxidative and proinflammatory properties. Moreover, hMPO has been validated as a biomarker for acute coronary syndrome and as a risk marker for clinical diagnostics.</column>
        </table>
        <table name="target">
            <column name="TargetID">1578</column>
            <column name="TargetName">Alkaline phosphatase, tissue-nonspecific isozyme</column>
            <column name="TargetSynonyms">EC:3.1.3.1
AP-TNAP
TNSALP
Alkaline phosphatase liver/bone/kidney isozyme</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P09487</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1579</column>
            <column name="TargetName">Beta-glucuronidase, GUS</column>
            <column name="TargetSynonyms">EC:3.2.1.31
Beta-D-glucuronoside glucuronosohydrolase</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P05804</column>
            <column name="TargetStructure">3K46, 3K4A, 3K4D, 3LPF, 3LPG, 4JHZ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1580</column>
            <column name="TargetName">BCL1 IgM idiotype</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The BALB/c-derived B cell lymphoma (BCL1) soluble IgM idiotype was purified from the serum of a mouse with large BCL1 tumors.</column>
        </table>
        <table name="target">
            <column name="TargetID">1581</column>
            <column name="TargetName">Thrombin receptor</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1582</column>
            <column name="TargetName">Calmodulin, CaM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1583</column>
            <column name="TargetName">Echovirus 22, EV22</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1584</column>
            <column name="TargetName">Coxsackievirus A9, CAV9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1585</column>
            <column name="TargetName">Anti-aflatoxins B1 and G1 monoclonal antibody 24, MAb 24</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1586</column>
            <column name="TargetName">Anti-aflatoxins B1, G1 and B2 monoclonal antibody, MAb 13</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1587</column>
            <column name="TargetName">MH01 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1588</column>
            <column name="TargetName">MH04 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1589</column>
            <column name="TargetName">MH03 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1590</column>
            <column name="TargetName">MH06 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1591</column>
            <column name="TargetName">MH07 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1592</column>
            <column name="TargetName">MH05 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1593</column>
            <column name="TargetName">MH02 plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">From 14 LTNP patients, seven (MH01–MH07) were selected that were infected with HIV-1 (subtype B) for more than 15 years with viral loads &lt;10 000 copies/mL and a stable CD4 T cell count always &gt;500 cells/μL. All seven LTNP did not progress to AIDS in the absence of any antiretroviral therapy and none of them showed any deletions in the viral regulatory genes or the ccr5 receptor gene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1594</column>
            <column name="TargetName">PDZ domain of rho guanine nucleotide exchange factor 11</column>
            <column name="TargetSynonyms">Rho guanine nucleotide exchange factor 11 alternative name(s):
PDZ-RhoGEF</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O15085 [47-126]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1595</column>
            <column name="TargetName">PDZ domain of rho guanine nucleotide exchange factor 12</column>
            <column name="TargetSynonyms">Rho guanine nucleotide exchange factor 12 alternative name(s):
Leukemia-associated RhoGEF</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9NZN5 [72-151]</column>
            <column name="TargetStructure">1TXD, 1X86, 2OMJ, 2OS6</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1596</column>
            <column name="TargetName">PDZ domain of segment polarity protein dishevelled homolog DVL-2</column>
            <column name="TargetSynonyms">Segment polarity protein dishevelled homolog DVL-2 alternative name(s):
Dishevelled-2 
DSH homolog 2</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O14641 [264-353]</column>
            <column name="TargetStructure">2REY, 3CBX, 3CBY, 3CBZ, 3CC0</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1597</column>
            <column name="TargetName">Aspergillus conidium</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1598</column>
            <column name="TargetName">Aspergillus hypha</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1599</column>
            <column name="TargetName">Esophageal cancer cell line Eca109</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1600</column>
            <column name="TargetName">Bisphenol A, BPA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1601</column>
            <column name="TargetName">Envelope glycoprotein E2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Classical swine fever virus:11096</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q06DW6</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1602</column>
            <column name="TargetName">Sera IgG from patients with PMI</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1603</column>
            <column name="TargetName">Anti-buffalo β-lactoglobulin antibody from rabbit 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1604</column>
            <column name="TargetName">Anti-buffalo β-lactoglobulin antibody from rabbit 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1605</column>
            <column name="TargetName">β2-glycoprotein I, β2GPI</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1606</column>
            <column name="TargetName">Monoclonal chimeric IgG anti-β2GPI antibody, HCAL</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1607</column>
            <column name="TargetName">Low avidity (LAv) IgG anti-β2GPI polyclonal antibody from patient B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</column>
        </table>
        <table name="target">
            <column name="TargetID">1608</column>
            <column name="TargetName">High avidity (HAv) IgG anti-β2GPI polyclonal antibody from patient A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</column>
        </table>
        <table name="target">
            <column name="TargetID">1609</column>
            <column name="TargetName">High avidity (HAv) IgG anti-β2GPI polyclonal antibody from patient B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">High avidity (HAv) and low avidity (LAv) IgG anti-β2GPI were isolated from sera of two male patients with primary antiphospholipid syndrome (APS), who suffered initially from venous thrombosis and were positive for IgG anti-β2GPI.</column>
        </table>
        <table name="target">
            <column name="TargetID">1610</column>
            <column name="TargetName">Phosphatidylcholine liposome</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1611</column>
            <column name="TargetName">Endosomal lipid mix, ELM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1612</column>
            <column name="TargetName">Silver power</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1613</column>
            <column name="TargetName">Platinum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1614</column>
            <column name="TargetName">Polycrystalline platinum powder</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1615</column>
            <column name="TargetName">Bone-like mineral film and hydroxyapatite sintered disks</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1616</column>
            <column name="TargetName">82 nm silica nanoparticles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1617</column>
            <column name="TargetName">Germanium thin films on silicon, Ge-on-Si</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target Ge-on-Si was unannealed and of high defect density.</column>
        </table>
        <table name="target">
            <column name="TargetID">1618</column>
            <column name="TargetName">Squamous cell cancer cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1619</column>
            <column name="TargetName">Prostate cancer bone metastasis cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1620</column>
            <column name="TargetName">Heart muscle of mdx mouse</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1621</column>
            <column name="TargetName">Heart muscle and liver of mdx mouse</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1622</column>
            <column name="TargetName">Quadriceps muscle of mdx mouse</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1623</column>
            <column name="TargetName">Quadriceps muscle and liver of mdx mouse</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1624</column>
            <column name="TargetName">Monocytic myeloid-derived suppressor cells, monocytic MDSCs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1625</column>
            <column name="TargetName">Envelope glycoprotein E2(661)</column>
            <column name="TargetSynonyms">Envelope glycoprotein E2 alternative name(s):
NS1
gp68
gp70</column>
            <column name="TargetSource">Hepatitis C virus genotype 1a (isolate H) (HCV):11108</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P27958 [384-661]</column>
            <column name="TargetStructure">1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1R7Q, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2XI2, 2XI3</column>
            <column name="TargetComments">Full-length E2 protein extends from amino acids 384 to 746 of the HCV polyprotein. The C-terminal truncation of E2 at residue 661 is called E2(661). It has been shown that E2 truncated at residue 661 has a high folding efficiency.</column>
        </table>
        <table name="target">
            <column name="TargetID">1626</column>
            <column name="TargetName">Histone demethylase KDM1A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1627</column>
            <column name="TargetName">Histone demethylase KDM1B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1628</column>
            <column name="TargetName">Histone demethylase KDM4A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1629</column>
            <column name="TargetName">Histone demethylase KDM4C</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1630</column>
            <column name="TargetName">Human brain-seeking breast carcinoma cells</column>
            <column name="TargetSynonyms">231-BR cells</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1631</column>
            <column name="TargetName">Enantiomeric Lipid I(ent-Lipid I)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Phage display screens made use of lipid I inspired targets in both natural and enantiomeric forms. First, by doing so the amount of chemical space explored in the screen is effectively doubled. Secondly, it was considered that L-peptides selected in the screen that possess high affinity for natural lipidI/II might in fact be toxic towards the E.coli used in the amplification step of the phage display experiment, so using enantiomeric forms  was viewed as a way of avoiding any such negative selection bias.</column>
        </table>
        <table name="target">
            <column name="TargetID">1632</column>
            <column name="TargetName">Myoglobin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02144</column>
            <column name="TargetStructure">3RGK</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1633</column>
            <column name="TargetName">Anti-TsCa IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The total IgG from 120 serologically positive cattle with high titers was purified according to the procedure based on the reactivity against TsCa.</column>
        </table>
        <table name="target">
            <column name="TargetID">1634</column>
            <column name="TargetName">Anti-soluble CD14-fraction ST monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1635</column>
            <column name="TargetName">Anti-CD14 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1636</column>
            <column name="TargetName">Human ovarian adenocarcinoma cell line SKOV-3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1637</column>
            <column name="TargetName">Anti-1/3NH2TTPI polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1638</column>
            <column name="TargetName">Enterobactin synthase component E</column>
            <column name="TargetSynonyms">Enterochelin synthase E</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P10378</column>
            <column name="TargetStructure">3RG2, 4IZ6</column>
            <column name="TargetComments">The enterobactin biosynthetic enzyme EntA forms a complex with EntE, the next enzyme in the pathway, to enhance activation of the enterobactin precursor 2,3-dihydroxybenzoate.</column>
        </table>
        <table name="target">
            <column name="TargetID">1639</column>
            <column name="TargetName">Vaccinia virus strain NYCBOH</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">VACV strain NYCBOH (VR-1536TM) was purchased from ATCC®.</column>
        </table>
        <table name="target">
            <column name="TargetID">1640</column>
            <column name="TargetName">Surface glycoprotein Tc85-45</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Trypanosoma cruzi:5693</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q2VYD6</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1641</column>
            <column name="TargetName">Sera IgG from asymptomatic CVL and symptomatic CVL</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris:9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1642</column>
            <column name="TargetName">Anti-GapC monoclonal antibody 1E11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1643</column>
            <column name="TargetName">3-hydroxy-3-methylglutaryl-coenzyme A reductase ( (EC:1.1.1.34))</column>
            <column name="TargetSynonyms">HMG-CoA reductase</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P04035</column>
            <column name="TargetStructure">1DQ8, 1DQ9, 1DQA, 1HW8, 1HW9, 1HWI, 1HWJ, 1HWK, 1HWL, 2Q1L, 2Q6B, 2Q6C, 2R4F, 3BGL, 3CCT, 3CCW, 3CCZ, 3CD0, 3CD5, 3CD7, 3CDA, 3CDB</column>
            <column name="TargetComments">Human HMG-CoA reductase (hHMGR) is the rate-limiting enzyme of the mevalonate pathway that produces cholesterol and other isoprenoids. The enzyme contains 888 amino acids with the first 339 residues as the membrane anchor domain located in the endoplasmic reticulum. A linker region is located between residues ranging from 340 to 449, while the catalytic domain, from residues ranging from 450 to 888, resides in the cytoplasm.</column>
        </table>
        <table name="target">
            <column name="TargetID">1644</column>
            <column name="TargetName">Bone marrow-derived dendritic cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1645</column>
            <column name="TargetName">9-fluorenylmethoxycarbonyl-threonine and leucine-methyl ester (Fmoc-T/L-OMe)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Fmoc-T was purchased from Sigma-Aldrich and L-OMe.HCl from Fluka.</column>
        </table>
        <table name="target">
            <column name="TargetID">1646</column>
            <column name="TargetName">9-fluorenylmethoxycarbonyl-threonine and leucine-amide (Fmoc-T/L-NH2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Fmoc-T and L-NH2 were purchased from Sigma-Aldrich.</column>
        </table>
        <table name="target">
            <column name="TargetID">1647</column>
            <column name="TargetName">Cerebrospinal fluid</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1648</column>
            <column name="TargetName">Anti-Lpp20 monoclonal antibody L001</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1649</column>
            <column name="TargetName">Anti-EGFR monoclonal antibody ICR-62</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1650</column>
            <column name="TargetName">Tumor necrosis factor</column>
            <column name="TargetSynonyms">Cachectin
TNF-alpha
Tumor necrosis factor ligand superfamily member 2
TNF-α</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P01375</column>
            <column name="TargetStructure">1A8M, 1TNF, 2AZ5, 2E7A, 2TUN, 2ZJC, 2ZPX, 3ALQ, 3IT8, 3L9J, 3WD5, 4G3Y, 4TSV, 5TSW</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1651</column>
            <column name="TargetName">IgG from patients with CHB with HBsAg seroclearance following peg-IFN-α therapy</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1652</column>
            <column name="TargetName">Embryonic progenitor cell line SM30</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1653</column>
            <column name="TargetName">Ovarian cancer cell lines OC-3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The OC-3 cell line was a primary culture derived from a human surgical sample of clear cell adenocarcinoma of the ovary.</column>
        </table>
        <table name="target">
            <column name="TargetID">1654</column>
            <column name="TargetName">Polyclonal rabbit anti-AK IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1655</column>
            <column name="TargetName">Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3</column>
            <column name="TargetSynonyms">CDK4I, MTS-1, p16-INK4, p16INK4A</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P42771</column>
            <column name="TargetStructure">1A5E, 1BI7, 1DC2, 2A5E</column>
            <column name="TargetComments">The target protein (p16) is a cyclin-dependent kinase (CDK) inhibitor, which plays an important role in retinoblastoma (Rb) pathway. Protein p16 has been widely used as a biomarker for HPV-related cancer diagnosis.</column>
        </table>
        <table name="target">
            <column name="TargetID">1656</column>
            <column name="TargetName">Soft tissue of prostate cancer xenograft</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The specimen was obtained by needle biopsy from the sacroiliac zone of an exophytic osteoblastic lesion in the left hemipelvis of a 49-y-old Caucasian male with androgen-independent prostate cancer.</column>
        </table>
        <table name="target">
            <column name="TargetID">1657</column>
            <column name="TargetName">Bonelike matrix tissues of prostate cancer xenograft</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The specimen was obtained by needle biopsy from the sacroiliac zone of an exophytic osteoblastic lesion in the left hemipelvis of a 49-y-old Caucasian male with androgen-independent prostate cancer.</column>
        </table>
        <table name="target">
            <column name="TargetID">1658</column>
            <column name="TargetName">The ligated left carotid artery in male C57/BL6J mice</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">In vivo phage panning was performed in the partial carotid artery ligation model of disturbed flow in male C57/BL6J mice. In this surgical model, three of the four major branches of the left common carotid artery (LCA) are ligated. This results in low and oscillatory flow in the LCA, while flow in the right common carotid artery (RCA) remains normal. The ligated left carotid artery is the target for phage display, while the right artery serves as a normal flow control.</column>
        </table>
        <table name="target">
            <column name="TargetID">1659</column>
            <column name="TargetName">Polyclonal anti-LiAg IgGs</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (dog):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Antibodies used for biopanning were purified from 38 sera from L. infantum naturally infected dogs.</column>
        </table>
        <table name="target">
            <column name="TargetID">1660</column>
            <column name="TargetName">Anti-human cardiac troponin I mAb 11E12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1661</column>
            <column name="TargetName">Anti-HIV-1 monoclonal antibody VRC01</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1662</column>
            <column name="TargetName">Plasma kallikrein (EC:3.4.21.34)</column>
            <column name="TargetSynonyms">Fletcher factor, Plasma prekallikrein, Kininogenin</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P03952</column>
            <column name="TargetStructure">2ANW, 2ANY, 4OGX, 4OGY, 5F8T, 5F8X, 5F8Z, 5TJX</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1663</column>
            <column name="TargetName">Human alpha-FXIIa</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">FXII is expressed as a zymogen and activated by proteolytic cleavage in a two-step process. A first cleavage gives rise to the α-FXIIa being composed of a heavy and a catalytic light chain held together by a disulfide bond. Further cleavage yields the smaller β-FXIIa, which comprises only the catalytic domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">1664</column>
            <column name="TargetName">Human beta-FXIIa</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">FXII is expressed as a zymogen and activated by proteolytic cleavage in a two-step process. A first cleavage gives rise to the α-FXIIa being composed of a heavy and a catalytic light chain held together by a disulfide bond. Further cleavage yields the smaller β-FXIIa, which comprises only the catalytic domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">1665</column>
            <column name="TargetName">MgF2 nanoparticles (NPs)</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1973</column>
            <column name="TargetName">EAE-brain capillary endothelial cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Brain endothelial cells derived from four deeply anesthetized rats with acute experimental autoimmune encephalomyelitis (EAE) and four healthy rats were isolated. </column>
        </table>
        <table name="target">
            <column name="TargetID">1666</column>
            <column name="TargetName">Cathepsin G (EC:3.4.21.20)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P08311</column>
            <column name="TargetStructure">1AU8, 1CGH, 1KYN, 1T32</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1667</column>
            <column name="TargetName">Urokinase-type plasminogen activator (EC:3.4.21.73)</column>
            <column name="TargetSynonyms">U-plasminogen activator, uPA</column>
            <column name="TargetSource">U-plasminogen activator, uPA</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00749</column>
            <column name="TargetStructure">1C5W, 1C5X, 1C5Y, 1C5Z, 1EJN, 1F5K, 1F5L, 1F92, 1FV9, 1GI7, 1GI8, 1GI9, 1GJ7, 1GJ8, 1GJ9, 1GJA, 1GJB, 1GJC, 1GJD, 1KDU, 1LMW, 1O3P, 1O5A, 1O5B, 1O5C, 1OWD, 1OWE, 1OWH, 1OWI, 1OWJ, 1OWK, 1SC8, 1SQA, 1SQO, 1SQT, 1U6Q, 1URK, 1VJ9, 1VJA, 1W0Z, 1W10, 1W11, 1W12, 1W13, 1W14, 2FD6, 2I9A, 2I9B, 2NWN, 2O8T, 2O8U, 2O8W, 2R2W, 2VIN, 2VIO, 2VIP, 2VIQ, 2VIV, 2VIW, 2VNT, 3BT1, 3BT2, 3IG6, 3KGP, 3KHV, 3KID, 3M61, 3MHW, 3MWI, 3OX7, 3OY5, 3OY6, 3PB1, 3QN7, 3U73, 4DVA, 4DW2, 4FU7, 4FU8, 4FU9, 4FUB, 4FUC, 4FUD, 4FUE, 4FUF, 4FUG, 4FUH, 4FUI, 4FUJ, 4GLY, 4H42, 4JK5, 4JK6, 4JNI, 4JNL, 4K24, 4MNV, 4MNW, 4MNX, 4MNY, 4OS1, 4OS2, 4OS4, 4OS5, 4OS6, 4OS7</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1668</column>
            <column name="TargetName">Visfatin</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Recombinant visfatin with high purity was obtained from a prokaryotic expression system.</column>
        </table>
        <table name="target">
            <column name="TargetID">1669</column>
            <column name="TargetName">Polyclonal anti-LiPA IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (dog):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1670</column>
            <column name="TargetName">Mycobacterium tuberculosis (H37Rv)</column>
            <column name="TargetSynonyms">Mycobacterium tuberculosis strain H37Rv</column>
            <column name="TargetSource">Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv):83332</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1671</column>
            <column name="TargetName">B3β2γ</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unkown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">B3β2γ, with the sequence of LSALEKELASLEKE, is based on Acid-pp. The molecule possesses a pentad of alternating βand γ-amino acids, showed as βLγDβLγKβK.</column>
        </table>
        <table name="target">
            <column name="TargetID">1672</column>
            <column name="TargetName">B3β2γ-variant1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unkown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">B3β2γ-variant1, with the sequence of LSALEKELASLEKE, is based on Acid-pp. The molecule possesses a pentad of alternating βand γ-amino acids, showned as βAγDβAγKβK.</column>
        </table>
        <table name="target">
            <column name="TargetID">1673</column>
            <column name="TargetName">Anti-NTX monoclonal antibody BNTX21</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1674</column>
            <column name="TargetName">Fibroblast growth factor 23(180-205)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9GZV9 [180-205]</column>
            <column name="TargetStructure">2P39</column>
            <column name="TargetComments">Fibroblast growth factor 23 (FGF23) is a bone-derived endocrine regulator of phosphate homeostasis and has been considered as a potential therapeutic target for hypophosphatemic disorders.</column>
        </table>
        <table name="target">
            <column name="TargetID">1675</column>
            <column name="TargetName">Tumor necrosis factor ligand superfamily member 13</column>
            <column name="TargetSynonyms">A proliferation-inducing ligand, APRIL
TNF- and APOL-related leukocyte expressed ligand 2, TALL-2
TNF-related death ligand 1, TRDL-1
CD_antigen: CD256</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O75888</column>
            <column name="TargetStructure">4ZCH</column>
            <column name="TargetComments">A Proliferation-Inducing Ligand (APRIL) is a ligand in the tumor necrosis factor (TNF) superfamily that functions as a soluble factor. APRIL is primarily expressed by hematopoietic cells and has biological roles in B cell survival and T cell activation.</column>
        </table>
        <table name="target">
            <column name="TargetID">1676</column>
            <column name="TargetName">Extradomain-B fibronectin (EDB-FN)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Extradomain-B fibronectin (EDB-FN), one of the oncofetal fibronectin (onfFN) isoforms, is a high-molecular-weight glycoprotein that mediates cell adhesion and migration. The expression of EDB-FN is associated with a number of cancer-related biological processes such as tumorigenesis, angiogenesis, and epithelial-to-mesenchymal transition (EMT). The EDB fragment used in the experiment is a type-III homology repeat with a highly conserved sequence of 91 amino acids.</column>
        </table>
        <table name="target">
            <column name="TargetID">1677</column>
            <column name="TargetName">Esophageal squamous carcinoma cell Eca-109 </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1678</column>
            <column name="TargetName">Anti-aflatoxin monoclonal antibody 1C11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1679</column>
            <column name="TargetName">Anti-thiacloprid monoclonal antibody 3A5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1680</column>
            <column name="TargetName">Anti-GapC (1-150) mAb 1F2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1681</column>
            <column name="TargetName">His-tagged porcine reproductive and respiratory syndrome virus (PRRSV) nonstructuralprotein (nsp) 7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1682</column>
            <column name="TargetName">Cation-independent mannose-6-phosphate receptor</column>
            <column name="TargetSynonyms">Insulin-like growth factor II receptor, M6P/IGF2 receptor</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P11717</column>
            <column name="TargetStructure">1E6F, 1GP0, 1GP3, 1GQB, 1JPL, 1JWG, 1LF8, 2CNJ, 2L29, 2L2A, 2M68, 2M6T, 2V5N, 2V5O, 2V5P</column>
            <column name="TargetComments">IGF2R is a 300 kDa glycoprotein containing three domains, the cytoplasmic domain, transmembrane domain, and extracellular domain. The major function of IGF2R is to regulate lysosomal enzymes such as growth factor IGF2 by transporting them into lysosomes, followed by digestion by lysosomal acid hydrolases.</column>
        </table>
        <table name="target">
            <column name="TargetID">1683</column>
            <column name="TargetName">EC1 domain (EC187) of corticotropin-releasing factor receptor 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P34998 [20-106]</column>
            <column name="TargetStructure">2L27, 3EHS, 3EHT, 3EHU, 4K5Y</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1684</column>
            <column name="TargetName">Tocilizumab</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Tocilizumab is a humanized monoclonal antibody that specifically targets both soluble interleukin-6 receptor (sIL-6R) and membrane bound interleukin-6 receptor (mIL-6R) with a high affinity, thereby preventing pro-inflammatory effects of IL-6.</column>
        </table>
        <table name="target">
            <column name="TargetID">1685</column>
            <column name="TargetName">Imidacloprid hapten IMI</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1686</column>
            <column name="TargetName">Site-specifically biotinylated Complement C3 beta chain (C3b)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1687</column>
            <column name="TargetName">Type IV secretion system protein virB10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Brucella suis biovar 1 (strain 1330):204722</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9RPX5</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1688</column>
            <column name="TargetName">Magnesium fluoride (MgF2) particles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1689</column>
            <column name="TargetName">Anti-coagulation factor VIII monoclonal antibody (mAb) 2-76</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1690</column>
            <column name="TargetName">Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1691</column>
            <column name="TargetName">Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1692</column>
            <column name="TargetName">Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1693</column>
            <column name="TargetName">Anti-coagulation factor VIII polyclonal antibody IgG from haemophilia A patient 10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1694</column>
            <column name="TargetName">Anti-avian hepatitis E virus (HEV) capsid protein monoclonal antibody 3E8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1695</column>
            <column name="TargetName">Anti-avian hepatitis E virus (HEV) capsid protein monoclonal antibody 1B5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1696</column>
            <column name="TargetName">δ2 CDR3 peptide CACDVLGVNTDKLIFGKG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1697</column>
            <column name="TargetName">δ2 CDR3 peptide CACDTLGDRDYTDKLIFGKG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1698</column>
            <column name="TargetName">δ2 CDR3 peptide CACDTIGTGGHYTDKLIFGKG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1699</column>
            <column name="TargetName">δ2 CDR3 peptide CACDTLWGIQGNTDKLIFGKG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1700</column>
            <column name="TargetName">Biotinylated anti-lysozyme polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1701</column>
            <column name="TargetName">Biopolymer transport protein ExbD (43–141)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0ABV2 [43-141]</column>
            <column name="TargetStructure">2PFU</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1702</column>
            <column name="TargetName">Protein TonB (33-239)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli (strain K12):83333</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02929 [33-239]</column>
            <column name="TargetStructure">1IHR, 1QXX, 1U07, 1XX3, 2GRX, 2GSK</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1703</column>
            <column name="TargetName">Membrane protein (FXYD2)γa</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1704</column>
            <column name="TargetName">Recombinant S-AD (rS-AD) protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Porcine transmissible gastroenteritis coronavirus (strain Purdue) (TGEV):11151</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The spike (S) protein of porcine transmissible gastroenteritis virus (TGEV) is located within the viral envelope and is the only structural protein that possesses epitopes capable of inducing virus-neutralizing antibodies. Among the four N-terminal antigenic sites A, B, C, and D,
site A and to a lesser extent site D (S-AD) induce key neutralizing antibodies. Recently, S-AD (rSAD) in recombinant form was expressed by our group.</column>
        </table>
        <table name="target">
            <column name="TargetID">1705</column>
            <column name="TargetName">Plasmodium berghei female gametes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Plasmodium berghei:5821</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1706</column>
            <column name="TargetName">Anti-bovine herpesvirus type 1(BoHV-1) polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bos taurus (Bovine):9913</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1707</column>
            <column name="TargetName">Agrobacterium vitis polygalacturonase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Agrobacterium vitis (strain S4 / ATCC BAA-846) (Rhizobium vitis (strain S4)):311402</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">B9JUR9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1708</column>
            <column name="TargetName">TGF-β1 receptors onto peripheral blood mononuclear cells (PBMC) surface</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Peripheral blood mononuclear cells (PBMC) were obtained from twenty healthy volunteers using Ficoll-Paque PLUS (GE Healthcare).</column>
        </table>
        <table name="target">
            <column name="TargetID">1709</column>
            <column name="TargetName">Anti-dengue virus 2 monoclonal antibody DB21-6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1710</column>
            <column name="TargetName">Anti-dengue virus 2 monoclonal antibody DB39-2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1711</column>
            <column name="TargetName">Dengue virus serotype 2(DENV-2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Dengue virus 2:11060</column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1712</column>
            <column name="TargetName">BG1 ovarian cancer cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The ovarian cancer cell line BG1 (serous type) was obtained from Dr. Keng-Fu Hsu (Department of Obsterics and Gynecology, National Cheng Kung University, Taiwan).</column>
        </table>
        <table name="target">
            <column name="TargetID">1713</column>
            <column name="TargetName">Kupffer cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1714</column>
            <column name="TargetName">Chromium(III)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1715</column>
            <column name="TargetName">Extracellular domains(ECD) of epidermal growth factor receptor(EGFR)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P00533 [1-645]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1716</column>
            <column name="TargetName">IgG from Alzheimer’s disease (AD) patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1717</column>
            <column name="TargetName">Anti-avian influenza virus nonstructural protein 1 MAb D9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1718</column>
            <column name="TargetName">Cholera toxin B protein, CTB</column>
            <column name="TargetSynonyms">Cholera toxin B subunit, Cholera toxin beta subunit</column>
            <column name="TargetSource">Vibrio cholerae:666</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1719</column>
            <column name="TargetName">Ovarian cancer A2780 cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1720</column>
            <column name="TargetName">Histiocytic lymphoma cell line U937</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">U937 cell line was purchased from American Type Culture Collection.</column>
        </table>
        <table name="target">
            <column name="TargetID">1721</column>
            <column name="TargetName">Anti-immunodominant region of the PEDV Spike protein (S1) monoclonal antibody 5E12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1722</column>
            <column name="TargetName">Small cell lung cancer (SCLC) H446 cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">H446 cell was supplied by Cell Resource Center of Peking Union Medical College and grown in RPMI 1640 with 10% FBS.</column>
        </table>
        <table name="target">
            <column name="TargetID">1723</column>
            <column name="TargetName">Caprine umbilical vein endothelial cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Capra hircus (Goat):9925</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Caprine umbilical vein endothelial cell(CUVEC) were isolated from goat umbilical cords.</column>
        </table>
        <table name="target">
            <column name="TargetID">1724</column>
            <column name="TargetName">Amino acid sequence FDYSEPGNFSDISWPCNSSD from ACKR3/CXCR7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1725</column>
            <column name="TargetName">Beta-tri calcium phosphate</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Scaffolds were fabricated at Integra Life Sciences (Plainsboro, NJ, USA) from beta-tri calcium phosphate using the TheriForm 3D rapid prototyping platform.</column>
        </table>
        <table name="target">
            <column name="TargetID">1726</column>
            <column name="TargetName">The composite of beta-tri calcium phosphate and polylactide-co-glycolide (PLGA)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Scaffolds were fabricated at Integra Life Sciences (Plainsboro, NJ, USA) from a composite of beta-tri calcium phosphate and polylactide-co-glycolide (PLGA) using the TheriForm 3D rapid prototyping platform.</column>
        </table>
        <table name="target">
            <column name="TargetID">1727</column>
            <column name="TargetName">Anti-vibrio cholerae O1 Ogawa monoclonal antibody IXiao3G6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1728</column>
            <column name="TargetName">Anti-S1 subunit of IBV Sczy3 monoclonal antibody 1D5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1729</column>
            <column name="TargetName">Anti-S1 subunit of IBV Sczy3 monoclonal antibody 6A12</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1730</column>
            <column name="TargetName">Anti-NS3 monoclonal antibody 3B1C4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1731</column>
            <column name="TargetName">Serum immunoglobulin (Ig) G antibodies from patients with SARS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1732</column>
            <column name="TargetName">Anti-burkholderia pseudomallei protease polyclonal antibody IgG</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus:9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1733</column>
            <column name="TargetName">Anti-LKM1 autoantibodies from hepatitis C–infected patient 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were obtained from patients (2 females and 1 male, average age: 63 ± 12 years) chronically infected by HCV 1a who were shown to be LKM1+ by indirect immunofluorescence using rat or human liver and kidney sections and by western blot against human liver microsomal fractions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1734</column>
            <column name="TargetName">Anti-LKM1 autoantibodies from hepatitis C–infected patient 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were obtained from patients (2 females and 1 male, average age: 63 ± 12 years) chronically infected by HCV 1a who were shown to be LKM1+ by indirect immunofluorescence using rat or human liver and kidney sections and by western blot against human liver microsomal fractions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1735</column>
            <column name="TargetName">Anti-LKM1 autoantibodies from hepatitis C–infected patient 3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sera were obtained from patients (2 females and 1 male, average age: 63 ± 12 years) chronically infected by HCV 1a who were shown to be LKM1+ by indirect immunofluorescence using rat or human liver and kidney sections and by western blot against human liver microsomal fractions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1736</column>
            <column name="TargetName">Duck hepatitis B virus polymerase (DHBVP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Duck hepatitis B virus (isolate brown Shanghai duck S5) (DHBV):10439</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1737</column>
            <column name="TargetName">Sheep intestinal lymph</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1738</column>
            <column name="TargetName">Cells from sheep lymph plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1739</column>
            <column name="TargetName">Epithelial layer overlaying Peyer’s Patches (PP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1740</column>
            <column name="TargetName">Anti-pkMSP-142 antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Anti-pkMSP-142 antibodies were obtained via immunization of mice with purified recombinant pkMSP-142.</column>
        </table>
        <table name="target">
            <column name="TargetID">1741</column>
            <column name="TargetName">Human soluble receptor for advanced glycation end products (sRAGE)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human soluble receptor for advanced glycation end products (sRAGE) were obtained from R&amp;D(R&amp;D, USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1742</column>
            <column name="TargetName">Anti-plant potyviruses capsid proteins (CPs) monoclonal antibody C4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1743</column>
            <column name="TargetName">Maltase-glucoamylase (MGAM)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1744</column>
            <column name="TargetName">Colorectal cancer cell(HCT-8)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1745</column>
            <column name="TargetName">Cancer stem cell(CSCs)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1746</column>
            <column name="TargetName">Human squalene synthase(hSQS)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P37268</column>
            <column name="TargetStructure">1EZF, 3ASX, 3LEE, 3Q2Z, 3V66, 3VJ8, 3VJ9, 3VJA, 3VJB, 3VJC, 3WC9, 3WCD, 3WCF, 3WCH, 3WCI, 3WCJ, 3WCL, 3WCM, 3WEF, 3WEG, 3WEH, 3WEI, 3WEJ, 3WEK, 3WSA</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1747</column>
            <column name="TargetName">Beta-lactamase 2 (EC:3.5.2.6)</column>
            <column name="TargetSynonyms">Beta-lactamase II, Cephalosporinase, Penicillinase</column>
            <column name="TargetSource">Bacillus cereus:1396</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P04190</column>
            <column name="TargetStructure">1BC2, 1BMC, 1BVT, 1DXK, 1MQO, 2BC2, 2BFK, 2BFL, 2BFZ, 2BG2, 2BG6, 2BG7, 2BG8, 2BGA, 2M5C, 2M5D, 2NXA, 2NYP, 2NZE, 2NZF, 2UYX, 3BC2, 3FCZ, 3I0V, 3I11, 3I13, 3I14, 3I15, 3KNR, 4NQ4, 4NQ6, 4NQ7, 4TYT</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1748</column>
            <column name="TargetName">Anti-DNA polyclonal antibody IgG1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1749</column>
            <column name="TargetName">Anti-DNA polyclonal antibody IgG2a</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1750</column>
            <column name="TargetName">Anti-DNA polyclonal antibody IgG2b</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1751</column>
            <column name="TargetName">Anti-DNA polyclonal antibody IgG3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1752</column>
            <column name="TargetName">Human ovarian cancer cell line HO8910</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The human ovarian cancer cell line, HO8910, was obtained from the Laboratory Animal Center, Sun-Yatsen University, Guangdong, China.</column>
        </table>
        <table name="target">
            <column name="TargetID">1753</column>
            <column name="TargetName">CD44v3-v10 glycoprotein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">CD44s was encoded by the standard exons (S1–S10). Between S5 and S6, variant exons (V3–V10) are spliced to form the variant protein isoforms, CD44v3-v10.</column>
        </table>
        <table name="target">
            <column name="TargetID">1754</column>
            <column name="TargetName">Immunoglobulin G (IgG) of Tuberculosis (TB) patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1755</column>
            <column name="TargetName">Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of cat 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Felis catus:9685</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Two cats and a dog received one milliliterof Canine Gonadotropin Releasing Factor Immunotherapeutic(Pfizer Animal Health, Exton, PA, USA) twice. GnRH antibody was purified from the sera of cat 1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1756</column>
            <column name="TargetName">Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of cat 2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Felis catus:9685</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Two cats and a dog received one milliliterof Canine Gonadotropin Releasing Factor Immunotherapeutic(Pfizer Animal Health, Exton, PA, USA) twice. GnRH antibody was purified from the sera of cat 2.</column>
        </table>
        <table name="target">
            <column name="TargetID">1757</column>
            <column name="TargetName">Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of dog</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Canis familiaris (dog):9615</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Two cats and a dog received one milliliterof Canine Gonadotropin Releasing Factor Immunotherapeutic(Pfizer Animal Health, Exton, PA, USA) twice. GnRH antibody was purified from the sera of dog.</column>
        </table>
        <table name="target">
            <column name="TargetID">1758</column>
            <column name="TargetName">Anti-Gonadotropin releasing hormone (GnRH) polyclonal antibody of rabbit</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1759</column>
            <column name="TargetName">FvTox1 protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">FvTox1 was expressed in an insect cell line and immobilized on a plate for screening the phage display library.</column>
        </table>
        <table name="target">
            <column name="TargetID">1760</column>
            <column name="TargetName">Anti-HBX monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1761</column>
            <column name="TargetName">Human KRAS-mutant colorectal cancer cell lines and tissues</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1762</column>
            <column name="TargetName">Purified IgG from serum of juvenile idiopathic arthritis (JIA) persistent oligoarticular subtype </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1763</column>
            <column name="TargetName">Purified IgG from serum of juvenile idiopathic arthritis (JIA) extended oligoarticular subtype</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1764</column>
            <column name="TargetName">Purified IgG from serum of juvenile idiopathic arthritis (JIA) polyarticular rheumatoid factor negative subtype</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1765</column>
            <column name="TargetName">Purified IgG from serum of juvenile idiopathic arthritis (JIA) polyarticular rheumatoid factor positive subtype </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1766</column>
            <column name="TargetName">Hemagglutinin-esterase (HE)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Infectious salmon anemia virus:652965</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q8V3U0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1767</column>
            <column name="TargetName">Fusion glycoprotein F0</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Infectious salmon anemia virus:652965</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q8V3T9</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1768</column>
            <column name="TargetName">Mucin-5AC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P98088</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MUC5AC is a large secreted glycoprotein belonging to a family of proteins called mucins with molecular weights ranging from 0.5 to 20 Mda.</column>
        </table>
        <table name="target">
            <column name="TargetID">1769</column>
            <column name="TargetName">Glycoprotein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Vesicular stomatitis Indiana virus (strain San Juan) (VSIV):11285</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P03522</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1770</column>
            <column name="TargetName">Milled wood lignins</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Milled wood lignins (MWLs) derived from a softwood, Japanese cedar (CMWLs) was used as biopanning target.</column>
        </table>
        <table name="target">
            <column name="TargetID">1771</column>
            <column name="TargetName">Fibronectin extradomain B, EDB</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human fibronectin extradomainB (EDB) is a validated tumor-specific biomarker that has been used in tumor imaging and therapy.</column>
        </table>
        <table name="target">
            <column name="TargetID">1772</column>
            <column name="TargetName">Fe3O4 nanoparticles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1773</column>
            <column name="TargetName">Anti-birch pollen HMW allergens monoclonal antibody BIP3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1774</column>
            <column name="TargetName">Nogo-66 receptor (NgR1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1775</column>
            <column name="TargetName">Glypican-3 (GPC3) protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">GPC3 is composed of a core protein and two heparansulfate chains and participates in a variety of pathways related to HCC.</column>
        </table>
        <table name="target">
            <column name="TargetID">1776</column>
            <column name="TargetName">Anti-OchratoxinA(OTA) monoclonal antibody 2A11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-OTA mAb 2A11 were prepared in author's laboratory.</column>
        </table>
        <table name="target">
            <column name="TargetID">1777</column>
            <column name="TargetName">α1β glycine receptor</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1778</column>
            <column name="TargetName">Leishmania major metacyclic parasite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">L. major (Zymodeme MON25; MHOM/TN/94/GLC94) isolated from skin lesions of patients with CL.</column>
        </table>
        <table name="target">
            <column name="TargetID">1779</column>
            <column name="TargetName">Heterotrimeric tRNA-dependent amidotransferase (GatCAB)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Helicobacter pylori (strain ATCC 700392 / 26695):85962</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1780</column>
            <column name="TargetName">Lipopolysaccharide, LPS</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Salmonella Typhimurium (Sigma, India)</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Lipopolysaccharide (LPS) of S. Typhimurium is a major surface exposed cell wall component of the outer membrane of bacteria and highly specific for a particular strain. LPS from S. Typhimurium (Sigma, India) was used as a target.</column>
        </table>
        <table name="target">
            <column name="TargetID">1781</column>
            <column name="TargetName">Endothelial cells (ECs) of ligated left carotid artery (LCA)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">We used the partial carotid ligation model of atherosclerosis, which develops disturbed flow rapidly inducing endothelial dysfunction and atherosclerosis (within 2 weeks) in the entire length of left carotid artery (LCA) while the contralateral non-ligated right carotid artery (RCA) in the same mouse exposed to normal laminar flow remains plaque free.</column>
        </table>
        <table name="target">
            <column name="TargetID">1782</column>
            <column name="TargetName">Endothelial cells (ECs) of non-ligated right carotid artery (RCA)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">We used the partial carotid ligation model of atherosclerosis, which develops disturbed flow rapidly inducing endothelial dysfunction and atherosclerosis (within 2 weeks) in the entire length of left carotid artery (LCA) while the contralateral non-ligated right carotid artery (RCA) in the same mouse exposed to normal laminar flow remains plaque free.</column>
        </table>
        <table name="target">
            <column name="TargetID">1783</column>
            <column name="TargetName">Serum from mice with traumatic brain injury (TBI)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Male C57BL/6 mice, 8–10 weeks old, were anesthetized with isoﬂurane (3% induction, 2.5% maintenance). The head was secured in a stereotaxic frame (David Kopf Instruments, CA), and following a midline scalp incision a 5 mm diameter craniotomy was conducted over the left parietal cortex. Cortical contusion was produced using a pneumatically driven impactor (Precision Systems and Instrumentation LLC, Fairfax Station, VA) with a 3 mm diameter rounded impactor tip, 1 mm impact depth, and a velocity of 3.5 m/s. Following injury, the craniotomy was sealed with dental cement and the scalp was sutured. Body temperature was maintained at 37◦C. Six hours following injury, animals were euthanized and blood was collected transcardially in a BD SST
tube, retained 30 min for clotting, and centrifuged at 1300 × g for 15 min. Aliquoted serum was stored at −80◦C. One aliquot of serum
(5 μl) from each of four injured animals was pooled and diluted in 1:100 in TBS. The target protein was glial fibrillary acidic protein (GFAP).</column>
        </table>
        <table name="target">
            <column name="TargetID">1784</column>
            <column name="TargetName">Helix 69 of Escherichia coli 23S rRNA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli</column>
            <column name="TargetType">Nucleic acids</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Helix 69 (H69) RNA(50-GGCCGWAACm3WAWAACGGUC-30)was custom synthesized at Dharmacon Research, Inc. (Lafayette, CO). The 3-methylpseudouridine (m3W) phosphoramidite was synthesized. H69 was biotinylated at the 50 end using an oligonucleotide biotin-labeling kit from Amersham GE Healthcare Life Sciences (Piscataway, NJ).</column>
        </table>
        <table name="target">
            <column name="TargetID">1785</column>
            <column name="TargetName">Anti-VP3 monoclonal antibody 4A6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mab 4A6 is specific for the VP3 protein of waterfowl parvovirus (WPV). VP3 is a major structural protein that induces neutralizing antibodies in the waterfowl.</column>
        </table>
        <table name="target">
            <column name="TargetID">1786</column>
            <column name="TargetName">Anti-gp90 monoclonal antibody A9E8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The mAb A9E8 is specific for the gp90 of avian reticuloendotheliosis-associated virus (REV-A). The gp90 protein is an important envelope glycoprotein, which is responsible for inducing protective antibody immune responses in animals.</column>
        </table>
        <table name="target">
            <column name="TargetID">1787</column>
            <column name="TargetName">Anti-VP1 monoclonal antibody 2D10</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1788</column>
            <column name="TargetName">Low affinity immunoglobulin gamma Fc region receptor III, IgG Fc receptor III</column>
            <column name="TargetSynonyms">Fc-gamma RIII
FcRIII
CD_antigen: CD16</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P08508</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1789</column>
            <column name="TargetName">Hemagglutinin-esterase, HE</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Infectious salmon anemia virus:55987</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">A0A0D3MN31</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Hemagglutinin-esterase (HE) is coded by genomic segment 6 and carries the receptor binding domain (hemagglutinin) and receptor destroying activity (esterase).</column>
        </table>
        <table name="target">
            <column name="TargetID">1790</column>
            <column name="TargetName">Fusion protein</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Infectious salmon anemia virus:55987</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">A0A0A0R8Q4</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Infectious salmon anemia virus (ISAV) fusion activity is related to a second membrane-bound protein, termed fusion protein (F) and coded by segment 5.</column>
        </table>
        <table name="target">
            <column name="TargetID">1791</column>
            <column name="TargetName">C-terminal half of aryl hydrocarbon receptor (AhR)</column>
            <column name="TargetSynonyms">Aryl hydrocarbon receptor alternative name(s):
Ah receptor
AhR
Class E basic helix-loop-helix protein 76
bHLHe76</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P35869 [516-848]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The N-terminal half of aryl hydrocarbon receptor (AHR) harbors the bHLH/PAS domain which is responsible for binding of DNA enhancer regions, HSP90, ligand, and ARNT. The transactivation domain where coactivators bind is located at the C-terminal half of AHR.</column>
        </table>
        <table name="target">
            <column name="TargetID">1792</column>
            <column name="TargetName">Neural stem/progenitor cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Primary neural stem and progenitor cells (NSPCs) were isolated from the lateral wall of lateral ventricles (SVZ) and hippocampus (HC) of 4-week-old C57/B6 mice (Charles River Lab., USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1793</column>
            <column name="TargetName">Granzyme-like I</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ictalurus punctatus (Channel catfish) (Silurus punctatus):7998</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q58J84</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1794</column>
            <column name="TargetName">Human non-muscle-invasive bladder cancer cell line BIU-87</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1795</column>
            <column name="TargetName">Human prostate cancer cell line PC3				</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1796</column>
            <column name="TargetName">Anti-GRA2 monoclonal antibody C3C5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1797</column>
            <column name="TargetName">Gastric cancer cell line SGC-7901</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1798</column>
            <column name="TargetName">Protein EaeB</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Escherichia coli O127:H6 (strain E2348/69 / EPEC):574521</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q05129</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The translocator EspB is a key virulence factor in the process of the attaching and effacing effect of enteropathogenic Escherichia coli (EPEC) and plays a critical role in the pathogenesis of the bacteria.</column>
        </table>
        <table name="target">
            <column name="TargetID">1799</column>
            <column name="TargetName">Human ovarian cancer cell line HO-8910</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1800</column>
            <column name="TargetName">Human blood-brain barrier (BBB) cellular model</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The human blood-brain barrier (BBB) cellular model was developed in Prof. Cecchelli’s laboratory and this model consists of a co-culture of human brain capillary endothelial cells derived from pluripotent stem cells and bovine pericytes on semi-permeable membranes of a transwell.</column>
        </table>
        <table name="target">
            <column name="TargetID">1801</column>
            <column name="TargetName">The envelope protein Ampho4070A</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1802</column>
            <column name="TargetName">The cell surface of multidrug resistant Listeria monocytogenes</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Listeria monocytogenes:1639</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1803</column>
            <column name="TargetName">Deinagkistrodon acutus venom</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Deinagkistrodon acutus:36307</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Lyophilized D. acutus venom was obtained from snake farms inYingtan, Jiangxi, China.</column>
        </table>
        <table name="target">
            <column name="TargetID">1804</column>
            <column name="TargetName">Mammary adenocarcinoma murine 4T1 cell line</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Mammary adenocarcinoma murine 4T1 cell line was kindly provided by Dr. João Nuno Moreira, from Centre for Neuroscience and Cell Biology(University of Coimbra, Portugal).</column>
        </table>
        <table name="target">
            <column name="TargetID">1805</column>
            <column name="TargetName">Traumatic brain injury (TBI)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1806</column>
            <column name="TargetName">Anti-Salmonella Typhimurium polyclonal antibody IgY</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1807</column>
            <column name="TargetName">Staphylococcus aureus biofilm</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Staphylococcus aureus：196620</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1808</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM023</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1809</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM025</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1810</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM031</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1811</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM040</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1812</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM040</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1813</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM041</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1814</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM043</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1815</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM043</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1816</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM045</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1817</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM045</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1818</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM046</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1819</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM046</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1820</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM047</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1821</column>
            <column name="TargetName">Lambda fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM047</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1822</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM051</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1823</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM035</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1824</column>
            <column name="TargetName">Kappa fractions of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM077</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1825</column>
            <column name="TargetName">Kappa fractions mixture of polyclonal immunoglobulin G(IgG) of multiplemyeloma patient MM023 and MM031 and MM041</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1826</column>
            <column name="TargetName">Peptide nanotubes (PNTs)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1827</column>
            <column name="TargetName">Cellulose of paper</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1828</column>
            <column name="TargetName">The printed toner of standard office laser printers</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1829</column>
            <column name="TargetName">Recombinant human prostate-specific membrane antigen (PSMA) extracellular domain (ECD)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1830</column>
            <column name="TargetName">Anti-carbohydrate larval antigen (CarLA) mAb PAB1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries (Sheep):9940</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1831</column>
            <column name="TargetName">Tuberculosis (TB)-positive sera</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1832</column>
            <column name="TargetName">Tyrosinase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1833</column>
            <column name="TargetName">Interleukin-7 receptor subunit alpha, IL-7RA</column>
            <column name="TargetSynonyms">&quot;IL-7 receptor subunit alpha
IL-7R subunit alpha
IL-7R-alpha
CDw127
CD_antigen: CD127&quot;</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1834</column>
            <column name="TargetName">Glioma-initiating cell, GIC</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1835</column>
            <column name="TargetName">Fluorescent phosphor LaPO4:Ce3+,Tb3+ (LAP)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1836</column>
            <column name="TargetName">Anti-EGFR monoclonal antibody panitumumab</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1837</column>
            <column name="TargetName">Human β-Ⅻa</column>
            <column name="TargetSynonyms">Alternative names for coagulation factor XII (EC:3.4.21.38): Hageman factor HAF</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00748</column>
            <column name="TargetStructure">4BDW, 4BDX, 4XDE, 4XE4</column>
            <column name="TargetComments">Human β-FⅫa is a naturally occurring proteolytic product of coagulation factor Ⅻa (FⅫa) comprising only the catalytic domain.</column>
        </table>
        <table name="target">
            <column name="TargetID">1838</column>
            <column name="TargetName">Anti-E protein monoclonal antibody (mAb) 3B6</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1839</column>
            <column name="TargetName">Outer membrane protein U, OmpU</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Vibrio mimicus</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1840</column>
            <column name="TargetName">Anti-E protein monoclonal antibody (mAb) 1F3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1841</column>
            <column name="TargetName">Anti-E protein monoclonal antibody (mAb) 1A5</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1842</column>
            <column name="TargetName">Phospholipid hydroperoxidase glutathione peroxidase (GPX4) mutant, GPX4mu</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target is biotinylated Avi-tagged phospholipid hydroperoxidase glutathione peroxidase (GPX4) possessing seven mutations (GPX4mu). The seven mutations are Sec73Cys, Cys37Ala, Cys93Arg, Cys134Glu, Cys175Val, Cys64Ser, Cys102Ser. In addition, the GPX4mu had a SUMO-tag in its N-terminus.</column>
        </table>
        <table name="target">
            <column name="TargetID">1843</column>
            <column name="TargetName">Cryptococcus neoformans H99</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1844</column>
            <column name="TargetName">IgGs of horse immunized by the crude venom of the Hemiscorpius lepturus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Equus caballus (horse):9796</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The target is IgGs purified from the sera of horses immunized by the venom of theHemiscorpius lepturus.</column>
        </table>
        <table name="target">
            <column name="TargetID">1845</column>
            <column name="TargetName">BTB domain of B cell lymphoma 6(5-129)</column>
            <column name="TargetSynonyms">Alternative names for B-cell lymphoma 6 protein:
BCL-6, B-cell lymphoma 5 protein, BCL-5,
Protein LAZ-3, Zinc finger and BTB domain-containing, protein 27, Zinc finger protein 51.</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P41182</column>
            <column name="TargetStructure">1R28, 1R29, 1R2B, 2EN2, 2EOS, 2LCE, 2YRM, 3BIM, 3E4U, 3LBZ, 4CP3, 4U2M</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1846</column>
            <column name="TargetName">Anti-rVMH-HD polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1847</column>
            <column name="TargetName">Enargite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1848</column>
            <column name="TargetName">Chalcopyrite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1849</column>
            <column name="TargetName">Prominin-1</column>
            <column name="TargetSynonyms">Antigen AC133
Prominin-like protein 1
CD_antigen: CD133</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">O43490</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1850</column>
            <column name="TargetName">TiO2 nanoparticles</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1851</column>
            <column name="TargetName">The LMP1 C-terminus region</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Epstein-Barr virus (EBV) is a ubiquitous human herpes virus. The Latent Membrane Protein 1 (LMP1) has been reported as the main transforming oncoprotein of this virus. LMP1 is a trans-membranous protein containing three domains: a short cytoplasmic N-terminus, six trans-membrane spanning regions, and a large cytoplasmic C-terminus tail.</column>
        </table>
        <table name="target">
            <column name="TargetID">1852</column>
            <column name="TargetName">Pentaerythritol trinitrate  hemisuccinate(PETNH)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Organic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1853</column>
            <column name="TargetName">The FGFR1c/KLB complex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Fibroblast growth factor receptor-1c (FGFR1c)/βKlotho (KLB) complex is a receptor of fibroblast growth factor 21 (FGF21).</column>
        </table>
        <table name="target">
            <column name="TargetID">1854</column>
            <column name="TargetName">Tumor necrosis factor-α(TNF-α)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1855</column>
            <column name="TargetName">The heteroternary complex with methyl viologen and cucurbit[8]uril(MV·CB[8])</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1856</column>
            <column name="TargetName">The acid–alkali treated titanium</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1857</column>
            <column name="TargetName">The fifth fragment of plasminogen Plasmin light chain B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P00747 [581–810]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Plasminogen was cleaved into the following 5 chains: plasmin heavy chain A, activation peptide, angiostatin, plasmin heavy chain A, short form, plasmin light chain B.</column>
        </table>
        <table name="target">
            <column name="TargetID">1858</column>
            <column name="TargetName">Coxsackievirus A9 lacking the RGD motif (CV-A9-RGDdel)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Virus</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1859</column>
            <column name="TargetName">Anti-LPS single-domain antibody fragment VHH</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Camelus dromedarius (Dromedary) (Arabian camel):9838</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1860</column>
            <column name="TargetName">Ocular tissues </column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1861</column>
            <column name="TargetName">Tetragonal Barium Titanate (BaTiO3 or BT) Nanocrystals</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1862</column>
            <column name="TargetName">Anti-OPs monoclonal antibody mAb3C9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1863</column>
            <column name="TargetName">Anti-TIM polyclonal antibody (pAb)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1864</column>
            <column name="TargetName">Anti-Dengue virus (DENV) polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">P00748</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1865</column>
            <column name="TargetName">NIST RM8670 (NISTmAb)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unkown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1866</column>
            <column name="TargetName">GST-N1-Src SH3 domain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unkown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1867</column>
            <column name="TargetName">Kelch-like ECH-associated protein 1</column>
            <column name="TargetSynonyms">Cytosolic inhibitor of Nrf2, INrf2,
Kelch-like protein 19</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">Q14145</column>
            <column name="TargetStructure">1U6D, 1ZGK, 2FLU, 3VNG, 3VNH, 3ZGC, 3ZGD, 4CXI, 4CXJ, 4CXT, 4IFJ, 4IFL, 4IFN, 4IN4, 4IQK, 4L7B, 4L7C, 4L7D, 4N1B, 4XMB, 5DAD, 5DAF, 5F72</column>
            <column name="TargetComments">Keap1 is increasingly recognized as an attractive target for treating diseases involving oxidative stress, including cancer, atherosclerosis, diabetes, arthritis, and neurodegeneration.</column>
        </table>
        <table name="target">
            <column name="TargetID">1868</column>
            <column name="TargetName">Toll-like receptor-4 (TLR4) and myeloid differentiation factor 2 (MD2) complex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1869</column>
            <column name="TargetName">Toll-like receptor-4 (TLR4) and myeloid differentiation factor 2 (MD2) complex</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1870</column>
            <column name="TargetName">Anti-E. rhusiopathiae polyclonal antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Erysipelothrix rhusiopathiae(ERYRF):650150</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1871</column>
            <column name="TargetName">Anti-E. rhusiopathiae polyclonal antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Erysipelothrix rhusiopathiae(ERYRF):650150</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1872</column>
            <column name="TargetName">Serum antibodies</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1873</column>
            <column name="TargetName">BDNF/NT-3 growth factors receptor (EC:2.7.10.1)</column>
            <column name="TargetSynonyms">GP145-TrkB, Trk-B
Neurotrophic tyrosine kinase receptor type 2
TrkB tyrosine kinase
Tropomyosin-related kinase B</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q16620</column>
            <column name="TargetStructure">1HCF, 1WWB, 2MFQ, 4ASZ, 4AT3, 4AT4, 4AT5</column>
            <column name="TargetComments">Protein constructs of the extracellular domain of human tropomyosin-related kinase B (Met1-His430) fused to the Fc portion of immunoglobulin G (TrkB-Fc) were produced internally, using a proprietary vector and expression in FreeStyle 293 cells.</column>
        </table>
        <table name="target">
            <column name="TargetID">1874</column>
            <column name="TargetName">Lactotransferrin (EC:3.4.21.-), Lactoferrin</column>
            <column name="TargetSynonyms">Growth-inhibiting protein 12 Talalactoferrin</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02788</column>
            <column name="TargetStructure">1B0L, 1BKA, 1CB6, 1DSN, 1EH3, 1FCK, 1H43, 1H44, 1H45, 1HSE, 1L5T, 1LCF, 1LCT, 1LFG, 1LFH, 1LFI, 1LGB, 1N76, 1SQY, 1U62, 1VFD, 1VFE, 1XV4, 1XV7, 1Z6V, 1Z6W, 2BJJ, 2DP4, 2GMC, 2GMD, 2HD4, 2PMS</column>
            <column name="TargetComments">Lactoferrin (LF) is an iron-binding secretory protein, which is distributed in the secondary granules of polynuclear lymphocytes as well as in the milk  produced by female mammals.</column>
        </table>
        <table name="target">
            <column name="TargetID">1875</column>
            <column name="TargetName">ATG8</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1876</column>
            <column name="TargetName">Serum of soy allergic patients</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1877</column>
            <column name="TargetName">Dedicator of cytokinesis 2 (DOCK2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1878</column>
            <column name="TargetName">Viral protein 1 and 2 (VP1 and VP2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Norwalk virus (strain GI/Human/United States/Norwalk/1968) (Hu/NV/NV/1968/US):524364</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q83884</column>
            <column name="TargetStructure">1IHM,2ZL5,2ZL6,2ZL7,3BY1,3BY2,3D26,5KW9</column>
            <column name="TargetComments">Recombinant GI.1 virus-like particles (VLPs) were generated through the use of a baculovirus expression system. Specifically, VP1 and VP2 capsid proteins were expressed in Sf9 insect cells, and purified through a cesium chloride gradient.</column>
        </table>
        <table name="target">
            <column name="TargetID">1879</column>
            <column name="TargetName">Recombinant V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (K-Ras) with G12D substitution</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1880</column>
            <column name="TargetName">Anti-TIM polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit): 9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1881</column>
            <column name="TargetName">Anti-PRRSV monoclonal antibody A1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The purified porcine reproductive and respiratory syndrome virus (PRRSV) antigen was resuspended in PBS and stored at − 80 °C. BALB/c mice (n = 10) were intraperitoneally injected twice (on day 1 and 14) with 20 μg of purified PRRSV antigens (JS07). Finally, the mAbs in the ascitic fluids were purified by saturated ammonium sulphate precipitation and Protein-G chromatography (GE Healthcare).</column>
        </table>
        <table name="target">
            <column name="TargetID">1882</column>
            <column name="TargetName">Anti-PRRSV monoclonal antibody A2</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The purified porcine reproductive and respiratory syndrome virus (PRRSV) antigen was resuspended in PBS and stored at − 80 °C. BALB/c mice (n = 10) were intraperitoneally injected twice (on day 1 and 14) with 20 μg of purified PRRSV antigens (JS07). Finally, the mAbs in the ascitic fluids were purified by saturated ammonium sulphate precipitation and Protein-G chromatography (GE Healthcare).</column>
        </table>
        <table name="target">
            <column name="TargetID">1883</column>
            <column name="TargetName">Anti-PRRSV monoclonal antibody A7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The purified porcine reproductive and respiratory syndrome virus (PRRSV) antigen was resuspended in PBS and stored at − 80 °C. BALB/c mice (n = 10) were intraperitoneally injected twice (on day 1 and 14) with 20 μg of purified PRRSV antigens (JS07). Finally, the mAbs in the ascitic fluids were purified by saturated ammonium sulphate precipitation and Protein-G chromatography (GE Healthcare).</column>
        </table>
        <table name="target">
            <column name="TargetID">1884</column>
            <column name="TargetName">Metacaspase, MCA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Leishmania amazonensis</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">B6DU80</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1885</column>
            <column name="TargetName">Protein-glutamine gamma-glutamyltransferase K</column>
            <column name="TargetSynonyms">Epidermal TGase
Transglutaminase K
TG(K)
TGK
TGase K
Transglutaminase-1
TGase-1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P22735</column>
            <column name="TargetStructure">2XZZ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1886</column>
            <column name="TargetName">Sera of peanut allergic patient 1</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1887</column>
            <column name="TargetName">Sera of peanut allergic patient 2</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1888</column>
            <column name="TargetName">Sera of peanut allergic patient 3</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1889</column>
            <column name="TargetName">Sera of peanut allergic patient 4</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1890</column>
            <column name="TargetName">Plasma of peanut allergic patient 1</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">The patient plasma samples were obtained about 9 years after the patient sera samples.</column>
        </table>
        <table name="target">
            <column name="TargetID">1891</column>
            <column name="TargetName">Plasma of peanut allergic patient 4</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">The patient plasma samples were obtained about 9 years after the patient sera samples.</column>
        </table>
        <table name="target">
            <column name="TargetID">1892</column>
            <column name="TargetName">Sera of peanut-tolerant subject 1</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1893</column>
            <column name="TargetName">Sera of peanut-tolerant subject 2</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1894</column>
            <column name="TargetName">Sera of peanut-tolerant subject 3</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1895</column>
            <column name="TargetName">Sera of peanut-tolerant subject 4</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1896</column>
            <column name="TargetName">Plasma of peanut-tolerant subject 2</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1897</column>
            <column name="TargetName">Plasma of peanut-tolerant subject 3</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments"></column>
        </table>
        <table name="target">
            <column name="TargetID">1898</column>
            <column name="TargetName">Progenitor stem cell line KS483 at 4 days of differentiation</column>
            <column name="TargetSynonyms"></column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence"></column>
            <column name="TargetStructure"></column>
            <column name="TargetComments">A murine mesenchymal progenitor stem cell line (KS483, Percuros,Enschede, The Netherlands) was cultured into osteoblasts in a-MEM (minimum essential medium, 1 ) with GlutaMAX supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (all from Gibco, Breda, The Netherlands) under 5% CO2. For differentiation, KS483 cells were seeded at a density of 15,000 cells/cm2 in an 8.6-cm Petri dish.</column>
        </table>
        <table name="target">
            <column name="TargetID">1899</column>
            <column name="TargetName">Progenitor stem cell line KS483 at 8 days of differentiation</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A murine mesenchymal progenitor stem cell line (KS483, Percuros,Enschede, The Netherlands) was cultured into osteoblasts in a-MEM (minimum essential medium, 1 ) with GlutaMAX supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (all from Gibco, Breda, The Netherlands) under 5% CO2. For differentiation, KS483 cells were seeded at a density of 15,000 cells/cm2 in an 8.6-cm Petri dish.</column>
        </table>
        <table name="target">
            <column name="TargetID">1900</column>
            <column name="TargetName">IL-4-polarized M2 macrophage</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1901</column>
            <column name="TargetName">Mycobacterium tuberculosis △leucineD and △panthothenateCD double auxotroph, △leu/△pan</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1902</column>
            <column name="TargetName">Sortase A from S. aureus (SrtA)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1903</column>
            <column name="TargetName">Neuraminidase</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Influenza A virus (A/California/05/2009(H1N1)):641807</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">C3W5V0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1904</column>
            <column name="TargetName">Eu2O3</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1905</column>
            <column name="TargetName">Annexin A2</column>
            <column name="TargetSynonyms">Annexin II
Annexin-2
Calpactin I heavy chain
Calpactin-1 heavy chain
Chromobindin-8
Lipocortin II
Placental anticoagulant protein IV
PAP-IV
Protein I
p36</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P07355</column>
            <column name="TargetStructure">1W7B,1XJL,2HYU,2HYV,2HYW,4DRW,4FTG,4HRH</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1906</column>
            <column name="TargetName">Human Hair</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1907</column>
            <column name="TargetName">Human bone marrow stromal cell (hBMSC)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Clonally derived human bone marrow stromal cells (hBMSC) were a generous gift from the NIH.</column>
        </table>
        <table name="target">
            <column name="TargetID">1908</column>
            <column name="TargetName">Enargite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1909</column>
            <column name="TargetName">Chalcopyrite</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1910</column>
            <column name="TargetName">LaPO4:Ce3+,Tb3+, LAP</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The rare earth mineral lanthanum phosphate doped with 27 mole percent cerium and 13 mole percent terbium (LAP) (Leuchtstoffwerk Breitungen GmbH) that is part of the fluorescent phosphors of CFL was used as the bio-panning target.</column>
        </table>
        <table name="target">
            <column name="TargetID">1911</column>
            <column name="TargetName">Particulate matter, PM</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Particulate matter (PM) is defined as fine solid or liquid matter suspended in the Earth’s atmosphere. Both natural and man-made sources contribute to airborne PM. Natural sources include smoke from forest fires and volcanic eruptions while man-made sources include automobile exhaust and smoke from power generation activities. PM is a complex mixture of elemental and organic carbon (EC and OC), inorganic compounds such as sulfates and nitrates, as well as metal compounds. Airborne PM is an important metric of air quality and amajor source of health concern in urban areas. Long-term exposure to fine PM with diameters of less than 2.5 mm is associated with increased risk of lung cancer and cardiovascular diseases, while short-term exposure is associated with cardiopulmonary diseases.</column>
        </table>
        <table name="target">
            <column name="TargetID">1912</column>
            <column name="TargetName">SECp43180</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The DNA encoding full-length SECp43 was amplified from pUC19-SECp43 (D. Su and D. Söll, Yale University) and subcloned into the PstI/HindIII sites of pETDuet-1 vector (Novagen), containing a Histag coding sequence; a tobacco etch virus (TEV) protease cleavage sequence was added by PCR. The pETDuet-1-SECp43180 construct contains a stop codon inserted by directed mutagenesis after amino acid 180. pETDuet-1-SECp43180 and pRARE (Novagen), required to express human tRNAs for codons not well translated in E. coli, were co-transformed into BL21(DE3) cells and grown under selection in ampicillin (100 μg/mL).</column>
        </table>
        <table name="target">
            <column name="TargetID">1913</column>
            <column name="TargetName">Major structural protein VP28</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">White spot syndrome virus:342409</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q4U3X7</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The recombinant VP28 (rVP28) protein of the white spot syndrome virus (WSSV) was chosen as the target protein. The rVP 28 was expressed in Escherichia coli GJ1158 by cloning the VP28 gene of WSSV into pRSET B expression vector.</column>
        </table>
        <table name="target">
            <column name="TargetID">1914</column>
            <column name="TargetName">Tumor vessels</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1915</column>
            <column name="TargetName">Anti-Fumonisins B1 monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The anti-fumonisin monoclonal antibody was purchased from BioTez (Berlin, Germany), which has specifity for Fumonisins B1 and B2.</column>
        </table>
        <table name="target">
            <column name="TargetID">1916</column>
            <column name="TargetName"> Polystyrene 96-well microtiter plate (polystyrene, PS)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The polystyrene 96-well microtiter plates were purchased from Corning, Inc. NY, USA. The real target is polystyrene.</column>
        </table>
        <table name="target">
            <column name="TargetID">1917</column>
            <column name="TargetName">T lymphocyte leukemia cell line Jurkat</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">T lymphocyte leukemia cell line Jurkat was purchased from the American Type Culture Collection (ATCC, VA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1918</column>
            <column name="TargetName">Nitrite reductase AniA</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Neisseria gonorrhoeae (strain ATCC 700825 / FA 1090)</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1919</column>
            <column name="TargetName">Gap junction alpha-5 protein</column>
            <column name="TargetSynonyms">Connexin-40
Cx40</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q01231</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Recombinant Cx40 (amino acids 231-358) was used as the bait protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">1920</column>
            <column name="TargetName">Anti-triosephosphate isomerase (TIM) polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Oryctolagus cuniculus (Rabbit):9986</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1921</column>
            <column name="TargetName">Human gastric cancer cell line MKN-45P</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MKN-45P human gastric cancer cells were isolated from parental MKN-45.3. Nude mice were intraperitoneally injected with 2e6 MKN-45P cells. For dual tumors, nude mice were simultaneously injected  intraperitoneally with 2e6 MKN-45P cells and subcutaneously with 2e5 MKN-45P cells in the right flank. The MKN-45P tumors were grown for 2 weeks.</column>
        </table>
        <table name="target">
            <column name="TargetID">1922</column>
            <column name="TargetName">Mouse colon adenocarcinoma cell line CT26</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">CT26 cell lines were purchased from American Type Culture Collection (CT.26 ATCC CLR-2638; ATCC, United Kingdom). Balb/c mice were intraperitoneally injected with 2e6 CT26 cells. The CT26 tumors were grown for 1 week.</column>
        </table>
        <table name="target">
            <column name="TargetID">1923</column>
            <column name="TargetName">Kidney</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1924</column>
            <column name="TargetName">Crohn disease (CD) inflamed mucosa</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1925</column>
            <column name="TargetName">Ulcerative colitis (UC) inflamed mucosa</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1926</column>
            <column name="TargetName">Normal colon mucosa of healthy volunteers</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1927</column>
            <column name="TargetName">Huamn large cell carcinoma (LCC) cell line H460</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human large cell carcinoma (LCC) cell line H460 was purchased from the American Type Culture Collection (ATCC) and authenticated by ATCC based on their DNA profiles, cytogenetic analyses, and isoenzymology.</column>
        </table>
        <table name="target">
            <column name="TargetID">1928</column>
            <column name="TargetName">Anti-HO-1 polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Heme oxygenase-1 (HO-1) is a transmembrane protein, which makes it difficult to obtain prokaryotic, soluble expression of active, full-length rat HO-1. For this reason, the △rHO-1 (recombinant rat HO-1) protein used in the present study was modified. The transmembrane domain of HO-1 was removed. Anti-△rHO-1 polyclonal antibodies were obtained from two rabbits immunized with purified △rHO-1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1929</column>
            <column name="TargetName">Human colorectal cancer cell line HT29</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Human colorectal adenocarcinoma cells  (HT29) were obtained from the American Type Culture Collection (ATCC). HT29 cells were cultured in McCoy’s medium (Gibco)  containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Invitrogen). These cells have the V600E BRAF point mutation found in sessile serrated adenoma (SSA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1930</column>
            <column name="TargetName">Human whole serum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1931</column>
            <column name="TargetName">Pancreatic secretory granule membrane major glycoprotein GP2</column>
            <column name="TargetSynonyms">Pancreatic zymogen granule membrane protein GP-2
ZAP75</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P55259</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1932</column>
            <column name="TargetName">Human IgG anti-HEV positive serum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1933</column>
            <column name="TargetName">T-cell antigen CD7</column>
            <column name="TargetSynonyms">GP40
T-cell leukemia antigen
T-cell surface antigen Leu-9
TP41
CD_antigen: CD7</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P09564</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1934</column>
            <column name="TargetName">His6-tag</column>
            <column name="TargetSynonyms">Polyhistidine-tag
Hexa histidine-tag
6xHis-tag</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A polyhistidine-tag is an amino acid motif in proteins that consists of at least six histidine (His) residues, often at the N- or C-terminus of the protein.</column>
        </table>
        <table name="target">
            <column name="TargetID">1935</column>
            <column name="TargetName">Gold nanocube</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1936</column>
            <column name="TargetName">Head and neck squamous cell carcinoma (HNSCC) cell line HNO97</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The phages were exposed alternatingly to HNO97 cells and HNO97 protein fractions (100 nmol/L) in 96-well plates for 1 hour.</column>
        </table>
        <table name="target">
            <column name="TargetID">1937</column>
            <column name="TargetName">The μ (mu) homology domain of suppressor of yeast profilin deletion</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Yeast：559292</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1938</column>
            <column name="TargetName">Cellular tumor antigen p53</column>
            <column name="TargetSynonyms">Antigen NY-CO-13
Phosphoprotein p53
Tumor suppressor p53</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P02340</column>
            <column name="TargetStructure">1A1U, 1AIE, 1C26, 1DT7, 1GZH, 1H26, 1HS5, 1JSP, 1KZY, 1MA3, 1OLG, 1OLH, 1PES, 1PET, 1SAE, 1SAF, 1SAK, 1SAL, 1TSR, 1TUP, 1UOL, 1XQH, 1YC5, 1YCQ, 1YCR, 1YCS, 2AC0, 2ADY, 2AHI, 2ATA, 2B3G, 2BIM, 2BIN, 2BIO, 2BIP, 2BIQ, 2F1X, 2FEJ, 2FOJ, 2FOO, 2GS0, 2H1L 92-292 [»], 2H2D, 2H2F, 2H4F, 2H4H, 2H4J, 2H59, 2J0Z, 2J10, 2J11, 2J1W, 2J1X, 2J1Y, 2J1Z, 2J20, 2J21, 2K8F, 2L14, 2LY4, 2MEJ, 2MWO, 2MWP, 2MWY, 2MZD, 2OCJ, 2PCX, 2RUK, 2VUK, 2WGX, 2X0U, 2X0V, 2X0W, 2XWR, 2YBG, 2YDR, 2Z5S, 2Z5T, 3D05, 3D06, 3D07, 3D08, 3D09, 3D0A, 3DAB, 3DAC, 3IGK, 3IGL, 3KMD, 3KZ8, 3LW1, 3OQ5, 3PDH, 3Q01, 3Q05, 3Q06, 3SAK, 3TG5, 3TS8, 3ZME, 4AGL, 4AGM, 4AGN, 4AGO, 4AGP, 4AGQ, 4BUZ, 4BV2, 4HFZ, 4HJE, 4IBQ, 4IBS, 4IBT, 4IBU, 4IBV, 4IBW, 4IBY, 4IBZ, 4IJT, 4KVP, 4LO9, 4LOE, 4LOF, 4MZI, 4MZR, 4QO1, 4RP6, 4RP7, 4X34, 4XR8, 4ZZJ, 5A7B, 5AB9, 5ABA, 5AOI, 5AOJ, 5AOK, 5AOL, 5AOM, 5BUA, 5ECG, 5G4M, 5G4N, 5G4O, 5HOU, 5HP0, 5HPD, 5LAP, 5LGY, 5UN8</column>
            <column name="TargetComments">pGEX-4T-3 vector (Invitrogen) was used to clone the human-p53 coding DNA (cDNA) into the EcoRI site under the tac promoter, inducible by Isopropyl β-D-1thiogalactopyranoside (IPTG). The p53 coding sequence was thus fused downstream the GST.</column>
        </table>
        <table name="target">
            <column name="TargetID">1939</column>
            <column name="TargetName">Anti-FMDV monoclonal antibody 6C9</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1940</column>
            <column name="TargetName">Tumor necrosis factor receptor superfamily member 12A</column>
            <column name="TargetSynonyms">Fibroblast growth factor-inducible immediate-early response protein 14, FGF-inducible 14
Tweak-receptor, TweakR
CD_antigen: CD266</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q9NP84</column>
            <column name="TargetStructure">2EQP, 2KMZ, 2RPJ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1941</column>
            <column name="TargetName">The middle ear</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat): 10116</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1942</column>
            <column name="TargetName">CTP synthase 1</column>
            <column name="TargetSynonyms">CTP synthetase 1
UTP--ammonia ligase 1</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P17812</column>
            <column name="TargetStructure">2VO1,5U03</column>
            <column name="TargetComments">CTP synthase 1 (CTPS1) is an enzyme expressed in activated lymphocytes that catalyzes the conversion of uridine triphosphate (UTP) to cytidine triphosphate (CTP) with ATP-dependent amination.</column>
        </table>
        <table name="target">
            <column name="TargetID">1943</column>
            <column name="TargetName">Cholera toxin subunit B, CTX-B</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Vibrio cholerae:666</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1944</column>
            <column name="TargetName">Chicken egg yolk immunoglobulin, IgY</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Gallus gallus (Chicken):9031</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1945</column>
            <column name="TargetName">The extracellular portion of tumor necrosis factor receptor superfamily member 10B</column>
            <column name="TargetSynonyms">Alternative name(s) for tumor necrosis factor receptor superfamily member 10B:
Death receptor 5
MK
CD_antigen: CD262</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q9QZM4 [53-180]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A commercially available nucleotide sequence of the DR5 (DR5-Origen) was used to create a vector containing an extracellular portion of the death receptor fused to the mouse antibody Fc domain (pFUSE-DR5-Fcm). HEK293F line cells were transfected with the genetic construct pFUSE-DR5-Fcm by lipofection with 293fectin (Invitrogen). In 5 days, the produced recombinant protein was purified by affinity chromatography on a Protein G chromatographic column (Thermo Fisher Scientific). The homogeneity of the purified samples was evaluated by electrophoresis.</column>
        </table>
        <table name="target">
            <column name="TargetID">1946</column>
            <column name="TargetName">The extracellular domain of receptor tyrosine-protein kinase erbB-3</column>
            <column name="TargetSynonyms">Alternative name(s) for receptor tyrosine-protein kinase erbB-3:
Proto-oncogene-like protein c-ErbB-3
Tyrosine kinase-type cell surface receptor HER3</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P21860 [20-642]</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1947</column>
            <column name="TargetName">Mouse melanoma carcinoma cell line B16</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1948</column>
            <column name="TargetName">Anti-VP2 monoclonal antibody 3G11</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1949</column>
            <column name="TargetName">Human pancreatic ductal carcinoma cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1950</column>
            <column name="TargetName">Refolded apical merozoite antigen 1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Plasmodium vivax (strain Salvador I):126793</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">DNA from a clinical specimen with PCR-confirmed P.vivax infection was used as the template for recombinant protein expression study. Sequencing of the 18S ssurRNA clone confirmed that this isolate belongs to the P.vivax strain Sal-1 (GenBank accession number: U03079). Protein refolding was performed by dialysis method using 3 ml Slide-A-Lyzer Dialysis Cassettes with 10 kDa MWCO (Pierces Thermo Scientific, Waltham, MA, USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1951</column>
            <column name="TargetName">Anti-imidaclothiz monoclonal antibody 1E7</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1952</column>
            <column name="TargetName">Macrophage-stimulating protein receptor, MSP receptor</column>
            <column name="TargetSynonyms">CDw136
Protein-tyrosine kinase 8
p185-Ron
CD_antigen: CD136</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q04912</column>
            <column name="TargetStructure">3PLS, 4FWW, 4QT8</column>
            <column name="TargetComments">Human recombinant RON (rhRON) protein was purchased from R&amp;D Systems (Minneapolis, MN).</column>
        </table>
        <table name="target">
            <column name="TargetID">1953</column>
            <column name="TargetName">PCSK9ΔP'</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The deleted α-helix version of PCSK9, called PCSK9ΔP'includes an engineered TEV (tobacco etch virus) protease cleavage site (deletion of residues Y166 and R167; insertion of ENLYFQS sequence between R165 and A168). The above procedure was performed and then purified protein was treated with TEV protease (100 µl at 2.5 mg/ml per 10 mg of protein) for 24 h at 4 °C using dialysis (Slidelyzer 10K, Thermo Scientific) versus 0.15 M NaCl, 50 mM Tris, pH 8.0, 10% glycerol and 3 mM reduced glutathione/ 0.3 mM oxidized glutathione. The repurified PCSK9ΔP'protein (Superdex 75 column) was homogenous and had the expected mass, consistent with the loss of the N-terminal sequence 153SIPWNLERITPPR165ENLYFQ (ENLYFQ is TEV cleavage sequence). The new N terminus of the PCSK9 catalytic domain was SA168 (the serine is from the TEV cleavage sequence), which was confirmed by N-terminal sequencing. Therefore, the PCSK9ΔP'construct is missing the first 15 residues of its native N-terminal sequence (153SIPWNLERITPPRYR167).</column>
        </table>
        <table name="target">
            <column name="TargetID">1954</column>
            <column name="TargetName">Immunoglobulins (Igs) of murine 5T33MM cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Igs were purified from the culture supernatants by using the Mab Trap™ antibody purification Kit [GE Healthcare, Little Chalfont, UK], according to the manufacturer’s instructions.</column>
        </table>
        <table name="target">
            <column name="TargetID">1955</column>
            <column name="TargetName">Human Colon cancer cell line COLO320HSR</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1956</column>
            <column name="TargetName">G-protein coupled receptor 55</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1957</column>
            <column name="TargetName">Anti-CD43 monoclonal antibody UN1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The IgG1 isotype UN1 mAb was produced and puriﬁed by MAbTrap Kit (GEHealthcare).</column>
        </table>
        <table name="target">
            <column name="TargetID">1958</column>
            <column name="TargetName">Human endothelial cells stimulated with vascular endothelial growth factor (VEGF)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1959</column>
            <column name="TargetName">Peptide KEQWFGNRWHEGYR</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Peptide KEQWFGNRWHEGYR encompassed a 14 amino acid of v6 domain of human CD44 protein, which was synthesized using an Advanced Chem Tech 396 multiple peptide synthesizer (Advanced ChemTech, Louisville, KY) using solid-phase Fmoc chemistry. A linker amino acid sequence of Gly-Ser-Gly (GSG) was inserted between the biotin and the NH2 terminus of the peptide to minimize any steric or chemical effects. Peptides were purified by reverse-phase highpressure liquid chromatography (RP-HPLC) on a C18 column (218TP54, Vydac, Hesparia, CA), lyophilized, and stored at -20 °C. Purity of the peptides was greater than 90% as assessed by HPLC. Identities of the peptides were confirmed by electrospray ionization mass spectrometry (Mass Consortium, San Diego, CA) at the Structure Core of University of Missouri, Columbia.</column>
        </table>
        <table name="target">
            <column name="TargetID">1960</column>
            <column name="TargetName">SH3 domain</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">To conduct a large-scale analysis of human SH3 domain binding specificities, we identified 320 SH3 domains within 219 human proteins from an InterPro scan of the Ensembl database. We cloned genes encoding the 320 SH3 domains fused to the C-terminus of glutathione S-transferase(GST). In a high-throughput manner, we expressed the GST-SH3 fusions in Escherichia coli and successfully purified 215 GST-SH3 domains as determined by the presence of bands of the correct size by SDS-PAGE.</column>
        </table>
        <table name="target">
            <column name="TargetID">1961</column>
            <column name="TargetName">Connective tissue growth factor (CTGF)</column>
            <column name="TargetSynonyms">CCN family member 2
Hypertrophic chondrocyte-specific protein 24
Protein FISP-12</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1962</column>
            <column name="TargetName">1-deoxy-D-xylulose-5-phosphate synthase</column>
            <column name="TargetSynonyms">1-deoxyxylulose-5-phosphate synthase
DXP synthase
DXPS</column>
            <column name="TargetSource">Deinococcus radiodurans</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1963</column>
            <column name="TargetName">Peritoneal macrophage of mouse bearing breast cell line 4T1</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Eight-week old Balb/c mice (Charles River, Wilmington, MA, USA) were injected in the mammary fat pad with 1.0e6 4T1 cells in PBS and grown for ten days.</column>
        </table>
        <table name="target">
            <column name="TargetID">1964</column>
            <column name="TargetName">Peritoneal macrophage of healthy mouse</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Eight-week old Balb/c mice (Charles River, Wilmington, MA, USA) were used for in vivo panning.</column>
        </table>
        <table name="target">
            <column name="TargetID">1965</column>
            <column name="TargetName">Mouse macrophage cell line Raw 267.4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1966</column>
            <column name="TargetName">bB2-crystallin fibrils</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1967</column>
            <column name="TargetName">Mouse heart</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1968</column>
            <column name="TargetName">The second extracellular loop (107-130) of C-C chemokine receptor type 9</column>
            <column name="TargetSynonyms">Alternative names for C-C chemokine receptor type 9 (CCR-9)
C-C CKR-9
CC-CKR-9
G-protein coupled receptor 28
GPR-9-6
CD_antigen: CDw199</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P51686</column>
            <column name="TargetStructure">5LWE</column>
            <column name="TargetComments">The second extracellular loop of CCR9 (AAADQWKFQTFMCKVVNSMYK; SBS Genetech Co., Ltd., Beijing, China) was the target molecule. </column>
        </table>
        <table name="target">
            <column name="TargetID">1969</column>
            <column name="TargetName">Mouse muscle</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1970</column>
            <column name="TargetName">Extracellular domain of Fibroblast growth factor receptor 2 [1-377]</column>
            <column name="TargetSynonyms">Alternative names for fibroblast growth factor receptor 2:
FGFR-2
K-sam
KGFR
Keratinocyte growth factor receptor
CD_antigen: CD332</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P21802</column>
            <column name="TargetStructure">1DJS, 1E0O, 1EV2, 1GJO, 1II4, 1IIL, 1NUN, 1OEC, 1WVZ, 2FDB, 2PSQ, 2PVF, 2PVY, 2PWL, 2PY3, 2PZ5, 2PZP, 2PZR, 2Q0B, 3B2T, 3CAF, 3CLY, 3CU1, 3DAR, 3EUU, 3OJ2, 3OJM, 3RI1, 4J23, 4J95, 4J96, 4J97, 4J98, 4J99, 4WV1, 5EG3, 5UGL, 5UGX, 5UHN, 5UI0</column>
            <column name="TargetComments">The recombinant extracellular domain (ECD) of fibroblast growth factor receptor 2 (FGFR-2c) consisted of 367 amino acids after removal of the signal peptide (#10824-H08H50, Sino Biological). </column>
        </table>
        <table name="target">
            <column name="TargetID">1971</column>
            <column name="TargetName">Domain 3332-3779 of prolow-density lipoprotein receptor-related protein 1</column>
            <column name="TargetSynonyms">Alternative name(s) for Prolow-density lipoprotein receptor-related protein 1:
LRP-1
Alpha-2-macroglobulin receptor1 Publication, A2MR
Apolipoprotein E receptor, APOER
CD_antigen: CD91</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q07954</column>
            <column name="TargetStructure">1CR8, 1D2L, 1J8E, 2FYJ, 2FYL, 2KNX, 2KNY</column>
            <column name="TargetComments">Human low-density lipoprotein receptor-related protein 1 (LRP1)-Fc (5395-L4) was purchased from R&amp;D Systems (Minneapolis, MN, USA).</column>
        </table>
        <table name="target">
            <column name="TargetID">1972</column>
            <column name="TargetName">Pesticidal crystal protein Cry1Ab</column>
            <column name="TargetSynonyms">130 kDa crystal protein
Crystaline entomocidal protoxin
Insecticidal delta-endotoxin CryIA(b)</column>
            <column name="TargetSource">Bacillus thuringiensis:1428</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P0A370</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Cry1Ab protein was obtained from Youlong Co., Ltd. (Shanghai, China).</column>
        </table>
        <table name="target">
            <column name="TargetID">1974</column>
            <column name="TargetName">EAE-CNS brain endothelial cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Experimental autoimmune encephalomyelitis-Inflammatory central nervous system(EAE-CNS) cell. CNS cells were prepared from rat CNS. A rat with acute EAE (score 3) was deeply anesthetized and perfused with 50 mL ice-cold PBS 1×. The whole CNS tissues from both rats were recovered separately (about 2.3 g), cut into small pieces, and incubated for 50 min at 37 ℃.</column>
        </table>
        <table name="target">
            <column name="TargetID">1975</column>
            <column name="TargetName">Anti-S.aureus GapC monoclonal antibody(mAb2A9)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The S.aureus GapC protein in Escherichia coli. (E. coli) Recombinant GapC expressed by molecular cloning techniques was purified and used to immunize BALB/c mice to generate a specific monoclonal antibody (mAb2A9) using a cell hybridization technique.</column>
        </table>
        <table name="target">
            <column name="TargetID">1976</column>
            <column name="TargetName">Vibrio parahaemolyticus</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1977</column>
            <column name="TargetName">Immunoglobulin G(IgG) of patients with Rheumatoid arthritis-Secondary Sjögren’s syndrome(RA-sSS)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource"></column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A affinity-purified and dialyzed IgGs from ten patients with Rheumatoid arthritis-Secondary Sjögren’s syndrome(RA-sSS) for specific binding to peptides.</column>
        </table>
        <table name="target">
            <column name="TargetID">1978</column>
            <column name="TargetName">Thrombin from prothrombin[328-622]</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P00734</column>
            <column name="TargetStructure">1A2C,1A3B,1A3E,1A46,1A4W,1A5G,1A61,1ABI,1ABJ,1AD8,1AE8,1AFE,1AHT,1AI8,1AIX,1AWF,1AWH,1AY6,1B5G,1B7X,1BA8,1BB0,1BCU,1BHX,1BMM,1BMN,1BTH,1C1U,1C1V,1C1W,1C4U,1C4V,1C4Y,1C5L,1C5N,1C5O,1CA8,1D3D,1D3P,1D3Q,1D3T,1D4P,1D6W,1D9I,1DE7,1DIT,1DM4,1DOJ,1DWB,1DWC,1DWD,1DWE,1DX5,1E0F,1EB1,1EOJ,1EOL,1FPC,1FPH,1G30,1G32,1G37,1GHV,1GHW,1GHX,1GHY,1GJ4,1GJ5,1H8D,1H8I,1HAG,1HAH,1HAI,1HAO,1HAP,1HBT,1HDT,1HGT,1HLT,1HUT,1HXE,1HXF,1IHS,1IHT,1JMO,1JOU,1JWT,1K21,1K22,1KTS,1KTT,1LHC,1LHD,1LHE,1LHF,1LHG,1MH0,1MU6,1MU8,1MUE,1NM6,1NO9,1NRN,1NRO,1NRP,1NRQ,1NRR,1NRS,1NT1,1NU7,1NU9,1NY2,1NZQ,1O0D,1O2G,1O5G,1OOK,1OYT,1P8V,1PPB,1QBV,1QHR,1QJ1,1QJ6,1QJ7,1QUR,1RD3,1RIW,1SB1,1SFQ,1SG8,1SGI,1SHH,1SL3,1SR5,1T4U,1T4V,1TA2,1TA6,1TB6,1TBZ,1THP,1THR,1THS,1TMB,1TMT,1TMU,1TOM,1TQ0,1TQ7,1TWX,1UMA,1UVS,1VR1,1VZQ,1W7G,1WAY,1WBG,1XM1,1XMN,1YPE,1YPG,1YPJ,1YPK,1YPL,1YPM,1Z71,1Z8I,1Z8J,1ZGI,1ZGV,1ZRB,2A0Q,2A2X,2A45,2AFQ,2ANK,2ANM,2B5T,2BDY,2BVR,2BVS,2BVX,2BXT,2BXU,2C8W,2C8X,2C8Y,2C8Z,2C90,2C93,2CF8,2CF9,2CN0,2FEQ,2FES,2GDE,2GP9,2H9T,2HGT,2HNT,2HPP,2HPQ,2HWL,2JH0,2JH5,2JH6,2OD3,2PGB,2PGQ,2PKS,2PW8,2R2M,2THF,2UUF,2UUJ,2UUK,2V3H,2V3O,2ZC9,2ZDA,2ZDV,2ZF0,2ZFF,2ZFP,2ZFQ,2ZFR,2ZG0,2ZGB,2ZGX,2ZHE,2ZHF,2ZHQ,2ZHW,2ZI2,2ZIQ,2ZNK,2ZO3,3B23,3B9F,3BEF,3BEI,3BF6,3BIU,3BIV,3BV9,3C1K,3C27,3D49,3DA9,3DD2,3DHK,3DT0,3DUX,3E6P,3EE0,3EGK,3EQ0,3F68,3GIC,3GIS,3HAT,3HKJ,3HTC,3JZ1,3JZ2,3K65,3LDX,3LU9,3NXP,3P17,3P6Z,3P70,3PMH,3PO1,3QDZ,3QGN,3QLP,3QTO,3QTV,3QWC,3QX5,3R3G,3RLW,3RLY,3RM0,3RM2,3RML,3RMM,3RMN,3RMO,3S7H,3S7K,3SHA,3SHC,3SI3,3SI4,3SQE,3SQH,3SV2,3T5F,3TU7,3U69,3U8O,3U8R,3U8T,3U98,3U9A,3UTU,3UWJ,3VXE,3VXF,4AX9,4AYV,4AYY,4AZ2,4BAH,4BAK,4BAM,4BAN,4BAO,4BAQ,4BOH,4CH2,4CH8,4DIH,4DII,4DT7,4DY7,4E05,4E06,4E7R,4H6S,4H6T,4HFP,4HTC,4HZH,4I7Y,4LOY,4LXB,4LZ1,4LZ4,4MLF,4NZQ,4O03,4RKJ,4RKO,4RN6,4THN,4UD9,4UDW,4UE7,4UEH,4UFD,4UFE,4UFF,4UFG,4YES,5A2M,5AF9,5AFY,5AFZ,5AHG,5CMX,5DO4,5E8E,5EDK,5EDM,5EW1,5EW2,5GDS,5GIM,5JDU,5JFD,5JZY,5L6N,5MJT,5MLS,5MM6,5NHU,5TO3,6EO6,6EO7,6EO8,6EO9,7KME,8KME</column>
            <column name="TargetComments">Thrombin is a well-characterized serine protease, with known substrate recognition determinants. </column>
        </table>
        <table name="target">
            <column name="TargetID">1979</column>
            <column name="TargetName">A disintegrin and metalloproteinase with thrombospondin motifs 13(ADAM-TS 13)</column>
            <column name="TargetSynonyms">von Willebrand factor-cleaving protease(vWF-CP)</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q76LX8</column>
            <column name="TargetStructure">3GHM,3GHN,3VN4</column>
            <column name="TargetComments">VWF is currently the only known substrate for the metalloprotease ADAMTS13.</column>
        </table>
        <table name="target">
            <column name="TargetID">1980</column>
            <column name="TargetName">Cervical cancer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1981</column>
            <column name="TargetName">Insulin-degrading enzyme</column>
            <column name="TargetSynonyms">Abeta-degrading protease
Insulin protease(Insulinase)
Insulysin</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">P14735</column>
            <column name="TargetStructure">2G47,2G48,2G49,2G54,2G56,2JBU,2JG4,2WBY,2WC0,2WK3,2YPU,3CWW,3E4A,3E4Z,3E50,3H44,3HGZ,3N56,3N57,3OFI,3QZ2,4DTT,4DWK,4GS8,4GSC,4GSF,4IFH,4IOF,4LTE,4M1C,4NXO,4PES,4PF7,4PF9,4PFC,4Q5Z,4QIA,4RAL,4RE9,5CJO,5UOE,6B3Q,6B70,6B7Y,6B7Z,6BF6,6BF7,6BF9,6BFC</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1982</column>
            <column name="TargetName">MoS2</column>
            <column name="TargetSynonyms">molybdenite</column>
            <column name="TargetSource">None</column>
            <column name="TargetType">Inorganic molecules or materials</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1983</column>
            <column name="TargetName">glucagon receptor(GCGR-) and glucagon-like peptide-1 receptor(GLP1R-)overexpressing cells</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1984</column>
            <column name="TargetName">Avi-tagged interleukin-17A</column>
            <column name="TargetSynonyms">IL-17A
IL-17
CTLA-8
Cytotoxic T-lymphocyte-associated antigen 8</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">Q16552</column>
            <column name="TargetStructure">2VXS,4HR9,4HSA,4QHU,5HHV,5HHX,5HI3,5HI4,5HI5,5N92,5NAN,5VB9</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1985</column>
            <column name="TargetName">Anti-GapC monoclonal antibody (mAb) 1F4</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1986</column>
            <column name="TargetName">Glycoprotein G</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Bovine ephemeral fever virus (BEFV):11303</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">A0A1P8VHU0</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1987</column>
            <column name="TargetName">Anti-RhD monoclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Unknown</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1988</column>
            <column name="TargetName">Recombinant dengue virus type 2 NS1 protein(DENV2 NS1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Dengue virus 2:11060</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Dengue virus type 2 NS1 (DENV2 NS1) is a specific and sensitive protein biomarker for dengue fever diagnosis.</column>
        </table>
        <table name="target">
            <column name="TargetID">1989</column>
            <column name="TargetName">Astrocyte(AS1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The phages were amplified after screening against spinal cord in vivo first, and then the phage library was incubated with AS1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1990</column>
            <column name="TargetName">Proinflammatory microglia(MG1)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The phages were amplified after screening against spinal cord in vivo first, and then the phage library was incubated with MG1.</column>
        </table>
        <table name="target">
            <column name="TargetID">1991</column>
            <column name="TargetName">Antiinflammatory microglia(MG2)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">The phages were amplified after screening against spinal cord in vivo first, and then the phage library was incubated with MG2.</column>
        </table>
        <table name="target">
            <column name="TargetID">1992</column>
            <column name="TargetName">Acinetobacter baumannii cell</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Acinetobacter baumannii:710095</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">A. baumannii grown in human blood (blood biopanning).</column>
        </table>
        <table name="target">
            <column name="TargetID">1993</column>
            <column name="TargetName">CD63 protein fragment containing the second extracellular loop (CD63 LEL)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1994</column>
            <column name="TargetName">Folate receptor alpha</column>
            <column name="TargetSynonyms">Adult folate-binding protein
Short name:
FBP
Folate receptor 1
Folate receptor, adult
KB cells FBP
Ovarian tumor-associated antigen MOv18
FR-alpha</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Others</column>
            <column name="TargetSequence">P15328</column>
            <column name="TargetStructure">4KM6, 4KM7, 4KMX, 4LRH, 5TZQ</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1995</column>
            <column name="TargetName">Anti-Haemonchus contortus polyclonal antibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Ovis aries(sheep):9940</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Sheep polyclonal antibody against H. contortus</column>
        </table>
        <table name="target">
            <column name="TargetID">1996</column>
            <column name="TargetName">Anti-M. pneumoniae serum</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">1997</column>
            <column name="TargetName">Human gastric cancer cell line MKN-45</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Cell</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">MKN-45 human gastric cancer cells were obtained from American Type Culture Collection (ATCC).</column>
        </table>
        <table name="target">
            <column name="TargetID">1998</column>
            <column name="TargetName">human cathepsin G (hCG)</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Enzyme</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">hCG has previously been reported to have a dual specific ity consisting of chymase and tryptase-type activities. In this study, tryptase activity against substrates with Lys in P1 cleavage position was indeed only 2-fold less efficient as compared to optimal chymase substrates supporting strong dual-type specificity.</column>
        </table>
        <table name="target">
            <column name="TargetID">1999</column>
            <column name="TargetName">Anti-splicing factor 3b subunit 1(SF3B1) monoclonal antibody, XC24</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Mus musculus (Mouse):10090</column>
            <column name="TargetType">Protein&gt;Monoclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">XC24, an autoantibody secreted from one of our tumor model mouse B-cell clones, was the bait.</column>
        </table>
        <table name="target">
            <column name="TargetID">2000</column>
            <column name="TargetName">Anti-glomerular basement membrane (GBM) autoantibody</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Rattus norvegicus (Rat):10116</column>
            <column name="TargetType">Protein&gt;Polyclonal antibody</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">2001</column>
            <column name="TargetName">Platelet-rich plasma</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">2002</column>
            <column name="TargetName">CD177 antigen</column>
            <column name="TargetSynonyms">Human neutrophil alloantigen 2a, HNA-2a
NB1 glycoprotein, NB1 GP
Polycythemia rubra vera protein 1, PRV-1
CD_antigen: CD177</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">Q8N6Q3</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">2003</column>
            <column name="TargetName">Purified serum IgG from a year 1 patient with advancing prostate cancer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</column>
        </table>
        <table name="target">
            <column name="TargetID">2004</column>
            <column name="TargetName">Purified serum IgG from a year 5 patient with advancing prostate cancer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</column>
        </table>
        <table name="target">
            <column name="TargetID">2005</column>
            <column name="TargetName">Purified serum IgG from a year 7 patient with advancing prostate cancer</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Miscellaneous</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">Serum samples are from a patient with advancing prostate cancer,IgGs were purified from individual serum samples using protein G beads.</column>
        </table>
        <table name="target">
            <column name="TargetID">2006</column>
            <column name="TargetName">Fibroblast growth factor receptor 3, FGFR-3</column>
            <column name="TargetSynonyms">CD_antigen: CD333</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Protein&gt;Receptor</column>
            <column name="TargetSequence">P22607</column>
            <column name="TargetStructure">1RY7,2LZL,4K33</column>
            <column name="TargetComments">NULL</column>
        </table>
        <table name="target">
            <column name="TargetID">2007</column>
            <column name="TargetName">Human sural nerve tissue</column>
            <column name="TargetSynonyms">NULL</column>
            <column name="TargetSource">Homo sapiens (Human):9606</column>
            <column name="TargetType">Organ and tissue</column>
            <column name="TargetSequence">NULL</column>
            <column name="TargetStructure">NULL</column>
            <column name="TargetComments">NULL</column>
        </table>
    </database>
</pma_xml_export>